0001144204-13-063027.txt : 20131119 0001144204-13-063027.hdr.sgml : 20131119 20131119154626 ACCESSION NUMBER: 0001144204-13-063027 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 24 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131119 DATE AS OF CHANGE: 20131119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NaturalNano, Inc. CENTRAL INDEX KEY: 0000863895 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS PRODUCTS, NEC [3089] IRS NUMBER: 870646435 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-49901 FILM NUMBER: 131229935 BUSINESS ADDRESS: STREET 1: 15 SCHOEN PLACE CITY: PITTSFORD STATE: NY ZIP: 14534 BUSINESS PHONE: (585) 267-4850 MAIL ADDRESS: STREET 1: 15 SCHOEN PLACE CITY: PITTSFORD STATE: NY ZIP: 14534 FORMER COMPANY: FORMER CONFORMED NAME: NaturalNano , Inc. DATE OF NAME CHANGE: 20060127 FORMER COMPANY: FORMER CONFORMED NAME: NaturalNano Research, Inc DATE OF NAME CHANGE: 20051221 FORMER COMPANY: FORMER CONFORMED NAME: NATURALNANO INC DATE OF NAME CHANGE: 20051208 10-Q 1 v360860_10q.htm FORM 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the quarterly period ended :                                                                           September 30, 2013

 

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from                                                 to                                   

 

Commission File Number :                             000-49901  

 

NATURALNANO, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   87-0646435
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
763 Linden Ave  Rochester NY   14625
(Address of principal executive offices)   (Zip Code)

 

585-267-4848

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by checkmark if the registrant has submitted electronically and posted on its Website, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x     No   ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨   Accelerated filer ¨
Non-accelerated filer ¨   Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

420,329,246 as of November 15, 2013

 

 
 

  

Table of Contents

 

PART I—FINANCIAL INFORMATION    
  Item 1.   Financial Statements  (unaudited)    
    Consolidated Balance Sheets   3
    Consolidated Statements of Operations   4
    Consolidated Statement of Stockholders’ Deficiency   5
    Consolidated Statements of Cash Flows   6
    Notes to Consolidated Financial Statements   7
         
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   14
         
  Item 4.  Controls and Procedures   19
         
PART II—OTHER INFORMATION    
  Item 1. Legal Proceedings     21
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   21
  Item 3. Defaults Upon Senior Securities   21
  Item 4. Mine Safety Disclosures   23
  Item 5. Other Information   23
  Item 6. Exhibits   24
         
SIGNATURES   25

 

2
 

 

PART I—FINANCIAL INFORMATION

Item 1.  Financial Statements

NATURALNANO, INC.

CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2013   2012 
   (Unaudited)     
Assets        
Current assets:        
Cash  $10   $6,160 
Accounts receivable   25,706    5,400 
Inventory   13,251    19,480 
Prepaid expenses and other current assets   12,040    10,196 
Total current assets   51,007    41,236 
           
Total assets  $51,007   $41,236 
Liabilities and Stockholders' Deficiency          
Liabilities          
Current liabilities:          
Notes payable (See Note 2)  $4,042,965   $3,893,972 
Accounts payable   429,941    502,814 
Accrued expenses   100,289    96,343 
Accrued interest   656,769    444,131 
Accrued payroll   950,473    871,610 
Deferred revenue   100,000    100,000 
Registration rights liability (See Note 2)   82,489    82,489 
Derivative liability (see Note 4)   12,884    25,732 
Total current liabilities   6,375,810    6,017,091 
Total liabilities   6,375,810    6,017,091 
Preferred Stock - $.001 par value, 10 million shares authorized          
Series B - issued and outstanding  5,000 and 142,500 respectively with an
aggregate liquidation preference of $10 and $310, respectively
   872    14,111 
Series C - issued and outstanding  3,303,640 and 4,049,495  respectively with
an aggregate liquidation preference value of  $6,607 and $8,099,  respectively
   61,488    153,648 
           
Commitments and contingencies (See Note 7)   -    - 
Stockholder’s Deficiency          
Common Stock - $.001 par  value 800,000,000 authorized and  332,909,406
and 93,200,171 issued and outstanding, respectively
   332,909    93,200 
Series D – issued and outstanding 100 and 0 respectively with no liquidation rights   -    - 
Additional paid in capital   21,115,545    21,159,134 
Non-controlling interest in subsidiary   -    14,264 
Accumulated deficit   (27,835,617)   (27,410,212)
Total stockholders' deficiency   (6,387,163)   (6,143,614)
Total liabilities and stockholders' deficiency  $51,007   $41,236 

 

 

 

 

 

 

See notes to consolidated financial statements

 

3
 

 

NATURALNANO, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

   For the three months ended   For the nine months ended 
   September 30,   September 30, 
   2013   2012   2013   2012 
Income:                
Revenue  $18,674   $6,783   $141,992   $55,331 
Cost of goods sold   3,657    749    27,687    3,880 
Gross profit   15,017    6,034    114,305    51,451 
Operating expenses:                    
Research and development   14,031    21,377    41,623    90,084 
General and administrative   81,884    93,549    265,150    268,437 
    95,915    114,926    306,773    358,521 
(Loss) from operations   (80,898)   (108,892)   (192,468)   (307,070)
Other income (expense):                    
Interest expense, net   (93,208)   (87,149)   (274,758)   (295,650)
Net gain on derivative liability   89,536    534    12,848    534 
Net (loss) on forgiveness/modification
of debt
   -    (163,566)   (10,336)   (473,566)
Gain on dissolution of Combotexs   39,373    -    39,373    - 
    35,701    (250,181)   (232,873)   (768,682)
Net loss from continuing operations   (45,197)   (359,073)   (425,341)   (1,075,752)
                     
Net income from discontinued operations   -    6,457    11,115    17,477 
Loss on write-off of discontinued operation   -    -    (11,179)   - 
Consolidated net loss attributable controlling interest  $(45,197)  $(352,616)  $(425,405)  $(1,058,275)
                     
Less: Preferred Stock conversion inducement   -    -    -    (12,235)
Consolidated net loss attributable to common shareholders  $(45,197)  $(352,616)  $(425,405)  $(1,070,510)
                     
Continuing operations loss per common share – basic and diluted  $(0.00)  $(0.01)  $(0.00)  $(0.03)
Discontinued operations income (loss) per common share – basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
Weighted average shares outstanding   311,664,926    55,644,823    240,252,062    42,169,055 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See notes to consolidated financial statements 

 

4
 

 

NATURALNANO, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY

(unaudited)

 

                   Additional       Non-controlling     
   Common Stock   Preferred Stock   Paid-in   Accumulated   Interest   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   in Subsidiary   (Deficiency) 
                                 
Balance at December 31, 2012   93,200,171   $93,200    -   $-   $21,159,134   $(27,410,212)  $14,264   $(6,143,614)
Series B preferred converted to Common Stock and change in value   22,000,000    22,000              (21,716)             284 
Series C preferred converted to Common Stock and change in value   119,336,800    119,337              (14,225)             105,112 
Warrant issued for services                       8,721              8,721 
Shares issued on debt conversion   21,500,000    21,500              (1,587)             19,913 
Shares issued for interest payment   76,872,435    76,872              (14,782)             62,090 
Dissolution of Non-controlling interest                                 (14,264)   (14,264)
Issuance of Series D preferred shares             100    -                   - 
                                         
Net loss                            (425,405)        (425,405)
                                         
Balance at September 30, 2013   332,909,406   $332,909    100   $-   $21,115,545   $(27,835,617)  $-   $(6,387,163)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See notes to consolidated financial statements

 

5
 

  

NATURALNANO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

   For the nine months ended 
   September 30, 
   2013   2012 
Cash flows from operating activities:        
Net loss attributable to controlling interest  $(425,405)  $(1,058,275)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization        39,454 
Fair value adjustment of derivative liabilities   (12,848)   (534)
Issuance of stock for services        10,800 
Gain on dissolution of Combotexs    (39,373)   - 

Inducement to convert interest

   -    24,221 
Issuance of warrants for services   8,721    8,720 
Loss on forgiveness/modification of debt   10,336    473,566 
Changes in operating assets and liabilities:          
Decrease (increase) in accounts receivable   (20,306)   2,651 
Decrease (increase) in inventory   6,229    (4,282)
(Increase) in other current assets   (1,844)   (1,337)
Increase in accounts payable, accrued payroll and accrued expenses   329,434    404,284 
(Decrease) in other liability   -    (4,000)
Net cash used in operating activities   (145,056)   (104,732)
Cash flows from financing activities:          
Proceeds from senior secured Promissory Notes   138,906    103,000 
Net cash provided by financing activities   138,906    103,000 
(Decrease) in cash and cash equivalents   (6,150)   (1,732)
Cash at beginning of period   6,160    1,732 
Cash at end of period  $10   $- 
           
Schedule of non-cash investing and financing activities:          
Common stock issued for convertible notes  $19,913   $983,585 
Common stock issued for accrued interest  $62,090   $216,943 
Conversion of preferred shares into common shares  $141,337   $15,669 
Transfer of preferred shares to temporary equity  $-   $4,376 

 

 

 

 

 

 

 

 

 

 

See notes to consolidated financial statements

 

6
 

 

NaturalNano, Inc.

For the three and nine months ended September 30, 2013 and 2012

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1.   PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES

 

Interim Financial Statements

The consolidated financial statements as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 are unaudited. However, in the opinion of management of the Company, these financial statements reflect all material adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position and results of operations for such interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results to be obtained for a full year. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X for smaller reporting companies.  Accordingly, these financial statements do not include all of the information required by U.S. generally accepted accounting principles for complete financial statements.  These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

 

Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate such estimates. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

 

Fair Value of Financial Instruments

Financial instruments include cash and cash equivalents, accounts payable and accrued expenses, notes payable, capital leases and derivative liabilities. Fair values for all instruments except for derivative liabilities were assumed to approximate carrying values for these financial instruments since they are short-term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of the Company’s convertible notes payable is estimated based upon the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The carrying value approximates the fair value of these debt instruments as of September 30, 2013 and December 31, 2012 based on rates charged being consistent with current market rates available to the Company. See Note 4 for discussion on the fair value of derivative liabilities.

 

Basis of Consolidation

The consolidated financial statements include the accounts of NaturalNano, Inc. (“NaturalNano” or the “Company”), a Nevada corporation, and its wholly owned subsidiary NaturalNano Research, Inc. (“NN Research”) a Delaware corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.

 

In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a 51% controlling interest in Combotexs.  The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $14,264 and a gain of $39,373 was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.

 

Description of the Business

NaturalNano (the “Company”), located in Rochester, New York, is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house. The Company’s current activities are directed toward research, development, production and marketing of its proprietary technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for:

 

  · cosmetics, health and beauty products
  · polymers, plastics and composites

 

During the nine months ended September 30, 2013 and 2012, the Company derived 82% and 79%, respectively, of its nanotechnology revenue from one customer.

 

7
 

 

During the fourth quarter of 2011, the Company entered into a supply agreement with another company, which is 50% owned by NaturalNano’s CEO, to manufacture and sell Error Prevention/Safety Checklist Boards which the related party will then market to the end user. In the second quarter of 2013, the Company made a decision to cease the medical board segment’s operations and ceased production of Error Prevention/Safety checklist Boards (the Medical Board business segment.) This business segment was not generating sufficient income to offset the efforts of production and administrative expenses. The Consolidated Statement of Operations as of September 30, 2013 reflects the results of the Medical Board business as a discontinued operation effective as of the second quarter of 2013. As of September 30, 2013, $13,000 of amounts due from the entity which is 50% owned by NaturalNano’s CEO is included in Accounts Receivable on the balance sheet. (See Note 3 “Discontinued Operations”).

 

NaturalNano is domiciled in the state of Nevada as a result of the merger with Cementitious Materials, Inc., (“CMI”), which was completed on November 29, 2005.

 

Liquidity and Going Concern

Going Concern – The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company incurred a net loss for the nine months ended September 30, 2013 of $425,405 and had negative working capital of $6,324,803 and a stockholders’ deficiency of $6,387,163 at September 30, 2013. Since inception the Company’s growth has been funded through a combination of convertible debt from private investors and from cash advances from its former parent and former majority shareholder Technology Innovations, LLC. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations, to obtain additional financing, renegotiate the terms of existing financing obligations and ultimately to attain successful operations. The ability to successfully achieve those items is uncertain. The financial statements do not include any adjustments that might result from the uncertainty.

 

As of September 30, 2013, the Company continued to require waivers for debt covenant violations and extensions of maturity dates. Refer to Note 2 for lenders waivers and maturity extensions received from the lenders.

 

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

 

Income Taxes

The Company accounts for income taxes in accordance with ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income items is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.  The Company recognizes penalties and accrued interest related to unrecognized tax benefits in income tax expense. Income tax expense was $0 for the nine month periods ending September 30, 2013 and 2012.

 

Increase in Authorized Common Stock

On July 1, 2013 the Company received a unanimous written consent in lieu of a meeting from the members of the Board of Directors and a written consent from the Series D stockholder (Note 5) to amend its articles of incorporation to increase the Company’s authorized common shares from 294,117,647 shares to 800,000,000 shares of common stock. As of September 30, 2013 there were 6,412,911,665 underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments.

 

Loss Per Share

Basic loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per common share gives effect to dilutive convertible preferred stock, convertible debt, options and warrants outstanding during the period. Shares to be issued upon the exercise of these instruments have not been included in the computation of diluted loss per share as their effect is anti-dilutive based on the net loss incurred.

 

As of September 30, 2013 and 2012 there were 6,412,911,665 and 2,656,482,041, respectively, underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. These potentially dilutive shares have been limited by certain debt and equity agreements with Platinum, Platinum Advisors, Merit Consulting, Alpha Capital and Technology Innovations LLC (“TI”). These agreements provide limitations on the conversion of the dilutive instruments such that the number of shares of Common Stock that may be acquired by the holder upon conversion of such instruments shall be limited to ensure that following such conversion the total number of shares of Common Stock then beneficially owned by the holder does not exceed 4.99% of the total number of issued and outstanding shares of Common Stock. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments. See Note 9 Subsequent Events for shares of common stock issued subsequent to September 30, 2013.

 

8
 

 

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted, would have a material effect on the accompanying financial statements.

 

 

2.  NOTES PAYABLE

 

Notes payable consisted of the following:

 

Notes Payable  September 30,
2013
   December 31,
2012
 
Senior Secured Convertible Notes  $3,124,403   $3,134,415 
Senior Secured Promissory Notes   647,462    508,557 
Subordinated Secured Convertible Note   271,100    251,000 
Total  $4,042,965   $3,893,972 

 

 

Senior Secured Convertible Notes and Senior Secured Promissory Notes

As of September 30, 2013, notes payable include $3,771,865 ($3,642,972 at December 31, 2012) for senior secured convertible and non-convertible promissory notes.  As further described below, the Company has defaulted on certain provisions of the notes. Platinum Long Term Growth and Merit Consulting, LLC (to whom Platinum Advisors has assigned their ownership interest in notes receivable from the Company) have granted waivers of default on their outstanding principal balance of $3,148,349 through December 31, 2013 and November 30, 2013, respectively. Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) has granted a waiver of default on their outstanding principal of $623,516 through November 30, 2013.

 

The Loan and Security Agreement and the related underlying convertible notes issued in accordance with the Initial Note agreement had the original conversion price of $3.74 (as cited in the March 7, 2007 agreement) which was adjusted to a conversion price of $0.085 in accordance with the anti-dilution provisions of this loan and security agreement. This conversion price adjustment was triggered as a result of the issuance of the 2008 Promissory Notes on September 29, 2008 thereby resulting in a reset of (a) the conversion price of the Initial Notes, (b) the exercise price of the warrants related to the Initial Notes and (c) the number of shares that may be purchased by such warrants. As compensation for forbearance from the lenders in 2012, the conversion rate was further adjusted to 75% of the lowest daily volume weighted average price (VWAP) of the Company’s common stock for the 1, 5 or 10 days immediately prior to the conversion.

 

During the nine month period ended September 30, 2013, the Company issued 9,500,000 shares of common stock to Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) upon the conversion of $10,013 of outstanding principal due on the 8% Senior Secured Convertible Notes held by Longview Special Finance. Also during this period the Company issued 42,000,000 shares of common stock to Alpha Capital Anstalt upon the conversion of $31,838 of interest due on the 8% Senior Secured Convertible Notes held by Longview Special Finance.

 

During the nine month period ended September 30, 2013, the Company issued 25,872,435 shares of common stock to Merit Consulting upon the conversion of $21,478 of interest due on the 8% Senior Secured Convertible Notes held by Platinum Advisors.

 

2013 Senior Secured Promissory Notes

During the nine month period ended September 30, 2013, the Company entered into various Senior Secured Promissory Notes aggregating to $138,906 with Platinum and Alpha (“the 2013 Senior Secured Promissory Notes”). The 2013 Senior Secured Promissory Notes are secured by, among other things, (i) the continuing security interest in certain assets of the Company pursuant to the terms of the Initial Notes dated March 7, 2007, (ii) the Pledge Agreement, as defined in the Initial Notes, and (iii) the Patent Security Agreement, dated as of March 6, 2007. The proceeds from the 2013 Senior Secured Promissory Notes are available for general working capital purposes and cannot be used to redeem or make any payment on account of any securities due to the Lenders.  The 2013 Senior Secured Promissory Notes bear interest, in arrears, at a rate of 8% per annum and are payable in cash as follows: $21,000 due on June 30, 2013, $30,006 due on July 30, 2013, $49,400 due on September 30, 2013, $2,500 due October 30, 2013 and $36,000 due November 30, 2013. Past due amounts have been extended through forbearance agreements with the principal and interest due on dates ranging from November 30, 2013 to December 31, 2013.

 

2012 Forbearance

During the nine month period ended September 30, 2012, the Company entered into various forbearance agreements between the Company and Platinum, Platinum Advisors, Merit Consulting, Longview Special Finance and Alpha Capital Anstalt (the lenders) which extended the due dates of all outstanding notes and accrued interest.  As consideration for these forbearances, the lenders added $50,000 to the principal balance of the Initial Notes and resulted in a loss on modification of debt of $50,000 for the nine month period ended September 30, 2012 and is reported in the statement of operations.

 

9
 

 

Subordinated Secured Convertible Note

 

Convertible Notes

On December 4, 2009, the Company received net proceeds of $197,500 pursuant to the terms of a subscription agreement dated as of November 30, 2009 with Cape One an accredited investor.  Pursuant to the terms of the Subscription Agreement the Company issued (i) a 10% Subordinated Secured Convertible Promissory Note (“the 10% Convertible Note”) in the principal amount of $225,000 and (ii) a five-year common stock purchase warrant to purchase 2,647,059 shares, subject to certain anti-dilution provisions in the agreement of the Company’s common stock, par value $0.001 per share at an exercise price of $0.425 per share. The balance of this note as of September 30, 2013 is $271,100, a result of increases as consideration for forbearance and conversions of principal.

 

The 10% Convertible Note had a 15-month term, bears interest at 10% per annum and is secured by certain assets of the Company pursuant to a security agreement, dated November 30, 2009.  The 10% Convertible Note is convertible into Common Stock at any time prior to maturity (provided that such conversion does not result in the holder and its affiliates beneficially owning in excess of 4.99% (9.99% upon 61 days prior written notice) of the issued and outstanding Common Stock at $0.085 per share (the “Conversion Price”), subject to adjustment upon the occurrence of certain anti-dilution events.  Interest under the Note is due quarterly in cash or if registered, in the Company’s common stock at a 20% discount in accordance with a formula set forth in the 10% Note.  The 10% Note and security interest is subordinate to certain outstanding senior indebtedness of the Company held by Platinum Long Term Growth IV, LLC, Merit Consulting and Alpha Capital Anstalt. (“Senior Lenders”). Upon the occurrence of Events of Default as set forth in the Note, the principal and interest due under the Note may be accelerated and the interest rate payable may be increased to 18%.  The company has entered into various forbearance agreements between Cape One and the Company which extended the due date of the outstanding principal and interest, which is accruing at the default rate of 18%.

 

During nine month periods ended September 30, 2013 and 2012, the Company entered into various forbearance agreements which extended the due date of all the outstanding principal and interest balances.  As consideration for these forbearances, Cape One will be paid $55,000 which was added to the principal balance of the note and resulted in a loss on modification of debt of $30,000 and $25,000 for the nine month periods ended September 30, 2013 and 2012, respectively, as reported in the statement of operations. In consideration for forbearance in 2012, the conversion rate of the note was adjusted from $0.085 to 75% of the lowest VWAP for the 1, 5 or 10-day period immediately prior to the conversion. This note has been extended through forbearance agreements and is now due and payable on November 30, 2013.

 

During nine month period ended September 30, 2013, the Company issued 12,000,000 shares of common stock to Cape One upon the conversion of $9,900 of outstanding principal due on the Subordinated Senior Convertible note. During the nine month period ended September 30, 2013, the Company issued 9,000,000 shares of common stock to Cape One in payment of $8,775 of interest expense obligations on the Subordinated Secured Convertible Note.

 

Registration Rights Agreement

On March 7, 2007, the Company entered into a Registration Rights Agreement with the Agent and the other investors, pursuant to which the Company agreed to prepare and file within 60 days of the March 7, 2007 agreement, a registration statement for resale under the Securities Act of 1933, the common stock issuable upon the exercise of the Warrants, in payment of interest on, or upon conversion of, the Notes. The Company further agreed to use its best efforts to cause the Registration Statement to be declared effective 120 days following the March 7, 2007 agreement date, or within 150 days if the Company receives a comment letter from the SEC, and to maintain such Registration Statement for the two year period following this date. This agreement allows for liquidated damages based on a daily amount of 0.0333% of the principal amount of the notes relating to the common stock issuable upon conversion of the Notes included in the Registration Statement.

 

The registration statement had not been updated with the requisite SEC filings outlined above and as such, the Company was in default of this provision of the Registration Rights Agreement. The Company recorded a total of $146,028 in such liquidated damages as of December 17, 2007, the date the registration statement was declared effective. As of December 31, 2007, $63,539 of this obligation was paid in cash and $82,489 was recorded as an accrued liability. The lender has the option to settle the liquidated damages in common stock valued at the average price for the five days prior to the end of a payment period. At September 30, 2013 and December 31, 2012 the outstanding balance for this obligation was $82,489.

 

3.     DISCONTINUED OPERATIONS

 

On May 10, 2013 the Company ceased all activities associated with the Medical Board business segment. The Company assessed this segment and determined that inadequate income had been generated relative to the efforts of production and administrative support. The Statement of Operations for the three and nine months ended September 30, 2013 reflects the Medical Board business as a discontinued operation and prior reported periods have been reclassified to reflect this presentation. The results of discontinued operations are as follows: 

 

   For the three months ended   For the nine months ended 
   September 30,
2013
   September 30,
2012
   September 30,
2013
   September 30,
2012
 
                 
Revenues from Medical Board business  $-   $9,375   $14,750   $31,250 
                     
Profit from Medical Board business  $-   $6,457   $11,115   $17,477 

 

10
 

 

In connection with this decision to exit the Medical Board business, the Company filed a Certificate of Dissolution on May 10, 2013 with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs. As a result of this decision, certain unrecovered sample inventory amounts were written off during the second quarter of 2013. The loss on write-off of discontinued operations was $11,179 and is reflected in the Statement of Operations for the three months ended September 30, 2013.

 

The Nanotechnology business remains as the Company’s only reportable operating segment.

 

4.  DERIVATIVE LIABILITY

 

For stock based derivative financial instruments, the Company estimated the total enterprise value based upon trending of the firm value from December 2006 to September 2013 considering company specific factors including the changes in forward estimated revenues and market factors.  Once the enterprise value was determined an option pricing model was used to allocate the enterprise value to the individual derivative and other securities in the Company’s capital structure.  Significant unobservable inputs used in determining the value of the Company’s derivative liability include the trended firm value and volatility. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.

 

The Company’s derivative liabilities as of September 30, 2013 are as follows:

 

  · The debt conversion feature embedded in the 8% Senior Secured Convertible Notes entered into in March 2007, August 2008, September 2008 and October 2008 which contains anti-dilution provisions that would be triggered if the Company issued instruments with rights to the Company’s common stock at prices below this exercise price.
  · The debt conversion feature and the 2,647,059 warrants exercisable at $0.425 per share granted in connection with the 10% Subordinated Secured Convertible Note (for which the rate has been increased to 18%) entered into in November 2009.  These agreements contain anti-dilution provisions that would be triggered if the Company issued instruments with rights to the Company’s common stock at prices below the exercise price.
  · The 882,353 warrant shares granted to the CEO of the Company at an exercise price of $0.17 per share on January 2011 which vest over three years, for which the value is not material.
  · The 28,500,000 warrants granted to the CEO of the Company and to three independent contractors at an exercise price of $0.0014 per share on February 26, 2013 which vested upon grant, for which the value is not material.

 

The fair value of the derivatives is as follows:

 

Derivative Liability  September 30,
2013
   December 31,
2012
 
8% Notes conversion feature  $10,516   $24,285 
10% Notes conversion feature   2,368    1,447 
Total  $12,884   $25,732 

 

The decrease in the fair value of the derivative liability of $12,848 was recognized as a gain on change in derivative liability in the statement of operations for the nine months ended September 30, 2013.

 

Significant fluctuations in the variables used in calculating the value of the Company’s derivative liabilities could have significant impact on the fair market valuation.

 

11
 

 

Fair Value Valuation Hierarchy Measurement

ASC 820 establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows.

 

  · Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
  ·

Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.

 

  · Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value.

 

A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The derivative liability was determined utilizing Level 3 inputs.

 

5.  STOCKHOLDERS EQUITY

 

As of September 30, 2013 the Company was authorized to issue up to 800,000,000 shares of common stock and 10,000,000 shares of preferred stock.

 

Preferred Stock Issuances

 

On June 10, 2013 the Company obtained the consent of the holders of the majority of the outstanding preferred shares for the creation of a Series D Preferred Stock. The holder of the Series D Preferred Stock is entitled to a 51% vote on all matters submitted to a vote of the shareholders of the Company. There are no other rights or preferences attached to the Series D Preferred Stock. On July 1, 2013, the Company issued 100 shares of the Company’s Series D Preferred Stock to Jim Wemett, the sole officer and a director of the Company, in consideration for services provided to the Company. Such securities were issued under Section 4(2) of the Securities Act of 1933, as amended and Regulation D promulgated by the Securities and Exchange Commission.

 

On September 29, 2008 Platinum and Longview agreed to exchange detachable warrants to purchase 71,691,180 shares of common stock of the Company for $0.085 per share held by such Investors related to the March 6, 2007 convertible notes payable for 5,000,000 shares of Series B and C preferred stock.

 

On October 7, 2008, the Company filed a Certificate of Designation of Rights, Preferences, Designations, Qualifications and Limitations of the Series C Preferred Stock (the “Series C Designation”) with the Secretary of State of the State of Nevada, and prepared a preferred stock certificate for delivery to Platinum Long Term Growth IV, LLC, evidencing 4,250,000 shares of Series C Convertible Preferred Stock of the Company (“Series C”).  On October 7, 2008, the Company also filed a Certificate of Designation of Rights, Preferences, Designations, Qualifications and Limitations of the Series B Preferred Stock (the “Series B Designation”) with the Secretary of State of the State of Nevada, and prepared a preferred stock certificate for delivery to Longview Special Funding, Inc., evidencing 750,000 shares of Series B Convertible Preferred Stock of the Company (“Series B”).  The Series B and Series C have an aggregate liquidation preference of $10,000 and participate in any dividends or distributions to the common shareholders on an as converted basis.

 

Each share of the Series B and Series C Convertible Preferred Stock is convertible into 160 shares of the Company’s common stock and votes on an as-converted basis (with each share having 160 votes).  The conversion rate was reduced to 9.41 as a result of the 2012 reverse split (Note 8), but was subsequently changed back to 160 as part of the consideration related to 2012 forbearance agreements (Note 2). Both the Series B and Series C designations limits the holders’ rights to convert its Convertible Preferred Stock, and the aggregate voting powers, to no more than 4.99% of the votes attributable to the total outstanding common shares.  Accordingly, the votes attributable to the Series B and Series C Convertible Preferred constitutes 4.99% of the aggregate votes attributable to the Company’s outstanding shares on an as converted basis and the votes Series B and Series C Convertible Preferred and the Series C Convertible Preferred, voting together represent approximately 9.98% of the aggregate votes attributable to the Company’s outstanding shares (on an as converted basis).  As of September 30, 2013 the Series B Convertible Preferred Stock has an aggregate liquidation value of $10 and the Series C Convertible Preferred Stock has an aggregate liquidation value of $6,607.

 

As a result of the Company not having sufficient authorized shares to satisfy the conversion of all outstanding convertible debt, convertible preferred stock, warrants and options, the Series B and C preferred shares have been moved into temporary equity classification on the balance sheet as of December 31, 2012. The preferred shares are presented at their fair value based on an allocation of the estimated total enterprise value to the preferred shares and other securities in the Company’s capital structure. The valuation methodology used is similar to that used in valuing the Company’s derivative liabilities (Level III inputs, see note 4). Any change in fair value of the preferred shares, which are deemed to be temporary equity, is reflected in additional paid in capital.

  

During the nine months ended September 30, 2013, Alpha elected to convert 137,500 shares of Series B preferred shares owned by Longview into 22,000,000 common shares at the conversion rate of 160 common shares per each Series B share. Longview has assigned its Series B preferred stock ownership to Alpha Capital Anstalt.

 

During the nine months ended September 30, 2013, Platinum elected to convert 745,855 shares of their Series C preferred shares into 119,336,800 common shares at the conversion rate of 160 common shares per each Series C share.

 

12
 

 

Common Stock Issuances

During the nine months ended September 30, 2013, the Company issued an aggregate of 76,872,435 shares in satisfaction of $62,090 of interest obligations to lenders on convertible debt. Also during this period, the Company issued an aggregate of 21,500,000 shares of its common stock in satisfaction of $19,913 of principal obligations to lenders on convertible debt.

 

During the nine months ended September 30, 2012, the Company issued an aggregate of 6,221,156 shares of its common stock in satisfaction of interest obligations of $241,164 and 13,594,382 shares in satisfaction of principal obligations of $983,585 to its senior debt holders. During the nine months ended September 30, 2012, the Company issued an aggregate of 1,764,706 shares of common stock to various individuals or entities in connection with professional consulting provided to the Company in an aggregate amount of $10,800.

 

Warrants Grants

The Company has issued warrants to purchase shares of its common stock to certain consultants and debt holders. As of September 30, 2013 and December 31, 2012 there were common stock warrants outstanding to purchase an aggregate 32,735,294 and 4,247,059 shares, respectively, of common stock pursuant to the warrant grant agreements summarized below.

 

On February 26, 2013 the Company issued warrants to purchase common stock to certain consultants, the Company’s CEO and the Company’s sole board member. These warrants (summarized below) grant the right to purchase one share of common stock at an exercise price of $0.0014 per share. The warrants were fully vested as of the grant date, expire February 26, 2023 and contain a cashless exercise provision. The fair value of the warrants was determined by estimating the total enterprise value of the Company based upon trending the firm value and considering company specific factors thereafter including the changes in forward estimated revenues and market factors.

 

Warrant grants made during the first quarter of 2013 are as follows:

  · 15,000,000 James Wemett CEO
  · 7,500,000 Paul LeFrois Consultant
  · 3,000,000 David Lubin Consultant
  · 3,000,000 Alexander Ruckdaeschel Board Member

 

A summary of the outstanding warrants is presented below:

 

   2013 
   Shares   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Life-years
 
             
Outstanding at January 1, 2013   4,247,059   $0.37    2.24 
Granted during the year   28,500,000    0.0014    9.92 
Cancelled or forfeited   (11,765)   5.61      
Warrants outstanding at September 30, 2013   32,735,294   $0.05    8.51 

 

 

 

6.  INCENTIVE STOCK PLANS

 

A summary of the status of the outstanding incentive stock plans is presented below at September 30, 2013:

 

   Shares   Weighted
Average
Exercise Price
   Weighted Average
Remaining
Life-years
 
             
Outstanding at January 1, 2013   723,137   $3.07    3.53 
Granted/Exercises/Cancelled/Forfeited   (14,117)          
Options outstanding at September 30, 2013   709,020   $3.57    2.37 
                
Options exercisable at September 30, 2013   709,020   $3.57    2.37 

  

All compensation costs for the above options have been previously recognized in operations.

 

13
 

 

7.  COMMITMENTS and CONTINGENCIES

 

Legal Proceedings

 

On March 24, 2009 the Company received a demand notice from an attorney representing a group of certain former employees of the Company, including but not limited to the Company’s former President and Chief Financial Officer, demanding immediate payment of $331,265 for certain deferred compensation, severance and vacation benefits. Each of the former employees cited in the demand notice, as well as other former employees, had executed written agreements during 2008 that allowed the Company to defer certain of these compensation payments. The Company has accrued for earned and unused vacation benefits and deferred payroll costs for amounts electively deferred by these and other former employees as of December 31, 2009. The Company has retained counsel in connection with this demand and continues to evaluate this demand notice and has responded to this demand. No actions or probable settlement discussions between the parties have developed since the filing of this demand. Due to the Company’s current cash and liquidity position discussed above and the current evaluation of the items in the demand notice the timing of future payment of these outstanding amounts is uncertain. No further communication has been had regarding this notice.

 

8. REVERSE STOCK SPLIT

 

On June 14, 2012, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Nevada, to effect a 1-for-17 reverse stock split of its common stock, or the Reverse Stock Split. This action had previously been approved by the Company’s Board of Directors on March 23, 2012. As a result of the Reverse Stock Split, every seventeen shares of the Company’s pre-reverse split common stock were combined and reclassified into one share of its common stock. No fractional shares were issued in connections with the Reverse Stock Split. Stockholders who would have been entitled to receive a fractional share in connection with the Reverse Stock Split received one whole share. The par value and other terms of the common stock were not affected by the Reverse Stock Split.

 

The Company’s authorized shares immediately prior to the Reverse Stock Split totaled 5,000,000,000. These were adjusted to 294,117,647. The Company’s shares outstanding immediately prior to the Reverse Stock Split totaled 732,073,557. These were adjusted to 43,063,150 shares outstanding as a result of the Reverse Stock Split. The Company’s common stock began trading at its post-Reverse Stock Split price at the beginning of trading on June 14, 2012. Share, per share, and stock option amounts for all periods presented within this quarterly report on Form 10-Q for common stock and additional paid-in-capital were retroactively adjusted to reflect the Reverse Stock Split.

 

9.   SUBSEQUENT EVENTS

 

Subsequent to September 30, 2013 and prior to the filing of this report, the following items occurred:

 

Promissory Notes: On October 15, 2013, the Company borrowed $14,025 from Platinum Long Term Growth IV, LLC pursuant to the terms of a Senior secured Promissory Note. The note bears interest at the rate of 8% per annum and is due and payable January 30, 2014.

 

Series C Preferred Stock Conversion to Common Stock: On October 15, 2013, Platinum Long Term Growth IV, LLC elected to convert 207,863 shares of their Series C preferred shares into 33,258,080 common shares at the conversion rate of 160 shares per each Series C share. On November 11, 2013, Platinum Long Term Growth IV, LLC elected to convert 238,511 shares of their Series C preferred shares into 38,161,760 common shares at the conversion rate of 160 shares per each Series C share.

 

Payment of Accrued Interest with Common Stock: On November 7, 2013, the Company issued an aggregate of 16,000,000 shares of its common stock in satisfaction of $6,000 in interest obligations to Alpha Capital Anstalt.

  

 

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

FORWARD-LOOKING STATEMENTS

 

This quarterly report on Form 10-Q and other reports that we file with the SEC contain statements that are considered forward-looking statements that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” and similar expressions. Such forward looking statements include statements addressing operating performance, events or developments that the Company expects or anticipates will occur in the future, including statements relating to revenue realization, revenue growth, earnings, earnings per share, or similar projections. These statements estimates involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed for the reasons described in this report. You should not place undue reliance on these forward-looking statements.

 

14
 

 

You should be aware that our actual results could differ materially from those contained in the forward-looking statements due to a number of factors such as:

 

  · the ability to raise capital to fund our operations until we generate adequate cash flow internally;
  · the terms and timing of product sales and licensing agreements;
  · our ability to enter into strategic partnering and joint development agreements;
  · our ability to competitively market our controlled release and filled tube products;
  · the successful implementation of research and development programs;
  · our ability to attract and retain key personnel;
  · general market conditions.

 

Our actual results may differ materially from management’s expectations. The following discussion and analysis should be read in conjunction with our financial statements included herewith.  This discussion should not be construed to imply that the results discussed herein will necessarily continue in the future, or that any conclusion reached herein will necessarily be indicative of actual operating performance in the future. Such discussion represents only the best present assessment of our management.

 

The forward-looking statements speak only as of the date on which they are made, and except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

General

Our primary mission is to develop and exploit technologies in the area of advanced materials science, with an emphasis on additives to industrial and consumer products, taking advantage of technological advances we have developed in-house. These technologies include a specific focus on nanoscale materials using modifications to tubular and spherical materials found in clay. Our strategy is to develop patentable processes and technologies related to these nanoscale materials and to develop products in the polymers and plastics industries as well as the composites, cosmetics, household products and agrichemical industries. During the second quarter of 2013, the Company made a decision to cease its Medical Board operating segment which focused on the design, manufacture and sale of customer designed error prevention/safety checklist boards to a related party which marketed and sold the boards.

 

NaturalNano is domiciled in the state of Nevada as a result of the merger with Cementitious Materials, Inc. (“CMI”), which was completed on November 29, 2005.

 

Liquidity and Capital Resources

Liquidity and Going Concern

Going Concern – The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company incurred a net loss for the nine months ended September 30, 2013 of $425,405 and had negative working capital of $6,324,803 and a stockholders’ deficiency of $6,387,163 at September 30, 2013. Since inception the Company’s growth has been funded through a combination of convertible debt and non-convertible debt from private investors and from cash advances from its former parent and former majority shareholder Technology Innovations, LLC. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations, to obtain additional financing, renegotiate the terms of existing financing obligations and ultimately to attain successful operations. The ability to successfully achieve those items is uncertain. The financial statements do not include any adjustments that might result from this uncertainty.

 

As of September 30, 2013, the Company had $3,771,865 in principal that was outstanding and past due under the terms of the Senior Secured Convertible Notes and Promissory Notes with Platinum Partners Long Term Growth IV (“Platinum”), Merit Consulting, LLC (“Merit”) (to whom Platinum Advisors has assigned their ownership interest in notes receivable from the Company), and Alpha Capital Anstalt (“Alpha”) (to whom Longview Special Finance Inc. has assigned their ownership interest in notes receivable from the Company). The Company entered into various Senior Secured Convertible Notes and Promissory Note obligations during the period from 2007 through 2010 with Platinum, Platinum Advisors and Longview, the holders of the Company’s primary debt obligations since 2007. The outstanding principal and all accrued and unpaid interest on these obligations was due and payable in full on various dates between March 6, 2009 and September 30, 2013. Platinum and Merit have granted waivers of default, extended the due dates of all the outstanding principal balances to December 31, 2013 and November 30, 2013, respectively, and waived the application of the 16% default interest rate. Additionally Platinum and Merit waived the automatic adjustment of the conversion rate for past and future S-8 stock issuances made for compensation and payments of services. Alpha has granted waivers of default, extended the due dates of all the outstanding principal balances to November 30, 2013, and waived the application of the 16% default interest rate. Additionally, Alpha waived the automatic adjustment of the conversion rate for past and future S-8 stock issuances made for compensation and payments of services.

 

15
 

 

As of September 30, 2013 the Company had $271,100 in principal that was outstanding and due under the terms of the Convertible Note with Cape One. Through a series of forbearance agreements, the Convertible Note matures and all outstanding principal is due and payable on November 30, 2013.

 

As of September 30, 2013, the Company continued to require waivers for debt covenant violations and extensions of maturity dates. Refer to Note 2 to the consolidated financial statements for lenders waivers and maturity extensions received from the lenders.

 

Operating activities

Net cash used in operating activities in the nine months ended September 30, 2013 and 2012 was $145,056 and $104,732, respectively. The net loss generated in the first nine months of 2013 was $632,870 less than the prior year period.  The Company continues to actively monitor spending and cash outflows in an effort to reduce costs until continuing revenue sources are developed. The Company is actively seeking opportunities to continue to reduce expenses and improve its liquidity position. We expect that total consolidated spending in 2013 to be equal if not slightly less than the 2012 levels, although we will continue to invest in product and commercialization efforts as our cash position and liquidity allow.

 

Total adjustments to reconcile the net loss to the cash used in operations aggregated $(33,164) in the first nine months of 2013 versus $556,227 in first nine months of 2012. The change in these non-cash items reflects decreases in Depreciation expense in 2013, and a reduction in the Loss on modification of debt and the impact of common shares issued in 2012 for services that did not recur in the first half of 2013.

 

Investing activities

No cash was used in investing activities in the nine months ended September 30, 2013 or 2012.

 

Financing Activities

Net cash provided from financing activities in the nine months ended September 30, 2013 and 2012 was $138,906 and $103,000, respectively. The cash flows from financing activities in the nine months of 2013 include the receipt of an aggregate of $114,300 in proceeds from Platinum Long Term Growth IV and $24,606 in proceeds from Alpha (to whom Longview Special Finance has assigned portions of its ownership interest in notes receivable from the Company). The cash flows from financing activities in the nine months of 2012 reflect a receipt of $79,000 in proceeds from Platinum Long Term Growth IV and $24,000 in proceeds from Longview special Finance.

 

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. Our actual results may differ from these estimates.

 

Refer to the Company’s December 31, 2012 report on Form 10K for a complete discussion of the critical accounting policies which have not changed during the nine months ended September 30, 2013.

 

Comparison of Statement of Operations for the three months ended September 30, 2013 and 2012

 

Revenue and Gross Profit

During the three months ended September 30, 2013 and 2012, the Company recorded $18,674 and $6,783, respectively in revenue from continuing operations. Cost of goods sold for continuing operations was $3,657 and $749 for the shipments completed in these respective quarters. Gross margin for continuing operations of $15,017 and $6,034 was realized for the three months ended September 30, 2013 and 2012, respectively.

 

The change in the Nanotechnology products sales year over year is a result of the unique market application of these products. The Company expects that it will experience significant variations in sales and gross margins with its Nanotechnology products as it continues to introduce to market and develop new products and related applications. Gross margin realized in the three months ended September 30, 2013 was 80% and 2012 was 89%.

 

Operating Expenses

Research and development expenses for the three months ended September 30, 2013 were $14,031 compared to $21,377 for the three months ended September 30, 2012.  The reduction in costs is primarily attributed to the reduction in depreciation due to the life of several long lived assets. Future research and development expenditure levels will be largely depend upon the availability of discretionary cash flow which is anticipated to be limited.

 

16
 

 

   For the three months ended   Variance 
   September 30,   increase 
Research and Development  2013   2012   (decrease) 
Salaries and benefits  $2,902   $-   $2,902 
Consulting services   -    5,200    (5,200)
Patent costs   -    910    (910)
Depreciation   -    5,401    (5,401)
Rent & utilities   11,327    8,346    2,981 
Supplies and other   (198)   1,520    (1,718)
   $14,031   $21,377   $(7,346)

 

 

Total general and administrative expenses for the three months ended September 30, 2013 was $81,884 as compared to expenses of $93,549 for the three months ended September 30, 2012. Management continues to actively assess the Company’s operating structure with the objective align cash expenditures and expenses with growth in total revenue.

 

   For the three months ended   Variance 
   September 30,   Increase 
General and Administrative  2013   2012   (decrease) 
Salaries & benefits  $46,156   $48,602   $(2,446)
Consulting Services   7,884    5,751    2,133 
Legal & professional fees   12,415    21,214    (8,799)
Insurance expense   850    969    (119)
Shareholder and board expense   8,501    12,057    (3,556)
Travel and entertainment   2,453    1,855    598 
State tax   50    25    25 
Supplies and other   3,575    3,076    499 
   $81,884   $93,549   $(11,665)

 

Other (Expense) Income

Other (expense) income consists of interest expense on convertible and promissory notes outstanding and other debt related financing and amortization expenses considered components of interest expense for financial reporting.

 

   For the three months ended   Variance 
   September 30,   increase 
Other (Expense) Income  2013   2012   (decrease) 
Interest on Senior convertible and promissory notes  $(81,259)  $(75,692)  $5,567 
Interest on 10% Subordinated Secured Convertible Notes   (11,949)   (11,457)   492 
   $(93,208)  $(87,149)  $6,059 
Net (loss) gain on derivative liability  $89,536   $534   $89,002 
                
Gain (loss) on forgiveness/modification of debt  $-   $(163,566)  $(163,566)

 

Gain on dissolution of Combotexs  $39,373   $-   $39,373 

 

The increase in interest expense for the third quarter of 2013 as compared to the third quarter of 2012 reflects additions to principal through new notes or forbearance consideration during the current quarter.

 

The gain on derivative liability in the third quarter of 2013 is the result of updated valuations performed for the Company on instruments that, due to the Company’s number of authorized common shares being insufficient, result in derivative liabilities. As of September 30, 2013 the Company did not have sufficient shares to satisfy conversion of all outstanding instruments.

 

The Company regularly received forbearance agreements from lenders due to the Company being in default of loan requirements. These amounts are recorded as losses on modification of debt in the income statement. During the third quarter of 2012, the Company recorded a loss on modification of debt in consideration for a change in the conversion rate of debt and preferred stock as defined in the Initial Notes and the 2008 Senior Convertible Promissory Notes in the amount of $163,566.

 

In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a 51% controlling interest in Combotexs.  The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $14,264 and a gain of $39,373 was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.

 

17
 

 

Comparison of Statement of Operations for the nine months ended September 30, 2013 and 2012

 

Revenue and Gross Profit

During the nine months ended September 30, 2013 and 2012, the Company recorded $141,992 and $55,331, respectively in revenue from continuing operations. Cost of goods sold was $27,687 and $3,880 for the shipments completed in the respective quarters. Gross margin of $114,305 and $51,451 was realized for the nine months ended September 30, 2013 and 2012, respectively.

 

The change in the Nanotechnology products sales year over year is a result of the unique market application of these products. The Company expects that it will experience significant variations in sales and gross margins with its Nanotechnology products as it continues to introduce to market and develop new products and related applications. Gross margin realized from continuing operations in the nine months ended September 30, 2013 was 81% and in 2012 was 93%.

 

Operating Expenses

Research and development expenses for the nine months ended September 30, 2013 were $41,623 compared to $90,084 for the nine months ended September 30, 2012.  The reduction in costs is primarily attributed to the reduction in depreciation. Future research and development expenditure levels will be largely depend upon the availability of discretionary cash flow which is anticipated to be limited.

 

   For the nine months ended   Variance 
   September 30,   increase 
Research and Development  2013   2012   (decrease) 
Salaries and benefits  $9,633   $-   $9,633 
Consulting services   -    15,462    (15,462)
Patent costs   619    5,561    (4,942)
Depreciation   -    39,454    (39,454)
Rent & utilities   30,721    24,112    6,609 
Supplies and other   650    5,495    (4,845)
   $41,623   $90,084   $(48,461)

 

Total general and administrative expenses for the nine months ended September 30, 2013 was $265,150 as compared to expenses of $268,437 for the nine months ended September 30, 2012. The increase is primarily a result of an increase in audit fees year over year. Management continues to actively assess the Company’s operating structure with the objective align cash expenditures and expenses with growth in total revenue.
 

 

   For the nine months ended   Variance 
   September 30,   Increase 
General and Administrative  2013   2012   (decrease) 
Salaries & benefits  $136,702   $143,500   $(6,798)
Consulting Services   23,365    27,119    (3,754)
Legal & professional fees   50,975    45,714    5,261 
Insurance expense   4,097    2,762    1,335 
Shareholder and board expense   30,233    29,637    596 
Travel and entertainment   6,243    7,313    (1,070)
State tax   1,151    1,784    (633)
Supplies and other   12,384    10,608    1,776 
   $265,150   $268,437   $(3,287)

 

Other (Expense) Income

Other (expense) income consists of interest expense on convertible and promissory notes outstanding and other debt related financing and amortization expenses considered components of interest expense for financial reporting.

 

   For the nine months ended   Variance 
   September 30,   increase 
Other (Expense) Income  2013   2012   (decrease) 
Interest on Senior convertible and promissory notes  $(238,248)  $(263,417)  $(25,169)
Interest on 10% Subordinated Secured Convertible Notes   (36,500)   (32,233)   4,267 
   $(274,748)  $(295,650)  $(20,902)
Net gain on derivative liability  $12,848   $534   $12,314 
                
Gain (loss) on forgiveness/modification of debt  $(10,336)  $(473,566)  $(463,230)
                
Gain on dissolution of Combotexs  $39,373   $-   $39,373 

 

18
 

 

The overall decrease in interest expense in 2013 as compared to 2012 is due to conversions of outstanding principal to common stock during 2013 being greater than additions to principal through new notes or forbearance consideration.

 

The loss on derivative liability in 2013 is the result of updated valuations performed for the Company on instruments that, due to the Company’s current number of authorized common shares being insufficient, result in derivative liabilities. As of September 30, 2013 the Company had sufficient shares to satisfy conversion of all outstanding instruments.

 

During 2013, the Company entered into various agreements with certain vendors to settle accounts payable that were outstanding for amounts less than the liability that was recorded in the accompanying balance sheet. As a result of these agreements, liabilities of $19,664 were relieved, resulting in a gain on forgiveness of debt. These vendor concessions have been treated as gains in the period that the underlying agreement was reached. Also 2013, as consideration for a waiver of forbearances from Cape One, $30,000 was added to the outstanding principal balance of the note and resulted in a loss on modification of debt of $30,000.

 

The Company regularly receives forbearance agreements from lenders due to the Company being in default of loan requirements. From time to time the lenders, as consideration for the forbearance agreements, add amounts to the principal of the outstanding notes. These amounts are recorded as losses on modification of debt in the income statement. During the nine months ended September 30, 2013 $30,000 was added to the outstanding principal owed to Cape One in exchange for forbearance. During the nine months ended September 30, 2012, $130,000 was added to the outstanding principal owed to Longview, $125,000 was added to the outstanding principal owed to Platinum, and $55,000 was added to the outstanding principal owed to Cape One in exchange for such forbearances.

 

In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a 51% controlling interest in Combotexs.  The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $14,264 and a gain of $39,373 was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.

 

Item 4. - Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

The Company’s management is responsible for establishing and maintaining effective disclosure controls and procedures. Our Chief Executive Officer has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the CEO as appropriate, to allow timely decisions regarding required disclosure.

 

Based on this evaluation, and in light of the material weaknesses in our internal control over financial reporting that are discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010 our Chief Executive Officer has concluded that our disclosure controls and procedures were not effective. The material weaknesses consist of an insufficient complement of qualified accounting personnel and controls associated with segregation of duties and ineffective controls associated with identifying and accounting for complex and non-routine transactions in accordance with U.S. generally accepted accounting principles.

 

The Company did not maintain a sufficient complement of qualified accounting personnel and controls associated with the segregation of duties were ineffective. During the fourth quarter of 2008 and the first half of 2009 the Company experienced the resignations in the positions of controller, Chief Financial Officer and Chief Executive Officer. These roles have been filled since the first quarter of 2009 by part time and contract staffing. To address the material weaknesses the Company performed additional analyses and other post-closing procedures to ensure our consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). Notwithstanding these material weaknesses, management believes that the financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial condition, result of operations and cash flows for the periods presented.

 

19
 

 

There can be no assurance, however, that our disclosure controls and procedures will detect or uncover all failures of persons within the Company and its consolidated subsidiaries to disclose material information otherwise required to be set forth in our periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

20
 

  

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings

There have been no material developments to the legal proceeding disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Recent Sales of Unregistered Securities

 

  I. During the third quarter of 2013, the Company issued shares of common stock in transactions exempt from the registration requirements of the Securities Act of 1933 pursuant to Section 4(2) of such Act. We issued these shares in connection with a Notice of Conversion received from Alpha Capital Anstalt as specified under the terms and conditions of the 8% Senior Secured Convertible Debt. These shares were converted at the per share price presented below reflecting satisfaction in interest payments on the outstanding notes.

 

August 21, 2013 13,000,000 shares in satisfaction of $7,800 in interest payments converted at $0.0006 per share

 

  II. During the third quarter of 2013, the Company issued shares of common stock in transactions exempt from the registration requirements of the Securities Act of 1933 pursuant to Section 4 (2) of such Act. We issued these shares in connection with a Notice of Conversion received from Platinum Long Term Growth IV as specified under the terms and conditions of the Preferred C shareholder agreement. These shares were converted at 160 shares for each preferred share:

 

August 13, 2013 29,056,640 shares in conversion of 181,604 shares of Preferred C shares

 

  III. On July 1, 2013, the Company issued 100 shares of the Company’s Series D Preferred Stock to Jim Wemett, the sole officer and a director of the Company, in consideration for services provided to the Company. Such securities were issued under Section 4(2) of the Securities Act of 1933, as amended and Regulation D promulgated by the Securities and Exchange Commission.

 

  IV. On October 11, 2013 the Company issued shares of common stock in transactions exempt from the registration requirements of the Securities Act of 1933 pursuant to Section 4 (2) of such Act. We issued these shares in connection with a Notice of Conversion received from Platinum Long Term Growth IV as specified under the terms and conditions of the Preferred C shareholder agreement. These shares were converted at 160 shares for each preferred share:

 

October 11, 2013 33,258,080 shares in conversion of 207,863 shares of Preferred C shares

 

  V. On November 6, 2013 the Company issued shares of common stock in transactions exempt from the registration requirements of the Securities Act of 1933 pursuant to Section 4(2) of such Act. We issued these shares in connection with a Notice of Conversion received from Alpha Capital Anstalt as specified under the terms and conditions of the 8% Senior Secured Convertible Debt. These shares were converted at the per share price presented below reflecting satisfaction in interest payments on the outstanding notes. 

  

November 6, 2013 16,000,000 shares in satisfaction of $6,000 in interest payments converted at $0.000375 per share

 

VI. On November 11, 2013 the Company issued shares of common stock in transactions exempt from the registration requirements of the Securities Act of 1933 pursuant to Section 4(2) of such Act. We issued these shares in connection with a Notice of Conversion received from Platinum Long Term Growth IV as specified under the terms and conditions of the Preferred C shareholder agreement. These shares were converted at 160 shares for each preferred share:

 

November 11, 2013 38,161,760 shares in conversion of 238,511 shares of Preferred C shares

 

 

Item 3. Defaults Upon Senior Securities

 

Effective as of September 30, 2013, the Company entered into various Forbearance Agreements with Platinum Long Term Growth IV LLC and Merit Consulting LLC relating to the Company’s default on various terms and conditions with borrowing agreements. Platinum Long Term Growth IV LLC and Merit Consulting LLC agreed to not take any action or exercise or move to enforce any rights or remedies provided for in the various loan documents or otherwise available to it, under law or equity, due to the events of default under the existing Notes until December 31, 2013 and November 30, 2013, respectively, unless extended by the lenders in their discretion.

 

21
 

  

These Forbearance Agreements also extend to the Registration Rights Agreement entered into by the Company on March 7, 2007. Platinum Long Term Growth and Merit Consulting LLC have agreed to forbear from demanding payments defined in these agreements until November 30, 2013.

 

Effective as of September 30, 2013 the Company entered into a Forbearance Agreement with Platinum Long Term Growth LLC due to the Company’s default on various terms and conditions under the following borrowing agreements:

$2,750,000 8% Senior Secured Notes due March 6, 2009,

$150,000 8% Senior Secured Notes due March 6, 2009,

$59,500 8% Senior Secured Notes due January 31, 2010,

$190,000 8% Senior Secured Promissory Note due January 31, 2010,

$136,375 8% Senior Secured Promissory Note due January 31, 2010,

$5,000 8% Senior Secured Promissory Note due June 30, 2009,

$15,000 8% Senior Secured Promissory Note due June 30, 2009,

$25,000 16% Senior Secured Promissory Note due October 12, 2009, and

one or more secured bridge notes in the current principal amount of $394,973 (together the “Notes”).

 

Also, effective as of  September 30, 2013 the Company entered into a Forbearance Agreement with Merit Consulting LLC (to whom Platinum Advisors LLC has assigned its ownership interest in notes receivable to the Company) relating to the Company’s default on $97,500 of 8% Senior Secured Notes due March 6, 2009. Merit agreed to not take any action or exercise or move to enforce any rights or remedies provided for in the various loan documents or otherwise available to it, under law or equity, due to the events of default under the existing Notes until November 30, 2013 unless extended by Merit in their discretion.

 

Effective as of August 15, 2013 the Company entered into a Forbearance Agreement with Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) relating to the Company’s default on various terms and conditions with borrowing agreements. Alpha Capital Anstalt  agreed to not take any action or exercise or move to enforce any rights or remedies provided for in the various loan documents or otherwise available to it, under law or equity, due to the events of default under the existing Notes until November 30, 2013 unless extended by Alpha Capital Anstalt in their discretion.

 

As consideration for the January 1, 2012 forbearance agreement Longview was paid $30,000 which was added to the principle balance of the note. The January 1, 2012 forbearance agreement was considered and accounted for as modification of debt and a loss of $30,000 for the three months ending March 31, 2013 and reported in the statement of operations. As consideration for the forbearance agreement, effective April 16, 2012, Longview/Alpha will be paid $50,000 which will be added to the principle balance of the note. The forbearance agreement was considered and accounted for as modification of debt and a loss of $50,000 for the three months ending June 30, 2012 and was reported in the statement of operations.

 

The Company is in default on various terms and conditions under the assigned Alpha Capital Anstalt borrowing agreements:

 

$500,000 8% Senior Secured Notes due March 6, 2009,

$20,000 8% Senior Secured Notes due March 6, 2009,

$30,000 Senior Secured Promissory Note due January 31, 2010,

$25,500 Senior Secured Promissory Note due January 31, 2010,

$34,750 16% Senior Secured Promissory Note due January 31, 2010,

$40,000 16% Senior Secured Promissory Note due November 1, 2009,

one or more secured bridge notes in the current principal amount of $106,778 (together the “Notes.”)

 

Alpha Capital Anstalt has agreed to forbear from demanding payments defined in the Registration Rights Agreement until November 30, 2013.

 

As of December 31, 2009, the Company was not in compliance with certain debt covenants of the Subordinated Secured Convertible Note including limitations on the use of proceeds.  On January 31, 2013 the Company received a waiver from the Cape One Financial LP (“Cape One”) indicating that the Lender will not demand payment of principal, default interest and liquidated damages as a result of non-compliance with any existing covenant violations through September 30, 2013. On March 15, 2011, the Company entered into a forbearance agreement with Cape One which extended the due date from March 1, 2011 to June 30, 2011. As consideration for this forbearance, Cape One will be paid $30,000 which will be added to the principle balance of the note. In addition, the interest rate on the outstanding amount during the forbearance period will be adjusted to 18%. The forbearance agreement was considered and accounted for as a modification of debt and resulted in a loss of $30,000 for the three months ended March 31, 2011 reported in the statement of operations. Effective June 30, 2011, the Company and Cape One entered into a forbearance agreement which altered the due date of the Convertible Note from June 30, 2011 to October 1, 2011. Effective September 30, 2011, the Company and Cape One entered into another forbearance agreement which altered the due date of the Convertible note from October 1, 2011 to November 22, 2011. As consideration for this forbearance, Cape One will be paid $30,000 which will be added to the principal balance of the note. This forbearance agreement was considered and accounted for as a modification of debt and resulted in a loss of $30,000 for the three months ended September 30, 2011 reported in the statement of operations. Effective January 17, 2012, the Company entered into a forbearance agreement which extends the due date of all the outstanding principal and interest balances to April 16, 2012.  As consideration for this forbearance, Cape One will be paid $30,000 which will be added to the principle balance of the note. The forbearance agreement was considered and accounted for as modification of debt and a loss of $30,000 for the three months ending March 31, 2012 and reported in the statement of operations. Effective June 30, 2013, the Company and Cape One entered into another forbearance agreement which altered the due date of the Convertible note to August 31, 2013. As consideration for this forbearance, Cape One will be paid $30,000 which will be added to the principal balance of the note. This forbearance agreement was considered and accounted for as a modification of debt and resulted in a loss of $30,000 for the nine months ended September 30, 2013 reported in the statement of operations.

 

22
 

 

Item 4. Mine Safety Disclosures

Not applicable.

 

Item 5. Other Information

None.

 

23
 

  

Item 6. Exhibits

 

Exhibit

No.

  Description
     
     
10.148  

8% Senior secured Promissory Note dated as of July 2, 2013 in the original principal amount of $2,400 issued by NaturalNano, Inc. and NaturalNano Research, Inc. to Platinum Long Term Growth IV, LLC.

 

10.149  

8% Senior secured Promissory Note dated as of July 2, 2013 in the original principal amount of $20,400 issued by NaturalNano, Inc. and NaturalNano Research, Inc. to Platinum Long Term Growth IV, LLC.

 

10.150  

8% Senior secured Promissory Note dated as of July 2, 2013 in the original principal amount of $3,600 issued by NaturalNano, Inc. and NaturalNano Research, Inc. to Alpha Capital Anstalt.

 

10.151  

8% Senior secured Promissory Note dated as of October 15, 2013 in the original principal amount of $14,025 issued by NaturalNano, Inc. and NaturalNano Research, Inc. to Platinum Long Term Growth IV, LLC.

 

10.152  

Letter Agreement effective as of September 30, 2013 with Platinum Long Term Growth IV, LLC regarding their forbearance with respect to the $2,750,000 8% Senior Secured Notes due March 6, 2009, $150,000 8% Senior Secured Notes due March 6, 2009, $59,500 8% Senior Secured Notes due January 31, 2010, $190,000 8% Senior Secured Promissory Note due January 31, 2010, $136,375 8% Senior Secured Promissory Note due January 31, 2010, $5,000 8% Senior Secured Promissory Note due June 30, 2009, $15,000 8% Senior Secured Promissory Note due June 30, 2009, $25,000 16% Senior Secured Promissory Note due October 12, 2009, and one or more secured bridge notes in the current principal amount of $330,573 (together the “Notes”).

 

10.153  

Letter Agreement effective as of September 30, 2013 with Cape One Financial regarding their forbearance with respect to the $225,000 10% Senior Secured Convertible Note due March 1, 2010.

 

31.1   Certification of principal executive officer and principal accounting officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002

 

32.1   Certification of principal executive officer and principal accounting officer pursuant to section 906 of the Sarbanes-Oxley Act of 2002

  

24
 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

           
        NaturalNano, Inc.  
           
  Date: November 19, 2013   /s/ James Wemett  
        James Wemett  
       

President and Director

(Principal Executive, Financial and Accounting Officer)

 

  

25

EX-10.148 2 v360860_ex10-148.htm EXHIBIT 10.148

 

NATURALNANO, INC.

NATURALNANO RESEARCH, INC.

 

8% Senior Secured Promissory Note

 

Issuance Date: July 2, 2013
Principal Amount: $2400.00

 

For value received, Naturalnano, inc., a Nevada corporation, and NATURALNANO RESEARCH, INC., a Delaware corporation (jointly and severally, the “Maker”), hereby promises to pay to the order of Platinum Long Term Growth IV, LLC, a Delaware limited liability company with an address of 152 West 57th Street, 54th Floor, New York, NY 10019 (together with its successors, representatives, and permitted assigns, the “Holder”), in accordance with the terms hereinafter provided, the principal amount of Twenty FIVE thousand ($2400.00), together with interest thereon.

 

All payments under or pursuant to this Note shall be made in United States Dollars in immediately available funds to the Holder at the address of the Holder first set forth above or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer of funds to the Holder’s account, as requested by the Holder. The outstanding principal balance of this Note, together with all accrued and unpaid interest, shall be due and payable in full on September 30, 2013 (the “Maturity Date”) or at such earlier time as provided herein.

 

ARTICLE I

PAYMENT

 

Section 1.1 Interest. Beginning on the date of this Note (the “Issuance Date”), the outstanding principal balance of this Note shall bear interest, in arrears, at a rate per annum equal to eight percent (8%), payable in cash on the Maturity Date. Interest shall be computed on the basis of a 360-day year of twelve (12) 30-day months, shall compound monthly and shall accrue commencing on the Issuance Date. Furthermore, upon the occurrence of an Event of Default (as defined in Section 2.1 hereof), the Maker will pay interest to the Holder, payable on demand, on the outstanding principal balance of and unpaid interest on the Note from the date of the Event of Default until such Event of Default is cured at the rate of the lesser of sixteen percent (16%) and the maximum applicable legal rate per annum.

 

Section 1.2 Payment of Principal; Prepayment. The Principal Amount hereof shall be paid in full on the earliest of (i) the Maturity Date, or (ii) upon acceleration of this Note in accordance with the terms hereof. Any amount of principal repaid hereunder may not be reborrowed. The Maker may prepay all or any portion of the principal amount of this Note without premium or penalty.

 

Section 1.3 Security Agreement. The obligations of the Maker hereunder are secured by, among other things, (i) a continuing security interest in certain assets of the Maker pursuant to the terms of a Loan and Security Agreement, dated on or about March 7, 2007 (the “Loan and Security Agreement”), by and among the Maker, on the one hand, and the Holder, certain other investors and Platinum Advisors, LLC, as agent (the “Agent”), on the other hand, (ii) the Pledge Agreement (as defined in the Loan and Security Agreement) and (iii) the Patent Security Agreement, dated as of March 6, 2007, by and among the Maker, the Agent and the other parties named therein ((i), (ii) and (iii), collectively, the “Security Agreements”). Maker hereby ratifies and confirms said Security Agreements and acknowledges and agrees that the term “Obligations” under the Security Agreements includes all indebtedness and obligations of the Maker to the Holder under this Note, which obligations shall be secured on a parity basis with all other obligations secured pursuant to the Security Agreements. The Maker hereby ratifies and confirms the Security Agreements. Maker hereby further authorizes the Holder and the Agent to file one or more financing statements, describing the collateral as “All Assets,” with such governmental authorities as the Holder and/or the Agent may deem necessary or advisable.

 

-1-
 

 

Section 1.4 Payment on Non-Business Days. Whenever any payment to be made shall be due on a Saturday, Sunday or a public holiday under the laws of the State of New York, such payment may be due on the next succeeding business day and such next succeeding day shall be included in the calculation of the amount of accrued interest payable on such date.

 

Section 1.5 Use of Proceeds. The Maker shall use the proceeds of this Note only for general working capital and not to redeem or make any payment on account of any securities of the Maker.

 

Section 1.6 Mandatory Prepayment. Notwithstanding anything to the contrary contained herein, payments on this Note shall be made on a pro rata basis with payments under the $20,000 8% Senior Secured Promissory Note issued as of the date hereof to Longview Special Finance Inc. (the “Other Note”) (based on the principal amount of outstanding hereunder and under the Other Note).

 

ARTICLE II

EVENTS OF DEFAULT; REMEDIES

 

Section 2.1 Events of Default. Unless waived in writing by the holders of at least a majority of the principal amount of this Note and the Other Note, the occurrence of any of the following events shall be an “Event of Default” under this Note:

 

(a) any default in the payment of (1) the principal amount hereunder when due, or (2) interest on this Note when the same shall become due and payable (whether on the Maturity Date, the date of any mandatory prepayment, by acceleration or otherwise); or

 

(b) the Maker shall fail to observe or perform any other covenant or agreement contained in this Note, the Other Note, any existing notes issued to the Holder (the “Existing Notes”) or any of the Security Agreements; or

 

(c) a default or “event of default,” or event that, with the passage of time or giving of notice or both, constitutes or would constitute a default or “event of default,” shall have occurred under any of the Security Agreements, the Other Note or the Existing Notes; or

 

-2-
 

 

(d) any material representation or warranty made by the Maker herein or in the Security Agreements or the Existing Notes shall prove to have been false or incorrect or breached in a material respect on the date as of which made; or

 

(e) the Maker shall (A) default in any payment of any amount or amounts of principal of or interest on any indebtedness (other than the indebtedness hereunder) the aggregate principal amount of which indebtedness is in excess of $50,000 or (B) default in the observance or performance of any other agreement or condition relating to any indebtedness, that, in the aggregate, exceeds $50,000, or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such indebtedness to cause with the giving of notice if required, such Indebtedness to become due prior to its stated maturity; or

 

(f) the Maker shall (i) apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets, (ii) make a general assignment for the benefit of its creditors, (iii) commence a voluntary case under the United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic), (iv) file a petition seeking to take advantage of any bankruptcy, insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors’ rights generally, (v) acquiesce in writing to any petition filed against it in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic), (vi) issue a notice of bankruptcy or winding down of its operations or issue a press release regarding same, or (vii) take any action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing; or

 

(g) a proceeding or case shall be commenced in respect of the Maker, without its application or consent, in any court of competent jurisdiction, seeking (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or readjustment of its debts, (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial part of its assets in connection with the liquidation or dissolution of the Maker or (iii) similar relief in respect of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of thirty (30) days or any order for relief shall be entered in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic) against the Maker or action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing shall be taken with respect to the Maker and shall continue undismissed, or unstayed and in effect for a period of thirty (30) days.

 

Section 2.2 Remedies Upon An Event of Default. If an Event of Default shall have occurred and shall be continuing, the Holder of this Note may, at any time, at its option, declare the entire unpaid principal balance of this Note, together with all interest accrued hereon, due and payable, and thereupon, the same shall be accelerated and so due and payable, without presentment, demand, protest, or notice, all of which are hereby expressly unconditionally and irrevocably waived by the Maker. Upon an Event of Default, the Holder may proceed to exercise all rights and remedies against any and all collateral pledged to the Holder as security for this Note, including all collateral pledged under the Security Agreements. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit a holder’s right to pursue actual damages for any failure by the Maker to comply with the terms of this Note.

 

-3-
 

 

ARTICLE III
MISCELLANEOUS

 

Section 3.1 Notices. Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery, telecopy or facsimile at the address set forth on the signature page hereto (in the case of the Maker) or above (in the case of the Holder) (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.

 

Section 3.2 Governing Law; Drafting; Representation. This Note shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive law of another jurisdiction. This Note shall not be interpreted or construed with any presumption against the party causing this Note to be drafted. It is acknowledged by the Holder and the Maker that Platinum Long Term Growth IV, LLC has retained Burak Anderson & Melloni, PLC to act as its counsel in connection with its investment in and loans to the Maker and that Burak Anderson & Melloni, PLC has not acted as counsel for any party, other than the Platinum Long Term Growth IV, LLC, in connection with such transactions.

 

Section 3.3 Headings. Article and section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a part of this Note for any other purpose.

 

Section 3.4 Binding Effect; Amendments. The obligations of the Maker and the Holder set forth herein shall be binding upon the successors and assigns of each such party. This Note may not be modified or amended in any manner except in writing executed by the Maker and the Holder.

 

Section 3.5 Consent to Jurisdiction. Each of the Maker and the Holder (i) hereby irrevocably submits to the exclusive jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in New York county for the purposes of any suit, action or proceeding arising out of or relating to this Note and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper. Each of the Maker and the Holder consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it hereunder and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section shall affect or limit any right to serve process in any other manner permitted by law.

 

-4-
 

 

Section 3.6 Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.

 

Section 3.7 Maker Waivers; Dispute Resolution. Except as otherwise specifically provided herein, the Maker and all others that may become liable for all or any part of the obligations evidenced by this Note, hereby waive presentment, demand, notice of nonpayment, protest and all other demands’ and notices in connection with the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such persons and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting the liability of the other persons, firms or Maker liable for the payment of this Note, AND DO HEREBY WAIVE TRIAL BY JURY.

 

(a) No delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto, shall operate as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights on any one occasion be deemed a waiver of the same right or rights on any future occasion.

 

(b) THE MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS MAY DESIRE TO USE.

 

Section 3.8 Fees and Expenses. Upon execution of this Note, the Maker shall reimburse the Holder for reasonable and actual legal fees incurred by the Holder in the drafting and negotiation of this Note, together with un-reimbursed legal fees and expenses incurred by the Holder in connection with the Holder’s prior loans to and investments in the Maker (which amount may be withheld by the Holder from amounts to be delivered to the Maker in connection with the issuance of this Note). The Maker will pay on demand all costs of collection and attorneys’ fees paid or incurred by the Holder in enforcing the obligations of the Maker. The Borrower represents and warrants that this Note is the legal, valid and binding obligation of the Borrower, enforceable in accordance with its terms.

 

-5-
 

 

IN WITNESS WHEREOF, the Maker has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.

 

 

  NATURALNANO, INC.
     
     
    Description: JW1
  By:  
  Name: James Wemett
  Title:    CEO/president
     
     
  NATURALNANO RESEARCH, INC.
     
     
    Description: JW1
  By:  
  Name: James Wemett
  Title: CEO//President
     
     
  Address of Maker:
   
  11 Schoen Place
  Pittsford, NY 14534
  Fax: 585-267-4861

 

-6-

 

 

 

EX-10.149 3 v360860_ex10-149.htm EXHIBIT 10.149

 

NATURALNANO, INC.

NATURALNANO RESEARCH, INC.

 

8% Senior Secured Promissory Note

 

Issuance Date:August 14, 2013
Principal Amount:$20,400

 

For value received, Naturalnano, inc., a Nevada corporation, and NATURALNANO RESEARCH, INC., a Delaware corporation (jointly and severally, the “Maker”), hereby promises to pay to the order of Platinum Long Term Growth IV, LLC, a Delaware limited liability company with an address of 152 West 57th Street, 54th Floor, New York, NY 10019 (together with its successors, representatives, and permitted assigns, the “Holder”), in accordance with the terms hereinafter provided, the principal amount of Twenty Thousand four hundred ($20,400), together with interest thereon.

 

All payments under or pursuant to this Note shall be made in United States Dollars in immediately available funds to the Holder at the address of the Holder first set forth above or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer of funds to the Holder’s account, as requested by the Holder. The outstanding principal balance of this Note, together with all accrued and unpaid interest, shall be due and payable in full on November 30, 2013 (the “Maturity Date”) or at such earlier time as provided herein.

 

ARTICLE I

PAYMENT

 

Section 1.1 Interest. Beginning on the date of this Note (the “Issuance Date”), the outstanding principal balance of this Note shall bear interest, in arrears, at a rate per annum equal to eight percent (8%), payable in cash on the Maturity Date. Interest shall be computed on the basis of a 360-day year of twelve (12) 30-day months, shall compound monthly and shall accrue commencing on the Issuance Date. Furthermore, upon the occurrence of an Event of Default (as defined in Section 2.1 hereof), the Maker will pay interest to the Holder, payable on demand, on the outstanding principal balance of and unpaid interest on the Note from the date of the Event of Default until such Event of Default is cured at the rate of the lesser of sixteen percent (16%) and the maximum applicable legal rate per annum.

 

Section 1.2 Payment of Principal; Prepayment. The Principal Amount hereof shall be paid in full on the earliest of (i) the Maturity Date, or (ii) upon acceleration of this Note in accordance with the terms hereof. Any amount of principal repaid hereunder may not be reborrowed. The Maker may prepay all or any portion of the principal amount of this Note without premium or penalty.

 

-1-
 

 

Section 1.3 Security Agreement. The obligations of the Maker hereunder are secured by, among other things, (i) a continuing security interest in certain assets of the Maker pursuant to the terms of a Loan and Security Agreement, dated on or about March 7, 2007 (the “Loan and Security Agreement”), by and among the Maker, on the one hand, and the Holder, certain other investors and Platinum Advisors, LLC, as agent (the “Agent”), on the other hand, (ii) the Pledge Agreement (as defined in the Loan and Security Agreement) and (iii) the Patent Security Agreement, dated as of March 6, 2007, by and among the Maker, the Agent and the other parties named therein ((i), (ii) and (iii), collectively, the “Security Agreements”). Maker hereby ratifies and confirms said Security Agreements and acknowledges and agrees that the term “Obligations” under the Security Agreements includes all indebtedness and obligations of the Maker to the Holder under this Note, which obligations shall be secured on a parity basis with all other obligations secured pursuant to the Security Agreements. The Maker hereby ratifies and confirms the Security Agreements. Maker hereby further authorizes the Holder and the Agent to file one or more financing statements, describing the collateral as “All Assets,” with such governmental authorities as the Holder and/or the Agent may deem necessary or advisable.

 

Section 1.4 Payment on Non-Business Days. Whenever any payment to be made shall be due on a Saturday, Sunday or a public holiday under the laws of the State of New York, such payment may be due on the next succeeding business day and such next succeeding day shall be included in the calculation of the amount of accrued interest payable on such date.

 

Section 1.5 Use of Proceeds. The Maker shall use the proceeds of this Note only for general working capital and not to redeem or make any payment on account of any securities of the Maker.

 

Section 1.6 Mandatory Prepayment. Notwithstanding anything to the contrary contained herein, payments on this Note shall be made on a pro rata basis with payments under the $37,000 8% Senior Secured Promissory Note issued as of the date hereof to Longview Special Finance Inc. (the “Other Note”) (based on the principal amount of outstanding hereunder and under the Other Note).

 

ARTICLE II

EVENTS OF DEFAULT; REMEDIES

 

Section 2.1 Events of Default. Unless waived in writing by the holders of at least a majority of the principal amount of this Note and the Other Note, the occurrence of any of the following events shall be an “Event of Default” under this Note:

 

(a) any default in the payment of (1) the principal amount hereunder when due, or (2) interest on this Note when the same shall become due and payable (whether on the Maturity Date, the date of any mandatory prepayment, by acceleration or otherwise); or

 

(b) the Maker shall fail to observe or perform any other covenant or agreement contained in this Note, the Other Note, any existing notes issued to the Holder (the “Existing Notes”) or any of the Security Agreements; or

 

(c) a default or “event of default,” or event that, with the passage of time or giving of notice or both, constitutes or would constitute a default or “event of default,” shall have occurred under any of the Security Agreements, the Other Note or the Existing Notes; or

 

-2-
 

 

(d) any material representation or warranty made by the Maker herein or in the Security Agreements or the Existing Notes shall prove to have been false or incorrect or breached in a material respect on the date as of which made; or

 

(e) the Maker shall (A) default in any payment of any amount or amounts of principal of or interest on any indebtedness (other than the indebtedness hereunder) the aggregate principal amount of which indebtedness is in excess of $50,000 or (B) default in the observance or performance of any other agreement or condition relating to any indebtedness, that, in the aggregate, exceeds $50,000, or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such indebtedness to cause with the giving of notice if required, such Indebtedness to become due prior to its stated maturity; or

 

(f) the Maker shall (i) apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets, (ii) make a general assignment for the benefit of its creditors, (iii) commence a voluntary case under the United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic), (iv) file a petition seeking to take advantage of any bankruptcy, insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors’ rights generally, (v) acquiesce in writing to any petition filed against it in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic), (vi) issue a notice of bankruptcy or winding down of its operations or issue a press release regarding same, or (vii) take any action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing; or

 

(g) a proceeding or case shall be commenced in respect of the Maker, without its application or consent, in any court of competent jurisdiction, seeking (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or readjustment of its debts, (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial part of its assets in connection with the liquidation or dissolution of the Maker or (iii) similar relief in respect of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of thirty (30) days or any order for relief shall be entered in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic) against the Maker or action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing shall be taken with respect to the Maker and shall continue undismissed, or unstayed and in effect for a period of thirty (30) days.

 

Section 2.2 Remedies Upon An Event of Default. If an Event of Default shall have occurred and shall be continuing, the Holder of this Note may, at any time, at its option, declare the entire unpaid principal balance of this Note, together with all interest accrued hereon, due and payable, and thereupon, the same shall be accelerated and so due and payable, without presentment, demand, protest, or notice, all of which are hereby expressly unconditionally and irrevocably waived by the Maker. Upon an Event of Default, the Holder may proceed to exercise all rights and remedies against any and all collateral pledged to the Holder as security for this Note, including all collateral pledged under the Security Agreements. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit a holder’s right to pursue actual damages for any failure by the Maker to comply with the terms of this Note.

 

-3-
 

 

ARTICLE III
MISCELLANEOUS

 

Section 3.1 Notices. Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery, telecopy or facsimile at the address set forth on the signature page hereto (in the case of the Maker) or above (in the case of the Holder) (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.

 

Section 3.2 Governing Law; Drafting; Representation. This Note shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive law of another jurisdiction. This Note shall not be interpreted or construed with any presumption against the party causing this Note to be drafted. It is acknowledged by the Holder and the Maker that Platinum Long Term Growth IV, LLC has retained Burak Anderson & Melloni, PLC to act as its counsel in connection with its investment in and loans to the Maker and that Burak Anderson & Melloni, PLC has not acted as counsel for any party, other than the Platinum Long Term Growth IV, LLC, in connection with such transactions.

 

Section 3.3 Headings. Article and section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a part of this Note for any other purpose.

 

Section 3.4 Binding Effect; Amendments. The obligations of the Maker and the Holder set forth herein shall be binding upon the successors and assigns of each such party. This Note may not be modified or amended in any manner except in writing executed by the Maker and the Holder.

 

Section 3.5 Consent to Jurisdiction. Each of the Maker and the Holder (i) hereby irrevocably submits to the exclusive jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in New York county for the purposes of any suit, action or proceeding arising out of or relating to this Note and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper. Each of the Maker and the Holder consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it hereunder and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section shall affect or limit any right to serve process in any other manner permitted by law.

 

-4-
 

 

Section 3.6 Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.

 

Section 3.7 Maker Waivers; Dispute Resolution. Except as otherwise specifically provided herein, the Maker and all others that may become liable for all or any part of the obligations evidenced by this Note, hereby waive presentment, demand, notice of nonpayment, protest and all other demands’ and notices in connection with the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such persons and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting the liability of the other persons, firms or Maker liable for the payment of this Note, AND DO HEREBY WAIVE TRIAL BY JURY.

 

(a) No delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto, shall operate as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights on any one occasion be deemed a waiver of the same right or rights on any future occasion.

 

(b) THE MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS MAY DESIRE TO USE.

 

Section 3.8 Fees and Expenses. Upon execution of this Note, the Maker shall reimburse the Holder for reasonable and actual legal fees incurred by the Holder in the drafting and negotiation of this Note, together with un-reimbursed legal fees and expenses incurred by the Holder in connection with the Holder’s prior loans to and investments in the Maker (which amount may be withheld by the Holder from amounts to be delivered to the Maker in connection with the issuance of this Note). The Maker will pay on demand all costs of collection and attorneys’ fees paid or incurred by the Holder in enforcing the obligations of the Maker. The Borrower represents and warrants that this Note is the legal, valid and binding obligation of the Borrower, enforceable in accordance with its terms.

 

-5-
 

 

IN WITNESS WHEREOF, the Maker has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.

 

 

  NATURALNANO, INC.
     
     
    Description: JW2
  By:  
  Name: James Wemett
  Title: CEO/president
     
     
  NATURALNANO RESEARCH, INC.
     
     
    Description: JW2
  By:  
  Name: James Wemett
  Title:    CEO//President
     
     
  Address of Maker:
   
  11 Schoen Place
  Pittsford, NY 14534
  Fax: 585-267-4861

 

-6-

 

 

EX-10.150 4 v360860_ex10-150.htm EXHIBIT 10.150

 

NaturalNano, Inc.
15 Schoen Place
Pittsford, NY 14534

 

September 9, 2013

Alpha Capital

C/o LH Financial 150 Central Park South
2nd Floor

New York, NY 10019

 

Ladies and Gentlemen:

 

This letter shall serve as the agreement and promise of NaturalNano, Inc. (the "Company") to pay to the order of Alpha Capital. ("Alpha"), the sum of $3600.00 plus interest at 8% per annum. The Company acknowledges that Alpha has advanced $3600.00 in funds at the Company's request, and the Company's obligations hereunder shall be secured by all other collateral that secures the various senior secured promissory notes that the Company has previously issued to Longview. In the event the Company fails to repay Alpha in accordance with the terms of this letter, Alpha should be entitled to exercise all rights granted to it as a secured creditor pursuant to the Security Agreements (as defined in the 8% Senior Secured Promissory Note issued to Longview by the Company on or about November 5, 2008).

 

All payments under or pursuant to this Note shall be made in United States Dollars, in immediately available funds, to Longview at the address set forth above or at such other place as Longview may designate from time to time in writing to the Company or by wire transfer of funds to Longview's account, as requested by Longview. The outstanding principal balance of this Note, together with all accrued and unpaid interest, shall be due and payable in full on November 30, 2013.

 

  Very truly yours,
   
  Natural Nano, Inc.
   
   
 
  Name: James Wemett
  Title: CEO

 

 

 

  

EX-10.151 5 v360860_ex10-151.htm EXHIBIT 10.151

 

NATURALNANO, INC.

NATURALNANO RESEARCH, INC.

 

8% Senior Secured Promissory Note

 

Issuance Date:October 15, 2013
Principal Amount:$14,025

 

For value received, Naturalnano, inc., a Nevada corporation, and NATURALNANO RESEARCH, INC., a Delaware corporation (jointly and severally, the “Maker”), hereby promises to pay to the order of Platinum Long Term Growth IV, LLC, a Delaware limited liability company with an address of 152 West 57th Street, 54th Floor, New York, NY 10019 (together with its successors, representatives, and permitted assigns, the “Holder”), in accordance with the terms hereinafter provided, the principal amount of fourteen thousand Twenty Five($14,025), together with interest thereon.

 

All payments under or pursuant to this Note shall be made in United States Dollars in immediately available funds to the Holder at the address of the Holder first set forth above or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer of funds to the Holder’s account, as requested by the Holder. The outstanding principal balance of this Note, together with all accrued and unpaid interest, shall be due and payable in full on JANUARY 30, 2014 (the “Maturity Date”) or at such earlier time as provided herein.

 

ARTICLE I 

PAYMENT

 

Section 1.1            Interest. Beginning on the date of this Note (the “Issuance Date”), the outstanding principal balance of this Note shall bear interest, in arrears, at a rate per annum equal to eight percent (8%), payable in cash on the Maturity Date. Interest shall be computed on the basis of a 360-day year of twelve (12) 30-day months, shall compound monthly and shall accrue commencing on the Issuance Date. Furthermore, upon the occurrence of an Event of Default (as defined in Section 2.1 hereof), the Maker will pay interest to the Holder, payable on demand, on the outstanding principal balance of and unpaid interest on the Note from the date of the Event of Default until such Event of Default is cured at the rate of the lesser of sixteen percent (16%) and the maximum applicable legal rate per annum.

 

Section 1.2            Payment of Principal; Prepayment. The Principal Amount hereof shall be paid in full on the earliest of (i) the Maturity Date, or (ii) upon acceleration of this Note in accordance with the terms hereof. Any amount of principal repaid hereunder may not be reborrowed. The Maker may prepay all or any portion of the principal amount of this Note without premium or penalty.

 

-1-
 

 

Section 1.3            Security Agreement. The obligations of the Maker hereunder are secured by, among other things, (i) a continuing security interest in certain assets of the Maker pursuant to the terms of a Loan and Security Agreement, dated on or about March 7, 2007 (the “Loan and Security Agreement”), by and among the Maker, on the one hand, and the Holder, certain other investors and Platinum Advisors, LLC, as agent (the “Agent”), on the other hand, (ii) the Pledge Agreement (as defined in the Loan and Security Agreement) and (iii) the Patent Security Agreement, dated as of March 6, 2007, by and among the Maker, the Agent and the other parties named therein ((i), (ii) and (iii), collectively, the “Security Agreements”). Maker hereby ratifies and confirms said Security Agreements and acknowledges and agrees that the term “Obligations” under the Security Agreements includes all indebtedness and obligations of the Maker to the Holder under this Note, which obligations shall be secured on a parity basis with all other obligations secured pursuant to the Security Agreements. The Maker hereby ratifies and confirms the Security Agreements. Maker hereby further authorizes the Holder and the Agent to file one or more financing statements, describing the collateral as “All Assets,” with such governmental authorities as the Holder and/or the Agent may deem necessary or advisable.

 

Section 1.4            Payment on Non-Business Days. Whenever any payment to be made shall be due on a Saturday, Sunday or a public holiday under the laws of the State of New York, such payment may be due on the next succeeding business day and such next succeeding day shall be included in the calculation of the amount of accrued interest payable on such date.

 

Section 1.5            Use of Proceeds. The Maker shall use the proceeds of this Note only for general working capital and not to redeem or make any payment on account of any securities of the Maker.

 

Section 1.6            Mandatory Prepayment. Notwithstanding anything to the contrary contained herein, payments on this Note shall be made on a pro rata basis with payments under the $37,000 8% Senior Secured Promissory Note issued as of the date hereof to Longview Special Finance Inc. (the “Other Note”) (based on the principal amount of outstanding hereunder and under the Other Note).

 

ARTICLE II 

EVENTS OF DEFAULT; REMEDIES

 

Section 2.1            Events of Default. Unless waived in writing by the holders of at least a majority of the principal amount of this Note and the Other Note, the occurrence of any of the following events shall be an “Event of Default” under this Note:

 

(a)                any default in the payment of (1) the principal amount hereunder when due, or (2) interest on this Note when the same shall become due and payable (whether on the Maturity Date, the date of any mandatory prepayment, by acceleration or otherwise); or

 

(b)               the Maker shall fail to observe or perform any other covenant or agreement contained in this Note, the Other Note, any existing notes issued to the Holder (the “Existing Notes”) or any of the Security Agreements; or

 

(c)                a default or “event of default,” or event that, with the passage of time or giving of notice or both, constitutes or would constitute a default or “event of default,” shall have occurred under any of the Security Agreements, the Other Note or the Existing Notes; or

 

-2-
 

 

(d)               any material representation or warranty made by the Maker herein or in the Security Agreements or the Existing Notes shall prove to have been false or incorrect or breached in a material respect on the date as of which made; or

 

(e)                the Maker shall (A) default in any payment of any amount or amounts of principal of or interest on any indebtedness (other than the indebtedness hereunder) the aggregate principal amount of which indebtedness is in excess of $50,000 or (B) default in the observance or performance of any other agreement or condition relating to any indebtedness, that, in the aggregate, exceeds $50,000, or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such indebtedness to cause with the giving of notice if required, such Indebtedness to become due prior to its stated maturity; or

 

(f)                the Maker shall (i) apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets, (ii) make a general assignment for the benefit of its creditors, (iii) commence a voluntary case under the United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic), (iv) file a petition seeking to take advantage of any bankruptcy, insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors’ rights generally, (v) acquiesce in writing to any petition filed against it in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic), (vi) issue a notice of bankruptcy or winding down of its operations or issue a press release regarding same, or (vii) take any action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing; or

 

(g)               a proceeding or case shall be commenced in respect of the Maker, without its application or consent, in any court of competent jurisdiction, seeking (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or readjustment of its debts, (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial part of its assets in connection with the liquidation or dissolution of the Maker or (iii) similar relief in respect of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of thirty (30) days or any order for relief shall be entered in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic) against the Maker or action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing shall be taken with respect to the Maker and shall continue undismissed, or unstayed and in effect for a period of thirty (30) days.

 

Section 2.2            Remedies Upon An Event of Default. If an Event of Default shall have occurred and shall be continuing, the Holder of this Note may, at any time, at its option, declare the entire unpaid principal balance of this Note, together with all interest accrued hereon, due and payable, and thereupon, the same shall be accelerated and so due and payable, without presentment, demand, protest, or notice, all of which are hereby expressly unconditionally and irrevocably waived by the Maker. Upon an Event of Default, the Holder may proceed to exercise all rights and remedies against any and all collateral pledged to the Holder as security for this Note, including all collateral pledged under the Security Agreements. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit a holder’s right to pursue actual damages for any failure by the Maker to comply with the terms of this Note.

 

-3-
 

 

ARTICLE III
MISCELLANEOUS

 

Section 3.1            Notices. Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery, telecopy or facsimile at the address set forth on the signature page hereto (in the case of the Maker) or above (in the case of the Holder) (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.

 

Section 3.2            Governing Law; Drafting; Representation. This Note shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive law of another jurisdiction. This Note shall not be interpreted or construed with any presumption against the party causing this Note to be drafted. It is acknowledged by the Holder and the Maker that Platinum Long Term Growth IV, LLC has retained Burak Anderson & Melloni, PLC to act as its counsel in connection with its investment in and loans to the Maker and that Burak Anderson & Melloni, PLC has not acted as counsel for any party, other than the Platinum Long Term Growth IV, LLC, in connection with such transactions.

 

Section 3.3            Headings. Article and section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a part of this Note for any other purpose.

 

Section 3.4            Binding Effect; Amendments. The obligations of the Maker and the Holder set forth herein shall be binding upon the successors and assigns of each such party. This Note may not be modified or amended in any manner except in writing executed by the Maker and the Holder.

 

Section 3.5            Consent to Jurisdiction. Each of the Maker and the Holder (i) hereby irrevocably submits to the exclusive jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in New York county for the purposes of any suit, action or proceeding arising out of or relating to this Note and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper. Each of the Maker and the Holder consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it hereunder and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section shall affect or limit any right to serve process in any other manner permitted by law.

 

-4-
 

 

Section 3.6            Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.

 

Section 3.7            Maker Waivers; Dispute Resolution. Except as otherwise specifically provided herein, the Maker and all others that may become liable for all or any part of the obligations evidenced by this Note, hereby waive presentment, demand, notice of nonpayment, protest and all other demands’ and notices in connection with the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such persons and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting the liability of the other persons, firms or Maker liable for the payment of this Note, AND DO HEREBY WAIVE TRIAL BY JURY.

 

(a)                No delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto, shall operate as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights on any one occasion be deemed a waiver of the same right or rights on any future occasion.

 

(b)               THE MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS MAY DESIRE TO USE.

 

Section 3.8            Fees and Expenses. Upon execution of this Note, the Maker shall reimburse the Holder for reasonable and actual legal fees incurred by the Holder in the drafting and negotiation of this Note, together with un-reimbursed legal fees and expenses incurred by the Holder in connection with the Holder’s prior loans to and investments in the Maker (which amount may be withheld by the Holder from amounts to be delivered to the Maker in connection with the issuance of this Note). The Maker will pay on demand all costs of collection and attorneys’ fees paid or incurred by the Holder in enforcing the obligations of the Maker. The Borrower represents and warrants that this Note is the legal, valid and binding obligation of the Borrower, enforceable in accordance with its terms.

 

-5-
 

 

IN WITNESS WHEREOF, the Maker has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.

 

  NATURALNANO, INC.
     
     
    Description: JW2
  By:  
  Name: James Wemett
  Title: CEO/president
     
     
  NATURALNANO RESEARCH, INC.
     
     
    Description: JW2
  By:  
  Name: James Wemett
  Title:    CEO//President
     
     
  Address of Maker:
   
  11 Schoen Place
  Pittsford,NY 14534
  Fax:585-267-4861

 

-6-

 

EX-10.152 6 v360860_ex10-152.htm EXHIBIT 10.152

 

PLATINUM LONG TERM GROWTH IV, LLC

152 WEST 57TH STREET, 54TH FLOOR

NEW YORK, NEW YORK 10019

 

VIA FACSIMILE AND FIRST CLASS MAIL

 

Effective as of September 30, 2013

 

Re: FORBEARANCE AGREEMENT

 

Ladies and Gentlemen:

 

Reference is made to the $2,750,000 8% Senior Secured Promissory Note, issued on or about March 6, 2007, the $150,000 8% Senior Secured Promissory, issued on or about August 4, 2008, the $190,000 Senior Secured Promissory Note, issued on or about September 29, 2008, the $59,500 Senior Secured Promissory Note, issued on or about October 31, the $136,376 8% Senior Secured Promissory Note, issued on or about April 3, 2009, the $5,000 8% Senior Secured Promissory Note, issued on or about April 17, 2009, the $15,000 8% Senior Secured Promissory Note, issued on or about May 12, 2009, the $25,000 8% Senior Secured Promissory Note, issued on or about October 2, 2009, the $20,000 8% senior secured promissory note, issued on or about July 1, 2010, the $16,923 8% Senior Secured Promissory Note, issued on or about October 20, 2010, the $51,000 8% Senior Secured Promissory Note, issued on or about November 12, 2010, the $15,000 8% Senior Secured Promissory Note, issued on or about January 26, 2011, the $12,750 8% Senior Secured Promissory Note, issued on or about April 15, 2011, the $15,000 8% Senior Secured Promissory Note, issued on or about September 21, 2011, the $15,000 8% senior secured Promissary note, issued on or about October 11, 2011, the $15,000 8% Senior Secured Promissory Note, issued on or about December 6, 2011, the $15,000 8% Senior Secured Promissory Note, issued on or about December 19, 2011, the $25,000 8% Senior Secured Promissory Note, issued on or about February 10, 2012, the $12,000 8% Senior Secured Promissory Note, issued on or about March 7, 2012, the $15,000 8% Senior Secured Promissory Note, issued on or about April 16, 2012, and the $20,000 8% Senior Secured Promissory note, issued on or about May 15, 2012, on or about July 20 for $7,000, and on or about October 17, 2012 for $13,500, and on or about November 15, 2012 for $12,500, and on or about February 7, 2013 for $17,500, $2400 on or about July 2, 2013, $12,000 on or about July 25, 2013, and $20,400 on or about August 14, 2013 (together the “Notes”) from NaturalNano, Inc. and NaturalNano Research, Inc. (jointly and severally, the “Borrower”) to Platinum Long Term Growth IV, LLC (the “Lender”). Capitalized terms used herein and not otherwise defined shall have the respective meanings given in the Notes.

 

The Borrower has requested that the Lender forbear from exercising its various rights and remedies under the Notes and other related documents (collectively, the “Loan Documents”) that may otherwise be exercised by the Lender, in order to provide the Borrower with additional time during which it may resolve its current financial problems.

 

The Lender is prepared to forbear from demanding payment of principal on the Notes on the Maturity Date of the Notes, or taking any other action to collect the principal amount of the Notes (other than conversions in respect thereof) until the earlier of December 31, 2013 (unless extended by the Lender in its discretion) or the termination of the Forbearance Period pursuant to the terms of this Letter Agreement (such period, the “Forbearance Period”), provided the Borrower accepts and agrees to the terms, conditions and covenants set forth herein, and communicates such acceptance (by delivering a signed copy of this Letter Agreement) to the Lender no later than 5:00 p.m. on December 31, 2013; provided further that it is understood that the Borrower is not obligated to make all interest payments required under the Notes during the Forbearance Period.

 

 
 

 

Upon execution by the Borrower, this letter shall be a binding agreement among the respective parties hereto (referred to as the “Letter Agreement”).

 

By its execution, the Borrower represents, warrants and covenants as follows:

 

1. No Duress. The Borrower has freely and voluntarily entered into this Letter Agreement after an adequate opportunity to review and discuss the terms and conditions and all factual and legal matters relevant hereto with counsel freely and independently chosen by it and this Letter Agreement is being executed without fraud, duress, undue influence or coercion of any kind or nature whatsoever having been exerted by or imposed upon any party.

 

2. Amount Due. The Borrower acknowledges and agrees that the Borrower owes the Lender $2,700,605.62 (the “Outstanding Amount”) as of September 30, 2013. The Borrower shall also be responsible for reimbursing the Lender for all costs and expenses, including the fees and expenses of legal counsel that may be incurred in connection with the enforcement of this Letter Agreement, which, if incurred, shall be added to the Outstanding Amount. The Borrower acknowledges and agrees that the Outstanding Amount (as reduced by payments made pursuant hereto), plus interest accrued thereon, shall be due and owing upon termination of the Forbearance Period.

 

3. No Defenses. The Borrower has no defenses, affirmative or otherwise, rights of setoff, rights of recoupment, claims, counterclaims, or causes of action of any kind or nature whatsoever against the Lender, its officers, directors, employees, attorneys, legal representatives or affiliates (collectively, the “Lender Group”), directly or indirectly, arising out of, based upon, or in any manner connected with, any transaction, event, circumstance, action, failure to act, or occurrence of any sort or type, whether known or unknown, which occurred, existed, was taken, permitted, or began prior to the execution of this Letter Agreement and accrued, existed, was taken, permitted or begun in accordance with, pursuant to, or by virtue of the Notes or any of the terms or conditions of the Loan Documents, or which directly or indirectly relate to or arise out of or in any manner are connected with the Notes or any of the Loan Documents; TO THE EXTENT ANY SUCH DEFENSES, AFFIRMATIVE OR OTHERWISE, RIGHTS OF SETOFF, RIGHTS OF RECOUPMENT, CLAIMS, COUNTERCLAIMS, OR CAUSES OF ACTION EXIST, SUCH DEFENSES, RIGHTS, CLAIMS, COUNTERCLAIMS, AND CAUSES OF ACTION ARE HEREBY FOREVER WAIVED, DISCHARGED AND RELEASED.

 

4. Interest Continues to Accrue. During the Forbearance Period, the Outstanding Amount shall bear interest at the interest rate set forth under the Notes (8%); it being understood that the default rate shall apply upon the occurrence of any Event of Default (other than Existing Defaults) thereunder or upon termination of the Forbearance Period.

 

 
 

 

5. Other Notes. The Borrower agrees that it shall not provide any holder of the Notes issued on or about March 6, 2007, August 5, 2008, September 29, 2008 or October 31, 2008 or any other promissory note (collectively, the “Other Notes”) any concession or payment with respect to such Other Notes without first offering the Lender the opportunity to receive such payment or concession with respect to the Notes.

 

6. Adjustment of Conversion Prices and Ratios. In consideration of the agreement of the Lender to forbear from exercising its rights and remedies as is set forth herein, (i) the Borrowers covenant and agree that, with respect to any Note that is convertible pursuant to its terms, the Conversion Price (as defined and as set forth in the Notes) is, effective as of the date hereof, hereafter reduced to the lowest of (A) 75% of the lowest of the average VWAP (as defined in such Notes) for the one business day, five business day or ten business day period immediately preceding the date of the conversion request, such period to be selected by the Lender, or (B) $0.01 per share, effective as of the date hereof, which $0.01 per share Conversion Price shall be subject to such further adjustment as may be set forth in the Notes, and (ii) within five (5) business days of the date hereof, NaturalNano, Inc. shall cause an amendment to the Amended and Restated Certificate of Designations (the “Certificate of Designations”) of the Rights, Preferences, Designations, Qualifications and Limitations of the Series C Preferred Stock, par value $0.01 per share, of NaturalNano, Inc. to provide that each of the 4,250,000 shares of Series C Preferred Stock held by the Lender shall convert into 160 shares of Common Stock of NaturalNano, Inc. (or an aggregate of 680,000,000 shares of Common Stock of NaturalNano, Inc.).

 

7. Beneficial Ownership Provisions. The Lender and the Borrower agree that the conversion restriction set forth in Section 7(a) of the Certificate of Designations shall be deemed waived by the Lender, which waiver shall be deemed effective immediately, notwithstanding the provisions of such Section 7(a); provided, that, it is understood and agreed that the limitations set forth in Section 7(b) of the Certificate of Designations shall remain in full force and effect. Further, the 4.99% Limitation, as set forth and as defined in Notes convertible pursuant to their terms shall be deemed waived by the Lender, which waiver shall be deemed effective immediately, notwithstanding the provisions of such Notes requiring at least 61 days’ advance written notice; provided, that, it is understood and agreed that in no event shall the Lender be entitled to convert such Notes into shares of Common Stock to the extent such conversion would result in the beneficial ownership of more than 9.99% of the then outstanding number of shares of Common Stock on such date without providing at least 61 days’ advance written notice to the Borrowers that the Lender elects to waive such restriction with respect to all or a portion of such Notes. For purposes hereof, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934 and Regulation 13d-3 thereunder.

 

Forbearance. During the Forbearance Period, the Lender agrees that it will not take any further action against the Borrower or exercise or move to enforce any other rights or remedies provided for in the Loan Documents or otherwise available to it, at law or in equity, by virtue of the occurrence and/or continuation of any default or Event of Default under the Notes existing on the date hereof, including any default relating to the Borrower’s failure to maintain the effectiveness of any registration statement (the “Existing Defaults”), or take any action against any property in which the Borrower has any interest.

 

 
 

 

Lender to Retain all Rights. It is understood and agreed that this Letter Agreement does not waive or evidence consent to any default or Event of Default (including the Existing Defaults) under the Notes or the Loan Documents. The parties hereto acknowledge and agree that the Lender (i) shall retain all rights and remedies it may now have with respect to the Notes and the Borrower’s obligations under the Loan Documents (“Default Rights”), and (ii) shall have the right to exercise and enforce such Default Rights upon termination of the Forbearance Period. The parties further agree that the exercise of any Default Rights by the Lender upon termination of the Forbearance Period shall not be affected by reason of this Letter Agreement, and the parties hereto shall not assert as a defense thereto the passage of time, estoppel, laches or any statute of limitations to the extent that the exercise of any Default Rights was precluded by this Letter Agreement.

 

Termination of Forbearance Period. The Forbearance Period shall terminate upon the earlier to occur of: (1) 5:00 pm (New York City Time) on November 30, 2013; (2) the Borrower shall fail to observe, perform, or comply with any of the terms, conditions or provisions of this Letter Agreement as and when required and/or any other Event of Default (other than the Existing Defaults occurring prior to the date hereof) shall occur under the Notes or any of the Loan Documents or any other agreement between the Borrower and the Lender (or its affiliates) or any other indebtedness issued by the Borrower to the Lender or its affiliates; (3) any representation or warranty made herein, in any document executed and delivered in connection herewith, or in any report, certificate, financial statement or other instrument or document now or hereafter furnished by or on behalf of the Borrower in connection with this Letter Agreement, shall prove to have been false, incomplete or misleading in any material respect on the date as of which it was made; (4) any suit preceding or other action is commenced by any other creditor against the Company; (5) any default or event of default shall occur under any other indebtedness of the Company, including the Subordinated Notes issued on or about November 2009 or the “Transaction Documents” referred to therein; or (6) a court of competent jurisdiction shall enter an order for relief or take any similar action in respect of the Borrower in an involuntary case under any applicable bankruptcy, insolvency, reorganization, moratorium or similar law now or hereafter in effect or a petition for relief under any applicable bankruptcy, insolvency, reorganization, moratorium or other similar law shall be filed by or against the Borrower.

 

Upon termination of the Forbearance Period, should the Notes or any of the Borrower’s obligations under the Loan Documents not be satisfied in full, the Lender shall be entitled to pursue immediately its various rights and remedies, including its Default Rights, against the Borrower, all collateral given by the Borrower to secure the Loan and the obligations under the Loan Documents, without regard to notice and cure periods, all of which are hereby waived by the Borrower. Without limiting the generality of the foregoing, upon termination of the Forbearance Period, the Lender shall be permitted to immediately exercise its rights to demand and collect on the Outstanding Amount.

 

 
 

 

If the foregoing is acceptable to you, please sign in the space provided below.

 

  Sincerely,
     
  PLATINUM LONG TERM GROWTH IV LLC
     
  By:
    Name:
    Title:

 

 

Accepted and Agreed as of the executed date above

 

NATURALNANO, INC.

 

By:

Name: JAMES WEMETT

Title: CEO

 

 

NATURALNANO RESEARCH, INC.

 

By

Name: JAMES WEMETT

Title: CEO

 

 

 

 

 

 

EX-10.153 7 v360860_ex10-153.htm EXHIBIT 10.153

  

Cape One Financial Master Fund LTD

  

410 Park Avenue, 15TH floor

New York, New York 10022

 

Via Facsimile and First Class Mail

 

Effective September 30, 2013                   

 

Re:       FORBEARANCE AGREEMENT

 

Ladies and Gentlemen:

 

Reference is made to the $225,000 8% Senior Secured Convertible Note due March 1, 2010, issued on or about November 30, 2009 and the $30,000 added to principle on or about March 8., 2011 from NaturalNano, Inc. and NaturalNano Research, Inc. (jointly and severally, the “Borrower”) and $25,000 January 17, 2012, and the $30,000 June 30, 2012 and the $30,000 January 17, 2013 to Cape One Financial Master Fund LTD (the “Lender”). Capitalized terms used herein and not otherwise defined shall have the respective meanings given in the Notes.

 

The Borrower has requested that the Lender forbear from exercising its various rights and remedies under the Notes and other related documents (collectively, the “Loan Documents”) that may otherwise be exercised by the Lender on the date hereof, in order to provide the Borrower with additional time during which it may resolve its current financial problems.

 

The Lender is prepared to forbear from demanding payment of principal on the Notes on the Maturity Date of the Notes, or taking any other action to collect the principal amount of the Notes until the earlier of November 30, 2013 (unless extended by the Lender in its discretion) or the termination of the Forbearance Period pursuant to the terms of this Letter Agreement (such period, the “Forbearance Period”), provided the Borrower accepts and agrees to the terms, conditions and covenants set forth herein, and communicates such acceptance (by delivering a signed copy of this Letter Agreement) to the Lender no later than 5:00 p.m. on November 30, 2013; provided further it is understood that Borrower is not obligated to make any interest payments required under the Notes during the Forbearance Period.

 

Upon execution by the Borrower, this letter shall be a binding agreement among the respective parties hereto (referred to as the “Letter Agreement”).

 

 
 

 

By its execution, the Borrower represents warrants and covenants as follows:

 

1.          No Duress. The Borrower has freely and voluntarily entered into this Letter Agreement after an adequate opportunity to review and discuss the terms and conditions and all factual and legal matters relevant hereto with counsel freely and independently chosen by it and this Letter Agreement is being executed without fraud, duress, undue influence or coercion of any kind or nature whatsoever having been exerted by or imposed upon any party.

 

2.          Amount Due. The Borrower does not contest the amounts outstanding under the Notes as set forth in the Lender’s books and records (the “Outstanding Amount”). The Borrower shall also be responsible for reimbursing the Lender for all costs and expenses, including the fees and expenses of legal counsel that may be incurred in connection with the enforcement of this Letter Agreement, which, if incurred, shall be added to the Outstanding Amount. The Borrower acknowledges and agrees that the Outstanding Amount, plus interest accrued thereon, shall be due and owing upon termination of the Forbearance Period.

 

3.          No Defenses. The Borrower has no defenses, affirmative or otherwise, rights of setoff, rights of recoupment, claims, counterclaims, or causes of action of any kind or nature whatsoever against the Lender, its officers, directors, employees, attorneys, legal representatives or affiliates (collectively, the “Lender Group”), directly or indirectly, arising out of, based upon, or in any manner connected with, any transaction, event, circumstance, action, failure to act, or occurrence of any sort or type, whether known or unknown, which occurred, existed, was taken, permitted, or began prior to the execution of this Letter Agreement and accrued, existed, was taken, permitted or begun in accordance with, pursuant to, or by virtue of the Notes or any of the terms or conditions of the Loan Documents, or which directly or indirectly relate to or arise out of or in any manner are connected with the Notes or any of the Loan Documents; TO THE EXTENT ANY SUCH DEFENSES, AFFIRMATIVE OR OTHERWISE, RIGHTS OF SETOFF, RIGHTS OF RECOUPMENT, CLAIMS, COUNTERCLAIMS, OR CAUSES OF ACTION EXIST, SUCH DEFENSES, RIGHTS, CLAIMS, COUNTERCLAIMS, AND CAUSES OF ACTION ARE HEREBY FOREVER WAIVED, DISCHARGED AND RELEASED.

 

4.          Interest Continues to Accrue. During the Forbearance Period, the Outstanding Amount shall bear interest at a new interest rate under the Notes of eighteen percent (18%).

 

5.          Other Notes. none

 

6.          Forbearance. During the Forbearance Period, the Lender agrees that it will not take any further action against the Borrower or exercise or move to enforce any other rights or remedies provided for in the Loan Documents or otherwise available to it, at law or in equity, by virtue of the occurrence and/or continuation of any default or Event of Default under the Notes existing on the date hereof, including any default relating to the Borrower’s failure to maintain the effectiveness of any registration statement (the “Existing Defaults”), or take any action against any property in which the Borrower has any interest.

 

 
 

 

7.          Lender to Retain all Rights. It is understood and agreed that this Letter Agreement does not waive or evidence consent to any default or Event of Default (including the Existing Defaults) under the Notes or the Loan Documents. The parties hereto acknowledge and agree that the Lender (i) shall retain all rights and remedies it may now have with respect to the Notes and the Borrower’s obligations under the Loan Documents (“Default Rights”), and (ii) shall have the right to exercise and enforce such Default Rights upon termination of the Forbearance Period. The parties further agree that the exercise of any Default Rights by the Lender upon termination of the Forbearance Period shall not be affected by reason of this Letter Agreement, and the parties hereto shall not assert as a defense thereto the passage of time, estoppel, laches or any statute of limitations to the extent that the exercise of any Default Rights was precluded by this Letter Agreement.

 

8.          Termination of Forbearance Period. The Forbearance Period shall terminate upon the earlier to occur of: (1) 5:00 pm (New York City Time) on November 30, 2013; (2) the Borrower shall fail to observe, perform, or comply with any of the terms, conditions or provisions of this Letter Agreement as and when required and/or any other Event of Default (other than the Existing Defaults occurring prior to the date hereof) shall occur under the Notes or any of the Loan Documents or any other agreement between the Borrower and the Lender (or its affiliates) or any other indebtedness issued by the Borrower to the Lender or its affiliates; (3) any representation or warranty made herein, in any document executed and delivered in connection herewith, or in any report, certificate, financial statement or other instrument or document now or hereafter furnished by or on behalf of the Borrower in connection with this Letter Agreement, shall prove to have been false, incomplete or misleading in any material respect on the date as of which it was made; (4) any suit preceding or other action is commenced by any other creditor against the Company; or (5) a court of competent jurisdiction shall enter an order for relief or take any similar action in respect of the Borrower in an involuntary case under any applicable bankruptcy, insolvency, reorganization, moratorium or similar law now or hereafter in effect or a petition for relief under any applicable bankruptcy, insolvency, reorganization, moratorium or other similar law shall be filed by or against the Borrower.

 

Upon termination of the Forbearance Period, should the Notes or any of the Borrower’s obligations under the Loan Documents not be satisfied in full, the Lender shall be entitled to pursue immediately its various rights and remedies, including its Default Rights, against the Borrower, all collateral given by the Borrower to secure the Loan and the obligations under the Loan Documents, without regard to notice and cure periods, all of which are hereby waived by the Borrower. Without limiting the generality of the foregoing, upon termination of the Forbearance Period, the Lender shall be permitted to immediately exercise its rights to demand and collect on the Outstanding Amount. If the foregoing is acceptable to you, please sign in the space provided below.

 

    Sincerely,
     
    Cape One Financial Advisors, LLC
       
    By: /s/ Reid Drescher
      Name:  Reid Drescher
      Title: Managing Member

 

 
 

 

Accepted and Agreed as date above  
     
NATURALNANO, INC.  
   
By:   
  Name:  
  Title:  
     
NATURALNANO RESEARCH, INC.  
   
By:   
  Name:  
  Title:  

 

 

 

EX-31.1 8 v360860_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

 

CERTIFICATION OF

PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER

PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, James Wemett, certify that:

 

1) I have reviewed this quarterly report on Form 10-Q of NaturalNano, Inc. (the “registrant”) for the period ended September 30, 2013,

 

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4) As the registrant's certifying officer I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5) As the registrant's certifying officer, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 19, 2013

 

By: /s/ James Wemett
Name:    James Wemett
Title:  President
  (Principal Executive, Financial and Accounting Officer)

 

 

EX-32.1 9 v360860_ex32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of NaturalNano, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report"), I, James Wemett, President of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 19, 2013

 

By: /s/ James Wemett
Name:    James Wemett
Title:  President
  (Principal Executive, Financial and Accounting Officer)

 

 

GRAPHIC 10 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX. M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_ MP``+"`!>`1H!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+ M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$( M(T*QP152T?`D,V)R@@D*%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9J**************2A?NCZ4M%%%%)2TE+1244=:*.* M,4<49YI:********1F"J68@`#))[5GC4IKE2^G6OGQ8)$COY:O\`[O!)^N,> M]6;&[2_L8+J,$),@<`]1D=#5BBBBBD7[H^E+1112>M%':BBBBBBBBBBCKWI: M********S)%_M:[DA?FR@;:Z_P#/9_[I_P!D<9'<\=CF?4I6BLF2'_7R_NHA M_M'O^'7Z"I[6W2SM(;>(8CB0(H]@,"I:****1?NCZ4M%%%)110***.U&***. MW-'THQFC%&3Z4M%%%%%%07LYMK.64#+*ORCU8\`?GBBUA6SLTC+<(OS,>YZD MG\RGJ_P!3_+ZFK]%%06UW%=F3R265&*%\?*2."`>^ M#Q4])4%Q>0VB1^:WSR':B*,LY]`*F0L4!9=I/;.<4ZBBBBD)QU.!33*@/+J/ MQIIN80>9HQ_P(4?:H.\T?_?8H^TP]YH_^^Q2^='VD3/^\*>&!Z'/THH[444= M^:,'U-+1124M%%9^J$M+80@@>9>."-@J2RKM$A[X'7CWQ44NLFXF-OI$0NI02KS9Q# M$?\`:;N?]E&`.2/K5&\LKR:]$B7< M@MMFTPH0A!_O;L$GMQQTJK=0:79H#J%W<1#.!Y]Y(,_3YN:HO>:"K`0P:A=- MZ11W$GZ]*UQH6G.%8V@R>0&+$C]:<-$TU<_Z%`?7*Y_G3_['TX'/V&US_P!< ME_PI1I6GX.+&UYY/[E?\*7^R[#'_`!XVW_?E?\*7^S;+G_0[?'_7)?\`"@Z= M9GK:6Y)_Z9K_`(4?V;9CI:PCZ(!2BQ@7&V(#'3!(J1844?+N'_`C3MO&,G\Z M4#GJ:7%'^>M+124M)10.E9FJ"2:6%K979K9]TA09(4@@A?5L'/X>XJQ;WUB( M56&XA"K\H4O@CV(/.:'U*'!^SAKAO2/D?BW0?G5"*X6TNGN=1UN)5?\`Y=BZ M"-/3!QN)_'GTIT^OM+%)_9%E/?2*I(;:8XLC_;;&?^`YJ/26N8=.B@M+:0S' MYY[BZ0Q@R-RQV_>)R3QT[9HO]"N)Q%+%<+-=!_WDLQ*D)CE8]OW.<<@9QGGO M4Z:*;B!(M0E#0J,"U@S'"!Z'NWXG'M5@BZB`@L[6WBB3A6+_`"@=L*!^F15" M;PZUS>QWLMWYDXB$962(-'@'(PF1R#GJ35]M,$^/M=Q-,,8*;MB'\%QG\BCK1_.C%'Z4$48&**.] M&WW/YTM%%%%%5WE::0PP]!P\@_A]A[_RJM+JEC8,+2-FEG`X@A4R/^('3ZG% M0O'J>H$92+3X_P"\0)9OP_A7_P`>I\/AK2HH4C:RBF*\EYEWLQZDDGJ2:MPZ M;96[;H+2WC;U2)0?T%6*6BBDH7[H^E+1112=N:/I11UHHZ4M)]*.U'6B@?G0 M<4>M+11114<]Q#:PF6XE2*->K.P`'XFLIM4NM2VC1[;?`PYNIB8T/^Z,;C]< M8]ZDBT>22,+?7I`_N@M=/$4@FN7\^X`P&(PL8]$7L/U]ZNTE+1 M111111124+]T?2EHHHI,<4=J.U'-'2BCM11Z4E+11248YZ+3J*********** M****1?NCZ4M%%)1VHHH%%%+2&COTHH[F:*.HI:0\"CFEK__9 ` end GRAPHIC 11 image_002.jpg GRAPHIC begin 644 image_002.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX. M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_ MP``+"`!>`1H!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+ M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$( M(T*QP152T?`D,V)R@@D*%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9J**************2A?NCZ4M%%%%)2TE+1244=:*.* M,4<49YI:********1F"J68@`#))[5GC4IKE2^G6OGQ8)$COY:O\`[O!)^N,> M]6;&[2_L8+J,$),@<`]1D=#5BBBBBD7[H^E+1112>M%':BBBBBBBBBBCKWI: M********S)%_M:[DA?FR@;:Z_P#/9_[I_P!D<9'<\=CF?4I6BLF2'_7R_NHA M_M'O^'7Z"I[6W2SM(;>(8CB0(H]@,"I:****1?NCZ4M%%%)110***.U&***. MW-'THQFC%&3Z4M%%%%%%07LYMK.64#+*ORCU8\`?GBBUA6SLTC+<(OS,>YZD MG\RGJ_P!3_+ZFK]%%06UW%=F3R265&*%\?*2."`>^ M#Q4])4%Q>0VB1^:WSR':B*,LY]`*F0L4!9=I/;.<4ZBBBBD)QU.!33*@/+J/ MQIIN80>9HQ_P(4?:H.\T?_?8H^TP]YH_^^Q2^='VD3/^\*>&!Z'/THH[444= M^:,'U-+1124M%%9^J$M+80@@>9>."-@J2RKM$A[X'7CWQ44NLFXF-OI$0NI02KS9Q# M$?\`:;N?]E&`.2/K5&\LKR:]$B7< M@MMFTPH0A!_O;L$GMQQTJK=0:79H#J%W<1#.!Y]Y(,_3YN:HO>:"K`0P:A=- MZ11W$GZ]*UQH6G.%8V@R>0&+$C]:<-$TU<_Z%`?7*Y_G3_['TX'/V&US_P!< ME_PI1I6GX.+&UYY/[E?\*7^R[#'_`!XVW_?E?\*7^S;+G_0[?'_7)?\`"@Z= M9GK:6Y)_Z9K_`(4?V;9CI:PCZ(!2BQ@7&V(#'3!(J1844?+N'_`C3MO&,G\Z M4#GJ:7%'^>M+124M)10.E9FJ"2:6%K979K9]TA09(4@@A?5L'/X>XJQ;WUB( M56&XA"K\H4O@CV(/.:'U*'!^SAKAO2/D?BW0?G5"*X6TNGN=1UN)5?\`Y=BZ M"-/3!QN)_'GTIT^OM+%)_9%E/?2*I(;:8XLC_;;&?^`YJ/26N8M-B@M+:0S' MYY[BZ0Q@R-RQV_>)R3QT[9HO]"N)Q%+%<+-=!_WDLQ*D)CE8]OW.<<@9QGGO M4Z:*;B!(M0E#0J,"U@S'"!Z'NWXG'M5@BZB`@L[6WBB3A6+_`"@=L*!^F15" M;PZUS>QWLMWYDXB$962(-'@'(PF1R#GJ35]M,$^/M=Q-,,8*;MB'\%QG\BCK1_.C%'Z4$48&**.] M&WW/YTM%%%%%5WE::0PP]!P\@_A]A[_RJM+JEC8,+2-FEG`X@A4R/^('3ZG% M0O'J>H$92+3X_P"\0)9OP_A7_P`>I\/AK2HH4C:RBF*\EYEWLQZDDGJ2:MPZ M;96[;H+2WC;U2)0?T%6*6BBDH7[H^E+1112=N:/I11UHHZ4M)]*.U'6B@?G0 M<4>M+11114<]Q#:PF6XE2*->K.P`'XFLIM4NM2VC1[;?`PYNIB8T/^Z,;C]< M8]ZDCT>22,+?7;9J%*!I`L!1S2U_]D_ ` end GRAPHIC 12 image_003.jpg GRAPHIC begin 644 image_003.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX. M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_ MP``+"``[`)`!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+ M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$( M(T*QP152T?`D,V)R@@D*%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9J***BGF$$>[!9B<*HZL?2H(6N!>[)9%8&,LR*O"'( MQ@]_XNOI5RBD/2EHHI******6BBBJTTBIOYT^WB9%9Y,>; M("X'_;(T\7,9ZB1?K&P_I4JL M&&1TIU%%5IW#ED9@L* M`>XB/_Q5!M9&'[VZF;V3"#]!G]:4:?;9RT?F'UD8O_.IDBCB&(T51_LC%.HH MHHHHI:3-4Y+UI3Y=DOF.>/,/"+[Y[_A2Q:>HVFX/?\`E]:M MPQ>6O."QZD=/H/:I*****0]*6BBDHHHHHJA(S)J#R-#)*ZJ%@`'RC/4YZ#GC MGL*LP0%&,LK;YF&"1T4>@]OYU/111112'I2T4E%%%%%%+1111124=J#TI:** +2@4M)WH]*.U?_]D_ ` end GRAPHIC 13 image_004.jpg GRAPHIC begin 644 image_004.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX. M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_ MP``+"``[`)`!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+ M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$( M(T*QP152T?`D,V)R@@D*%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9J***BGF$$>[!9B<*HZL?2H(6N!>[)9%8&,LR*O"'( MQ@]_XNOI5RBD/2EHHI******6BBBJTTBIOYT^WB9%9Y,>; M("X'_;(T\7,9ZB1?K&P_I4JL M&&1TIU%%5IW#ED9@L*_P"%+%IZC:;AS.RG(##"@^H'K[G) MJY1112'I2T4E%%%%%%1SW"6\>Y\G)PJ@9+'T`]:JNCRA6N^2WW+93P?]X]_Y M?6K<,7EKS@L>I'3Z#VJ2BBBBD/2EHHI******H2,R:@\C0R2.JA8`!\HSU.> M@YXY["K,$!1C+*V^9A@D=%'H/;^=3T44444AZ4M%)1111112T44444E':@]* -6BBDH%+2=Z/2CM7_V3\_ ` end GRAPHIC 14 image_005.jpg GRAPHIC begin 644 image_005.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BBB@`HHHH`*9+-%;PO--(L42`EG<@!1ZDTD\\=M!)/,X2*-2SL> MP'6LJVLY=4GCU'48W6-3NMK)^D?H[CN_?G[O0D6AR76X-T0.RQJ1D_P#`G0?C6O0` M4444`%%%%`!1110`@ZM]?Z4M(.K?7^E+0`4444`%%%%`!11THQ^?K0`4444` M%%%(>N.*`%HHQ1F@`HHH]<4`)U.:6BD[]J`#H.]'&:.O-+_.@!#CJ:3#>H_* MEQU'Y^]+0`4444`%%%%`!1110`4444`%%%%`&;?I]MO[:R89@7_2)AZ[2-BG MZMS_`,`QWK19@JEF(``R2>U4;/$FIZC*<91T@!'HJ!_YR&HKX?VG<_V:CX@3 M#79'<=1'_P`"ZGN%_P!X&@!-*0W5Q/J\@'^DA4MQC!6!O]!0`<^M&!0#UXI,-ZC\J`'4444`%%%%`!1110`4444`%%%1 M75S%9VTD\Q(1!DX&2?0`=R3P!W-`&/;WLD-I,L(#7ES>3I"CYQ\KE=QQT4!1 M^G3(K5LK1;*T2!9'D(Y:20Y9V/)8^Y-8_AF-C)J*`"D[GTHSZ\4<]S0`N*0^U![TO-+T M[4@[THZ4`%)C'04@/M]:7J?44`&><48Z=.*,>]'7T)H`3C@9I<\T8YH_.@`' MUS2TG?GK2T`%%%%`!1110`4?6BB@`HHHH`"0!D\"LRV/]J72WC#-I$?]&!!^ M<]#)].R\=,G)R,+;#1+Z5.TL^VW4CZ.=__`([2_P!L:A",W6@7H7C+6TD< MH'X;@Q_!30!LT5B_\)-;8^:PU=3Z?V=,?Y*13O[?#D"'2M5EW8Q_HIC_`/0R MN/QH`V*,N$WD_3C\*4V^N3_?U&TMEST@MB[# MK_$S8]/X:`-1?O-]?Z"DEECAC,DLBQH.K.<`?C64="\]F^UZIJ4XS]T7'DCI MT_=!:D3PYHRNKMIT$KJ20\Z^:P)ZG+9.:`!_$>C*Y0:G;22#C9$XD;/7&%R: M0:['(0+>PU*?=G&+5HQQ[R;16G'&D2!(T5$`P%48`IU`&1]OUF1V$6B+&`>& MN;M5SS_L!_K0W_"12_=_LNW^OF3?_$5KT4`9*6.LL%\_6HQSEO(LPN?;YF;_ M`":0Z-=O_K-?U,CG(40KVQVCS^M:])CWH`R?["5FWOJ>IL>F!M*OA MZT"A6N=2?TW:A-_1JUN!2'ICUH`QQX8TWO\`;6_WM0G/\W]Z3_A%M(P/W$[` M<8-U*>GU:MJD/)^GM0!D?\(QI((_T>4'GI<2#_V:G#P[IJMN47*M7!]:6@#(_X1RR50L=QJ2`'/&HS_U>G'0U'W=2U)?^WDG^>:U:3D4`98TB M8,-NLZB,8'WHS^>4_P`YI_\`9UZ%`76;HD=3)'$<_D@_R*T>?\*/IQ0!36#4 M%/-]$X[;K?G]&'O5B,7`QYKQ-P,[4(Y_,U)VX_6CKGTH`444G)X-)AO4?E0` MZBBB@`HHHH`****`"JEY<2ADM;;BYE4E7*Y6,#JQ_,8'<^V2)+N[CLX?,?DD MA47NS'H/\]*P[/56E,@TV#^T+R4YGN%8K;1GLOF$F%!/<@$F@#:AAMM+L M=@98H(P6=Y&QR3EF8GN222?>LTZK>:IM&APH8">;^Y!\K'_3-1@R?7A?<]*> MFA?:WCGUJ;[=*AW)#MVP1GV3^(^[9([8K8H`P/\`A$M/GAN/[2>?4+FYB:&6 MYG?#A&&&5`N!&I]%`]\UH6&C:?IC%[:W`F8!6GD8R2L!T!=B6(]LU?H-`!4$ MUE;7%Q!<301R36Y)B=ER4)X)'H:GHH`****`"BBB@`HHHH`:O5OK_2G4@ZMS MW_I2T`%%%%`!1110`G7G\J.^>.*4T4`%'?K110`F.^,FCV/-+1U'-`!CI1BB MB@!#UZ4M!&11U^E`"#UHXX_EBEZ44`'/:DQDGI^5'>EH`3`_'UQ2T@[#%+0` M4444`%&>,CFBJ%_JUM8.L!WSW;C,=K"-TC^^.P_VC@>]`%^LBYU^%6ECL5%V M\)_?N&VQ0`=2\AX&.X&3[4?8;W4?GU.?R8/^?.W8@'I]]^K?08'/.:EM88IQ M&D$*Q:=;X$,:J%60CN!C[H[>IYZ`9`*5MH\NJ.E[K@K>1%C1410JJ,!0,`"EHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`0=6^O\`2EI!U;Z_TI:`"BBB@`HHHH`.E%%)U.);N6UB&(ZD%>S9`'OJ M5SK,K6^C2>7;+E9=1*Y`//$0/#G/\7W1[G@:5CIMMIT;+`A+N=TDKL6>0^K, M>3_3M5I$6-%1%"JHP%`P`/2LN6X?5;J6QM79+>$[+J=<@DX_U:'UY&6[=!SR MH!([G5)'@B8?8ERDTBD'S6'!0>PY!/KQZXT%4*H50``,`#M0JA5"J,`=!2T` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"+U;Z_TI:0=6Z]:6@`HHHH` M****`"BBD&*`%P,8QQ11BB@`HI.]+]:`#VHH)P,T4`'7((I.G7\Z.*7.*`#' M3VHI.]&<]O\`ZU`"]Z*3Z=Z.GH*`#C^E+1WZ4W:/?\S0!F^(IIXM&ECM9C#< MW#I;12CJC2.$W#W`)/X5=L[2WT^RAM+:,100H$1!T`%-O["'4K1K:?=M+*ZL MIPR.I#*P/J"`1]*HMHDMT=FHZG[_@O/(U8+>&U@2""-8XD`5548`%.1%C1410J*,* MJC``]!3J`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`0=6X[TM- M7JWU_I3J`"BBB@`HHHH`****`"B@=!CI10`44=**`$'Z4M%'44`)T-+CFC/- M)ST[_2@!>]&>O>BC@<=*`$].:.U&<_C[4?TH`/Y]LTM)WZTM`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"`Y'XTM%%`#5ZM]?Z4ZBB@` MHHHH`****`"BBB@`HZ/Z444`?_9 ` end GRAPHIC 15 image_006.jpg GRAPHIC begin 644 image_006.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BFRR)#$ M\LKJD:`LS,<``=2:Y.;Q1J'VFSN[:S633;N4V]O'@B:4X)$@SP$X[]N:`.NH MK#TOQ)!>*D5X@L[UKF2U$!?=N=!D[3W&.:W,C.,\T`%107,%U&9+>5)4#%"R M-D9!P1^!K#\2>($L%CTRTESJUZXAMXU&XIN_Y:,.R@9/U&*UM,T^#2M-M[&W M7$4*!1[^I/N3S0!;J&ZN[>QMGN;N>."!!EI)&"JOU)J:L#68DO\`7](L)UWV MP$MS)&>C%``N1W&7)_`4`;J.LB*Z,&1AE64Y!'J*=7(Z-K4.F^!X)HU:ZEBW M0PVT7WW8$[8P/H/P`S5B+QI975YI=G9HUQ<7K8?8#LAPI9MS8ZC!&*`.FHJ+ M[5;Y0>?'^\8JGS#YB.P]>E)=7,5G:RW$[JD<2%V9CT`&30`UKZW34([!G_TF M2-I53!Y52`3GZD58KS?3=?.GZE'J%W#*XF(@D8_*(E),C2$=@H:,5T=AXL&J M^)!8Z?;&XT\1%GO%)PK=O8J>1GU^E`'2D@#).!3))8XE#2.J*3C+'`S7,>(= M3M]3N(_#EM.P>Z?9>/F))R,]*ZY M&N3`2T<:R]EW9'YT^"&.W@C@B4+'&H55'8#@5)0!6O["VU.S>TNX_,@DQO3< M1NPF2JKQ.K*&4J00 M1D&@#S*P"6TFBZ]?SRM#<337$+-&V\JRY5=O4.Y;./8#M6[;Z=XCAU$ZS`D< MEUJ$92:&YE(6U7.8P`.N`2"!U-=B$78@VC"XP,=*=0!Y_>V-QI.JZ>(XI[_6 M+F.:07$@&#,0`I8CA409P/0^IK9MM,\2V,;VL>IPW*S?.UW<@F2)R!N"H!@C MN!D8KIZ*`&QJR1(K.78``L1C)]:QK:&>?7;S4IX]D4P+8`] MESWK;H(!ZB@#C_"&GW4B6T]_92VWV"(V\$`#Z`^M&N66L7GB MJ"&R\R&W-LR_:U0;80S#?@]W(&!_O$]J["B@#EK?P98:1/;7FGH[261E>"-V M+$[D(V@L>.23^-9]YX>\37SI>7=W:SO($\VQP5C55.=BMGOGYCCG&.E=S10! MCZ7H-OI-Y--%&99;K<]SX[YZY]^M-_L.P5+*.&$0PV< 5GFQ11`*N[!&2/QK2HH`****`/__9 ` end GRAPHIC 16 image_007.jpg GRAPHIC begin 644 image_007.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/?Z*************1?NBEHHHHHHSD4444&DI>,^])QF MEXH[T44444456O;V*QA#N&=V.V.-!EI&]`/\@=ZS;^YU6TM!>L\"$21J+54W M;@SA=I;/WN>PQGUK;HHHHI%^Z*6BBBD]:7O1124&BE[TF:6DH]*6BBBBBBLZ MPC^U3OJ4O)?*VX/\$?K]6Z_3'I1(?M^IK$,^1:,'D/9I,?*OX`[C_P`!K1HH MHHI%^Z*6BBBCI10***,44E`YH[>U%'K_`#I:*****HZO*8M-D"MAY2L*GW=@ MO]:?:FHK*M M[R35;TO:.5T^!BIE'_+=QU"_[(YR>YX'0YUEQCQ^99:==S*&*G=LC(QZAF!'XBGB^U,GC1R![W* M4[[5JA`QID0/^U=?_8THGU9O^7&T7W-TQ_\`9*0OK&X?N+`>O[YS_P"RTF=: MZ^7IXY_YZ/T_*E!UG(REAC_??_"G*=5[K9?@S_X4Y6U//,5H?I*P_P#9:?YE MX,YMXLX[3'_XFI%DE/6'`]G!J0,<M[J:G;ZA=KHMK>H"P9[V2.0`PPK@$9SPS$A? M4`D^E6!>R/;+!HMLOD1IM6=E(B0`W*L&CMHXF\I#V*QC.XC^\V?;%5 M=1CU74-2LY19RI81(64$(SB;(PQ0MC@9P3G!R<9Q6C:65W;(Z6<,-MYAW23W M#&:61O5@,<_\"P/3%01/XIAL0\D5A/.)O]7N*EHR_P#>Z*0OLM%'>CM111CBBCFEHHHHJ*:=80."SL<*@ZL?\]ZJ MS26ME$UQJ4\*EP5)D(`P?X1GK_6LLB>X7R]'L[F)#G$US+)%$ON$SN/TPH]Z MGM_#C0HI;5[YI=H#R#RU9C]=F0/;-3?\(]9R`BZEN[L'JMQ8_*OXG/L:BAL]7N7,MSI[*ON M>*R%BOM;9A-./LY/*PD^2O\`L[NLI_)1Z&MVTLX+&W6"W0(@YX'4^IJ>BBBB MBBBBD7[HI:***3/!Q111_2EI,44'WHS1CI0:,^]+16'9Z#*JL-1O/M(E*._UI:0]*7O7__9 ` end GRAPHIC 17 image_008.jpg GRAPHIC begin 644 image_008.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/?Z**********1NWUI:********0T>M'%+1WHHHHHHK M/:2;4)FC@D,-HA*O*OWI&'!"GL!W/KP/6F:9&T=[?A'=K975$#R%\,%^8@GZ MC\0:TZ**1NWUI:***.U%%%!HI,T"BBEHHHHJM?RM':E8VVRR$1H?0DXS^'7\ M*CF/V.UBM+10)6'EP@\A0!RQ]AU]^G>K%O`MM;I"A)"CJ>I/)')WRMM1`,ECWX]`.IJ:D/;ZU#!>173N(#O1#M,@^[GT![_A4]%-,B+U91 M]33&NK=3\T\0^KBHVO[->MW;CZRBFG5-/'_+]:^O^N7_`!H_M33S_P`OUK_W M^7_&G#4;$]+RW/\`VU7_`!IRWEJ_W;F%OI(#4BR(WW74_0TZEZ4E+111FBLW M49?+OM/W9V"1VP.K$(0`/4\_I5JWA96:>;'G.,'!X4=E'^>:2XU"TMKF"VFG M1)YR?*0GE\>E.O+N*QLY;J8D1QKDXY)]`!W)/`K,@<6)-]J3;M0N!A8(_G*+ MU$:`=?<]SR>,8KVOB&:>X::1(TLRI$,$0,L\S?WAMX"]?4>^*L3KSOG`'^ROYGI6*ET->M2K.MM8-E%A"_,D8.!MC')!!`NYA]3T4>Y(JO';: MK>.)KJ6*S]$A_>.H]-S#`/O@_6K5OI5I;S>>(S+<8QYTS%W_``)Z?08%7:** M**0]OK2T44=Z3I112TE%%&/SHHI:BN+B*UA,LK;5!`'8`#/Y=*M4444444A[?6EHHH MI*,T9%&:****#1FEJ"ZL[>^B$=S"LJ*P8!AT([U+'''#&L<2*B*,*JC``]A3 MJ*******1NWUI:***2EHHHI*,4448I:**********0]OK2T44=Z*#24$XH/: *@\44M(>E+WK_V3\_ ` end GRAPHIC 18 tsig.jpg GRAPHIC begin 644 tsig.jpg M_]C_X``02D9)1@`!`@$`2`!(``#_X07N17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````<````<@$R``(````4````CH=I``0````!````I````-``"OR````G M$``*_(```"<0061O8F4@4&AO=&]S:&]P($-3,R!7:6YD;W=S`#(P,3,Z,3$Z M,3D@,#@Z-3$Z-3D``````Z`!``,````!__\``*`"``0````!````D*`#``0` M```!````00`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```2X```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B M95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`00"0`P$B``(1`0,1`?_=``0` M"?_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]522224I))))2E6LS`UX:QCK&AS6/>(A MI<0R/Y7TO?M1;MVR&Z.=H#X3W4`QA]K!+N$E(,JPM?2QI]SW&`?)K MM4=C`QL#YGQ/BJ]M>ZES[7^D[1WJ:#9M.YNI]OM_.0VYA=M#;Z[)AP]%I>XC MGZ.YVS=_*24WDE49U+%?8^H;_5K,/9L<2#&_78'-^B5,9^+W>6GP!_P">Q8DIL)(#&YA_G'UCR:TG M\7.3''N<"'9%G,^T-;_9^@DIL)D$8C))+[#/,V.C_JDQP<8DDM+B?%[C^5R2 MDZ2!]AQ>[./,_P!Z8<3_U M22G_T?54DD&S(8QWIM!LM(D,;S_:/T6?VDE)28509)NL<*1Z@;HUQ^A/[SG_ M`/?6)S2_()%[I:.6-T9_4=^=:K0:UH#6@``0`.`$E-<8;;"'Y)]9PU#3]`?U M:_\`R:-7574T,K8UC1H&M``_!3224L`!P(G4ITDDE*3)TDE*22224I))))2D MDDDE*22224__TO3V>MQ635NCA"24T$+P``````2@`= M`0!(````2```````````````T`(``$`"`````````````!@#``!D`@````'` M`P``L`0```$`#R7!E96YU;0````I%4VQI8V54>7!E M`````$EM9R`````&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4 M;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````00`` M``!29VAT;&]N9P```)`````#=7)L5$585`````$```````!N=6QL5$585``` M``$```````!-'1415A4`````0`````` M"6AOD%L:6=N````!V1E9F%U;'0` M```)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L M=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E0D=#;VQO7U5F9VAI:FML;6YO8W1U=G=X>7 MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_ MV@`,`P$``A$#$0`_`/54DDDE*22224I5K,P->&L8ZQHIE.^C2&_UW@?\`GL6)*;"2`QN8?YQ]8\FM)_%SDQQ[G`AV M19S/M#6_V?H)*;"9!&(R22^PSS-CH_ZI,<'&))+2XGQ>X_EG.'1V;'F'.'Y"DI.D@_9V=G/']MW]ZDRK8(#G&?WG$_]4DI_]'U5))! MLR&,=Z;0;+2)#&\_VC]%G]I)24F%4&2;K'"D>H&Z-Z6CEC=&?U'?G6JT&M:`UH``$`#@!)37&&VPA^2?6<-0T_0']6O_`,FC5U5U M-#*V-8T:!K0`/P4TDE+``<")U*=)))2DR=))2DDDDE*22224I))))2DDDDE/ M_]+TW(ML+VX]&ECQ+G]F-_?_`*SOHUJ%;65V?9Z`2=76VG4S[?I/_.M>IV8S MG6FUECJRYH:\"-0W=MB?H?31F,;6T-8(`X"2E,8UC0UH@#@*2222E))))*4D MDDDI22222E))))*4DDDDI22222E))))*?__3]527RJDDI^JDE\JI)*?JI)?* MJ22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22G M_]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O M`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"`` M0P!3`#,````!`#A"24T$!@``````!P`(`````0$`_^$.DVAT='`Z+R]N&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7 M-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT M&EF+S$N,"\B('AA<#I#&%P.DUE=&%D871A1&%T93TB,C`Q,RTQ,2TQ.50P.#HU,3HU.2LP M-3HS,"(@>&%P.D-R96%T;W)4;V]L/2)!9&]B92!0:&]T;W-H;W`@0U,S(%=I M;F1O=W,B(&1C.F9O&%P34TZ26YS=&%N8V5) M1#TB=75I9#HQ-C4W,#&EF.D-O;&]R4W!A8V4](BTQ(B!E>&EF.DYA=&EV941I9V5S=#TB,S8X-C0L M-#`Y-C`L-#`Y-C$L,S7J%AH>(B8J4E9:7F)F:I*6F MIZBIJK2UMK>XN;K$Q<;'R,G*U-76U]C9VN3EYN?HZ>KT]?;W^/GZ$0`"`0," M!`0#!00$!`8&!6T!`@,1!"$2!3$&`"(305$',F$4<0A"@2.1%5*A8A8S";$D MP=%#$A:.S MP]/C\RD:E*2TQ-3D])6EM<75Y?4H1U=F.':&EJ:VQM;F]F=WAY>GM\?7Y_=( M6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@`,`P$` M`A$#$0`_`-_CW[KW7O?NO=>]^Z]U[W[KW7$D`7-_]@#?ZV^@%_S[]U[H%-R= MR4V,R\%!A=L;@W/BZ3Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO__0W^/?NO=>]^Z]U[W[KW7O?NO=)?=S MUXP\E-C'E@K\E/3XFFJX=)>A.2F2EFKP'X)H:6229?\`:D`_/OW7NDE38?$R MU^$VC@\6HR%$S?Q&H)#,L@@=VU2>_= M>Z%7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U__]'?X]^Z]U[W[KW7O?NO=>]^Z]T#G9VX9*#-]:82@J*>+,;@ MW/E(Z$S#XB#$4:T M<),MR9:FJD"BIKZV4ZZNNK&55$E35SDNY_J;?0`#W7NG?W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7`.&%P&^MOI;_`'NW_&O?NO=="2_]F3_8K_2_ M-_IS[]U[KPDN+Z'_`#P5TGB_X8C^GOW7NN8-_P`$?ZXM[]U[KOW[KW7_TM_C MW[KW7O?NO=>]^Z]TUY;+T.%I&K*^1XX%*1J$1I)9II9$A@IX(UN\]1432*J( MH+,3_2_OW7N@AW9MQ&YDV-D8S0;E3=T53C<1&(IZ#L_KW=TM=!19B%>J] MI;BWCN#,X.II8\C2R18NCW!FL=M<9F@JJ>2*JKI9*81R:EN&5E]U[I48?Y)] M8YG/9_:4#;O3>.UZDT';VV]%2R*RR3*@DH M]I8[>,3(X5'6U0"58JQ0CW[KW6;$X[N"<(VXMS;!H`%=7I]M[4SE4[,2#'(N M0S6Z-*!1PR&D;5]=0]^Z]U$GZ[W9D(9H,IW'O\A\C]]"^#H]C[>DI80ZLF,6 M6FVE4338]0MOW&>=@3JD-Q;W7NI,/5.(CJ)JF;6Q M(BHHZ]U#DZ/Z[FGJ*FKQF8R4M2OC?\`BN]]]91! M':W[,60W)4QT\A_+(`Q)O>Y-_=>ZY-T=UA(83+M:.3P21RPO)F=PR2Q31$L) M4D?*F36QMJ.J[_5K^_=>ZDR=/[%:0O#AIZ%[G1-C=Q;HQLR%VA>5XGQ^8IGA MDD:$`LI!L6Y];AO=>Z#,;CJHYII)M>7W#DLW4QF5S*Z1U.5DJY8XE]^Z]UBDE2(:G)"Z7):W"JHNS,?HJ@HI]B4V3IY)(:O,Y7LH:BJ@@F,:5F3DR%<+L4EC!T#W7NA)P6V=N;6QU/A]LX#"[=Q-+% M#3TV,P>+H<3CX(*>,14\$-'0004\<4$2A44*`H``]^Z]TZQ4U/!Y/#3PP^:8 MU$QBC2/S3E44SRZ`/),5C4:FNUE'/`]^Z]UGM_OO];Z>_=>ZXE%;]2JW%N0# MQ>]N?\1[]U[KRHJWT@#4;FWY(%O]X`]^Z]UR]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7__4W^/?NO=!_N+L/%8>N7;^+I*W=.[ZFDEK*/:^ M%$;57VT MLQ=')#-5[6V]45%#L@U)BCCEV]DZEH8I:I\-$CL$%+K6Z>Z]T-]) MCZ&@I:6AH:*DHJ*BIH*.CHJ2GBIZ.CI*:-8J>EI:>)(XH*:")`J(BJJJ```/ M?NO=3??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U_]7>7[`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` end EX-101.INS 19 nnan-20130930.xml XBRL INSTANCE DOCUMENT 0000863895 2012-01-01 2012-09-30 0000863895 2012-01-01 2012-12-31 0000863895 2013-01-01 2013-09-30 0000863895 2011-01-31 0000863895 2013-02-26 0000863895 2009-03-24 0000863895 2012-07-01 2012-09-30 0000863895 2013-07-01 2013-09-30 0000863895 2013-09-30 0000863895 2013-11-15 0000863895 2009-11-30 0000863895 2007-12-01 2007-12-17 0000863895 2007-12-17 0000863895 2012-12-31 0000863895 2011-12-31 0000863895 2012-09-30 0000863895 us-gaap:SeriesBPreferredStockMember 2013-09-30 0000863895 us-gaap:SeriesBPreferredStockMember 2012-12-31 0000863895 us-gaap:SeriesCPreferredStockMember 2013-09-30 0000863895 us-gaap:SeriesCPreferredStockMember 2012-12-31 0000863895 us-gaap:SeriesDPreferredStockMember 2012-12-31 0000863895 us-gaap:SeriesDPreferredStockMember 2013-09-30 0000863895 us-gaap:CommonStockMember 2012-12-31 0000863895 us-gaap:PreferredStockMember 2012-12-31 0000863895 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000863895 us-gaap:RetainedEarningsMember 2012-12-31 0000863895 us-gaap:NoncontrollingInterestMember 2012-12-31 0000863895 us-gaap:CommonStockMember 2013-01-01 2013-09-30 0000863895 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-09-30 0000863895 us-gaap:RetainedEarningsMember 2013-01-01 2013-09-30 0000863895 us-gaap:CommonStockMember 2013-09-30 0000863895 us-gaap:PreferredStockMember 2013-09-30 0000863895 us-gaap:AdditionalPaidInCapitalMember 2013-09-30 0000863895 us-gaap:RetainedEarningsMember 2013-09-30 0000863895 us-gaap:NoncontrollingInterestMember 2013-09-30 0000863895 us-gaap:NoncontrollingInterestMember 2013-01-01 2013-09-30 0000863895 us-gaap:PreferredStockMember 2013-01-01 2013-09-30 0000863895 nnan:NanotechnologyMember us-gaap:SalesRevenueSegmentMember 2013-01-01 2013-09-30 0000863895 nnan:NanotechnologyMember us-gaap:SalesRevenueSegmentMember 2012-01-01 2012-09-30 0000863895 us-gaap:ChiefExecutiveOfficerMember 2013-09-30 0000863895 us-gaap:ChiefExecutiveOfficerMember us-gaap:AccountsReceivableMember 2013-09-30 0000863895 us-gaap:ChiefExecutiveOfficerMember us-gaap:AccountsReceivableMember 2013-01-01 2013-09-30 0000863895 nnan:BeforeAmendmentMember 2013-09-30 0000863895 nnan:SeniorSecuredNonconvertiblePromissoryNotesMember 2013-09-30 0000863895 nnan:SeniorSecuredNonconvertiblePromissoryNotesMember 2012-12-31 0000863895 nnan:PlatinumLongTermGrowthAndPlatinumAdvisorsMember 2013-09-30 0000863895 nnan:LongviewSpecialFinancingIncMember 2013-09-30 0000863895 nnan:SeniorSecuredConvertibleNotes8PercentMember 2013-01-01 2013-09-30 0000863895 nnan:SeniorSecuredConvertibleNotes8PercentMember 2013-09-30 0000863895 nnan:MeritConsultingMember 2013-01-01 2013-09-30 0000863895 nnan:SeniorSecuredPromissoryNotes2013Member 2013-09-30 0000863895 nnan:SeniorSecuredPromissoryNotes2013Member 2013-06-01 2013-06-30 0000863895 nnan:SeniorSecuredPromissoryNotes2013Member 2013-07-01 2013-07-30 0000863895 nnan:SeniorSecuredPromissoryNotes2013Member 2013-01-01 2013-09-30 0000863895 nnan:SeniorSecuredPromissoryNotes2013Member us-gaap:SubsequentEventMember 2013-10-01 2013-10-30 0000863895 nnan:SeniorSecuredPromissoryNotes2013Member us-gaap:SubsequentEventMember 2013-11-01 2013-11-30 0000863895 nnan:SubordinatedSecuredConvertiblePromissoryNote10PercentMember 2009-11-01 2009-11-04 0000863895 nnan:SubordinatedSecuredConvertiblePromissoryNote10PercentMember 2009-11-01 2009-11-30 0000863895 nnan:FiveYearCommonStockPurchaseWarrantMember 2013-09-30 0000863895 us-gaap:ConvertibleNotesPayableMember 2013-09-30 0000863895 nnan:CapeOneMember 2013-01-01 2013-09-30 0000863895 nnan:CapeOneMember 2012-01-01 2012-09-30 0000863895 nnan:SeniorSecuredConvertibleNotesMember 2013-09-30 0000863895 nnan:SeniorSecuredPromissoryNoteMember 2013-09-30 0000863895 nnan:SubordinatedSecuredConvertibleNotesMember 2013-09-30 0000863895 nnan:SeniorSecuredConvertibleNotesMember 2012-12-31 0000863895 nnan:SeniorSecuredPromissoryNoteMember 2012-12-31 0000863895 nnan:SubordinatedSecuredConvertibleNotesMember 2012-12-31 0000863895 nnan:MedicalBoardBusinessMember 2013-07-01 2013-09-30 0000863895 nnan:MedicalBoardBusinessMember 2012-07-01 2012-09-30 0000863895 nnan:MedicalBoardBusinessMember 2013-01-01 2013-09-30 0000863895 nnan:MedicalBoardBusinessMember 2012-01-01 2012-09-30 0000863895 nnan:NotesConversionFeatureMember 2013-09-30 0000863895 nnan:NotesConversionFeatureMember 2012-12-31 0000863895 nnan:NotesConversionFeatureAndWarrantsMember 2013-09-30 0000863895 nnan:NotesConversionFeatureAndWarrantsMember 2012-12-31 0000863895 us-gaap:SeriesDPreferredStockMember 2013-06-10 0000863895 us-gaap:SeriesDPreferredStockMember 2013-06-01 2013-06-30 0000863895 nnan:PlatinumPartnersLongTermGrowthIvAndLongviewSpecialFinancingIncMember us-gaap:SeriesBPreferredStockMember 2008-09-01 2008-09-30 0000863895 us-gaap:SeriesCPreferredStockMember nnan:PlatinumPartnersLongTermGrowthIvAndLongviewSpecialFinancingIncMember 2008-09-01 2008-09-30 0000863895 us-gaap:SeriesBPreferredStockMember nnan:PlatinumPartnersLongTermGrowthIvAndLongviewSpecialFinancingIncMember 2008-09-29 0000863895 us-gaap:SeriesCPreferredStockMember nnan:PlatinumPartnersLongTermGrowthIvAndLongviewSpecialFinancingIncMember 2008-09-29 0000863895 nnan:PlatinumPartnersLongTermGrowthIvMember nnan:LlcSeriesCConvertiblePreferredStockMember 2008-10-01 2008-10-07 0000863895 us-gaap:SeriesBPreferredStockMember 2008-10-01 2008-10-07 0000863895 us-gaap:ConvertiblePreferredStockMember 2013-09-30 0000863895 nnan:SeriesBAndSeriesCConvertiblePreferredStockMember 2008-10-01 2008-10-07 0000863895 nnan:SeriesBAndSeriesCConvertiblePreferredStockMember 2008-10-07 0000863895 us-gaap:SeriesCPreferredStockMember 2008-10-01 2008-10-07 0000863895 us-gaap:SeriesCPreferredStockMember 2008-10-07 0000863895 us-gaap:SeriesBPreferredStockMember 2008-10-07 0000863895 us-gaap:SeriesBPreferredStockMember nnan:LongviewSpecialFinancingIncMember 2013-01-01 2013-09-30 0000863895 nnan:PlatinumPartnersLongTermGrowthIvMember us-gaap:SeriesCPreferredStockMember 2013-01-01 2013-09-30 0000863895 nnan:AlphaCapitalMember 2013-01-01 2013-09-30 0000863895 us-gaap:CommonStockMember 2012-09-30 0000863895 nnan:AlphaCapitalMember 2012-09-30 0000863895 us-gaap:WarrantMember 2013-09-30 0000863895 us-gaap:WarrantMember 2012-12-31 0000863895 nnan:JamesWemettMember 2013-01-01 2013-03-31 0000863895 nnan:PaulLefroisMember 2013-01-01 2013-03-31 0000863895 nnan:DavidLubinMember 2013-01-01 2013-03-31 0000863895 nnan:AlexanderRuckdaeschelMember 2013-01-01 2013-03-31 0000863895 us-gaap:SeriesBPreferredStockMember 2013-01-01 2013-09-30 0000863895 us-gaap:SeriesCPreferredStockMember 2013-01-01 2013-09-30 0000863895 us-gaap:WarrantMember 2013-01-01 2013-09-30 0000863895 nnan:IncentiveStockPlansMember 2012-12-31 0000863895 nnan:IncentiveStockPlansMember 2013-09-30 0000863895 nnan:IncentiveStockPlansMember 2013-01-01 2013-09-30 0000863895 nnan:BeforeAmendmentMember 2012-12-31 0000863895 nnan:PriorToReverseStockSplitMember 2012-12-31 0000863895 nnan:AfterReverseStockSplitMember 2012-12-31 0000863895 us-gaap:SubsequentEventMember nnan:PlatinumLongTermGrowthIvMember 2013-10-15 0000863895 us-gaap:SubsequentEventMember nnan:PlatinumLongTermGrowthIvMember 2013-10-01 2013-10-31 0000863895 us-gaap:SubsequentEventMember nnan:PlatinumLongTermGrowthIvMember 2013-11-01 2013-11-11 0000863895 nnan:AlphaCapitalAnstaltMember us-gaap:SubsequentEventMember 2013-11-07 0000863895 nnan:AlphaCapitalAnstaltMember us-gaap:SubsequentEventMember 2013-11-01 2013-11-07 xbrli:shares iso4217:USD xbrli:shares iso4217:USD iso4217:USD nnan:Warrant iso4217:USD utr:Fee xbrli:pure 10-Q false 2013-09-30 2013 Q3 NNAN 420329246 NaturalNano, Inc. 0000863895 --12-31 Smaller Reporting Company 0.001 0.001 10000000 10000000 10 310 5000 142500 5000 142500 6607 8099 3303640 4049495 3303640 4049495 0.001 0.001 800000000 800000000 332909406 93200171 93200171 332909406 0 100 0 100 10 6160 25706 5400 13251 19480 12040 10196 51007 41236 51007 41236 4042965 3893972 429941 502814 100289 96343 656769 444131 950473 871610 100000 100000 82489 82489 12884 25732 6375810 6017091 6375810 6017091 872 14111 61488 153648 332909 93200 21115545 21159134 0 14264 -27835617 -27410212 -6387163 -6143614 51007 41236 0 0 18674 6783 141992 55331 3657 749 27687 3880 15017 6034 114305 51451 14031 21377 41623 90084 81884 93549 265150 268437 95915 114926 306773 358521 -80898 -108892 -192468 -307070 93208 87149 274758 295650 89536 534 12848 534 0 -163566 -10336 -473566 35701 -250181 -232873 -768682 -45197 -359073 -425341 -1075752 0 6457 11115 17477 0 0 11179 0 -45197 -352616 -425405 -1058275 0 0 0 12235 -45197 -352616 -425405 -1070510 -0.00 -0.01 -0.00 -0.03 -0.00 -0.00 -0.00 -0.00 311664926 55644823 240252062 42169055 39373 0 39373 0 93200 0 21159134 -27410212 14264 93200171 0 284 22000 -21716 22000000 105112 119337 -14225 119336800 8721 8721 19913 21500 -1587 21500000 62090 76872 -14782 76872435 -425405 -425405 332909 0 21115545 -27835617 0 332909406 100 -14264 -14264 0 0 100 39454 12848 534 10800 8721 8720 -10336 -473566 20306 -2651 -6229 4282 1844 1337 329434 404284 0 -4000 -145056 -104732 138906 103000 138906 103000 -6150 -1732 1732 0 19913 983585 62090 216943 141337 15669 0 24221 39373 0 0 4376 0.51 0.82 0.79 0.5 13000 0.5 6324803 6412911665 2656482041 0.0499 0 0 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Interim Financial Statements</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The consolidated financial statements as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 are unaudited. However, in the opinion of management of the Company, these financial statements reflect all material adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position and results of operations for such interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results to be obtained for a full year. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X for smaller reporting companies.&#160;&#160;Accordingly, these financial statements do not include all of the information required by&#160;U.S. generally accepted accounting principles for complete financial statements.&#160;&#160;These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Estimates</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate such estimates. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Fair Value of Financial Instruments</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Financial instruments include cash and cash equivalents, accounts payable and accrued expenses, notes payable, capital leases and derivative liabilities. Fair values for all instruments except for derivative liabilities were assumed to approximate carrying values for these financial instruments since they are short-term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of the Company&#8217;s convertible notes payable is estimated based upon the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The carrying value approximates the fair value of these debt instruments as of September 30, 2013 and December 31, 2012 based on rates charged being consistent with current market rates available to the Company. See Note 4 for discussion on the fair value of derivative liabilities.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Basis of Consolidation</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The consolidated financial statements include the accounts of NaturalNano, Inc. (&#8220;NaturalNano&#8221; or the &#8220;Company&#8221;), a Nevada corporation, and its wholly owned subsidiary NaturalNano Research, Inc. (&#8220;NN Research&#8221;) a Delaware corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% controlling interest in Combotexs.&#160; The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,264</font> and a gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">39,373</font> was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Description of the Business</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> NaturalNano (the &#8220;Company&#8221;), located in Rochester, New York, is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house. The Company&#8217;s current activities are directed toward research, development, production and marketing of its proprietary technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%"> <div>&#160;</div> </td> <td style="WIDTH: 3%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> <b>&#183;</b></font></div> </td> <td style="WIDTH: 94%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> cosmetics, health and beauty products</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> <b>&#183;</b></font></div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> polymers, plastics and composites</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine months ended September 30, 2013 and 2012, the Company derived <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 82</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 79</font>%, respectively, of its nanotechnology revenue from one customer.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr> <td style="TEXT-ALIGN: justify; WIDTH: 100%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the fourth quarter of 2011, the Company entered into a supply agreement with another company, which is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% owned by NaturalNano&#8217;s CEO, to manufacture and sell Error Prevention/Safety Checklist Boards which the related party will then market to the end user. In the second quarter of 2013, the Company made a decision to cease the medical board segment&#8217;s operations and ceased production of Error Prevention/Safety checklist Boards (the Medical Board business segment.) This business segment was not generating sufficient income to offset the efforts of production and administrative expenses. The Consolidated Statement of Operations as of September 30, 2013 reflects the results of the Medical Board business as a discontinued operation effective as of the second quarter of 2013. As of September 30, 2013, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13,000</font> of amounts due from the entity which is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% owned by NaturalNano&#8217;s CEO is included in Accounts Receivable on the balance sheet. (See Note 3 &#8220;Discontinued Operations&#8221;).</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> NaturalNano is domiciled in the state of Nevada as a result of the merger with Cementitious Materials, Inc., (&#8220;CMI&#8221;), which was completed on November 29, 2005.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Liquidity and Going Concern</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Going Concern &#150; The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company incurred a net loss for the nine months ended September 30, 2013 of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">425,405</font> and had negative working capital of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,324,803</font> and a stockholders&#8217; deficiency of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,387,163</font> at September 30, 2013. Since inception the Company&#8217;s growth has been funded through a combination of convertible debt from private investors and from cash advances from its former parent and former majority shareholder Technology Innovations, LLC. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations, to obtain additional financing, renegotiate the terms of existing financing obligations and ultimately to attain successful operations. The ability to successfully achieve those items is uncertain. The financial statements do not include any adjustments that might result from the uncertainty.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As of September 30, 2013, the Company continued to require waivers for debt covenant violations and extensions of maturity dates. Refer to Note 2 for lenders waivers and maturity extensions received from the lenders.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Reclassifications</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Certain prior year amounts have been reclassified to conform to the current year presentation.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Income Taxes</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company accounts for income taxes in accordance with ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income items is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.&#160; The Company recognizes penalties and accrued interest related to unrecognized tax benefits in income tax expense. Income tax expense was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font></font> for the nine month periods ending September 30, 2013 and 2012.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Loss Per Share</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Basic loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per common share gives effect to dilutive convertible preferred stock, convertible debt, options and warrants outstanding during the period. Shares to be issued upon the exercise of these instruments have not been included in the computation of diluted loss per share as their effect is anti-dilutive based on the net loss incurred.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As of September 30, 2013 and 2012 there were 6,412,911,665 and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,656,482,041</font>, respectively, underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. These potentially dilutive shares have been limited by certain debt and equity agreements with Platinum, Platinum Advisors, Merit Consulting, Alpha Capital and Technology Innovations LLC (&#8220;TI&#8221;). These agreements provide limitations on the conversion of the dilutive instruments such that the number of shares of Common Stock that may be acquired by the holder upon conversion of such instruments shall be limited to ensure that following such conversion the total number of shares of Common Stock then beneficially owned by the holder does not exceed <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.99</font>% of the total number of issued and outstanding shares of Common Stock. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments. See Note 9 Subsequent Events for shares of common stock issued subsequent to September 30, 2013.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Recent Accounting Pronouncements</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted, would have a material effect on the accompanying financial statements.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 39373 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Increase in Authorized Common Stock</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On July 1, 2013 the Company received a unanimous written consent in lieu of a meeting from the members of the Board of Directors and a written consent from the Series D stockholder (Note 5) to amend its articles of incorporation to increase the Company&#8217;s authorized common shares from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 294,117,647</font> shares to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 800,000,000</font> shares of common stock. As of September 30, 2013 there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6,412,911,665</font> underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>1. &#160; PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Interim Financial Statements</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The consolidated financial statements as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 are unaudited. However, in the opinion of management of the Company, these financial statements reflect all material adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position and results of operations for such interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results to be obtained for a full year. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X for smaller reporting companies.&#160;&#160;Accordingly, these financial statements do not include all of the information required by&#160;U.S. generally accepted accounting principles for complete financial statements.&#160;&#160;These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Estimates</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate such estimates. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Fair Value of Financial Instruments</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Financial instruments include cash and cash equivalents, accounts payable and accrued expenses, notes payable, capital leases and derivative liabilities. Fair values for all instruments except for derivative liabilities were assumed to approximate carrying values for these financial instruments since they are short-term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of the Company&#8217;s convertible notes payable is estimated based upon the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The carrying value approximates the fair value of these debt instruments as of September 30, 2013 and December 31, 2012 based on rates charged being consistent with current market rates available to the Company. See Note 4 for discussion on the fair value of derivative liabilities.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>&#160;</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Basis of Consolidation</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The consolidated financial statements include the accounts of NaturalNano, Inc. (&#8220;NaturalNano&#8221; or the &#8220;Company&#8221;), a Nevada corporation, and its wholly owned subsidiary NaturalNano Research, Inc. (&#8220;NN Research&#8221;) a Delaware corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% controlling interest in Combotexs.&#160; The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,264</font> and a gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">39,373</font> was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Description of the Business</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> NaturalNano (the &#8220;Company&#8221;), located in Rochester, New York, is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house. The Company&#8217;s current activities are directed toward research, development, production and marketing of its proprietary technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%"> <div>&#160;</div> </td> <td style="WIDTH: 3%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> <b>&#183;</b></font></div> </td> <td style="WIDTH: 94%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> cosmetics, health and beauty products</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> <b>&#183;</b></font></div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> polymers, plastics and composites</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine months ended September 30, 2013 and 2012, the Company derived <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 82</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 79</font>%, respectively, of its nanotechnology revenue from one customer.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr> <td style="TEXT-ALIGN: justify; WIDTH: 100%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the fourth quarter of 2011, the Company entered into a supply agreement with another company, which is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% owned by NaturalNano&#8217;s CEO, to manufacture and sell Error Prevention/Safety Checklist Boards which the related party will then market to the end user. In the second quarter of 2013, the Company made a decision to cease the medical board segment&#8217;s operations and ceased production of Error Prevention/Safety checklist Boards (the Medical Board business segment.) This business segment was not generating sufficient income to offset the efforts of production and administrative expenses. The Consolidated Statement of Operations as of September 30, 2013 reflects the results of the Medical Board business as a discontinued operation effective as of the second quarter of 2013. As of September 30, 2013, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13,000</font> of amounts due from the entity which is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% owned by NaturalNano&#8217;s CEO is included in Accounts Receivable on the balance sheet. (See Note 3 &#8220;Discontinued Operations&#8221;).</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> NaturalNano is domiciled in the state of Nevada as a result of the merger with Cementitious Materials, Inc., (&#8220;CMI&#8221;), which was completed on November 29, 2005.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>&#160;</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Liquidity and Going Concern</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Going Concern &#150; The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company incurred a net loss for the nine months ended September 30, 2013 of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">425,405</font> and had negative working capital of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,324,803</font> and a stockholders&#8217; deficiency of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,387,163</font> at September 30, 2013. Since inception the Company&#8217;s growth has been funded through a combination of convertible debt from private investors and from cash advances from its former parent and former majority shareholder Technology Innovations, LLC. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations, to obtain additional financing, renegotiate the terms of existing financing obligations and ultimately to attain successful operations. The ability to successfully achieve those items is uncertain. The financial statements do not include any adjustments that might result from the uncertainty.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As of September 30, 2013, the Company continued to require waivers for debt covenant violations and extensions of maturity dates. Refer to Note 2 for lenders waivers and maturity extensions received from the lenders.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Reclassifications</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Certain prior year amounts have been reclassified to conform to the current year presentation.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Income Taxes</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company accounts for income taxes in accordance with ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income items is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.&#160; The Company recognizes penalties and accrued interest related to unrecognized tax benefits in income tax expense. Income tax expense was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font></font> for the nine month periods ending September 30, 2013 and 2012.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Increase in Authorized Common Stock</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On July 1, 2013 the Company received a unanimous written consent in lieu of a meeting from the members of the Board of Directors and a written consent from the Series D stockholder (Note 5) to amend its articles of incorporation to increase the Company&#8217;s authorized common shares from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 294,117,647</font> shares to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 800,000,000</font> shares of common stock. As of September 30, 2013 there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6,412,911,665</font> underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>&#160;</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Loss Per Share</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Basic loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per common share gives effect to dilutive convertible preferred stock, convertible debt, options and warrants outstanding during the period. Shares to be issued upon the exercise of these instruments have not been included in the computation of diluted loss per share as their effect is anti-dilutive based on the net loss incurred.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As of September 30, 2013 and 2012 there were 6,412,911,665 and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,656,482,041</font>, respectively, underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. These potentially dilutive shares have been limited by certain debt and equity agreements with Platinum, Platinum Advisors, Merit Consulting, Alpha Capital and Technology Innovations LLC (&#8220;TI&#8221;). These agreements provide limitations on the conversion of the dilutive instruments such that the number of shares of Common Stock that may be acquired by the holder upon conversion of such instruments shall be limited to ensure that following such conversion the total number of shares of Common Stock then beneficially owned by the holder does not exceed <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.99</font>% of the total number of issued and outstanding shares of Common Stock. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments. See Note 9 Subsequent Events for shares of common stock issued subsequent to September 30, 2013.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Recent Accounting Pronouncements</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted, would have a material effect on the accompanying financial statements.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 294117647 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 13.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Notes payable consisted of the following:</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 13.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="71%"> <div>Notes Payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>December&#160;31,<br/> 2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Senior Secured Convertible Notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,124,403</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,134,415</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Senior Secured Promissory Notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>647,462</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>508,557</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Subordinated Secured Convertible Note</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>271,100</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>251,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,042,965</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>3,893,972</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 3771865 3642972 3148349 623516 3.74 0.085 9500000 10013 42000000 31838 0.08 25872435 138906 21000 30006 49400 2500 36000 50000 50000 197500 225000 2647059 0.001 0.425 271100 0.2 0.18 55000 30000 25000 12000000 9900 9000000 8775 0.000333 146028 63539 As compensation for forbearance from the lenders in 2012, the conversion rate was further adjusted to 75% of the lowest daily volume weighted average price (VWAP) of the Companys common stock for the 1, 5 or 10 days immediately prior to the conversion. The 10% Convertible Note is convertible into Common Stock at any time prior to maturity (provided that such conversion does not result in the holder and its affiliates beneficially owning in excess of 4.99% (9.99% upon 61 days prior written notice) of the issued and outstanding Common Stock at $0.085 per share (the &#8220;Conversion Price&#8221;), subject to adjustment upon the occurrence of certain anti-dilution events. In consideration for forbearance in 2012, the conversion rate of the note was adjusted from $0.085 to 75% of the lowest VWAP for the 1, 5 or 10-day period immediately prior to the conversion. <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>2.&#160; NOTES PAYABLE</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 13.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Notes payable consisted of the following:</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 13.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="71%"> <div>Notes Payable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>December&#160;31,<br/> 2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Senior Secured Convertible Notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,124,403</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3,134,415</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Senior Secured Promissory Notes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>647,462</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>508,557</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Subordinated Secured Convertible Note</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>271,100</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>251,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,042,965</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>3,893,972</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Senior Secured Convertible Notes and Senior Secured Promissory Notes</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As of September 30, 2013, notes payable include $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,771,865</font> ($<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,642,972</font> at December 31, 2012) for senior secured convertible and non-convertible promissory notes.&#160;&#160;As further described below, the Company has defaulted on certain provisions of the notes. Platinum Long Term Growth and Merit Consulting, LLC (to whom Platinum Advisors has assigned their ownership interest in notes receivable from the Company) have granted waivers of default on their outstanding principal balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,148,349</font> through December 31, 2013 and November 30, 2013, respectively. Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) has granted a waiver of default on their outstanding principal of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">623,516</font> through November 30, 2013.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Loan and Security Agreement and the related underlying convertible notes issued in accordance with the Initial Note agreement had the original conversion price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.74</font> (as cited in the March 7, 2007 agreement) which was adjusted to a conversion price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.085</font> in accordance with the anti-dilution provisions of this loan and security agreement. This conversion price adjustment was triggered as a result of the issuance of the 2008 Promissory Notes on September 29, 2008 thereby resulting in a reset of (a) the conversion price of the Initial Notes, (b) the exercise price of the warrants related to the Initial Notes and (c) the number of shares that may be purchased by such warrants.&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">As compensation for forbearance from the lenders in 2012, the conversion rate was further adjusted to 75% of the lowest daily volume weighted average price (VWAP) of the Company&#8217;s common stock for the 1, 5 or 10 days immediately prior to the conversion.</font>&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine month period ended September 30, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9,500,000</font> shares of common stock to Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) upon the conversion of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,013</font> of outstanding principal due on the 8% Senior Secured Convertible Notes held by Longview Special Finance. Also during this period the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 42,000,000</font> shares of common stock to Alpha Capital Anstalt upon the conversion of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">31,838</font> of interest due on the 8% Senior Secured Convertible Notes held by Longview Special Finance.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine month period ended September 30, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25,872,435</font> shares of common stock to Merit Consulting upon the conversion of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">21,478</font> of interest due on the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font>% Senior Secured Convertible Notes held by Platinum Advisors.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>2013 Senior Secured Promissory Notes</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine month period ended September 30, 2013, the Company entered into various Senior Secured Promissory Notes aggregating to&#160;$<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">138,906</font> with Platinum and Alpha (&#8220;the 2013 Senior Secured Promissory Notes&#8221;). The 2013 Senior Secured&#160;Promissory Notes are secured by, among other things, (i) the continuing security interest in certain assets of the Company pursuant to the terms of the Initial Notes dated March 7, 2007, (ii) the Pledge Agreement, as defined in the Initial Notes, and (iii) the Patent Security Agreement, dated as of March 6, 2007. The proceeds from the 2013 Senior Secured Promissory Notes are available for general working capital purposes and cannot be used to redeem or make any payment on account of any securities due to the Lenders.&#160;&#160;The 2013 Senior Secured Promissory Notes bear interest, in arrears, at a rate of 8% per annum and are payable in cash as follows: $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">21,000</font> due on June 30, 2013, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30,006</font> due on July 30, 2013, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">49,400</font> due on September 30, 2013, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,500</font> due October 30, 2013 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">36,000</font> due November 30, 2013. Past due amounts have been extended through forbearance agreements with the principal and interest due on dates ranging from November 30, 2013 to December 31, 2013.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>2012 Forbearance</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine month period ended September 30, 2012, the Company entered into various forbearance agreements between the Company and Platinum, Platinum Advisors, Merit Consulting, Longview Special Finance and Alpha Capital Anstalt (the lenders) which extended the due dates of all outstanding notes and accrued interest.&#160;&#160;As consideration for these forbearances, the lenders added $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,000</font> to the principal balance of the Initial Notes and resulted in a loss on modification of debt of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,000</font> for the nine month period ended September 30, 2012 and is reported in the statement of operations.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><u>Subordinated Secured Convertible Note</u></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Convertible Notes</u></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On December 4, 2009, the Company received net proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">197,500</font> pursuant to the terms of a subscription agreement dated as of November 30, 2009 with Cape One an accredited investor.&#160;&#160;Pursuant to the terms of the Subscription Agreement the Company issued (i) a 10% Subordinated Secured Convertible Promissory Note (&#8220;the 10% Convertible Note&#8221;) in the principal amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">225,000</font> and&#160;(ii) a five-year common stock purchase warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,647,059</font> shares, subject to certain anti-dilution provisions in the agreement of the Company&#8217;s common stock, par value $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.001</font> per share at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.425</font> per share. The balance of this note as of September 30, 2013 is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">271,100</font>, a result of increases as consideration for forbearance and conversions of principal.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr> <td style="TEXT-ALIGN: justify; WIDTH: 100%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The 10% Convertible Note had a 15-month term, bears interest at 10% per annum and is secured by certain assets of the Company pursuant to a security agreement, dated November 30, 2009.&#160;&#160;The 10% Convertible Note is convertible into Common Stock at any time prior to maturity (provided that such conversion does not result in the holder and its affiliates beneficially owning in excess of 4.99% (9.99% upon 61 days prior written notice) of the issued and outstanding Common Stock at $0.085 per share (the &#8220;Conversion Price&#8221;), subject to adjustment upon the occurrence of certain anti-dilution events.&#160;&#160;Interest under the Note is due quarterly in cash or if registered, in the Company&#8217;s common stock at a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>% discount in accordance with a formula set forth in the 10% Note.&#160;&#160;The 10% Note and security interest is subordinate to certain outstanding senior indebtedness of the Company held by Platinum Long Term Growth IV, LLC, Merit Consulting and Alpha Capital Anstalt. (&#8220;Senior Lenders&#8221;). Upon the occurrence of Events of Default as set forth in the Note, the principal and interest due under the Note may be accelerated and the interest rate payable may be increased to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>%.&#160;&#160;The company has entered into various forbearance agreements between Cape One and the Company which extended the due date of the outstanding principal and interest, which is accruing at the default rate of 18%.</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During nine month periods ended September 30, 2013 and 2012, the Company entered into various forbearance agreements which extended the due date of all the outstanding principal and interest balances.&#160; As consideration for these forbearances, Cape One will be paid $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">55,000</font> which was added to the principal balance of the note and resulted in a loss on modification of debt of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">25,000</font> for the nine month periods ended September 30, 2013 and 2012, respectively, as reported in the statement of operations. In consideration for forbearance in 2012, the conversion rate of the note was adjusted from $0.085 to 75% of the lowest VWAP for the 1, 5 or 10-day period immediately prior to the conversion. This note has been extended through forbearance agreements and is now due and payable on November 30, 2013.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During nine month period ended September 30, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12,000,000</font> shares of common stock to Cape One upon the conversion of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,900</font> of outstanding principal due on the Subordinated Senior Convertible note. During the nine month period ended September 30, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9,000,000</font> shares of common stock to Cape One in payment of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,775</font> of interest expense obligations on the Subordinated Secured Convertible Note.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 9pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Registration Rights Agreement</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On March 7, 2007, the Company entered into a Registration Rights Agreement with the Agent and the other investors, pursuant to which the Company agreed to prepare and file within 60 days of the March 7, 2007 agreement, a registration statement for resale under the Securities Act of 1933, the common stock issuable upon the exercise of the Warrants, in payment of interest on, or upon conversion of, the Notes. The Company further agreed to use its best efforts to cause the Registration Statement to be declared effective 120 days following the March 7, 2007 agreement date, or within 150 days if the Company receives a comment letter from the SEC, and to maintain such Registration Statement for the two year period following this date. This agreement allows for liquidated damages based on a daily amount of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.0333</font>% of the principal amount of the notes relating to the common stock issuable upon conversion of the Notes included in the Registration Statement.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The registration statement had not been updated with the requisite SEC filings outlined above and as such, the Company was in default of this provision of the Registration Rights Agreement. The Company recorded a total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">146,028</font> in such liquidated damages as of December 17, 2007, the date the registration statement was declared effective. As of December 31, 2007, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">63,539</font> of this obligation was paid in cash and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">82,489</font> was recorded as an accrued liability. The lender has the option to settle the liquidated damages in common stock valued at the average price for the five days prior to the end of a payment period. At September 30, 2013 and December 31, 2012 the outstanding balance for this obligation was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">82,489</font>.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 21478 3124403 647462 271100 3134415 508557 251000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>3.&#160;&#160;&#160;&#160;&#160;DISCONTINUED OPERATIONS</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> On May 10, 2013 the Company ceased all activities associated with the Medical Board business segment. The Company assessed this segment and determined that inadequate income had been generated relative to the efforts of production and administrative support. The Statement of Operations for the three and nine months ended September 30, 2013 reflects the Medical Board business as a discontinued operation and prior reported periods have been reclassified to reflect this presentation.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> The results of discontinued operations are as follows:&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>For&#160;the&#160;three&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>For&#160;the&#160;nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Revenues from Medical Board business</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>9,375</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,750</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>31,250</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Profit from Medical Board business</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>6,457</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>11,115</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>17,477</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> In connection with this decision to exit the Medical Board business, the Company filed a Certificate of Dissolution on May 10, 2013 with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs. As a result of this decision, certain unrecovered sample inventory amounts were written off during the second quarter of 2013. The loss on write-off of discontinued operations was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11,179</font> and is reflected in the Statement of Operations for the three months ended September 30, 2013.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The Nanotechnology business remains as the Company&#8217;s only reportable operating segment.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The results of discontinued operations are as follows:&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>For&#160;the&#160;three&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="27%" colspan="5"> <div>For&#160;the&#160;nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 700; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,<br/> 2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Revenues from Medical Board business</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>9,375</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,750</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>31,250</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="43%"> <div>Profit from Medical Board business</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>6,457</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>11,115</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>17,477</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 9375 14750 31250 0 6457 11115 17477 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>4.&#160;&#160;DERIVATIVE LIABILITY</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr> <td style="TEXT-ALIGN: justify; WIDTH: 100%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> For stock based derivative financial instruments, the Company estimated the total enterprise value based upon trending of the firm value from December 2006 to September 2013 considering company specific factors including the changes in forward estimated revenues and market factors.&#160;&#160;Once the enterprise value was determined an option pricing model was used to allocate the enterprise value to the individual derivative and other securities in the Company&#8217;s capital structure.&#160;&#160;Significant unobservable inputs used in determining the value of the Company&#8217;s derivative liability include the trended firm value and volatility. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company&#8217;s derivative liabilities as of September 30, 2013 are as follows:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 4.5pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%"> <div>&#160;</div> </td> <td style="WIDTH: 3%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td style="TEXT-ALIGN: justify; WIDTH: 94%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The debt conversion feature embedded in the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font>% Senior Secured Convertible Notes entered into in March 2007, August 2008, September 2008 and October 2008 which contains anti-dilution provisions that would be triggered if the Company issued instruments with rights to the Company&#8217;s common stock at prices below this exercise price.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td style="TEXT-ALIGN: justify; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The debt conversion feature and the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,647,059</font> warrants exercisable at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.425</font> per share granted in connection with the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% Subordinated Secured Convertible Note (for which the rate has been increased to 18%) entered into in November 2009.&#160;&#160;These agreements contain anti-dilution provisions that would be triggered if the Company issued instruments with rights to the Company&#8217;s common stock at prices below the exercise price.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td style="TEXT-ALIGN: justify; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 882,353</font> warrant shares granted to the CEO of the Company at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.17</font> per share on January 2011 which vest over three years, for which the value is not material.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td style="TEXT-ALIGN: justify; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 28,500,000</font> warrants granted to the CEO of the Company and to three independent contractors at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.0014</font> per share on February 26, 2013 which vested upon grant, for which the value is not material.</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The fair value of the derivatives is as follows:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 93%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="68%"> <div>Derivative Liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,<br/> 2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="68%"> <div>8% Notes conversion feature</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>10,516</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>24,285</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>10% Notes conversion feature</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,368</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,447</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,884</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>25,732</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The decrease in the fair value of the derivative liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12,848</font> was recognized as a gain on change in derivative liability in the statement of operations for the nine months ended September 30, 2013.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Significant fluctuations in the variables used in calculating the value of the Company&#8217;s derivative liabilities could have significant impact on the fair market valuation.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Fair Value Valuation Hierarchy Measurement</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> ASC 820 establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%"> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 10pt; WIDTH: 3%"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td style="TEXT-ALIGN: justify; WIDTH: 94%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 10pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.</div> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-BOTTOM: 10pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#183;</font></div> </td> <td style="TEXT-ALIGN: justify; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Level 3 inputs are unobservable inputs based on the Company&#8217;s own assumptions used to measure assets and liabilities at fair value.</font></div> <div>&#160;</div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The derivative liability was determined utilizing Level 3 inputs.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The fair value of the derivatives is as follows:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 93%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="68%"> <div>Derivative Liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September&#160;30,<br/> 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,<br/> 2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="68%"> <div>8% Notes conversion feature</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>10,516</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>24,285</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>10% Notes conversion feature</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,368</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,447</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,884</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>25,732</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 2647059 0.425 0.1 882353 0.17 28500000 0.0014 12884 25732 10516 24285 2368 1447 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>5.&#160; STOCKHOLDERS EQUITY</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As of September 30, 2013 the Company was authorized to issue up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 800,000,000</font> shares of common stock and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000,000</font> shares of preferred stock.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Preferred Stock Issuances</i></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On June 10, 2013 the Company obtained the consent of the holders of the majority of the outstanding preferred shares for the creation of a Series D Preferred Stock. The holder of the Series D Preferred Stock is entitled to a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>% vote on all matters submitted to a vote of the shareholders of the Company. There are no other rights or preferences attached to the Series D Preferred Stock. On July 1, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font> shares of the Company&#8217;s Series D Preferred Stock to Jim Wemett, the sole officer and a director of the Company, in consideration for services provided to the Company. Such securities were issued under Section 4(2) of the Securities Act of 1933, as amended and Regulation D promulgated by the Securities and Exchange Commission.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr> <td style="TEXT-ALIGN: justify; WIDTH: 100%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On September 29, 2008 Platinum and Longview agreed to exchange detachable warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 71,691,180</font></font> shares of common stock of the Company for $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.085</font></font> per share held by such Investors related to the March 6, 2007 convertible notes payable for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000,000</font></font> shares of Series B and C preferred stock.</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On October 7, 2008, the Company filed a Certificate of Designation of Rights, Preferences, Designations, Qualifications and Limitations of the Series C Preferred Stock (the &#8220;Series C Designation&#8221;) with the Secretary of State of the State of Nevada, and prepared a preferred stock certificate for delivery to Platinum Long Term Growth IV, LLC, evidencing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,250,000</font> shares of Series C Convertible Preferred Stock of the Company (&#8220;Series C&#8221;).&#160;&#160;On October 7, 2008, the Company also filed a Certificate of Designation of Rights, Preferences, Designations, Qualifications and Limitations of the Series B Preferred Stock (the &#8220;Series B Designation&#8221;) with the Secretary of State of the State of Nevada, and prepared a preferred stock certificate for delivery to Longview Special Funding, Inc., evidencing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 750,000</font> shares of Series B Convertible Preferred Stock of the Company (&#8220;Series B&#8221;).&#160;&#160;The Series B and Series C have an aggregate liquidation preference of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,000</font> and participate in any dividends or distributions to the common shareholders on an as converted basis.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Each share of the Series B and Series C Convertible Preferred Stock is convertible into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 160</font> shares of the Company&#8217;s common stock and votes on an as-converted basis (with each share having 160 votes).&#160; The conversion rate was reduced to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9.41</font> as a result of the 2012 reverse split (Note 8), but was subsequently changed back to 160 as part of the consideration related to 2012 forbearance agreements (Note 2). Both the Series B and Series C designations limits the holders&#8217; rights to convert its Convertible Preferred Stock, and the aggregate voting powers, to no more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.99</font>% of the votes attributable to the total outstanding common shares.&#160;&#160;Accordingly, the votes attributable to the Series B and Series C Convertible Preferred constitutes 4.99% of the aggregate votes attributable to the Company&#8217;s outstanding shares on an as converted basis and the votes Series B and Series C Convertible Preferred and the Series C Convertible Preferred, voting together represent approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9.98</font>% of the aggregate votes attributable to the Company&#8217;s outstanding shares (on an as converted basis).&#160;&#160;As of September 30, 2013 the Series B Convertible Preferred Stock has an aggregate liquidation value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10</font> and the Series C Convertible Preferred Stock has an aggregate liquidation value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,607</font>.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> As a result of the Company not having sufficient authorized shares to satisfy the conversion of all outstanding convertible debt, convertible preferred stock, warrants and options, the Series B and C preferred shares have been moved into temporary equity classification on the balance sheet as of December 31, 2012. The preferred shares are presented at their fair value based on an allocation of the estimated total enterprise value to the preferred shares and other securities in the Company&#8217;s capital structure. The valuation methodology used is similar to that used in valuing the Company&#8217;s derivative liabilities (Level III inputs, see note 4). Any change in fair value of the preferred shares, which are deemed to be temporary equity, is reflected in additional paid in capital.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine months ended September 30, 2013, Alpha elected to convert <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 137,500</font> shares of Series B preferred shares owned by Longview into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 22,000,000</font> common shares at the conversion rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 160</font> common shares per each Series B share. Longview has assigned its Series B preferred stock ownership to Alpha Capital Anstalt.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine months ended September 30, 2013, Platinum elected to convert <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 745,855</font> shares of their Series C preferred shares into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 119,336,800</font> common shares at the conversion rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 160</font> common shares per each Series C share.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Common Stock Issuances</i></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine months ended September 30, 2013, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 76,872,435</font> shares in satisfaction of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">62,090</font> of interest obligations to lenders on convertible debt. Also during this period, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,500,000</font> shares of its common stock in satisfaction of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">19,913</font> of principal obligations to lenders on convertible debt.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the nine months ended September 30, 2012, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6,221,156</font> shares of its common stock in satisfaction of interest obligations of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">241,164</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 13,594,382</font> shares in satisfaction of principal obligations of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">983,585</font> to its senior debt holders. During the nine months ended September 30, 2012, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,764,706</font> shares of common stock to various individuals or entities in connection with professional consulting provided to the Company in an aggregate amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,800</font>.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Warrants Grants</i></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company has issued warrants to purchase shares of its common stock to certain consultants and debt holders. As of September 30, 2013 and December 31, 2012 there were common stock warrants outstanding to purchase an aggregate <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 32,735,294</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,247,059</font> shares, respectively, of common stock pursuant to the warrant grant agreements summarized below.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On February 26, 2013 the Company issued warrants to purchase common stock to certain consultants, the Company&#8217;s CEO and the Company&#8217;s sole board member. These warrants (summarized below) grant the right to purchase one share of common stock at an exercise price of $0.0014 per share. The warrants were fully vested as of the grant date, expire February 26, 2023 and contain a cashless exercise provision. The fair value of the warrants was determined by estimating the total enterprise value of the Company based upon trending the firm value and considering company specific factors thereafter including the changes in forward estimated revenues and market factors.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Warrant grants made during the first quarter of 2013 are as follows:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%"> <div>&#160;</div> </td> <td style="WIDTH: 3%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#8901;</font></div> </td> <td style="WIDTH: 94%; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000,000</font> James Wemett CEO</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#8901;</font></div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7,500,000</font> Paul LeFrois Consultant</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#8901;</font></div> </td> <td style="TEXT-ALIGN: justify; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,000,000</font> David Lubin Consultant</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td style="PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Symbol; font-size-adjust: none; font-stretch: normal"> &#8901;</font></div> </td> <td style="TEXT-ALIGN: justify; PADDING-RIGHT: 0.8pt"> <div><font style="FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,000,000</font> Alexander Ruckdaeschel Board Member</font></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of the outstanding warrants is presented below:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%" colspan="8"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted<br/> Average<br/> Remaining<br/> Life-years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Outstanding at January 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,247,059</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.24</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Granted during the year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>28,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.0014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9.92</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Cancelled or forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(11,765)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.61</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Warrants outstanding at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>32,735,294</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.51</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> A summary of the outstanding warrants is presented below:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%" colspan="8"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted<br/> Average<br/> Remaining<br/> Life-years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Outstanding at January 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,247,059</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.24</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Granted during the year</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>28,500,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.0014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9.92</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Cancelled or forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(11,765)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.61</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="48%"> <div>Warrants outstanding at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>32,735,294</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.05</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.51</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.51 100 71691180 71691180 0.085 5000000 0.085 5000000 4250000 750000 10000 160 9.41 0.0499 0.0998 6607 10 137500 22000000 745855 119336800 76872435 62090 21500000 19913 13594382 6221156 241164 1764706 10800 32735294 4247059 15000000 7500000 3000000 3000000 160 160 4247059 28500000 11765 32735294 0.37 0.0014 5.61 0.05 P2Y2M26D P9Y11M1D P8Y6M4D <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>6.&#160;&#160;INCENTIVE STOCK PLANS</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of the status of the outstanding incentive stock plans is presented below at September 30, 2013:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Weighted<br/> Average<br/> Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Weighted&#160;Average<br/> Remaining<br/> Life-years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Outstanding at January 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>723,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.07</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.53</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Granted/Exercises/Cancelled/Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(14,117)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Options outstanding at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>709,020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Options exercisable at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>709,020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 9pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> All compensation costs for the above options have been previously recognized in operations.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> A summary of the status of the outstanding incentive stock plans is presented below at September 30, 2013:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Weighted<br/> Average<br/> Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Weighted&#160;Average<br/> Remaining<br/> Life-years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Outstanding at January 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>723,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.07</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.53</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Granted/Exercises/Cancelled/Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(14,117)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Options outstanding at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>709,020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Options exercisable at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>709,020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 723137 709020 3.07 3.57 P3Y6M11D P2Y4M13D P2Y4M13D 709020 3.57 14117 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>7.&#160;&#160;COMMITMENTS and CONTINGENCIES</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Legal Proceedings</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On March 24, 2009 the Company received a demand notice from an attorney representing a group of certain former employees of the Company, including but not limited to the Company&#8217;s former President and Chief Financial Officer, demanding immediate payment of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">331,265</font> for certain deferred compensation, severance and vacation benefits. Each of the former employees cited in the demand notice, as well as other former employees, had executed written agreements during 2008 that allowed the Company to defer certain of these compensation payments. The Company has accrued for earned and unused vacation benefits and deferred payroll costs for amounts electively deferred by these and other former employees as of December 31, 2009. The Company has retained counsel in connection with this demand and continues to evaluate this demand notice and has responded to this demand. No actions or probable settlement discussions between the parties have developed since the filing of this demand. Due to the Company&#8217;s current cash and liquidity position discussed above and the current evaluation of the items in the demand notice the timing of future payment of these outstanding amounts is uncertain. No further communication has been had regarding this notice.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 331265 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>8. REVERSE STOCK SPLIT</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>&#160;</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On June 14, 2012, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Nevada, to effect a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1-for-17 reverse stock split of its common stock</font>, or the Reverse Stock Split. This action had previously been approved by the Company&#8217;s Board of Directors on March 23, 2012. As a result of the Reverse Stock Split, every seventeen shares of the Company&#8217;s pre-reverse split common stock were combined and reclassified into one share of its common stock. No fractional shares were issued in connections with the Reverse Stock Split. Stockholders who would have been entitled to receive a fractional share in connection with the Reverse Stock Split received one whole share. The par value and other terms of the common stock were not affected by the Reverse Stock Split.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company&#8217;s authorized shares immediately prior to the Reverse Stock Split totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000,000,000</font>. These were adjusted to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 294,117,647</font>. The Company&#8217;s shares outstanding immediately prior to the Reverse Stock Split totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 732,073,557</font>. These were adjusted to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 43,063,150</font> shares outstanding as a result of the Reverse Stock Split. The Company&#8217;s common stock began trading at its post-Reverse Stock Split price at the beginning of trading on June 14, 2012. Share, per share, and stock option amounts for all periods presented within this quarterly report on Form 10-Q for common stock and additional paid-in-capital were retroactively adjusted to reflect the Reverse Stock Split.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 294117647 5000000000 732073557 43063150 1-for-17 reverse stock split of its common stock 14025 0.08 On October 15, 2013, Platinum Long Term Growth IV, LLC elected to convert 207,863 shares of their Series C preferred shares into 33,258,080 common shares at the conversion rate of 160 shares per each Series C share. On November 11, 2013, Platinum Long Term Growth IV, LLC elected to convert 238,511 shares of their Series C preferred shares into 38,161,760 common shares at the conversion rate of 160 shares per each Series C share. 16000000 6000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>9.&#160;&#160;&#160;SUBSEQUENT EVENTS</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>&#160;</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Subsequent to September 30, 2013 and prior to the filing of this report, the following items occurred:</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Promissory Notes:</u> On October 15, 2013, the Company borrowed $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,025</font> from Platinum Long Term Growth IV, LLC pursuant to the terms of a Senior secured Promissory Note. The note bears interest at the rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8</font>% per annum and is due and payable January 30, 2014.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr> <td style="WIDTH: 100%"> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Series C Preferred Stock Conversion to Common Stock:</u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On October 15, 2013, Platinum Long Term Growth IV, LLC elected to convert 207,863 shares of their Series C preferred shares into 33,258,080 common shares at the conversion rate of 160 shares per each Series C share.</font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">On November 11, 2013, Platinum Long Term Growth IV, LLC elected to convert 238,511 shares of their Series C preferred shares into 38,161,760 common shares at the conversion rate of 160 shares per each Series C share.</font></div> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Payment of Accrued Interest with Common Stock:</u> On November 7, 2013, the Company issued an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16,000,000</font> shares of its common stock in satisfaction of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,000</font> in interest obligations to Alpha Capital Anstalt.</div> </td> </tr> </table> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> EX-101.SCH 20 nnan-20130930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) link:presentationLink link:definitionLink link:calculationLink 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - NOTES PAYABLE link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - STOCKHOLDERS EQUITY link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - INCENTIVE STOCK PLANS link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - COMMITMENTS and CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - REVERSE STOCK SPLIT link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - DERIVATIVE LIABILITY (Tables) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - STOCKHOLDERS EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - INCENTIVE STOCK PLANS (Tables) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Details Textual) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - NOTES PAYABLE (Details Textual) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - DISCONTINUED OPERATIONS (Details) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - DISCONTINUED OPERATIONS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - DERIVATIVE LIABILITY (Details) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - DERIVATIVE LIABILITY (Details Textual) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - STOCKHOLDERS EQUITY (Details) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - STOCKHOLDERS EQUITY (Details Textual) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - INCENTIVE STOCK PLANS (Details) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - COMMITMENTS and CONTINGENCIES (Details Textual) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - REVERSE STOCK SPLIT (Details Textual) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - SUBSEQUENT EVENTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 21 nnan-20130930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 22 nnan-20130930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 23 nnan-20130930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 24 nnan-20130930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 25 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2013
Debt Disclosure [Abstract]  
Schedule of Debt [Table Text Block]
Notes payable consisted of the following:
 
Notes Payable
 
September 30,
2013
 
December 31,
2012
 
Senior Secured Convertible Notes
 
$
3,124,403
 
$
3,134,415
 
Senior Secured Promissory Notes
 
 
647,462
 
 
508,557
 
Subordinated Secured Convertible Note
 
 
271,100
 
 
251,000
 
Total
 
$
4,042,965
 
$
3,893,972
 
EXCEL 26 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`:,QE5V@$``#$6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/& MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,90'^@Y&JZJ, MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N M);GWYIY2E^50"1=K`RK[?9HII4'Y3N^GD&&@T>8 MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@ MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E M6,S*L9B58S$KQV)6CL6L'(M9.1:S*TG?'A$%@?0'[%K.M#=PGAGKT],"#.A+J`E:";,FF3>$[ M_`(``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\ M(V(T'4\4"_'L)MI< M3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?```` M__\#`%!+`P04``8`"````"$`_GO?E-(!```<%0``&@`(`7AL+U]R96QS+W=O M_%[)K?BL"EJL2UI0]@)88@((EL]X>W MKX40%*F=7J*]1+*C.*/)>KYX9XNOPS[[<#YLFSI7U.NKS-5%4V[K3:[>5L\/ M$Y6%:.O2[IO:Y>KH@EK,[^]F+VYO8WHH5-LV9&F5.N2JBK%]U#H4E3O8T&M: M5Z<[Z\8?;$Q#O]&M+79VXS3W^R/M?ZZAYC=K9LLR5WY9DE'9ZMBF5_^_>+-> M;POWU!3O!U?'7]ZA/QN_"Y5S,2UJ_<;%7%VF@C[=(=-+FI7^0T[R0U;.!,GA MD;`<'D$Y)"V'D!PS$)9C!DC.6%C-&(DA%E9##.5(FT/0'1X*N\-#Y(Z1#D$# M0U"Z='#E2$<@X0A,!!4%!/=1Y?!46LX4R9'F`\2#=.'`NB%Q:Z`W+(U.AN@T MTI%C8.:83FD5*NM=^1I]^ND.:;N>?TQOIM&FDF851!5)JR$HAZ7)R9B"'XJD MK2'H#4O#DB$LN5-87MHUUYRY3)T[.`R/=D8ZA/EWA MUI:F$H92TB_9\+L`6]_T-.??````__\#`%!+`P04``8`"````"$`>"3NTV@# M``#R"@``#P```'AL+W=O!//[?9J]OZ;I MNP0"23Z0UYQO;Q4E7Z[9)L@OTBU+X,DJS38!AV7VIN3;C`5AOF:,;V)%5]5+ M91-$B5PIW&;G:*2K5;1DDW2YV["$5R(9BP,.]O-UM,WEX=TJBMFBRD@*MEL[ MV(#O0RQ+<9!S$D:'ICJ(:L#.LDW4P*V2K8Q=R' M]([J4"^]I^N7Q3^+4BPBML\_@XJE='B.DC#=%W^%TG[4*P,,[,M'SU'(U_!< M5=7ZWB.+WM;\>!/D%:1?5A#V*:]24J9WK`@UDY"2A$?\@UI)5?THA1865;<@ M,TV6LML(?F16J!7&LLOC7@^^'DBMN]1YX$Z+D$J/:32.^FE5BE$/-\9(Q6H>UV4_GDJI9>Q MB>MRB51*)G!&[LRRQY9K3NEH[EDV\3QJCGUK8?DOU+21EP*,VLQ5VXSM^,2C MKOEBCJ:X#@;>_+H=-;$\:*UOV7/H*Q1P9OH6M!KO>H5VO1'BRO1F4[(S*/D][P5?(.#!22A:M#Y8N=2AKH`)3;> M@U/UN7<'CD]/EE_!`T.,5F7X2:`7I"'3.!<"CS.R`/-'#YX+!4#Y]_")T`0, MO?G(@[0A#0HR@#$.-;!]@;W3U(#G^ESW\$G0!/P:W%`_>(UACJ-H#)TF4/<% M/QTZ&$--Y+"#HPX1S*(FP-B!4X<&1A(F;VO0=5+5H8+9U`4V3W<'H*B[HV-" M8-&RT^S.A/$@BG%[=$P)+,X)ISX[\%T`K[W:11^?%5W@]*LN5WZ0CHYI@47+ MSFD=#"V\.C\/;_4>Q3,3!H8P=FA'=3`ON@CO"16*C['>8$:`MXN[#C,-9,Z" M]Y\(-`S5N(\'DG$FP*(=HR$C$#QV3HQ'BNP8&&!8M%K>,1^/C6JF96"28='2 M$48E4CEPY*??\%.BK)3HP'?1,HB7\,%67(HOGK)VRO%S=?@7``#__P,`4$L# M!!0`!@`(````(0#R*P`-:@8``"0:```8````>&PO=V]R:W-H965T&ULE%G;CN,V#'TOT'\P_#Z))5F^!)-9K"_;%FB!HNCEV>,XB;%Q'-B> MG=V_+V4YL4CGXID%9B?F(:5#4B2M/'_Z7AVL;T73EO5Q;;.%8UO%,:\WY7&W MMO_Y^\M38%MMEQTWV:$^%FO[1]':GUY^_NGYO6Z^MONBZ"RP<&S7]K[K3JOE MLLWW196UB_I4'$&RK9LJZ^!CLUNVIZ;(-KU2=5ARQ_&6558>;6UAU6K/UJI\CKDJ:[Z^G9[RNCJ!B=?R4'8_>J.V M5>6KWW;'NLE>#\#[.W.S_&R[_S`Q7Y5Y4[?UMEN`N:7>Z)1SN`R78.GE>5," M`^5VJRFV:_LS6Z7B[;Z4RJ1MY6]M M5U?_:1`;3&DC?#`"&H,1QA<\D$QZCZTL]8YZ@DG692_/3?UN0=;`FNTI4SG( M5F#YS$SOX\+U%E7@J(Q\5E;6MF];P**%^'Q[\<+GY3=P:3Y`HBG$=S`D/D.4 M`Y79Y/Q@-,NP2GI&J.@!HPLM<)9)ZWJ@SKM78+7[\[J1?@"V+W0X7C>>(GRR MM60*(4;2*<(P@NB(C]!18,@P8_<^63G2$->`2$+P(2)YB$CO(1`]V,C\:"GP MV@;?78+C"[SY2$."/A%9X/DNEL>FW/,#HIZ88N:R,"3N2TV`E$*,H4>TX#S- MIZ7`A!;9=J0ALJ1^AI,"$ M$DFS2$,T)28=1G85FW+/$<0CB2EFS!4.L9^:`,E<>2-24+GF1TJ!R?GR<"@B M#8$TN>0HV5C\$)$\1*3W$"AJ:@XQBOS]:JC`)&HD*I&&#%%SH8UA^K$IYTSX M1#\QY2[S.#F`J2D/'2<8PXYHA1^AI<"$5H"W'6F(IA6PP%BV;T>Q*0^%G!PQ M4\X]:,SC(>H-I!@0N&)T#"+&8$*9'[`>3:B1TQ\-&,TME"&C^8@`<)1"3G(Z M00CA>#XMNRE&R$#R,3$P/]6V9RK/A&>>H]&PT8S>\I<(*0!#?&".8$ M`2WK"8&$W/6(E11#A./#OTL688ZJN\_GJ&0I+' MD/0N!)-4+7X^23T0P!Y'DJ2U1DQCAD"&@CLD!#%&!#[DZB4"O:,2C."^ZTMB M)"604'K&8<445;.?3U&/!H@BJ6X1TYBASH12D),6#P#=R>6DZ2%]Q@-W0DXO M,-7'Q%3'-XBIT5]`X;G?'=1K#ZFCM$Y&`T:O/QZ//CCQ(!P"S#PA/<(_(1!' M4`^E&.'ZR`AFJ28`@^4#=GI>0.$CE3)BYDPA0D'+8#P`KM)/'FFG-[0Q*=7Y MYY/2,8W141'P:DJ*3XP`3QQ&-5J?$@(1/*"N23$$IE`O&`L`IJAF M@/D4]<2`*(Z]=2B?YE3Q!*-@2!`Q0P@A0X<22##$Y7`ZB:=2#&&.+WUYBZ0: M"`R2,X^@'B,065("(J8Q5W,P'H0ZV)Y+7R02)&?P0XY`B@%07T=/HB!R,L?, MX]=KX7DF("4^&C#7^=T3)H/P7'\8\XGM](8Z9D8FF)G,II-,2.ICQ#5FV-^U M-,4((;G'R'%.,`32U)V\&6$(]KI1'M< M&Y.[,LW,(#>=9L+Q95/W#76Y"GE\@]P=87)/,[TAQ*3(\#(S/:=#3#CF_T`* M#3&,>=[TC2^&*W7%7!\C*3W7#>BK>H(PW'6XY(XWMKM^-74W/QIR.?-"1XX[ MTI3UY;N^FZZ*9E?$Q>'06GG]IB[6!63/Y>GETO\S5W>VY'G$5G"3/'V>P)<$ M_?/E10'NZ$_9KO@C:W;EL;4.Q1:6?^IORU[J#V_G^SSU\ M&U/`';6S`/"VKKOS!W43??E^Y^5_````__\#`%!+`P04``8`"````"$`#7G> MVU0.``#7<@``&0```'AL+W=O[W^YTWFI"$V4G(`-W=^]N?)60#DJG_A#ZTJ?+S MLFQ9"]D6]O?__?/^=O/W8D[\+G:S_'A;UY7^SDOYN7V^WG9KEXVB_T_G;KWMVE;M\7JX^8CG"_N23& M^OEY];@LKA]_O2\_=CK(9OFVV$G]MZ^KSVT0[?WQDG#OB\U?OSZ_/:[?/R7$ MS]7;:O?O/FCLYOWQOO;RL=XL?K[)=O_C>(O'(/;^/Z'P[ZO'S7J[?M[%)=RM MKFAXF[.WV5N)]./[TTJV0.WVF\WR^2&6<^YS!3<5N_WQ?;^'QJOE[^W)SS?; MU_7ORF;UU%Q]+&5W2T.I)OBY7O^E:.U)%GG=27LG99/4EMT__5M<;A]EETJ8N)M4D1[7;U(!^?OF?:6.#=DEBW_V M__Y>/>U>'V*)5#R9ODLXPF]^+K>[\DJ%C-T\_MKNUN\3C1P_E`[B^D$\J;W_ M>S?N9I).,O6%*+*^?552QRB9N./=?25&VH\A_QXVY^+-D$ZQKX#\ZR_L>E^M M0-:/X:B6]'>H&_?<9#KSE3WJ'-I%?@CB?+UAG*!EG,0QC/OE]G6D8?51(FT4 MU.::K9*FU7%.V^?KU0D:RI&]';24&T\[=]E$^@M'K331OC;N25M]?1^[05.I M'_S:.-FO-[D;M)7Z(=@JYZO'GRL-K3?JV.)R%'^Y,[I!DZL?KJ]-T*?=8Y^Z M)K\$O222^5X1:_U3EOGT*+B]WBQ_?-^O>-?#!)@VT_%^ICSKE7 MH8/DJ5/=(9W^*9M*&E51CUM3EO1BM(/1%"Y01`V*!@&XEA; M*\8H$,$BXZ#@N$CZSMPIDX`$RTSM@IDND+\/1V`B9>W:>6""*#G_N(U<*NC,.+G=3X5KK6H7])(C/ZU_E!2="-E%;=**A@/B@X;I6U386P2%L[ MO!@F;MKIA8]6V$1:A*,VP M2:2M36J%C>=9IGW.6#7NA(U5XVY8A&K<"QLK2A_%("SL)AB&B;6:$8IQ6'A) MZ[B<7&"F%YC9.6,UP/R=A4O:4?R>Z6)CIMO9`@9I!@9 M0GT">S)HB,X4:BDC4]@%!;N@:!>4=(%123LQE"\PE3/&\\PN6PV;;,8DM3!) M6CN_SJ01)IZ7,M?4#)ND59D6D_898AT''2;=,/$\JS*]"TS_C$E:GZ*#"\PP M;!)V@AB=,U:*&(>-E[3,Y)RQ!E[3<\8ZN&;GC-7F\PM,+G<)RE^"_-YG]*V3 M8\Q(`')V$4H`"3D?BTX`:BDC`=@%!;N@:!>4=,%Q8%.V"RIV0=4NJ-D%=;N@ M81V-B)NA^08,`UL`N&0<%Q1796&@4D M"#*V"R9VP=0NF`4%?U[-G$DN=\98.2F7O\#XQ\[^R#".5?E$>UTNLML9N4&N;%Z1&]12#S$9>1_Z?2)C MI:R\-E&Y`44110E%&44%115%#44=14.+[/Y*G%R(/9YZ[*^K-3%`"T4;10=% M%T4/11_%`,40Q0C%&,4$Q13%#,4<12['A+MU_],<\U1J?$.4O&N)X)BBF*&8HY MBER."7>]7"$JBI$@Y,[8%0E"+64EB)35+'EMHA*$%OXQE$YYZ3OKRD$18Y10 ME%%44%11U%#44310-%&T4+11=%!T4?10]%$,4`Q1C%",44Q03%',4,Q1Y'), MN-?E"E%1C-P@]Z2OR`UJ*3LW6(/@O#91N4&+C!X\W(4^6XH8H82BC**"HHJB MAJ*.HH&BB:*%HHVB@Z*+HJ>%;MFTEY1I%.;G>1]##%`,48Q0C%%,4$Q1S%#, M4>1R3+C+Y0I148S$H*:7&9DA^GKYGMLIP3H5R/LH*BDS&3`9^B0X24TG0V<7'&3,9,)DRF3&9,Y$9MZH M[BMWND\N_%DY6";>L"E$&C-AR-VXKR0,Q>V$8=V=S*M)JM%;46!29%)B4F92 M85)E4F-29])@TF328M)FTF'29=)CTFU'&S!AJ0I`].Y9OS:LIYZ',81W*&[9%0<21X:171)21Y1QDP>:I[0%4U,;KYY3*F_F-^>!1\%)']BI?$*7&<,I,*DRJ3&I,Z MDP:3)I,6DS:3#I,NDQZ3/I,!DR&3$9,QDPF3*9,9DSD321JZOT5T)4D:;**[ MI)DTU%ROT\$&)`T]->QTD)&R;X^HKU`?DH;SAYR!4\R*%X0I^29B?Y695)A4 MF=28U)DTF#29M)BTF728=)GTF/29#)@,F8R8C)E,F$R9S)C,F4C*P)XD*8-- M(=*8*4/-WSI-&>J+1Q=?NB4OEFCS8(3-77,_^9O=(@2 MAR@SJ3"I,JDQJ3-I,&DR:3%I,^DPZ3+I,>DS&3`9,ADQ&3.9,)DRF3&9^T3W MH$S3FAO8.$?Y8U3Z3`9,ADQ&3,9,) MDRF3&9,Y$TD=V+TD=;")[H-FLE#3OZY(%GK6F)DL["^+.%%3R_QD@:3(44I, MRDPJ/O$OS84/_BK'J!W(OH=9O:=^^.T?>T^#29-)BTG;)WIK4ZD[J_$Z'*++ MI,>DSV3`9,ADQ&3,9,)DRF3&9,Y$\@5V'\D7;`J1QLP7:E;8%?E"3R8S\X7U MY?J\>H(6W4M!4N0H)29E)A4F528U)G4F#9^DT_J)3_%L-C0P;7*8%I.VN:9L M/)L)K:G#8;I,>DSZ3`9,ADQ&3,9,)DRF3&9,YDPD=V!7DMS!IA!IC-RA'FUW M1>[8+V;>5_%2]I?6?11QX;+`I,BDQ*3,I.(3_Y1"GAOG>@EKS%\U3,IU'7F" MI3D1ZCI.RI@X-.?,^BLP7 M.DX$*7*4DD_\CY_,N7F&90Y385)E4F-29])@TF328M)FTF'29=)CTF<+O& M9LY0<\BN&&OHJ6=2E>-L4?MQ?7GU0&RXPL&DR*3D$W]SW70BZ6:MP6O9,)XK MW[>W'P56X355F=28U)DTF#29M)BTF728=)GTF/29#)@,F8R8C)E,F$R9S)C, MF4CJP,XFJ8--(=*8J4,^\:])'6HQ:]B1MFXKY]6C[REU("ERE!*3,I,*DRJ3 M&I,ZDP:3)I.63_Q+K'=Q^R'*;8[18=)ETF/29S)@,F0R8C)F,F$R93)C,F0.[D>0--H5(8^8--9WLBB&'GH5F#CFL&5YY%Z>J%9@4F928E)E4F%29U)C4 MF328-`]$W^^UQLFMPZ^/@T+K*F^;28=)ETF/29_)@,F0R8C)F,F$R93)C,F< MB60-[&>2-=A$=T8S:Z@Y9%=D#3WUS,P:UKE!7MX2ID8;_@-WPE]34J\1.X)L M)B$/;C%/`(N^D$1Y."&R2(E)F4F%295)C4F=28-)DTF+29M)ATF728])G\F` MR9#)B,F8R83)E,F,R9R)I`W=CR)ZB:0--D%_/!]'IPW]VC[]SJGWY>9E65B^ MO6UO'M>_U"OY5%<_E![?%^BI-^!8Y7GG7MZ[$R[O.??]<^5#YUY>-13V8^=> MWAX4+L^[]_ESZRVX]_(X]+`ONO?R1'TIOSU45-XJ^+EX6;86FY?5Q_;F;?DL MFW@75Z_GVNCW$NK_[-:?^S=O_5SOY'V"^Q]?Y0622WG#E8SP8S?/Z_4N^(]: M@7H?XO[573_^#P``__\#`%!+`P04``8`"````"$`P9UJL7@#``#G"@``&0`` M`'AL+W=O?<92ZSNGTI"^.9"LEX M%9NNY9@&K1*>LFH;FW]^/][,34,J4J6DX!6-S5$528R+,4U M'#S+6$(?>+(K::601-""*/`OV$#TWJ5,HA`I]T0 M-(O-.W=Y[X:FO5XU"?K+Z%X.K@V9\_T7P=+OK**0;:B3KL"&\R<-_9;J1[#8 M/EK]V%3@IS!2FI%=H7[Q_5?*MKF"F*4TCV4G%RW\("W M)?%\*_#":'X%BXV.F@`?B"+KE>![`[H&-&5-=`^Z2V`^1(8^NEC/A0KV-,F= M9HG-R#0@"@GU>5X'WFQE/T-.DQ9SCQCX[C!NA[#!36<);`PMG4[R05F#M;+. ME+9RCP^&,MYI&?\],AH/'3TIX.,I*%-A\%?EM;@J73?MYAVQ*#TC>M&LS-UUZ^# MP5Z[+*S!4^&^DU$8,2CL>Y$?>HO@=,R+L;1NN;<+KA=-+?@=/UI`S*(IN&/Y M_9X8I=R%YAJ&?IU^LVIJH`\0#;0@=.!:P>>;WN+8@QY`@_1?Z0''UFCG^WU] M6P\(0@^A->L;9.Q`SZ;W.\")-G9P-%P1=*B#TSL<.Y@,O2MS<&+Z#2K=YN!X M_`5^/Z#&-DY,P+?;T<7Q-DY$/UY:&\=N><.Z\YJ71_P#&C M)EOZ@X@MJZ11T`R6.E8$^@(/*GBC>-V\[#=E8`,XX5X<; M?13JCJCK_P```/__`P!02P,$%``&``@````A`)*I./B^`P``QPP``!D```!X M;"]W;W)K&ULE)==CZ(P%(;O-]G_0+@?OA$TZF84 MT4UVD\UF/ZXK5"4#E+1UG/GW>TJ%@3(CKAGY3C_\E+DVC.F+"/E M0K<-2]=PF9`T*X\+_?>O^"'4-<91F:*(&:3")?0<""T0AUMZ-%E%,4KK045N.I8U,0N4E;I4F-%[ M-,CAD"4X(LFYP"67(A3GB,/\V2FK6*-6)/?(%8@^G:N'A!052.RS/..OM:BN M%9I!!,)V MC>+#0G^T9[M`-Y?SVI\_&;ZPSF^-GCXWH!?E`MQ0=TSOE/P6(H]"9:%#>&`H@TQY7GJ..S>? M87F3*[,:,H'51]8-(A93Z$9-PYNNW1^R:8AF2"P;Y"H*C:W:L.LTF.!":P6L M==>*]_.LB5C`(N+FN2O9`-JM!4Y_JNLA$2C11$-$$=D,"54D'B+NQ._/9?L> M,^DSN_>8H&5ZUKG_8YV`83-VG/+L::M;+_Q*,EZ'42)8CQ+1*+$9)>)18CM* M[&X1/1K MH;@=C2AL1A7B46([2NR46;SMGIZ-<*)V;;QMGX`5^QRO;\]*,O#PC^Q9CQ+1 M*+$9)6))^/4JPCO($I_^5+==)`P=UU=.X5T7<"9>8/EO6Z_G(KSQNB[>EXQB MD.*FIWW726SHVZO[82>V3,H(Z#=;`=`'5FA(_Z.Z#$KF9;C`SS*,D2Q1F4E*F\X MJ>H2:D\X5)#USQ/\8',C'M#^!5G^`P``__\#`%!+`P04``8` M"````"$`QBD;3,H"``"G"```&0```'AL+W=O@,8/W[S?@?;6=R^\`H]4ZF8J%,<>@%&M,Y$SNIMBO_\?KB98J0TJ7-2 MB9JF^)4J?+O\^F5Q$'*G2DHU`H5:I;C4NIG[OLI*RHGR1$-KF"F$Y$3#4&Y] MU4A*\G81K_PH",8^)ZS&5F$NK]$01<$R>B^R/:>UMB*25D2#?U6R1KVI\>P: M.4[D;M_<9((W(+%A%=.OK2A&/)L_;FLAR::"N%_"F&1OVNW@3)ZS3`HE"NV! MG&^-GL<\\V<^*"T7.8,(3-J1I$6*[\+Y>H;]Y:+-SU]&#ZKS&ZE2'+Y)EO]@ M-85D0YE,`39"[`SZF)N_8+%_MOJA+ MO]Y3E4%"0<:+$J.4B0H,P"?BS'0&)(2\M-\'ENLRQ:.QETR"40@XVE"E'YB1 MQ"C;*RWX/PN%1RDK$AU%1N#^.!]YT30)D_%E%=\Z:@.\)YHL%U(<$#0-/%,U MQ+1@.`?ECR."4`Q[9^!V"9A54(7G91Q.%_XSI"X[,JMS)G*)]0?$Y(3XX.MD M#D*^WIR!(;$8=@]K8XO"*[KR[3J"!I^N+!F4=]?Z#Y_99FAW`T1CD=H M^J['86\&OE17RPQY&R(<;^//>#-P/V_]NEHFL74-DG#LYG7=G8]BV-"G>\(R0[D;(AR/YKJ[^C`Q\*6Z6F;(VQ#A>)M]QIN!^WGK MU]4R=K]&HW'O'(3KR$@]?8H[@A6_I$Y);5"E6T@!T;>!-H6&EO M&CO0HFF/WHW0<$.T/TMX(:!P+@<>P(40^FU@[K+3*\;R/P```/__`P!02P,$ M%``&``@````A`,H2HH>O`@``[08``!D```!X;"]W;W)K&ULE)5=;YLP%(;O)^T_6+XO8)(T*0JIFI!NDS9IFO9Q[1@#5@$CVVG: M?[]C'!B!K>UN$FQ>/S[O.?9A??M4E>B1*RUD'6/B!1CQFLE4U'F,?WR_OUIA MI`VM4UK*FL?XF6M\NWG_;GV2ZD$7G!L$A%K'N#"FB7Q?LX)75'NRX36\R:2J MJ(&ARGW=*$[3=E%5^F$07/L5%35VA$B]A2&S3#">2':L>&T<1/&2&HA?%Z+1 M':UB;\%55#T&:04(!XX4+2V*RA`#@%U7"G@Q("'UJ_T\B-46,9]?>8AG,",C1@6MS M+RP2(W;41E:_G(B<40X2GB&PX@PAH1>N%F1Q_3K%=Q&U!A-JZ&:MY`G!H8$] M=4/M$201D#MG+H[>Z[^L@D<+N;.4&"\Q`A<:RO.XF9/EVG^$G+*S9CO5+(-+ MR:Z3V`Q:;M)-_.&2RR7[3F'+!Y9Z7Y"MH:^_5ZH+WXIM^-V^6S+GO M;JI8CD)+II(19#]5#"`7=F;_8\>*X8@-HI^3Q67\6Z>9#S0CQ>Y51?*J8O^2 MXL(?!#(LESV&,[BF+Y?-+HHQ)+&OTNIF9--)5NV1')^V%]XEPW>$D.6("\W& M;CWF.DNNC;A;5G&5\QTO2XV8/-H6,8-8^MF^>]V%]O"-YK&PO=V]R:W-H965TX[Q\>KAM7:1)9C&J2,64++P]K\]?/I;F$:0N(RP3DKR=I\(\)\V'S\L#HQ_BPR M0J0!"J58FYF4U=*V19R1`@N+5:2$GI3Q`DMXY`=;5)S@I!Y4Y+;K.'.[P+0T MM<*2WZ+!TI3&)&3QL2"EU"*>[^U[&Y0VJX2" M`Q5V@Y-T;3ZB9;0P[S#ZJ4[`=VXD),7'7/Y@I\^$'C()V?;!D/*U3-Y"(F((*,A8KJ^48I;# M`N#;**C:&1`0_%K_GF@BL[4YFUM^X,P0X,:>"/E$E:1IQ$P7B&E\9K9#)G"ZR*Y!5`25;M@T7'51=TC4 M$"I]8.GB"Z+5]O7O3#7+5[!:?C/O5C>`]L6/VYUW-R2"WM+"(=(3B89$2Z1C M9_8>.PJ&+=9:O8?\[OJWFO%:3(_831+A)!&-$1U_L)#;TZ7@M0G!NV;'[05_ MJYDQ?Y-$J(E%O9_O/-?WG%Z,HC&-CC]XM6[WI^"N/P_->_G3S)B_22*<)*(Q MHN-O_AY_"I[:GYH9\S=)A)-$-$9T_,'1=GO^%-S-GXON>_G3C%?OK?XQJ/O\ MNN]^%O0V7=CN1E[@]X9'[7Y58:[]'4OJ;M(Z^<=/2`7W+`U>. M&:ZO"/I!LJHNLWLFH;37?S.XR1&H;XX%<,J8;!Y4%;O<#3=_`0``__\#`%!+ M`P04``8`"````"$`2'FY5U0.```U>```&0```'AL+W=O7ZZ^7N]VV^V+Y]NC;O*[;6_V[ZN7\3_?-WNGE<'\>ONV_W^=;=>/1Y? M]/QT;U8JC?OGU>;E5D;H[*Z)L?WZ=?.PMK8//Y[7+P<99+=^6AU$_???-Z_[ M4[3GAVO"/:]V?_UX_?"P?7X5(;YLGC:'?X]!;V^>'SK^MY?M;O7E2;SO?XS: MZN$4^_A++OSSYF&WW6^_'NY$N'M9T?Q[;M^W[T6DSQ\?-^(=I,U^LUM__73[ MI]%95LW;^\\?CPTTVZQ_[B]^OME_W_YT=YO'X>9E+5I;[*=T#WS9;O]*J?^8 M%HD7W^=>[1SW0+B[>5Q_7?UX.DRW/[WUYMOW@]C==?&.TC?6>?S76N\?1(N* M,'=F/8WTL'T2%1#_WCQOTD-#M,CJG^/WGYO'P_=/M]7&7;U9J1J"WWQ9[P_. M)@UY>_/P8W_8/L\E,K)0,HB9!1'?LR!&_:YFUINM]T2I9E'$]]^O2BT+TC@' M,;US2)R[-BVXOLIBOGNMFUG0<3W M+(@IWMN5.\80QY/>0?$\E:'5:?/^ZV/V_$V4DX.D%_JG@K6K:9OM2-(^9GVYVH!<,]8+@5/#+H*.3 M.%5]+`OD^27=2J@73$X%OPPZ/05]$]6&ULS1R9PV'&/8Y/22DK"SDSF%G>?# M5AM5=9I*?J=4\%E^^IIE:O MES=:Y:R\:&I'CYTGU49=W9"3-V93)6Z>5!L-U7A%1HOC2R,:]9R)VGOJHQB@ M&*((4(SR0F_;<9YH;R8L$%J+3`J(VJ[3O*@VM5T8%1EM2W'>:-5-\J+:;*FU MF1685D4U\R*C'9B+`M/0:KS,F[<:*]DH.DHE&].^I"HZX?*L3%^E9*5>T-,+ M++W`U@LV:89'1=DU09-X:_MCW MC:XPXR*CG8/#*\RDR&@GRVF1T4Y0T14FOL(D5YC9%69>8%I:.R^N,,LB\];. M2J*("T`E4L%0+PCT M@I%>,-8+0KU@HA=,]8)(+XCU@N14\-8#5IM:(L^N,/.3.5U2+/2"Y46!<@R( M:^UW'`.I%B?3BQZ[6M<2JRN-V-ZY5]?ZIQX*"X6-PD'AHO!0^"CZ*`8HAB@" M%",48Q0AB@F**8H(18PB03%#,4>Q0+$L$THBB@&%=R1BJC_=BDNBWZ02W,D41H8@OZV&(G5O1>H,$0\Q0S%$L M4"RED$UJ-@VC\G8MK*2A&#MZ1QJF6D]#K;?K2E.6AB@L%#8*!X6+PD/AH^BC M&$A1E^-W1JU5K6G71,-+T3"K=4,[[`+5ZX:VK7.R$&F*"8HHA0Q"@2%#,4/#U&]F8ODK/ M1FU4KRM-63:BL%#8*!P4+@H/A8^BCV*`8H@B0#%",99"9F/KKEY1OAKV!^TB M/\2($Q13%!&*&$6"8H9BCF*!8EDFE/1,'S'G\M-HX9CW\75ZAFJ#S=T,E:5H M`1'W`NJ`M%6`M$MEFXG#Q&7B,?&9])D,F`R9!$Q&3,9,0B83)E,F$9.X@%3; M;W=MQRR8+(L)6JJI@^>+U,54E0^IU93].T! MW/&TU34D*LF_'A.+B(R\9CX3/I,!DR&3`(F(R9C)B&324;DZ4(,3!K: MT3+E&!&3F$G"9,9DSF3!9%E*U`1-'WE?)F@ZX>.*OE0^*5<351M3Z*:S+L4] M;&FB(K$XBLW$8>(R\9CX3/I,!DR&3(*,R.1H-?6Y3B,.,682,IDH%:F)&?;I ME]Z3XJ$0\99B)@F3&9,YDP6392E1$U6DD9*HT).F7+L[;;]=3V<]J42E"8K$ M2N=4EZ>YS<1AXC+QF/A,^DP&3(9,`B8C)F,F(9-)1DY/CEI5;2QCRC$B)C&3 MA,F,R9S)@LFRE*@)FLY6N.Q)(4'EY`:U!]4?MZ1_;U">6CTF%A.;B(Q M\9GTF0R8#)D$3$9,QDQ")A,FTXQD.2SZ6.V`BA1@BNMEK1>.%5!KUW20**#: MR$68*<`4-\UJ/S_/_K^DTUDP6982-2_3V0N7>7G=E&9#3GI0\U-_`).ADO?2 M8V)E1.ZUXRB#VF0VQW"8N$P\)CZ3/I,!DR&3("-9PZ4MIS;Q"I>!*95D:1,E0LVB^$<_./;Y,'="M M5;0Y%-T,E=V/,K&8V$P<)BX3CXG/I)^1;/\U:LU*7;L,&7"4(9.`R8C)F$G( M9,)DRB1B$C-)F,R8S)DLF"Q+B9JJ11.-KDC5_$2C6D6?:&3B+*(>$XN)S<1A MXC+QF/A,^AF14V,-^X/V/'_`(89,`B8C)F,F(9,)DRF3B$G,)&$R8S)GLF"R M+"5JGHKK5^6B][K;4S-]F=ZE:L=;-T.E7:J,4T(LCF*?2?K)2\9=+7?H.V?Q M]H>KVA-=]TS2()4[0QNP]K3_KYFUMO*ECI_Z9_[++?;/1&X1(@[._)<1ATP" M)B,F8R8ADPF3*9.(2R8+(L)6KZIC,_+N]9KTQ?.6%$O7?5YR"9 M.*NDQ\1B8C-QF+A,/"8^DSZ3`9,ADX#)B,F82__1/?(JF>HY?EH90\U3T<+^3I^G+]&Y6Z[BZZ0Z&)TLM@G,]D$Y])G\F`R9!)P&3$9,PD9#)A,F42 M,8F9)$QF3.9,%DR6I41-T'1JRN4]*22HG,FBWHMJ'637Q'E"O8S('&Z9M=P? M@G,,FXE#FW$YAL?$9])G,F`R9!(P&3$9,PF93)A,F41,8B8)DQF3.9,%DV4I M4=/S]R8DF?D)2;6*UDUV,Y1=B)MWR@!IN]VT/VB#3+WL%26]IL7$9N(P<9EX M3'PF?28#)D,F`9,1DS&3D,F$R91)Q"1FDC"9,9DS63!9EA(U<_4)2E<.]A9, M5#*TZ:)=$V$S\C&2?1V[4])65^AQCP&3()&`R8C)F$C*9,)DRB9C$3!(F,R9S M)@LFZ>*EOYY9(--4+DXJUU1\7N^^K7OKIZ?]SLDICW?:,C%BG,EP=& M1ZQ$F"^?&IVHJ#PQ.F*EO[SOFIUN87W,CEBA*.\MLR,6*LJ7VV9'K%"@``&0```'AL+W=ONJY*M5M27F'+L)13.$26\83=BV17LDI;$LD*JD&_RGFM#FQE,H6NI/)I M5U\EHJR!8L,+KE\;4HS*9/FXK82DFP)\OY"0)@?NYN&$ON2)%$IDV@$ZUPH] M];QP%RXPK5F[$BR+,:W9'E'0NRN5TV!_G*V5[W?2.5B_U7R]#NO&%0; M^F0ZL!'BR4`?4_,*@MV3Z(>F`S\E2EE&=X7^)?;?&-_F&MH]`T?&V#)]O6//#%,B"A``GZCD9FE`1>A+\[WGJ:KE=2[!&L&LBI:FK6(%D" M\\&9U=%Y/6<5/!J26\,2XP@C<*&@/\_K,)JMW&>H:=)B[BP&/CL,Z1`NJ.DD M@8R^I+>+?,ALP":S*;J1&UFBPE[F&,) M!@8!,MV@`<-ZZ;&&433*;#$3,L-JZV?<7(P46,VM:'_D! M"8X2!]:O3P6$$'M9@`D:"8CF(P$68P5&<*3F!]]8U/R]]$C06,-UP+.BB8G5-@)D^O]!,5V'DUV/+S8V]M"8@% MO:O`#*6/*["C;*"@MZ]:!1;4W_OA_,Q@):.19PKQ_NYKHD:M"(\96AFGPR^< M'[?*8"?`27U2C0DR[)`;5&,^7I(--9CJ3\L3&?:8MZ=@R>26?6%%H5`B=N8( M)[">N[?=]>+6;RX(W1]PNM=TRWY0N>650@7+(-1S(IAETMX/[(,6=7/&;H2& M<[WYF<,]CL%)Y3D`SH30AP=S`^ENANO_````__\#`%!+`P04``8`"````"$` M>>+&^QL"``"N!```&0```'AL+W=O%OH/0?BP[M\D$V\.$D':@A5)Z62NR;(M8DI&4.'G['DE)"),I9#:6 M9?_GTW\N*'\^R`[MN;%"JP)G28H15TQ70C4%_OUK_3#'R#JJ*MIIQ0M\Y!8_ MEY\_Y8,V6]MR[A`0E"UPZUR_(,2REDMJ$]US!7]J;21UL#4-L;WAM`I!LB.C M-)T1287"D;`P]S!T70O&5YKM)%F90^( MC>B$.P8H1I(M7ANE#=UTD/&UP5^R1;+,29E'NKS1_#!7KTCV^KABQ'5-Z$X%!O:Y!NPT7KKI:^5 M_P3!Y"9Z'1KPPZ"*UW37N9]Z^,I%TSKH]A02\GDMJN.*6P8%!4PRFGH2TQT8 M@">2PD\&%(0>PCJ(RK4%'L^2Z6,ZSD".-MRZM?!(C-C..BW_1E%V0D7(Z`2! M]03)1O="2#04\EM11\O%4%!; M:,:^G,PG.=E#!=E)LWQ/,[UH"!Q_\0#G?MR##P*O&%UYF%WXP>WSB(FGFHT1BZ/7MK((Y<;$E/&_Z=FD8HBSI>`S9-'F$^ M3!RXN'&Z#Z7?:`>#$EY;N!MS[./#XO-S63A/3"HNJJ5+)K[KL"H3.:_V2_?/[X=/ M,]=1FE8Y+43%ENX+4^[GU<$%OI]X)>65BPIS.49#['8\8_RW=*](_,-25QOM6@"])>S MD[KX[*B#.'V1//_.*P;1ACR9#&R%>#3HM]P\@I>]J[T8P%&7CI3ET'S"I(P],JFLT6WA.$ M+FN9-3)PO6!2F]F<&1-S\-&9@?B,-V-@8\:$V[A;XX/+D8-I;^`;2$=83B`4 MXYT8&%)Z.>74[W31'#+1!1/;Q&:(L+R!R'AO!FX67I>.)+0'7B,2-_F<^>V? MS6R&&K.CQ]@S+RQH1M)>&4/G(E/3<72)A&*1^&OE)QUCN$MN=VLEU&:<_#&AF(4Q?H*`TZ#\TBV%PSKY.U7,(6&Q]#`]ONPJB_*Y&Y M=/4O?X\W`=MRNM@8BN/:"-")DFD3] MFC+,6/8(K+3QL6MHVV"4]C=O"PU%;Q"Q_9G"/#JW!,OX<-UKH4%_J',;L?V] MZX`@6.WAVFW)JP2W#&8X/A>_7O'>M-08AZ:*CX\@UGS+86]?K@DRZ'`*]6\: MQG%_#;;0&(/`O,.@H?M+,+*KVIH@='MP+"Z#B)WB=QT?I@E[L[ZTT*`_U+F- MV/YZ!\CPP0%-:3]^R56"D<$$1Z&?A"2^6H!OGQS8O&)O5S*Y9QM6%,K)Q-$T MI@1.]^YIUS3?!4W;VWT!/6M-]^P'E7M>*:=@.WC5GTPA.A*[7KS1HFXZQZW0 MT*TV'P_PZX1!%^9/`-X)H<\WIL?K?N^L_@,``/__`P!02P,$%``&``@````A M`%P`-1O(!0``6!D``!@```!X;"]W;W)KR.M".M5GNX)AC'*,980";)VV\UU3'=A4W@ M9B9.?Q1_5W75;\C=E[?JX/PLFK:LCQN7K7S7*8YYO2V/3QOWG[^_W42NTW;9 M<9L=ZF.Q<=^+UOUR_^LO=Z]U\]SNBZ)S(,*QW;C[KCO=>EZ;[XLJ:U?UJ3C" MRJYNJJR#C\V3UYZ:(MOV%U4'C_M^Z%59>70QPFTS)T:]VY5Y\5#G+U5Q[#!( M4QRR#O2W^_+4?D2K\CGAJJQY?CG=Y'5U@A"/Y:'LWON@KE/EM]^?CG63/1Y@ MWV],9OE'[/[#*'Q5YDW=UKMN!>$\%#K><^S%'D2ZO]N6L`.5=JAZ]W=]@OXMB]?6^-EI]_7K;TVY_:,\%I!MJ).JP&-=/ROT^U;]"B[V1E=_ MZROP9^-LBUWV'HLTAHQ!FQ0,5*:\/(`#^ M=:I2'0W(2/;6__]:;KO]QA7A*EC[@@'N/!9M]ZU4(5TG?VF[NOH/(:9#81"N M@PA0K]?YBDK`J8%[MJ=,G4%V"Y'5S@3DY_+. M8$OJFJ_JHOY2H%LHQ\]['MYY/R&#N4:2"XA-I!>(]1GQ0-Y9(^SD8%N2&,)BMA`)L,QP:$FE4W,]D/YPN:4*SOE\50HFJIB=BP01 M5,4$#\AZ:JW',KHB*[1ES3O^ZB(BCQ-YB&AYW)?#[?NDIM:ZS^(AJ5;6UK:\ MZ9.O8")+$%F(H*R`^?[0<"C+7)>,BRNRE*\90V-:EH*)+$ED(7)=EKD^(2M> M(DO!]IP09`HDB,#Y/OCBGMCQB`],593BZS4$FR$E*-*/E\3B6M$,M(O!YQ(9C88M3TWCV<6,X MNRUQU``T@^*@#7A$YG!J$7$HY-!)MK9%!L#&#B#(G1/-H+8P"-<$)8A'1FH6&B]GB%CF"^K9%I@@] M4(EFSE7U#2_2XBQ7@'6#L,417_BD'\:&((=&T^UJ3OR(R_&)NP[8TA9Y`AN; M@G&4M31SZC,>14,?ZK29``_68MB<+6V1+["Q,4ARYT0SNAG$.HB,XZ3%F>80 M^FSMQ]?:89$_,)SM5CN0`9MH9E(>AM'(E#Q.+&+>=Y'^*MLJ)+4*S9A&)LF\ M3J<9J\Q\D5GTM&VTDLYCS9@"2:K32<26IPS`F'HJC^&GCS1<747R2`9OHAFL MI1`\]@F16D0LX#']_$W'UKC(-OC8-H(A,#:Q9E`;9XP%@1SE$..X5^(4\T(_OG"*(^U8NHC$D>7I.UR#348S&I:3",+ITW MTQ)N^#H20GQHK_UQL6=3'R1YXN,I*?MU@W(T4\T,SEAT$@N M(W:)%QD)1P>`WCL_1HR>-#1S^=[H M)E"B7O[H8AA"EZ>?6&0@/4V$D09--#.5OTG$SA\QD.G9)]`X)LNKF4EY&.8R M8LM34]P8S3/+B[/?&M&C\B*#]8/Y$1&?3H4)L$"$AI/;&F$?IL9/4JAH4F%R MZT0@O=^_IO(_?\```#__P,`4$L#!!0`!@`( M````(0#@Y3AXO`,``#$.```8````>&PO=V]R:W-H965T&UL ME)=;;]HP%,??)^T[1'DOBMTB9-TR[/)C%@-8FCV)3VV^\X#A`; M2$,?*,%_'W[GXG/,_/ZMR*U74G/*RH6-1JYMD3)E&2TW"_O/[Z>[J6UQ@0+>RM$-7,Z,73=T"DQ+6UF8U4-LL/6:IN21I;N"E$(9J4F.!?#S+:WX MP5J1#C%7X/IE5]VEK*C`Q(KF5+PW1FVK2&?/FY+5>)6#WV_(Q^G!=O-P9KZ@ M:I/0YDQ_!9N=L]U.3@9^UE9$UWN7B%]M_(W2S M%9#N`#R2CLVR]T?"4X@HF!F-`VDI93D`P*M54%D:$!'\UOS?TTQL%[87CH*) MZR&06RO"Q1.5)FTKW7'!BG]*A%I3RLBX->(!?;L^'HVG`0K"CZTXBJAQ\!$+ MO)S7;&]!U![FIV0IJ#NEX70;1W'F%"*:M M)#Z7C'5%W,\I-"QM>CXRA>S3?N!$K2=0X@+[<>?IR'Z`R?%!A32OS56DD!!N>I/ER2]$@W.U^&&95=N,B"-W,5*L)"IRTS9R1LJ3?HV&%]Z")\4&GJ]G+582A>=YX\B-?#?4 M-4E7$WG0Y='D5!\:W>06.BDVZ`+]FV,EZ:?K:OKIY.#K=)7^0R'%.EU@TBD) ME-7Q,!N*I$^A!2[2T88=";E)1PR-U,5*,FW/K1[=I+OHH5-1:F0(^N[PJ#5J M@^G4/U6#:S4JJP$<"0-+6T?^&"1'A8YFC(G^A"+5VK7>.ST:;M&4YCI:=[T7 M3;;IP;6&5%/OH@5G45.:OFIKS5R6Z)$SYL.P>D,7!H59<*U&55P8NH8;B;8^ M=:/3A-8!9;,>'C^I_JCJE.;02UPO]$]EU60_05V)[_J1'YT.M(YWTY20ES(3 M[ZSRNC/`\R[B=27]>#=-"70^)H(S/*6!`%WM=:V9RQ(]>C>-"71A3AA5%;<: M_W`_T8]UHBV?LJY#W30=X%[_<4H/W5]>15&GB;75UETVH=2E7]V)*[PA/W"] MH26W,B<.#_%%Q M_+&W_`\``/__`P!02P,$%``&``@````A`%3/C@U!2```(^X``!0```!X;"]S M:&%R9613=')I;F=S+GAM;,R=2V\DV9F>]P;\'P*-:C0+R&+S?AFT-&`E62UJ M6"159'=;$&81S`R2*24SRX1&ZDA'G\EW?[W).?/./'Q_&V?MB7HZFDU]]L;F^\4563`;3X6AR M]ZLOOKM^\^K@BZQQE]O;6SL??V0 MCR9?9(/I;7V3+R>A?ED7?_;2[L?_%K[\I1[_^9O'KX^E@^5!, M%MG19)B=3!:CQ6-V.G$3L.YOOE[\^INO]:A[_#![.YTL[DL>'1;#YE^OBMEZ MMKW1R[8V-K>;?SR?OE_/-G>[_QB7D%L-"FRTT7Q4/YS<[2OFC_XM;\K M[D;E8IZSH_/\H6@^]=5YOEC.\_%Y/IGVV.A@O?F$'Z;?^HOYW->S]Z,R@%#_+[(YZ)7=IPOV@MZ]6ISZ]7V9G,, MOXPWHW$QS_J\>#>=M]=P]9"/]<"[8C:=+Q"LK#]]F.63UI/7\UQREUT]/MQ, MQ\W)OCH_/SIO_A@(,7UXF$ZRJ\5T\*=>=G6?SXLRNU@N3'(9LOE:Y.3UXZR] MV\V-5[]KOG&$_`U-!M^,\]9X7]WFX[(U4)SELIB/II+<;O+&YSPO_.-OD/JR MN8ZO?M>2V>;KQLKNE[M$OG]Q?G5Q=GI\='URG+T^.CLZ[Y]D5[\Y.;F^RM:^ MNSK.7KQL+N*X&*!"FZ8E6\T_'I5EL6BMNY^7]ZTG!Z;^938O!L7H?7XS;I'P M=/(>(>V0JLMY,$^GRYX8Y8_:IO9VE519/HIVVI1 M]RB0Q3_<0;;YLJBVONKOH\FB0`\6J_[.\//IN*5G;*'`-`SA"K1?ME@2C-<" MRYO-1W?WBS(;>Z(\/KFQ8]3@?;X8O2_2%\I`B9T6)>J\"I-`^>:6W(-//(#% M>1@MI+].4@8X".P"C!(?*V[LM];PU4\__O1C<[Z$Z?_GW_[ZG__77__+OY5/ M\%ZS!_.4OK&]L;"(*\^Q]/EX6V<'&1@\[K?_+\N7B?CH?_1GZ2Z*WM[=Z MAQN'O9V-/?OWX78/[]G;W-_,1F4I*3"YKRQ=#[:5LV(@*H];0G@T'"*YTPD: M8-HSFF2#?#9"(YH[/)].7HE(DA#9Y"!,_$=6+F_*T7"4MVT]HKM\6([Q!,-L M:*K0DC['JG*!I8Y:XQ[MTIH68VV_SWW["H&#O:\SK(47:N-<]H>WQ<--,6\Y M[.9S+5[ULLV-[&$$3>!GZ?Q,Q;(F$?W\_6?/[U\X?O8+3QGO/USB!L%!Q6*$ MA__G5<:\L>=>(IAK,'N(`.1S+!>6U3;W/G,P_[I2G MR:_.D:>5(/P;N7Y:C(<8..9F9]"'>+5O:&N#)Y:UZ^HD5 MUN3CZAH?__;D_/HJNWB375R>O#NZ/L7[KY*,[6?CZ!8(`+1.'XI_:!+L7;=+ MZ4\))J:WV=UT.BRS$F?:?/';^;1$!N?3VU'+HEP@FA`:(Q7`0,>\)?AV<&_6 M8\@BQM.9G$%KFF+"6&-[+!\^C"8&TV5+FT]6DYYX!-++S%@U'UP[8^4OL]OY M]"$C,M)*IY.6`[LPY#(RJF5K?A\O6_LX]2X][+2738K6)LZ+179'=)4A>J"2 MELMMKE#/KXUME;Q!5'7'?B=%67[]0!P(GG%2#'^&Q4UKMF_#3*C4=+PT@>=1 M5.D&>/.QM5,RF&KR:H7O'D--(/"7/, MY\MGKGY-S!+=/LQ'B^+5]/968MG];I.,?=@Z'4OGF6$25IPO%O/1S7)AJ*_+ MH3:'.8/P_]"R_[SI@W1V-5P.BB[I?<8*%E-";@,C9FF\!VZN@8'0IP:%'0?D M!M(1@#,W>3D:.,T:(0#L_GE^X[B;)8%M7B1_P0E_*(1665\.+?.[(CCPQ'[: MTIT1;OFY;ELJ4WIU?='_I]]GU[_/UHY/WISV3T_.^[]_ MN2Q#?)?'2*\Q"WR&^E2#H7;%`IR'323Z?H&7ERB?1 MY52DHW5:M9C7^3C'"V;Y`K#\1`@9GI,<>69\\IV(]9RW50#CE$8,1^QK5!5H M'MSG!`#"LX;"FSKPMX[WE"1%7/C+KK7OD<9G[_VIM?Z0SRU1Y<,-W$-6%O/W MHT$["KMR>-@_:=[G9N&YH/QBB\2?>/ZI9=7GTJIBA$)52%/9H>QV//W@77R%$')%LI9M:8&AL$M,0^)CS<.U MX]8F*8Z&?UR6/B'`*V2@L&7D,2O/S:_RX@,M;5EB1(2H(M1\8EW'!6H]&#G4 M)$N3/RCO^6?[H;F.-_DHI`'RN"0#'6WDUI'XB/(%3+&H6/AMI8*2)_;001;1 MF\>H.,VEI6-_<%8`]CPQ?`!///-9$+)OEKAL$-BR=P8KDKQ.2PCP(Y062C)J MH#W[KY<:)P\YM-6IQ15OCE9E'-<`J]4$STDUAA=J"_))O9Z6:&D\GX9S,8?_ M+00R39:LA47;)MT:`G5:R1[IQR>EMSE#4Q-O1Q/LE[#V$Q)_.9\.BH+0S:!V M64Q&)B4D65$;_O@@XSE_M(1G.R`(RR2Z>S\:\L;-8]8U;7.I=6+83LVO2V$+ MHF_CEN]/S M_NGET5GV^KNKT_.3JZOLJ']]^KW0\]'Y<79U^NWY*1CZZ/R:/_0OOCN_/CW_ M-KND6@&NOFKNYV)^ET^\F>V!]T(XIA2,N'!)9A2!B-'L&R?:A/M7_&@1%5#W MZ$:5N<&BE1O\1897S$,DBV+8DJY&=Q.+L%7;="9+`GE)'&F)Z3]<%Q\7V>LQ MG&VM9W,]^^G'[!>FH4'XT0-505/[&FV:]+Z^+R2<5=#KQ9R7J+L%@N;$T\(^ M,WX@Y1HKK[9_B2F9#_YO3A5`3$(ABXSP1^5;U`X=6/$JI:RMC`0G5>-\25:[ M&*YGOYE^(+>4T8`DD3B&H0@Y:[A)RI]CP4J*$69[4Q?F5#M*DNI M!3J"VDDHLUMP`"]K8=5*9M/2TO5&&1Y#F0Q='R'KPE*]>S M:X9:_8XF:KP2U@+-1=?)=`$`:\^'QJ>_C!:W&??K5^M9Q1Q ME+-CAO_I/CB2]Z4Z;T16^W?S#P8'R_OI=Y\QH%D'*Z+"G7D!1SQ1 M;'!QS&OT7__R/THZ129+5-#U'"BC%]CW3\8>/7[K.A\DH][4@*Z\D?*U[7;C M!:HN0]#VA0R(+B.JT;]\6LH1:1Y"+JE-/CJ:=(MNAXQ[$_?=1*;/>3`5TDT. M2@(6B>Q#_J/LR\4-\#@_+;6UDX$80X9:D"J9-9Z1$&6S M"_EN^'%0JA&C^X%'E+2!$10C,7[)"S]@-Q0/3)=P-6X=`;C'3%-95;.+ MX#6504M%L47^^#X'_T$T!ZG;1,(>WA3C$=[%DDE.JDL*J:`R\R!Q>VCGA_L1 M:Q);C:RV:),Z^*%=_'$YO),GHA1]0^[1'AH08#WJCY:,,BOO^@^,M`'CRWHT MW;!%D-];(9FYWT3'?3J1_;)Y6J_$AT;50T&=7,P@UAN239"TQ2Q.1'P48XM# M9&O]"!0E3$UCI.-+S-E8@9JKOW?4);2WK`J'G;V6O4O76'R4B3=B=@^!;,`K M8Z!C53XCKOAH&L"&ZD2&12)^S?NGLY58&(&3`M_"J)BT^>(5;O9!NC!1DY8# M+3Q!%!]'#WJ43BW_'GEKL[HQJ_@T8S&!K$CDD%ZZ"9CF6I8JOAR,?VKJ,"&` MGD45(,1A1F`HKP)88H@_S)8SQF:]V;\L8=(0!9S_B0`,-XFGCZ:QI"M-ZRE' MU+HQCQ:.()1`??=VZ)_!VO$:=1*H;IJAH?WB/)=(`7J/9:/.V1>H#$E']Y>4 M68SOVF6DGZE`EE`/8]9%!?BFBE1-0)Z$FRW[[HG"IMQ&!N3C[MC(3:$%RH!C M-`3/S%^%37N:N5?R]SDD4G"&P4UVOPYP]2T^.XX2&-)EJ3QH(&*=K=WRW%+W MUS*!HF@_0F^&;&JXT3,^P(XZK79`%5JV=SPV=*O_,%O[ZU_^9_+K7__RKQ(& MO<?$?W)U?`KYF2$P?M`Q0E;/_V@^D+51T(;9.QX MQ&>[8JUK?713G\=?F?HEDQP7XYRDE"*0.`VN!G-1)C&5P3WZ6`QY5EO4:@CR M)J5R&H)W%=S$R%/V1:K-WTD"7$V/QUJL.'6Z4"IW.$2A\CFV0:Q1FYWS"E$5 M2"WB3[.^%-5*JH:BTZRRC!&/NZII+SL[ZU(R9U?8[:6TQU"I,.C<5TBGX@7/-8CHQGUUU\2@"LO9&J""#O: MU\ET#U+,L]W-+[6&SMZC2"%@J=E&\$E,S']`^Y%C%P2013K__95V+:HL[D?S M%H\0&%[PKMMO%Z/BI<(MS5(Z*Q:3"+"?QK(WOJJ*<0K-@)%1GJ0WOA!F'=&9 MEEV7NY4K#MMQ+D9+?K&YT]O:VW&>V-?]^77[L+>]OVU#+T"!D_!B)QU`5`99 MC'X^F0X/O4&;%^:X-5E:*0T<[L(DQT4YF(\,9GJR1K%L6JI4\]>Z#`K)CZ". M[Z;DVC#(1/A!X(CUE2BX([B/"#5I\#"R(($/Q9R,_-AGA[2F@#RSTOHUD9!B M<#^9CJ=W;,AC\4E&!NO>&5QPJ#7/D=<386;3,54F-$*VQ*%&%>:!7)8BX$?9 M#N`73GT^)>V.\4,BX84\2SY\C]:H!"V!"!.#"/2['+'?@NWI%9%463@D@/C/ M2%I8B!/56A5VS+3B?IK6Q(EEJ M_@XHH!2L/$58H4B#.>="+QX+XS@HI-DY9"X$P+=/%\H:W#-W?`^>FC^0T M,-OCG.W*#J.R^%<8%MD*?<5[J;7N+E5@NIAWW'0-A1`MV\5FIJ[K=,]_/ MC@^VOK3Y]@^_K#=R]@);C**!'8^0RGIT'7DYH$%C,R8(J6LYJV2AM\1&D*/N ML(AXM0DO8*@4:F;B!YMS7#4,@&&TM[DDFKD/<=(-2IJ)DMK#O)"\&UA-*/P\R1@6R^G2N*C1^2C/L-O/^1*NB"@@Y$A-\8: M6+E)\SX4RHB-LQLM"!-O09WM,$G02>CLE6$0.JD<4KYJHYBX^D;-*K[U<]GF MLYO@X_VD.-=KXMO6[V;_89)/DKDTY?+6N24!9P3;@"L(GJY]DX#B%B2"`6") M#1M1[X@+/6A$;=Q@3Q M&4(O5Y7FK(YJ]EMO=N/OV`=P.V MX>SQ`K<*E80SYM/E'2!`TGBC$,_S`E;&](FE$TR_P3X<5=$\*N1./="S/[E* MP1$"DO?I?'O(_DG=$FJVPZH*#[+KRX:>3R53'8C"0%O:9 M/44&)"],3/!,/0Q`DZ_%**R!2@D%4%*\WXVEZGU.0J)*,Z>9PJ9, MB_.*?_+2I3)]]<@4?_10QYQ?28]M*$*HR\>6U;TR"C0Y==2>0G2@8*H"\K*!Z`&E!F1EWB82@RPV2#/1?9^ M-,7FB2M&/*K3G+ZS?Z*[/J'WF*D'&ECP3H=N-.XYJ<9LRX:C)0.P"WKS4TA/ MXGO)<"XOBMY&;^O?;.T3YPE4+V.C>@O3]QT#0#-*/UBY)[CS*N_#?'X4V0IK MCI+ZZC]%KA!KV=LSV("$&QU:R\$1"E-=YQ_;P<)U9:J4IW"I=!$9:V9`3"_Q M#_MC6N@\NNIG^SL;'O/&*@^+GM)`$"P9ALI$6;X]&2\FE>U1P<7)CJ=Y73*8( M%4EYBP4B"@CE>1(GA3DIO\*H32Z'S=*11A?C,CN)P("K+!3C)TO-@D!4)-9V M'IX>7WOP'MME?G&0RP&"0/"2Y'=YZ@9+PQ&4THJR*B/Y2%LFUT$`^A!\9JKO M,`B_&Y?^S-ZQC42BBJ+-%_K"B64I(2Q/HEQ._I:3^!KRF,Z,>"2,\YUB"FH" MRP,P-_#_8B/RM(I/0Y,`9%0)NL/-VOK48M$EW_(7\HS94758D$E4SZ*C87@P.&G63KQV M$1*/'ELB)+CNO)7>C`-MPI[>YN=_;V]D/OS-8>BC4/\V< MX75AJ-6ABRA,:MQ*87N]G4W.D&YN]O;V=EW:>&R%QAG&P&F9(3)K9<'JNSJ2 MK#XYA^KH&WZP,ONQ&]3@AROHSK#QH`,R/-A_.P<"\C(+07U=]9X8)[ID_'`* M%2>$IF:#RRHH38CE]PTU2HQM>:MD56(9K#CN@DN'!S,[YH)U&))Y,Q52JS!EWBXZ=[#5V]C!X`$5XFGLWM]?_:!_I[)XF:SP4*CC(.,>P#HD MJ"T*)2HX#\E`GRZ_%#)$S'M9^*_L:/A^5%H,\Q8;N\`HDA/'`0JT'XU)K65S`#V'HEP?3[H]=G)TV?>JQ& M#>4ML=X2\-5]UJTGG^B!WA+6?G+>\[052=[0.CH07"?:4<5:!27WXJ6[KZ6Y MFR@+/_W(35+-OQ[#,3E[_KC9^N.5.QUQI=Y@%`V+&$&73=D<[$7SA\8`2-B3 MQRL0?<M_O[F[T#4.L:_[VW M`XK=I^7;SHX:?>,51!RO)VXMZ^=.G+ETR$>FRA?R([7Q&H%P$PF)];FRR%L5 MQT`70ZMAW\`C5'+ZH9Y&57:1*#7'F?$`*A.5-;C3HTT3`/^<2T:]Z,9)$2E%5`2 M.-GT9D1(:"HE&,,>K/0,`_/2H;`[G?)DK)"8$>!R&_2^5#,D\0#9%#56YS@P MW\S`&_!I<^>@M[USR)I&LHX"SC'):9<@3D,LI.#4@DY]*NV.Y M=V*(@$QYFDW2$*=*&T&W-.!W%W]VX5ON$XP/#\2^VU_=W MZ/XA%+)>'Z;0D&_MAHU]*^KL5V.^3)M++*TIB551N7/LC?6-@UT);M>J$V"/ MSC5U#>0_#M2CVD<,E:)4`1&+WF($Z394I5HM84(#QQW5+M8H21)^5\;5NPO1 MU(X?^']3OCJ0CP^&1-0T[!D=1.:K7`6DZN`3)V M4:7)L9)2VXU[/`98D3UZ.$;H052\?*=L5YS$70T#-TX+2*8@=[;D\A22/I81 M,S`:)L!J'KF0&.3J0C798O[OAKC?:!4-3LC]LF^EEIQ%3;:KK)WQ()A@QQHG M+ON[$8]BC67/F;ON72$?&N(M^/=#HX<:]__<'3Y,K#/:[?E9`8^$6.G MYK1DD8V`;5>-C5SR-,P?@4\T#G'1U4+G>AA03_E\<(PK(,`WC?LGCZOHO95S M4\J-#57R41E`+<"O,(31A[U=?R]8!:YK"VSO;LJ)$+0FABEZB5O<'YK ML[>S_XN0HI5(:+E,M=HVA:=ID/\=Z$9`93X"7D_CX9&&##>7@4O$DZNHB>U? M3'_ZD?Z2`V[WVW-UBKA7666GU,IZR"H\9Y/6_&'=#QU/__1C>S$$8>8DS:C7 MBLQH#$N4CQE%EZ3,CM8=_6J4JCLD M%0X!PRF0T"K\,BYI6Z%E,N(A%FTHW"ZK81FM\7A`'FX4!V!XUF%&IH:L>E:R M-)?/XMW\>P[(N/S%K';"_;D\L7[,JH`D+^-/)U+?A,GF?NPISK M9PH52]#I#Q].V+E:CM#P&\)!(`9ZD_E@6U!2.A0>)2$Z%`^W M7+S-!5.D<1V!>[+HK7KT^5G*1!-!Z MJVX213,7,C`$FI2[^@?(J>MV/NEBF(?UV"J>C4%)KDA"DP.@WJA:CV`HSE>] MK2T1['\JF74QJ01YQ^PK/8"IA"C92A,U*=]4 MQPZB*M9,>T.W-@Y]5V,^*SAJ2B1LQA1KZP-;U_QEG+]\RHTIO1Q//$0'5=N: MC\?E4W,"#"#OIS)S#9]MW94BEEYNDMJ.17EV59+ES)<)Q188SRX8G@Q_^M%< M:LZAL/?%*VMIJ045D-BBO1!%RO[$WZAO[>SW-G8//5+LB>Q_I`]"3T4@4!7@ MZG&Z7V'%'%B;\+\5F:6WP[X@-:![DZO*'QZ(5I!0863;/C^QL4Z'8O6@<^$U M+4/(I>AR2:R@[4&D!2^V2#]RL@I7YS50SV+,<8#FJ:TAKF$*$B-@VE1!8YLI MLJ:E.]Q1IWKU*=[F)O MQ&@H4BMY$@!22W],-5:NG24X`K@T+):T>1&?6/B8T;=DCM(%V+$?;`T+X*X$ MLF1$LPH6:R8^2>.%RU?@S):1`.2`._>U@U/4#ZKNG:H,)I?+2ZIY45*&)*[L MM79HU2^+]/8V728`QK&X<$(.V4'68E[!J[9F3%T);B_VQ`@N28#);54"7)UW MBCFI2PFQZY].]"K)4<7X<\I=VZKL.)GOUCR=#N$3'#]QX<1IR`E;TM"4[EP: M`(OD#_UA$)69/%ICNU2/"%AT!!:+&&]5\=Z\I:L.$6XAAT/UIPN0,E8SC8?5 MH:^.ZS*0,CH9.6J@NTML/1)AK:DF4[9(438*9?#'6CHT"M6-U/ZD7/!E`5IF M*4$50SL:V9#^D%L(V,22#-EUDJ,__=Y:)GRJ>).M";] MU(I3WG:3(!P]0#X,PTG-43^]'$H:(6[1IK[I3M^U8).V*AS7X2U$S2JE&3;S M.91QIYE6;CQT.GUZ\Z$<(ZW7\5;L;\-%08<66HT,"?WC]GF`%[L.,R2G0PW) M(@TB9D7]FF]U)2^3L,\$KA;U\0T$J/G"PY65(/99W&#^I/L&88U7FWB3LPK9 M`L([*)_(ATM MQZ'/R#PG*>UJ'3:_=-3:JQ+AI3#P&\,Z4^\.D4;13;Z!433F`O7AR27]N0Y>A6'.W/V^(&&K=L=#^) M9T1+NO!">AGFQIO*`F-6F8?._1U^SO80MICN85<'5,9W'1B5:R97X=N`:Z<; MNC?6W7;08B)76N'W,9,T]V?OW%=>8ES3M)@7DV;.3M+?:09S3@4\,7+5LGU$ MIDS@T/F'<,+:'\8A+$@`:W42-$QITFQ>:V9W,CDI!@>BCO2$0\X]7^'Q3J66 M'K6LU6(,-4)-Z-]TY\MIHN8UE-164C3I+'(&*Y#0&,$V:9HARBP8%"A+]J9[@ZZ;M\+VO3%3/A(,_]JCT$ MU[+X,'6G0KQ]35?>TX&DEEC>RR8A@0OO0!&8;Y`V?Z(2?Q(:&`DC6N M2%G%X80`V]O;7P8P4[G0ZI'@.=I'[9\0H9H$&.E,`,!W]9[:;GZVU/\:UL]3 M1:T$WP[\A9;=Y4SDH6LDG+2PLREVPA]^D�QX,(K98+_H/GN/"*CEQI-5Y) M\5S=-LI7HIP!I9DJP`(+`ZT'P2M';1=-Z^3"_6`*D!PB!$T-B-6GOQB".S-( M_VX=:"X+*CMXR$IX,J9=Z<_'WV_POV*/-FW_L8)&VD=;.4+#?AS4?4)-@[[8 MHU=D^]")!3NN3JD9?J@^UJ0TNN`1_<4[!V2OF*C:H7RW@[SL-YPQ?73T<+E( M0^S:@6OG%ZXGPEA@B/1C!QF@4$WJ[&XFB.G@=&AN1XP)0X-"*:T$B1[%N*1F MCGO4_O+HRIR^096N@YZVS0:EN/'3UIZT(07DZ>9N4\X3JB7@QZ=7W%C.?;+? M\=6[ZE,X3<^FCD5_?C(]:>T6-RHIV2!1]'$M9T]='-\4E*R;H MU7HEG^B`W+:83`'^3S\^HZ&M-Q*O;!<.A,G MR0/>YWDW%N@6"YYT"E$Y,X2R.D0?I?@S[Z2MW6"P M@C@HZ\HK"PQFF[K$&,7I1WH[%:I>.Z7H)W5TG0%'<(P&V=P6^8'F)3-DEI*Q MT[NPH4KANPIE59=K-[.\F=+'"I7U/\"&GWZT-&3YTX^&=IOZ4CTM>/R)A_W7 MH)B=#BHR*^XVC?H-%\T)7C5_($G.@;S/&>+40KO&/5C()08[7O+!P6%GX;I7 M5?=:PI7R+WV=GNJ^W`LL\)8(+NI<])?F5V46PX5&'DV2[3+H_7>YV,V^;^H=D5V.EU@Z7APV0FGJ?P3KQ7QJHM1Z*EGN<3T+:_/HI3 M(>%V%G?7(4KO[HCPYM`2I],)J5:GZ>XX+LKN.D."!6T*.A\7.OV>#[9]?Y*= MG1Z]/CWCFO36,V0(_!T:;NGS$9%/`(4W)/[J7*!UG4#5K!DFPB-]YI9-X8ZE+$*X3X' M.3;O_#4%E38^0V2P%R]&6R715%RUO]Y)N"Y>U>FOA3`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`8*UT?.M)^#@^0)G0=V]VZDEV6#5U6T<-&2T??!W0[OD`B5H-;B MW^AF^N_MXP/Z7UMY]IL1L0PM9(_$]/%>GR;_=:71`<4"A)O=C8`?XD>?.5#$.]J4!R2+F5#$EQLYH>C;!!T M^F8^)?4TIH5FG.I%BP1G>B+;1'8,K`IE^;OUO3]^QE!>E_S+&[>IC`UD:*_\)&VM5[7IH`O_,I;3LF+,Z6T<:# M&$`"8A"ZP9!I^WS00ATXGM]=T=X*NFR';6@'70%%K,]HIA31Z))%]A>_D-(4 MJ!6D!(14YJBUJ*/D\OTV\5P;5>T&LU"CU.HJB45\0P"$-ZAMP1^(,UEU>X>& M+(I7TMOP3;0A;?4UB>1>+)?1?9?16Y: M@:OD,DB^G.PN%I$+>>*"@-7OI`F-)[(/NV"QVC>;5RSN:%7$D(B->97DRB)H M;$`:=RUX\.E;G`S7ZZQ2@<^$B>Z^"\2)+_^]Z3T5IK*AU[D>I/C=PF3S$:L&EM[^RT??ON!ROR"2[OTGCY% M!Q/).K%T&7Z5'2@>`$H#;_UFK;U`;*^?:"C])YY='*GR*;,D*UJG>YTT1)+M ML32OW\@2)#R'&"Z%O;.V%3ME^6TIMXN`D(C46ER#!'F'G-2!)M)RJ>\:P(&? MQUH"_:*2,00(DB6WQM(KO'9)_/DA9.$@#9"_5GN[F]EL-P:$1 MU9)'IZ0;T'SDN'&(VV4,_/DT#[5=@_7$P'?HUI+'M@8^:_PWB?<6S93PM9&Z M[P7:Z+NNRH]IW[,:IGZ4.2LGB&` M^QU9Q>H:3UO=67JED]-Q?Z*:.#R2CV_&(6'1!?+CP4E$E3+&R M0-"*^`_W$1O74(+&SS`&VJ-3_D@KJX2$DH_(34Z5PB0#(QM1MB17V757-W&A M[G;W>5V^XN'/![48U:^=]G`$K+;=D"O7=&P,[EN[L2K#GV(A5WA/_TY\?/TI M/KY.I>3OP<=H%N)=(]@WX$^X]#QAXOXJ%K[^F2Q\'5EX;68O4=PHYNX>)SR? M/UY<]7&H=\]);#@F8*?R<3.RFL@T,0=7N%BQG9_\=8:88-5CI MN_6@8R6YT->*&MSPH3/&#`8">YB"Q`AH)O5KZ1P;@7HFI.::>5[<]XU>29M0 M*K;N/,R178K#9/X#K%XJNH;K)DGWSL0&H"GW@Y;UU=;VR!^[)O+8P*0V!==! MME?HF6FS]NTH\CG+E1W0FT^K7D\CBR^+Z9VK;N$17;=)^ID^!)634^0`O4OZ M!;:\%K0T"%704NF@73TC#QX+);&FD^SI:=.K=+Z,5Z?M5&9).)H4HC.9R;!/ M.^5G#KO7V]O8;YG)H[;)"*@1@$='E)FCYUZ9JS4[C0P=E`J14O%R?W7V5.68 M^E7`,#H-0SES\M<`N[*A)7@U8NIC0/)4U7\_2"#`P/;0360DKT6\IS3QQFIL.IZ]$=%U:X7SA#5:YP6BKJ MXW7&G:[CEHY(^YL)D<[#&:LS\>$*6L[$A5O9\O/BE*FG8`6K*J]>?I;B?&1")T]N*UJM;D,S0A'L`Y97C MD\E"[8ZKZB(\!*;[Q.+?3-`8\G30='^'2X9V=^M`#2WT"^XP%T;'S4V^9,AM M'632&L1Q>OSS"-EWRVB)%?I2'=E=F5#[;$&3#?:JZ-*#2G,D3@?F[[/%^A5, M:)MN5$N_&\2=@KV-0SO0!''KAS`NO5M.OH]"^8Q5_VU2V;C"Q&>HFIO;ZVVQO\W=O40\ MG[.W3B[`S1=;7/Z]Z3_+R6?$=KGC?_M@*XS>0:5NTFBHPP/>Y]PX:JLE^?/, M339[.WO[?3V:72KS&"-URPH?#>]:@NST-'2LW(N;!0I MK+5@D,Z[I1L<]TH/&7]4B[)A_GC6OY9IU!`U;E4'913,8A9:2OQ#`"C?ZD[3 M5CK\.E%&F4\O$A'6L*V8UJMVWI(&'AOX/EB_"TUFH*C.&^`<;.P`J0+?+0@C M;(+GM'1JC=IQ?2ET2]=:H]+V5F]_>[?'MR5L1627&K=V`-^3H[$LL#99>KQ. MQLM/[EIK,%PT/:C32V'J`V4]*ZA;WT^+&1>3K-W8T&$/X_;2+=76U$WPFNVR MR(G/2]J>DTGL=TN*W]BW&MTG0PPM@N'BU&O-W;ST&]905@&0$D;AT/2]?UX8"NYK?6#SMY1+WUXXQT?I.P M6]NV;Z31]139K5LT#F`'JEX>+M2P_+@!S`0!LSK-4BV%F=-ZXV-H2PW0^F0G,X`;%6]4/4I?N\F0 MW.:CAD,M?W_)9=-47-_,IZ3`^LYN8G&:+]@G*^V%8^+$87:VO,&"/N?YHW'Q M$9,$==\M!W\:YMQ_33W"?T_GK=VXW9SLR.N_)=)%H=0V15%BO8!1%1:!^68E M6K>M7UF@UAS^!_\1E>;O1Z3..&C9_/G$2WGS]TN=3FO^^*[0(5'DK?F'L]&M MNQ2IY3@NDH02&AXZTWQ)KSF..1\VG,B/KEIJ/M973FZL"@KE`])TM_12%,/F M4UXP\23U-;2]2O/-T_/^">?<.#5@Y?CL\NSH_*KY4%(X1W^EN_$VWW"%/F1*;R1;9^.H6:2]$7X=QRJ^C MO'S]9I6P7/B/^'RVK(07O;NPE&KG/IOR^?GK3D&H$C5>V0BM`69E!84R4WK&XB]:L_1Y$.D;[PA&3NFV1^UD+/N!=V M3"7,+KQCA6W;$QO%_;UY1E@IE%PEU`M?41MBU]CIQ&ZH3R MHUTRI;6X.8[1TW3K+^S7%?07KD^!*\9LZ5I8O.(DGA5F&2^V2?-M\3D(B56` MWAP5=STR@T3\E,&2/NETC(CQ/O>Y1'P:Q?C-=SH"O`=JYF M4[J,0+=;UR<;)'"H_=Q(N`D&)-\]0ORR!&A"OB)#AK+Z3LA@DMURAEC4N2BP MS'5HJIR*/Q5;$/IVQJA0D#$D1I*ER-5J-01]47%GU-WQ+>]A%C$=J1H$,A5W:IV<%[_NH.4OT<:V?P]0 M;WEJ&%PH7&-[,W25QMQZL47``>X)%E?*G4M;"]/@)GB7<:M3&J3;+H4!.Y()" MW#YG2=JTMIB6VI;4T9@2QWMMY07L=JLO8.]]]J*ZD:=0\5$NAJ62`EJG2N&@ M%Y*?H'5+[T"$CQ)@*.,%`4H.H<$@^N9448@%!"C`T&6MF:ZI+2$DCI+L-`5,-:N>\3V[ M[."]MKKRHXJ,Z;OF2T99;F&CD$'I;ERYN$8FZT>Z&_7V(8D@!R1(.RDN>*^E M'+@`D0QQI\>;TYT?CZ&T.#`3J"Z6B2$?,;0:W-'VA'465OBV@X%IXN%__[/( M%H#MN6XKQ*_UIHP\HW!7UM?4T%*!PUN75.?Z*?W.["_E//SE")>&9%-,XO(%XR%_? MG\!/#H.JS,"_>"R3WKDO5Y=_F7T\.<4TX`(SA#R?/]A`&?`8[@H['?D.N$_" M-1Q25]"X#70#9:1010KZ",N71-=G+=JS5;*.\T4BR;!XJ3L^FP$4>#SP!*XT.T]_JXC:*5]1_`06G]#J*;[U\_B024C&"]SNE4=-O M_=G+Y55$>P>ZZ2--E`A"'PDP"G>3Q"A:KWYP1A/U8LXPBIEXW+O?P=!:YADR M9@.'&'JPE_!:TO'WJQY,J5V&8MY^2$:!:#SIM3`.7FT1;'\/Y*I3A7@U+\+- MI%2AXEA>DSXC)@#?RH@4QG)7OPS"+T4?,YY>5PQ'"FM0V$.82<<'HSVW>3P= M3W:F4S?:@DT8%63<:++MIN-7D_'N>&L$_C3:VMH_9F&T5^Y@?V],JYI[>'!S MB4CA\]EWEF_)?2'Y9%?:+]*:(Q'T:G%[*\.^(O3]RYW;1'&1#_^TXX^I4;YW M.S,-L)HA/X!+?74#QNXVN:>8HMG!N*E\L\ATH&OP$%Z@Q`1(VR(#-^=0\>EE M0[Y![`$Q8/][%TAW@P3RM66([(?982P"IGKU(GNE*HFB:DGN?U$<>I?JNAKJBZ6(I`@N_>:X=5$/PG\:6)O\8X71"12VR!) MZ-_--Q/U;1I:D=M.\HS,J^_G/5+*YY2>.\7:RACK!O088[E<8AP@Y`,=W? MA#U\S7PS>H>)7"Q9:\F)[3HIX?0N54`@$E;[^2O8PRD;@D:`0TD^#I$8L[R# M3O`EV\\$HCEV`^7UDN5W02F@:L"VB"?'OV^XG-.9;Q%..LMFV3R'XHUN>]%* M^59C`++[-M7OPF?NWVX*\PK-FM!HYU#VI^<_B[DS?&'/B;T112`Q4[DXO)A] M2-$F^UK<2'",PL]"?ZUW([G:[`D"`G@1)H#K%&5!H2".0E33HBOAI/Z-\+"T ME8G+H+81VOM%911+W5>[FF%/_I567^=$DID@2NN:'>]2O_1ZX+([HO7++NX5 M4([;4&SET^A'_`1M#2R]U!:.@5^%YM?%W5I`DA_AJ[T-?FB:'P,652]0,A M1J=5-(KM'&KS&CP#H3MMY9>U#4G5=8:4::MMX>_SRW!1:T_L1=%8%(PY`9N- M,0>R686.PD):GSG!CWQ9:Q&L+H$\[IXE5GUX@3W9VNJ?%V]85SMI_L`C_:K` M9I)2N0KM:GWC?KIEY0?PS??O[5E$G&^T1/)$6&N47.F?Q;HE$3M@%+`1YX32 MS+&<3A+^IYFE9P=A@&P!IPO>DV0SNZBB`=N@G6AI+`'62>8GK>7X-V9[0G2@ MZTQ-F*>Y78HVC&N:%C\S9N"W[E.3G0<./J@U44`6PWUZ'&&7(NB$=P6[KEZE(NW%__OJ M_2Y]]>R%&:+0OC=52"!Z^BI'#0&:T5&5*B@P;EQHGHQ=(<4$KF9__Z8=6".L MG=PN3JFW9;6U`R8IU6Y$;F_WM5\#")%J;<&H1B&@$B;O,$(9EY M/"]5&"I)KV_.8@T17XS0,Q>['ACS*?K@@$+0?S/VU9-$9?2":`G">B9^G4N. M:E^`SAGD+%RKU#U93O513JXE<+;@UH24#0^X'R`Q1UHIQ>XVMUWXN=&L.I3@ M`W*)U-&:?3.9?=^/R92]CIV'T%->`=R\S>DZ-JL:<00IT3LJ7/[V$_58+%>T MZ]DS=XT)$@.N'#8!Q,9GH]6^>L*`FNT3:=_VXX#LJ$V4 M=<;:1P5#%"B"VFI'94O`;*_!?N!T;95T@M=BAS>`Y"DT$P&CT`8NV`V"["#" M!A`@?:0-,MAY#9U8ALT-=SN2>*[>;^.U'`*XV(<&+36'L1-T'4)`?<\SE%NX MN(=]*C/L*.">$C#8:NK29=0J]X&H"MI54_!0HUO9K-I[LL:FVG68@ND511P; MLRO(U7GVG#IJNU;!0.%E(DP```\>T5`\NZ8==!Z]5[?OH&2)"="B*,[K'J+` MZ`R5RLHU8.V(HMVYN9_``<(AEUW9N&J_RY:A7[E@.78CEES^6;NQ@8&D%N9` M84>?V4V@"Q%RVRCM[ZT0GE+.BA\V,,/%?QT3%SH37?S':2`5=H1`23*>TEXR MRZ_A5\FE#SI;WWP##]TWS3!H],WR#6"*^4^N27AJR:!#$&%I78MON_50MG_] MN73^LFB<':2X_$#8+GWO5T5\`X)/:,B3+MT++NHG:42OQD-`3.G`N:67?NSS ML/[3XJF[:$0_(4NL$@>Q!HORTD!5[(G%OL-^)E=9?=V7P[176UU*V!\,]T9A\5TN&BZ)(4E3.@Z)ZH7F(8`J)\@DZ2:3-=TWB! M<\`L^C)$K@;OD3F#T!TPLZ`"-G).-JBL-(HHWJP59&&J+8V)("[\37.4Y?LN M:`6@-_LC'SZ&330#NGF@R^`KC&]19Y[^R"J$RV7M"B5<&4*SS[@`!%LT)_>@ M5EMJ]"%;3!URAJDTNA0/)):)2DRCNV5'ZIK5X]'BD[:=O\&O[>6>0PU#/1/T MWIW3Y!LM$_;,M2>V[/8_D^[^HKF@N&B[18M,4#+B[/"9EIY8(07B$KNR6FA$(>YID&;@Q"I]F.VM M+<2)XQ&U#$+UE>%;[4R5C?I\K\0D3'V]XL`BQH94X!'4"6`J+``A%;A+21++ M8O,Y-.40KDA:>`"E\8*=O$LQ%(74L?PX]CY0KK/+/1T57,7BKIW+%SY7*%37 M7Y9X#),P9[>PM&A>F)T`MD)0`]AM"]D1\3';02,I[;'(B"RI(8=N+:I)'*HA MR-KN)(I=>3#_I^KVU;E:D2GEQY!/8)>3O:C8GCMWVP+M",&M)Y>(1JPX2G-7 M<(>XQ=.M(#;H2ICNLD,CXSP.J,WZ!:6D<'<(=;6'68)%%@>2>B$N`!B!/)>0 M!%AI/0?I&\@*>UN:60RI!_ZY4]5]W/J3/UP4>TB2N-O@07&M-XPS"S=[WW/^ MD=(0F@M]/)O=;?P/``#__P,`4$L#!!0`!@`(````(0"\2<*D2PP``']U```- M````>&POX_BR!'_/U*^@^5-HCLI,X`Q`\P-<]IAQ\E* MF\GI=J)$RD61`3/C6S^(,;LS=\IW3U7[58W!;N.&9J4<8!XNW.!IHO_MT;H8Z=HZMH.%[86!,]%?G;7^ M_>UO?W.SCE\]Y^.SX\0:D`C6$_TYCE?7GK'&0[W6,;O>JX]MNH"<4KOVY"!'?CCYM5A?ST%_9L3MS/3=^9;1T MS9]?OW\*PLB>>0#UI6?:\XPV^U`B[[OS*%R'R_@2R'7"Y=*=.V64X\ZX`Y1N M;X*-;_GQ6IN'FR">Z$9^2$N^>;^8Z%>ZEH@\#1<`X@__V83Q=[]+_KSYXYLW MW7]_^]T_?W06__KIF_)W/WVK=S(VA";8H)KF9;>2+'R=4.ZD$MS>+,.`"#(` M-:&VKC\%X9?`PN_`&4`\_-GMS?H7[;/MP9$>PIN'7AAI,5@9Y&-'`MMWDE], M;<^=12[^;&G[KO>:'#;P`'.,]'>^"V;"@YV$PVGYS!!-)M,(87`R]?$(E@WI>;?3'\6)25,LEC5?9+THZ;,,KMQ7A$SW-)KIE00SI M=;NH5FJP(S$;3[O`[V3,K@8GDZQO]:VA5,DX7RS;#1GV+9FJK&%HO1V^.YDZ MY3/;)UT:AD\U`W#"R=6B"U.W8GX/+7R=PD].G-".8S%&E0OZ;.H5L?'1]9VU M]N!\T7X,?3M`Q=*DQG[-Y63.\>23STU?2_KCJS\+O9V`Y\]VM(9"E!4IK-9H M(4([/AOJSK4R-;;&D7D-W1]@E0E';F^@G(^=*+#@ M@Y:^?WQ=08T9P,H#[=Y)?E?SZZ?(?NT9K-(2&[`./7>!*)ZFK+)-*XOIU;TU MO6=\"3)1%'N(6M9T>`2B]W?CJ7RDT_%8-E'#@I=DHF\'^)),U(+_IM)TFN86 M4Q;(G)X6N[@2[5X.Q^/QJ'V##A?Y;,CH]`MDYA,:[8J@2!(JL2!(JL MRA9#'0F1/YTIT!=2;%6"0)%5"0)%5AU*CL!#Y58E"!19E2!09%76PI,X5Z'? MJGBN$@2*K$H0*+*JM.(SC>LXQA11JY3\_X-PY7\.\LC&,X MC71[LW#MIS"P/7C;R49D?RM&PHDV.*-G=_X)F'%]G$0W"8MC<ERWCO]$M2(NJT7G.@PR)FD[E#T$CMHA=1\ M@B.8J9FE!0>`3V0N(3A"AHQ%7UU41C)"3$8R0%!&,D)41I@ZNR97ILE%N(%S MO-L&MJQ1MYNT,$7Y5!,DP'=XS&X09$Q9G[5#=FBT=DQ362&^E.;&G8$O5AWO MD+1F1%G.F@$[I*P9(2HC[S>9=3GB>>L"P_,.)%OZYGY^&`Q@E`S,\&P%P30^ MX:F5Y.2*<+C;+6XM^7JI54("H9IET$RM6Y8KRT#D;LRD9,1:;E7.DM8%4&;, M'<_[B(G_'\N\UH#VW>W-RY)L`8%].;A'`G>8X%OHD:=OD[HB^0`0]PTR]@[2 M[-7*>WW8^#,GLMAF'<:"'<5>?/'ICA5$Q>>WGOL4^`YK0.H)F1^B,';F,=M, MQ,X=[,/3WX.GEQ(2P=.&O[F'/^A)6!]M^$.#:Z<102]*^8-S"?.7Z0^X;2IU M:C`!=>HJ/#(10!LC0P!&4($`MWFE.@#W5($`EH<9`G#0`@'`J?"*-O.@1Z(9 M^$#!$O@?BR7$F$Q*CN41I=P7?H%_A906%WY;J9G$6W#T0LWPH0)`*Y;[0JRJ M$$/,#C.M4`%\J%"!!5E73LJ#!D+N=Z"#`H`RA9"@RP&",%"E$7E>26(N\!35 MR)W$.H0X!88BU1``CA((Q!`]1?FW1S$HRL#4&Q2E8`J!R\'544+JG*"6X#*D M(@R`1\FL*.)UC\L8)U0#@:`J0A)O,%2%2(I!58PL3&&H"I$$@JH(22VA*D12 M#*IB)#&%JA!)((!&E$1(:@E5(9)B4!4C"U/T585(`D%5A"26Z!\Y1'9HVS1I MHI+^Z7!T4/]4>UG6-E)[^Q9-8/=L>+)Z2E:.8`NVEB)+:;RPSLYZI]IS&+F_ MP"(3+[";0S/5B72\(#-VY_3(E\A>/3HOL!1-SF^]+/?W>@%)UM_8=D8>X5Y, M!7_HF.M:$^;2]=,"2WM%U$J.?97:OOR68_"][5H'J<7`&@NJ0:"N4PS274#2 M%,&9JUI-D"258Z"F@H0I%BLLT!P&GYIH5NNLE#DJ(VUXPV&N@.$#U=?`G#KI MSYMU["Y?&T9.V>IH$3D-,+14T[3`TI/MHZTMA3XLY+=[$VR3:=*>VSDIOXGD MV'414_0Q`L0QW0[WV/#10<.+=)(0"Z?Q.U7UG72UM)X0YS=%CXHHL5XQJ[*R M_5#?[F\W$<$,ZPU,^:*,<$>%#!<@I`[71F8*@2 M6ICQZ7[O,HT640>MZ?%,X9DA.CL=T=H-)D#[-A"U6KO2]TAPVGGY7GWASIVJ MDN&@_"I1@4?!US;_(5_2Y(%DWB=0KO0;N5Z)T+G&65Z)\Y%*O]!JX9ZSTDV8+P7B" M^2%;J)*9"(?;E^\M0O'_\U:#;4)[UQ'RZB1Z0B0_P97<+TWT!!:5CW`NNQ]!@A+51*?ZEHA+&+?5V-V-9"%YO8A M.C2@.EO*["'2&%C7E9;.?.=:IPDB&DGX4-R#BJJJV\3'XH-F15*,R'.PDPN0 M)A>)$O!E+/CJ24Q0ZS$`:U<]N+4<+L$]XZI;=E5+9V(6EP[P"\R/F:;QK5"D MVJWFO2%TE[79?GO884_N5\+?K23?CZ_AS>;AX3C=WVL7VMLYRIJ?5<5=.;.- MZ\'=%7&C/5XK,8>MDJ%_EQQ,=[=7T-T/!'5O[K(CNPZ0Z`M$ M%L%%:15V!,T1?:'(36D5=@3#45H@CQ"97"=O".Z`C3MHB.$BJ% MU7@O[PMZ>4*EL!?OWZ:@?R=4"DL!/2*1"5^(2Y3;J,]KUQ34[IV]R*(N[S"8 M9T1@P&/4YAL/'F\7XL/QV$5IV&$E`N'&`B%*S\[\DS:%>XSEA/CY@&E4A-#] MR\JS`SL.HU<-+T3+R?%&'PB2^U,8YCKB*1CP4030G^%1@O"40@WTDFB(]V&\ M"*D)F7PN\.K!NU(T(0.C$S2\_^$RJ@D9&)V0X8,JUD\B9-X'JTUN(3Z68NH6 M(?'!#3XY"]YS>`WC8E6$TH.SB2,[]S]^2AF"BGG`.]/E-/@0D3RD)KN-7EI_ M/L"-Z#(EX@5R9.Y@#2T"_*^;F*@11Q$B>(6,")%'-X8;E6:3F".!L(1(A'!Q M:$YB*Z((TOB['04X6[BIN^6C>R0J+K6%ZG_Q4MRED.D]QH=MLOL7YNL!4-3" M6=H;+W[,OYSHQ?N_L%L`@S.EO_K!_1S&C,1$+]Y_P'LKPRR&G@F$FP]KN%\O M_-4VD3O1?[V_&X[?W5O&Q:A[-[HP^\[@8CRX>W/(G>T(I7&S;,Z_7'CP?-$J%3<%_+(Y-=/(A@<]NJ`JPX8J.3(C. M.G]RZNW_````__\#`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL M+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$ M;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8 MRTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L; M'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3', M3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ M`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K> M3!`6#? M!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`; MU69]>\W!&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY M$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^ M%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0` M]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N M,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7 MZ0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P M:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1: M!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W M1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[ M6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ. M&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y M:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:< ME,7*DB):#QL,^NQXBM4*W%J:[!MP.XN3BNSJ*]AEWGL3+V41O/`24#N9CBPN M)B>+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N M_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H! MT0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/9 M94FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3S MS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD! MS`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4 M(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F> M,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;Q MT7UP]`Y\-I@Q)4TPP:&PO=V]R:W-H965TDKO)9K-W]S5B53)`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`QR9@"YS*\.A]=GC;=:2?>;<<4JYHQLUD;HJ$9 MPJJ_$7Z_3[8V60'[>2196RD12HE(2L2,^.4PDC$%SFAXK8M&^])UE7;BC78- MAR_:-6-&G-I(B4!*;*5$^(0PA+*,GC'"EB%^PO`C3L8(SG-Z9GK8?4TK;MJ) M]]SQA/?RFC%CGDN)0$IL&>&V,\AR3-,34A]*)2(I$4N)Y#$,TS/:OSXCG-^P MP_VZW[23X/=,V$^M&3/FMY0(&,&63,\R?.$96ZE"*"4B*1%+"3A\4C^Z.,%L MP6IVLF2'C!+51[1!14&4#%_HJ=&&8NE;^P/MJTTWN$+[VIROG[5OS#GLUN@9 MMN\`!]!S>D1_I/4QKXA2H`,\RM#H":UF1UAVT^!S>^39X0:.GNW7$_RG`<'V MSM``/F#F\2`U23.;%/:?[_C."2Q`U5Z`P3>O.?Q.3[.877W MDF?>,Q62\2)">!0@CQ8)3UFQC]#O7X\WM\B3BA0IR7A!(_1*);I;?_RP.G'Q M)`^4*@\<"AFA@U+ETO=ET@)^V7&1$P678N_+4E"25C?EF1\&P#),:>%,B:"9D0!OSRP4I[=\F2(74[$T[&\27A>@L66 M94R]5J;(RY/EEWW!!=EFL.X7/"')V;NZZ-GG+!%<\IT:@9UO0/MK7O@+'YS6 MJY3!"G3:/4%W$;K'RQA/D+]>50GZP^A)=CY[\L!/GP1+O[*"0K:A3HIL?]*, M)HJF4#GDZ8IL.7_2MWZ!KP(((BN!#B+_G#!U+ MU2%"X]EH.@_&&.3>EDKUR+0E\I*C5#S_:T2XMC(F86T"[R?S>_A^DW%M`N^U M"0Z'DOAF557"'H@BZY7@)P^V*W#+DNC-CY=@?#DKD`ZMO=?B",VA;A&24)KG M=;#RGR'Y2:W8&`6\-@IL*^*S0M)F^?7?HFA]%M""/I,K8`!M$HIM71-PF#<;@()ZV+ M!8F!:'@&*[6#YW3CIM9T^;#3.?$%3;L&FT\?Q(,KC,VQW3U.L-.3FUK3Y0N= M]HDO:*[QZ0-[.)\YWKM\H=.7&VPT,U,]/)TX"8YK07@3#4)KFVV:FK(>]Y@>8SDJRI]^(V+-">AG=P:W!:`[/!&'F M.W.A>%G--UNN8"ZK/AY@>*&ULE)9=;YLP%(;O)^T_(-^7;TB(DE1MJFZ3-FF:]G'M@`E6`2/;:=I_ MOV.<)IA4#KU)0GC\\I[W&-O+VY>F=IX)%Y2U*Q2X/G)(F[."MKL5^O/[\6:. M'"%Q6^":M62%7HE`M^O/GY8'QI]$18AT0*$5*U1)V2T\3^05:;!P64=:N%,R MWF`)EWSGB8X37/2#FMH+?3_U&DQ;I!46?(H&*TN:DP>6[QO22BW"28TE^!<5 M[<2;6I-/D6LP?]IW-SEK.I#8TIK*UUX4.4V^^+9K&:"T7A84*E"Q.YR4*W07+#9!B+SUL@_H+R4',?CM MB(H=OG!:?*%/JM4'_!8.]B]&/?@9_<*4B)][7\Q0Y?"=U5 M$MJ=0$6JL$7Q^D!$#HF"C!LF2BEG-1B`3Z>A:FI`(OBE_S[00E8K%*5N,O.C M`'!G2X1\I$H2.?E>2-;\TU!PE-(BX5$D`O?'^Z$;SI,@2:^K>-I17^`#EGB] MY.S@P*R!9XH.JSD8+$#Y_8J@%,7>*;@?`F8%M.%Y'27)TGN&Z/(C8>8G1`/?)W,0:M3?-S/M88S\.LW3L;4A$\RS*9N=H#6]0X-";FJX13'I[<]6@L%2[WN0E1<'7.JL9FS<;87C+ M/N)-P>/J; M'NZ/D"U"*V+Z_-B>H9=[6+L&:]]X70XT9/5G0TQ_:@V?/`'AW'"]RT=(+\[A M+`C\4<+J^*%DCD0"P)G0[O3I0F^^'=Z1'YCO:"NS$O@MPR9A\NU"GE].I&PO=V]R:W-H965T5IA[20WB_UM]Z^9?WJ&'OGA\[?+>?"UJ)NRNBXM>SBV!L4UK_;E];BT_OP2 M?)I;@Z;-KOOL7%V+I?6]:*S/C[_^\O!6U2_-J2C:`2A#P;7;+R:E$%OWZ/1G4XE'FQ MJ?+72W%MJ4A=G+,6QM^^0N6?WR>ON45Y<;2#R7Y[+]WHE:@TON M1\=K56?/9YCW-]O-5TUU:(<@-Z(#Q7->C!8C4'I\V)'SJ#_BJ+MT;Y>="P+O=I>2W`;5@GL@+/5?5"0J,] M09`\0ME!MP*_UX-]<
S^T?U=NN*(^G%I9["C,B$_/WWS=%DX.C(#-TID0I MK\XP`/AW<"E):8`CV;?N\ZWE-9D-I]YX8D/XX+EHVJ`DDM8@?VW:ZO(W M#;*9%!5QF`A\-Q3X9"H?'XG'-."3CV1HN^,9F1E^A['(6L\(QMAZQYA&DQHCLQ@1;$P0F"$VP,T%D@M@$B0E2!8S`..$> M&/9_N$=DB'M\WBL.I)V.816/X"D;$VQ-$)@@-,'.!)$)8A,D)D@5H%DUZ;'* MA5KM/V5X79$L.$^4NG+F4]V*%8V!$U*Z982L18BP"Y$M(@$B(2([1")$8D02 M1%*5:+ZY/;Z1T_F#&Y3(P![7=ZAG.,F"[CDI0H23B&P1"1`)$=DA$B$2(Y(@ MDJI$'D84XQM:(;!#9(A(@$B*R0R1")$8D0215B68&;)0/ MF$&B=3,H<>69OF9D+NS94#+3"LJ;Z`6U%4&\H`)*O*XC[+XF0Q$C3T#'RR#IIY[UH7KIC'DTJL*Z4C7 M'#FBW#8<303:=PM)RX,M6=/S.W#@IUCR*WAII1T^U()%K;7G4K+LW>,[$GAB- M2V&TR3L6!8UF=R<9C@WEB,M(Y9@C.<3$E)D:IW3*9(+GO"$)-Q MAN:^2WE.3UF3-OO>$GRI;G"8_NQ^9Q,9X]"E2*G8-8M2T(8A3YZ*6XYD[04X M,<1HQY`K%R_"43%&"4Y,M2B]:$GC?<^Q=WVSDZN?:1A%1M$:)]2:)<(7'C]X M-PQYLB*V'-&#P.LM6O8X*11R[9\4+4V\4[1(.9;*?-0)0W>*5I71EX"T^_>6 MX)U%RVX-ZL%!4>35*WF5ZHSA5!"8ON==N3Y< M7F&>)I_Z<&GKX3,?[B^81YX/W17FL>=#[][#YSXTJ#U\X4.[A7GJ^=!T80[O MJ9^Z[6B.G[R_[HE?.3Z\+<(ZJXD/KT,P?W+])_H>W'R`YZ_Z!K3V_'4?WW@^ M=+;X`8'G0W^+>>CY<'OJX7,?K@@]?.%#PPM\)`8*[\MOV;'X+:N/Y;49G(L# M%,&XZ^IK^L:=_M*R4_.Y:N%->7>`GN`O(P6TGN,AU/6AJEK^"WF`^%O+XP\` M``#__P,`4$L#!!0`!@`(````(0#2!;"I+PT``+]&```9````>&PO=V]R:W-H M965TRL2[^16;6W- M[CXK,FVK8IDN24EF_OTV"(!`XW"L*)-Y&,0)0__N/WX\OH6W,Z M']K7N[$WF8U'S>N^?3B\/MV-__-;^F$Y'ITON]>'W4O[VMR-_VC.XW_<__UO M'[^WIR_GYZ:YC"C#Z_EN_'RYO*VGT_/^N3GNSI/VK7FEEL?V=-Q=Z-?3T_3\ M=FIV#UVGX\O4G\WFT^/N\#J6&=:G'\G1/CX>]DW<[K\>F]>+3')J7G87&O_Y M^?!VUMF.^Q])=]R=OGQ]^[!OCV^4XO/AY7#YHTLZ'AWWZ^+IM3WM/K_0>?_N MA;N]SMW]`NF/A_VI/;>/EPFEF\J!XCFOIJLI9;K_^'"@,Q"RCT[-X]WXD[>N MHV`\O?_8"?3?0_/];/U[='YNOV>GPT-]>&U(;;I.X@I\;MLO(K1X$(@Z3Z%W MVEV!?YU&#\WC[NO+Y=_M][PY/#U?Z')'=$;BQ-8/?\3->4^*4IJ)'XE,^_:% M!D#_'QT/HC1(D=WO=V.?#GQXN#S?C8/Y)%K,`H_"1Y^;\R4]B)3CT?[K^=(> M_R>#/)5*)@E4$OJIDH0FQSO]0M6/?O[\P6F8W1G03Y7$6TZ6413.EPMB[QQ^ MKGK23]US-5EXLU5PI>-"=:2?>MP_=D2ZZ[JQTD]]Q&#B+R,OF@NYWQGK2O7T M1(6H:_!C@_7T)1;_4%U7D]"/%LON&K]S4(^JHANO^,Z6[[=N^' M\X_3;W2'[%7,!F,\'K'5$>)V$&EC%R0N2%V0N2!W0>&"T@65"VH+3$FX7CT2 M[%>H)]((]?1Y;S2PY'2DTA&Z2^R"Q`6I"S(7Y"XH7%"ZH')!;0$F%DGU(KR20!$@*)`.2`RF`E$`J(+5-F)(TLS,EAY_- M>HH3T9U@^D0WDOA4\7V=^>&*2[CM@W2W&$@")`62`TLPLD>N6^J"^6(`D0%(@ M&9`<2`&D!%(!J6W"]!%N^0:!NG"ND$)VO2"*$26(4D09HAQ1@:A$5"&J&>+* M"*MIWT?"D`=+L4A4RY`?]^32M=(C7A?(1BPUJ-2<640LP%14%?4OS0PHO9A[YR.&7=[,-) M1*9+U^;6`Q0C2A"EB#)$.:("48FH0E0SQ)41+LQ61ER4>=!=DUO7XM+0L?M> M(N>^#_N+U*VVMV)_2LX.6ML848(H190ARA$5B$I$%:*:(2ZD<'"VD%=*3!H^ M)I;M`94R@&*QO.1B)8A21!FB'%&!J$14(:H9XLH([V8K\Q=*3-I`IEKO#&W/ MXJZ[J8>C6HPH090BRA#EB`I$):(*4GV4ECM& ME"!*$66(HD*.CLU&V-5%&Q]YK:Y1@5(HH0Y0C M*A"5B"I$-4-XN=F=6G5F8Z] M>[=NQ[F[P^;W45JT&%&"*$64(),F4DQQRJAKXU2Y:(HP&P=SLW'` MQ^DZVBMZHFL-%++'*=&U<:HHMC)=F)4I'Z=K&,W:[LJ(T3H&"MDCENC:B%44 M'[%9`[(1A[<9N2Z<&SF%K+MSBRA&E"!*$66(`MWI62B^@D/48(H190ARA$5B$I$%:*:(2[6;=8L1&NF$"LC M&66A&*,21"FB#%&.J$!4(JH0U0QQ98:LF1=U'X!?G@_[+YN6YC\JGH'R"NB- M\V[N_Q2B*U.(KHFNFZU&YB6"6*.5?'E]YCDKK,0$Z#0IH@Q1CJA`5"*J$-4: M=0/G\MUFR$(T9`J%YF/*K4;+7KI8H3GU-X^C!8@ETU.4$4LADSX;SN4LR7(3 MI7,5&IE.7-+;G%R(3DXA)JF,DH?K:C9647/Y-2#Q MGFR"*-7(7(M,(WJ.6=?"66_D)DJ?K9)6CMX9:JXY#L@JC>H-?48;8S#4;2MKI9S]1%+*?*`H9 M7YKHCO:T"!TS'64ZYAJ9CH5&YHBE1J9CI9'I6<\`RAXKU%&1'N>%R)Q"=@ MYM(OS2*@NUS;4$69"2_6R(PST6C>/9%#/US,(N?"ISK&9,HTLH?@K1PSF:LH MFKS$=]5FD\`IST*G,9E+C M)$P^.&:AT+U,HE(CDZCBB583]Y+6ND^7AHOKKE!^:B*-<.&BD%/NSE7?ZBA3 M2K%"M!6N)[]$(Z\3ZH/G+>;.DSS%1)E&IB9SA51I1Q/W4\U"]S'C*34R:2J3 M1@^QUE$#Y>LN:WY.85SM1&IIPZO:J:"MCC(5%"M$6\%Z^(E&LA0#?Q%$_LIQ MB"FFRC2RQX`SBHI2A3Z;S)RK5^@T9I"E1G:9RQ-6:983]UL?M>XS4.;75E"_ MM6]_MH*BC^'U$HJ^%>].ZPIUU2'O+/F]=_E-XF-S>FJVS;1OOXKOM$NQ_,+])HC68B>0+H?;$L[68G]AJ(6^I2\7;M#'IY;NXKHM_FHM/I`;R!;0 M<>0MY_8)Z#CT>VX+1[UD;LRT$)]Z)W/@1%XI#6]Q#C0 MXI/6],;>4`MI+; MQ!]J(:WIU?*A%M*:7JT>:*%D@[DHU6`F2C28A^0?O&(D_J#V)/V0\K027HMU M+HZ4UGC4,C0F6KU0R]"HR(!3R]"X:.%,)S[40G]:X].P[B3AP+@VXK(/<7&# M#?!/X?J3_-,=3@'1)@X-=JC+A@:[&1PL[7&LMX,MM-6Q%BL>%#*E%K'PP1;: MTEB+#8NAEHA:AL2G92BU#(E/*REJ&3H.[8"LQ7*)CC/M1:`_'_*V>VK^N3L] M'5[/HY?FD:;B6;>!=I)_@$3^*8_%-/0QL-,O#/[V+87 M_8LX0/^G9^[_#P``__\#`%!+`P04``8`"````"$`J>G(UO((``"E*```&0`` M`'AL+W=O]EFQE5A8VS(D9;/[[TO.11H.M;;3GI>Z^89#D1S.D*/5PR_? M3L?1UZ)NRNK\.'8FL_&H..^J?7E^>QS_[X_XY]5XU+3Y>9\?JW/Q./Y>-.-? MGO[ST\-'57]I#D71CD##N7D<']KVLIE.F]VA..7-I+H49QAYK>I3WL*?]=NT MN=1%OA>33L>I.YLMIJ>\/(^EADU]CX[J];7<%6&U>S\5YU8JJ8MCWH+]S:&\ M-%K;:7>/NE->?WF__+RK3A=0\5(>R_:[4#H>G7:;[.U3]=3T/3TL"_!`PS[J"Y>'\?/SB;SEN/ITX,( MT)]E\=$8_S]J#M5'4I?[7\MS`=&&=<(5>*FJ+RB:[1'!Y"F;'8L5^+T>[8O7 M_/W8_K?Z2(OR[=#"%LT.(@IJ)NX<->VJ(Q@`_QV=2DP-B$C^ M[7'LPH/+?7MX''N+R7PY\QP0'[T431N7J'(\VKTW;77Z2PHY2I54XBDE\*N5 M3);.;.TM0<>5>;Z:![]ZWN?+="!*P]?J'GPJ^>M[[)Z MJ2;"K[;ZKGFPY82A\*L?>)>A:S4/?O6\JX9.Y1*+C`GS-G]ZJ*N/$6Q#6,3F MDN.F=C:@3*>*C%&7/#_*'4@:5/*,6A['X#RD10,)__7)=?V'Z5=(TIV2V7(9 MATH$6@(S$M6&-HAL$-L@L4%J@\P`4PA"%PG(]O]#)%`+1D+[L-7`"(WEMI;0 M4T(;1#:(;9#8(+5!9@#B-NQ/VVT/3ISALT*O-TZ"4X&L]YRZM94R#FRE+BDL MD:`3Z5QG)&(D9B1A)&4D,PD)`!PT=@#PL/SD#D`ML(?H%EA8(5%"UT+2B70A M821B)&8D821E)#,)"0FX;X;D>BZ@L/!<6[R5Q(6,ZU;>=9%C$2, MQ(PDC*2,9"8ACL)*W.\H"E-')7%EX<,3*V`D9"1B)&8D821E)#,)\0J2T/0* MSW3/64\@"M=7$N=1!Q6A*[GJ5I(\%;M'HY)[ M7IRM1EZ'`H7F$,-NG9V%1]W%@FW;ZXN._9;).--:&X5, MDR6Z9;*2HB;WC1LU&6NL9?+"FV##?R/(JCB;05;(M%BB6Q8K*6JQ^X,@8PFT M+%["=>.FP:ITF@8K9!HLT2V#E10UN,\=&F(L98;!-^**TE8F2+1PC>1E*,0& M""8:4A%',4<)1RE'&4'4/RQJ]_LG2R#9G%U5-/>8=1<)L"L%_XRS*N0HXBCF M*.$HY2@CB+ILE>L;2\J+-#:=N,I&Z>0HY"CB*.8HX2CE*".(^H>U]?XE5978 MW%D2>;!/C&/3ODLX2DJ^T)#71X5@L;N)SLJJOI&>N.AV1*Q1KRO1B.A:]V>W MJ.1I+Z6K1::0OT+U-#!8BXW`R+NW."[;0[G[LJW`:C@5!A+"@SNVNGFK@F[& M2Z*Y>*+L,"`W,$6\WJ%0(7\MK^LSIS]QQ)RH%]"^Q%Q-TDN)6__,Z4]:%1+Y M:'B.5I/I.3PD[J>:$"%-CS>%YE"VNB5W/>L>%B@I]?)+Y,K01&=M.1-I*8S_ MUR=G-GA)IDU,=:JEI&K7=U=6AF=$-3Z#F]FE0CJ<;Q?YM_N-[S5XF%K[#>%7/-\6EMF!5K(V($*S>F1PE)./G"^E"GGKE96,8NY MZN0NU:F6DJK=^=*S'IX1U328V&9=">8?U>5'AQ=L.WUZN:K+,Z.I4']>!%JJ M1R%'$4/^2RA:2I*Q"\-/O4M_J!`.HAB(P M9E%D*.)2,4<)1RE'&4'496S![G=9-FS$98EH%OO]6P#99+J=5)_%#$5<*N8H MX2CE*".(N(S_A'&_RT*:;ER-^I0-.`HYBCB*.4HX2CG*"*+^#71\W@K_.7?H MN@!85UQ/MG3FZFIDO+E0Z,:;"RU%ZI7?]Q#4XH'N:^'\@\+I\0Y,H;FY6%)J M.DU*T8*BD:P[Y)I2Y@<;_[*(+[*C-3(F*F1"2&"@W$$.NJ80!> MNO]1_^;)`DTV4E>SS,"-='LWSB*.(HY2CA*.]XQ(T92,^C(A@62/P2="S>"5K\2U\*B22V.8N*!JR"AX]].1G?_,L/SFR M%8%%0P9M(2*#`8%X#(8#UG!P"6$%AQ80WHN!9T,C6\_=;.$0Y"$/8"08'`EA M)!PF]&Q>(4M/1-O+&OYF9G\HU67_Y>JA<_#Q'N``WP.6,"_D,^P MXK]65:O_@$=/NP\,G_X&``#__P,`4$L#!!0`!@`(````(0#Q'W.Z.0@``$XE M```8````>&PO=V]R:W-H965T&ULK)K;DN(X$H;O)V+>@>!^ M`)M3X:BJB0;C\V%C8W?GF@97031@`KNZNM]^4Y9E6?J]-&S,35%\RDS+OZ2T ME/CYSQ^G8^][=BT.^?FE;PQ&_5YVWN:[P_G]I?_O?SE_//5[1;DY[S;'_)R] M]']F1?_/U]]_>_[,K]^*?9:5/8IP+E[Z^[*\6,-AL=UGITTQR"_9F5K>\NMI M4]+7Z_NPN%RSS:YR.AV'YF@T&YXVAW.?1["N]\3(W]X.V\S.MQ^G[%SR(-?L MN"FI_\7^<"E$M-/VGG"GS?7;Q^6/;7ZZ4(BOA^.A_%D%[?=.6\M_/^?7S=9&_E0,*-^0=Q7M>#!=#BO3ZO#O0'3#9>]?L[:7_ MQ;!2<]0?OCY7`OWGD'T6K?][Q3[_=*^'770X9Z0VC1,;@:]Y_HV9^CN&R'D( MWDXU`O^X]G;9V^;C6/XS__2RP_N^I.&>TAVQ&[-V/^VLV)*B%&9@3EFD;7ZD M#M#?WNG`I@8ILOE1?7X>=N7^I3^>#:;ST=@@\][7K"B=`PO9[VT_BC(__<6- MC#H4#V+60>BS(\@-QW'M2)_2T7R:&M,9N_P-STGM29^UYWQPER.%K6Z8/FO' MV<"8C'YUO5GM1I\/]G1>>]+G8SVE)5KUE#YK1V-QWSTN:D_Z?+"S!DU`/A_8 M3.1C?:>P1C.5Z)_:U33E7+HQF(:80.R?1WLLYI`A)]&]/1:3R)"SZ-X>BVG$ MUMI]/1[RE5N#CP= M^#H(=!#J(-)!K(-$!VD+#$GK1G":9'^'X"P,$UQ(M12@-0*:NL)"N-@Z6.O` MT8&K`T\'O@X"'80ZB'00ZR#10=H"BKJT#$'=,663[B>2F+W,BYX]RNP=J^HM MN8U!*;B9XE/59-68-`H#60-Q@+A`/"`^D`!(""0"$@-)@*1MHJA-F0O49DGD MP>3!PE#^4;/'1!5W61O=TK\Q:?0'L@;B`'&!>$!\(`&0$$@$)`:2`$G;1-&? MI%;TOSW+F74ELY!GR8E)BZF9TZ:AS^K&2+C90-9`'"`N$`^(#R0`$@*)@,1` M$B!IFRBJTA1[0%5FK:K*BPQM@)B`UD#<8"X0#P@/I``2`@D`A(#28"D M;:)(2$M9D9#M*LSI@"1_,#6P0*JZG)"Z[3D[4Y/%JC%JYBR0-1`'B`O$`^(# M"8"$0"(@,9`$2-HFBN#L1-W>QMW.!,Q:5963]IP%8@-9`W&`N$`\(#Z0`$@( M)`(2`TF`I&VB2$CGE0(!\3GQ!PWEP\:F_;EG]3+AXV1N'P$)`:2`$DYF51WKPC-CGD/*%V9JU+7 M:"*WORN!GIJ[M6NDJ&T\+=3;74LK<;^.0+QDP3*X*U![Y""6)ZU$+%\@&2L0 MZ&:L4%J)6)%`,E8LT,U8B;02L=(:32J]U.%A)Y=V+N%'PL&Y/VR_+7.: MO&34D6/&=/2K#X3\_$.;.G'))3NCTYI11JU&[5&KT8*?(D>&MA%?BS"+)K)3 MH[$4QI56U6%TI)]&/6D@.NACF$!:U6&TWH320(2),$PLK;I[DT@#$285J&.$ MV.FG/4(=(T$5K&8H^&%)&0J.VLF*53_8Z+2RE4`R@ZP%FK3$!T=76$E'3R#I MZ`LDKQ@()!U#@:1C))!TC`62CHE`TC$5J",GL3/.`Y+61Z+V[.;(I,UZ*[=K MV6;%ZD2D,HV.&&=;H+:CL="*)^O::L(685-B,4=J,G-$+!G>%>AF>$]8S:I5 MMQC/M5.`+PQDY$"@FY%#8<4C&Y/Y5.MT)"QDZ%B@FZ$38<5#LZ*Q%CH5%E5H M-"JMZ#1F&?DB/A(4,'0MT,W0BK.K0 M\\E(WDLWS%*FS,2B(;T1J1@\A%Y"'R$06(0D01 MHAA1@BA5D+J&V`FOO8;^[Y,S*Z?I:C?'1[E*3%-[TJQJQ]99T$:T1N0@;XTVB?,:C.\0F0C6B-R M$+F(/$0^H@!1B"A"%"-*$*4*4B5E)\$').4'1T52CM2BCZEMQ5>4,JJ'@#R! MVXC6B!Q$+B(/D8\H0!0BBA#%B!)$J8(4E>EW_D=4KLS59%RC:K_,0_,?_OGO MA:?L^IZMLN.QZ&WS#_:C/OVN\OK<8/[&P=*862R]T6J`ECFU5.L$6IZHI=HS M0SMEPG%KUY^T`-- M+*K'H\-R:E%%N8.3'IURD!J=8I`675)0UQ9OKN^'<]$[9F^T,$95K>3*WX?A7\K\0HN-WFG)2WJ/I?IW3^\M951;&K&R M^%N>E^(+NT#S)M3K?P$``/__`P!02P,$%``&``@````A`+%B>7.J"@``KS4` M`!@```!X;"]W;W)K^TX2F)L;`6V=[/[[SL428G#5R>QT[U9;QX.QYH9 M?KRBY)O??^Q>1M_KPW';[&_'T=5T/*KWF^9ANW^Z'?_[3_';8CPZGM;[A_5+ MLZ]OQS_KX_CWN[__[>:M.7P]/M?U:40>]L?;\?/I]+J<3(Z;YWJW/EXUK_6> M6AZ;PVY]HC\/3Y/CZZ%>/[2==B^3>#J=3W;K[7YL/"P/Y_AH'A^WF[IH-M]V M]?YDG!SJE_6)KO_XO'T].F^[S3GN=NO#UV^OOVV:W2NYN-^^;$\_6Z?CT6ZS M5$_[YK"^?Z&X?T3I>N-\MW^`^]UV/IBMQ-S(5BS-DDFY"GNYN'+46@ MTSXZU(^WXR_14J7S\>3NIDW0?[;UV]'[_^CXW+Q5A^W#']M]3=FF.ND*W#?- M5VVJ'C2BSA/H+=H*_/,P>J@?U]]>3O]JWF2]?7H^4;EG%)$.;/GPLZB/&\HH MN;F*9]K3IGFA"Z!_1[NM'AJ4D?6/]O-M^W!ZOAW'\ZMX,8MF<[(?W=?'D]AJ MG^/1YMOQU.S^:ZPBZ\MXB:T7^K1>DOG5['J:1!/JT_:+LK(YSVY$^+[S4:]N3/B^Z5)JO[:72 MYV67FMF.]'G>I4[,"&D'7+$^K>]N#LW;B&8Q#8'CZUJO"=&2O+F19O+;C;V_ M&GHTYK23+]K+[9C"IT%UI/GR_2Y:)#>3[S3&-]9F-6##+7)GH0>T=EN$H`R! M"$$5`AD"Y8$)):'+!`WS7Y`)[45GPL6PL-@)3'N3(V$4VOSFC&3?+.I,L%D!*(`%(!D4"43UA& M:,'Y!1G17FA2\3D1Q+NR1N^EI#/I4@*D!"*`5$`D$.43EA):2_V4#.]#;C'0 MQFWD[HI7EM`RUU4^6LR#VG=&KEL!I`0B@%1`)!#E$Q8H5>+\0+4Q#]2213?] M^19!^:R149/MYFL)#2JO6\:[E9V1RYBPI-\!J\[&CM>8)L8@RXKXL=\B+WZ%YJV?B:10(FK(W<&Z$0U[T#G5N@NU? M]@;.C7)H(':M7LX>X9'1.K0).=D?2(>-H-J5;JV!E5LZD M=<1GDM9`7DJ,^K_2-V:GY^WFZZJA0*GN`^MH0A=NM;\54OU%K2*#@K$2Z,'< M6?7CH+`H:6^/6_>E0Y&9AM=1-`W6#H&.*M>K=R0=LHYFY"=PI)@CGBDMC?[O M3&DGP5)D$!M365#`/+)&_4@H+$IHL'EC,1A"I;/2Q?I^ET[3.)L'$T:@\\IU M>]>Y=%;&>;+(DNPZN`#%G/.$:@GV3D+_;%[_:NC1Z4,W]JR0\\>>15FWYN7Z MZ$3GO4<%HA*10%0ADH@40SQN+=*\N`>FEA^?E71^?`9Q-98%5LI9K7LAZE9G1JG+I&8-1?6Q%MD*0G'FS(+RQT/=@.A?F M=,L<+``JT4H@JA!)1(HAG@LM\KQ'Q:M7GQZ5K/DW9'N;3<1O^QV`VB0OKEAM6RLW))*VCF!R.@1"0058@D M(L402T=\D51MK?G^8)$W=G-$!:(2D4!4(9*(%$,\/BI%6.Y/3&U=T6!CM"BH M=7C7TEMUM494(A*(*D02D6*(YT(+/V_HOS^U]?H=AFP0?8,+)K=6'BH0E8@$ MH@J11*08XO$-B,5X=D5[ZX4S.T;!:)%.KK>0!S>;>6_E$E0@*A$)1!4BB4@Q MQ+,1",(/JHW*3XMCOBOEB`I$)2*!J$(D$2F&>'Q:,YT_FJW"\C8J_8Q(Q^>+ M2'J,&-QH]E9]2;N.#I5H)1!5B"0BQ1`/.9!F>N]:9/H)V\4C'&5;;`69/\+I M3"%,1V?E8B_ZC@Z5B`2B"I%$I!CBZ=`:Z?P18!25OUWKFQJ]Q/6W+3FB`E&) M2""J$$E$BB$>WT52+$8IYA"U=(M6/`UN@?+>RM6O0%0B$H@J1!*18HB'K'60 M5U(]PI/%IT:X452LW)W(\M,1'H_$G56?#D`E6@E$%2*)2#'$TD''#"P=[Z_A MK3579P[U-Y8YH@)1B4@@JA!)1(HA'E^@SCZ(#T588E!"!>I&>)2%YSB]55=2 M1"4B@:A")!$IAGC(%XDP?7P2B#"+/,65(RH0E8@$H@J11*08XO$%(NR#DJ+2 M2@Q*:>AW)8VG4-+.JB\IH++WY:P$H@J11*08XB$'2NN3QP?Z^4=8ZTZ"^;D( MCU)L1V]$%(A*1`)1A4@B4@SQ7&AMY"W@'Y3?*"E_D4ZLN/+N,1`5B$I$`E&% M2")2#/'X!B18.LVN"'\0JA%.+%2+N`#M#X?X%U\D=A(4.Q9YHR1'5"`J$0E$ M%2*)2#'$XPO$SN?/91(40A:QN[=X&I[+]%9NM2@0E8@$H@J11*08XNG0DN/\ M>60$"AMBH-SA MT4QOU94;48E((*H0242*(9Z.BX10BD+((KJ9=<'DB`I$)2*!J$(D$2F&>'P7 MJ9X458]%^J#/4P7A^4MOY;)0("H1"405(HE(,<1#UG+$F\&?7]!2(VS\V6T1 M'^%1>';16_7I,+Z\-:!$*X&H0B01*89X.@*1]/YNF:(6LLB[\AQ1@:A$)!!5 MB"0BQ1"/+Q`^GQ2!*2HBBX):AP1#2-)/M1".2`Q.]1R32WM:2A+_5Q MW("WF+S10=90"WFC\YZA%JH"'7T,M"14!3HT&&JA*M"]]4!+3'UH=QAJH3YF MU8!X*-=FQX06RC4=K0]YHUS3H?10"^6:CF('6B@%@QF(J`<]B!_H$5&FZ7GU M4`MEVNP$X35']#7F*!-:*-/T"!"]*=TPE#3Z_:)TC0X'K/E:C#B/%OJ=^PP1T6VI)<( M!W@T7>HW[+!%9$O]GATV5-F27B,%INS^. M7NI'6NBF[8/J@_G!C?GC9-]#N6].]#L9$L+T&PGZ851-/T^8ZF=?CTUS#B\W'S\MMV, MOI9-6]6[VW%R,1V/RMVJ7E>[Y]OQWW]]^G`Y'K5=L5L7FWI7WHZ_E^WXX]W/ M/]V\UESM8GNIF6W3XV3Q/VGU3 M%FNS:+N9I-/I?+(MJMW81KANCHE1/SU5JU+5J]=MN>MLD*;<%!WXMR_5ONVC M;5?'A-L6S9?7_8=5O=TCQ&.UJ;KO)NAXM%U=?W[>U4WQN,%Q?TOR8M7'-C^" M\-MJU=1M_=1=(-S$$@V/^6IR-4&DNYMUA2/0:1\UY=/M^#ZY5K-\/+F[,0GZ MIRK?6O+_4?M2O_W25.O?JEV);*-.N@*/=?U%NWY>:PB+)\'J3Z8"?S2C=?E4 MO&ZZ/^NW7\OJ^:5#N6P^=8AU6 M$6`"O@-II.9_(*VC:-+]=@\]X(\B%0Q[CWZ)(@!CB#)*AOD/6ZK/HEZ$YF%9 MO.(,'JQ/,B=.,^ZR'%P&EA1A-%%Q25-W_HG5UU'0/ZS\LREG]>"^MT52J"9)A>S[P6E(!448'7U5E()RE6CE/+6M="3. MU2(I9(%PS439!J>!*T48URO.]?TNTLZ0J%PNLN&]>I**09R3%EQ9O"DT[D1!2*QP0Q'Z31\<)&HGI/#RA"G$"6M1)80/5-%),.5D(22QWVVIKV$X M5PFD&,0):&4]GH#384K`0J**8OQ9ZDNVY$0ASDG+*^&DJSC/+A8XKE-/12O4 MK.V==G,9%8/&4E_.-5^O;HI!G*^66,+W0!&M(#-.5*/-\+=,`D@QB!/0.DL( MF+9/\K,R9B6;L1M4G%QXYF+"62:#5]^(BD&,L.X62OC]C!EO+O\]1,0KA!2# M.`&A]0<(A(JN1<`V-$V*'**\UY`4!G%.0M%U%2^OSID=TE#M':1W]]/#7$XZ MWLOSM;&P$!#GJV68=-V!'%K1IHV5.AWW)]DRA!2#.`$MJ\<3L"+,"#@H\^*9 M.@A_2)[$E*5Z+QP`\?+3!Z>I]?AXFE:]&4T'49H..D!S6$AI^K&#T]1Z?#Q- MJ]Z,IA-T6LX`4BF%.(&([*>S"QS#B:J?AJKO(-'^[3*LI(7R@BDY[*2<'T:X/(&6VP>EBO'C&M'02`CICV>4Y M`T)F19BJMX-$PN1`X[U\PGXHZ)D0]`,)"U7;!.A38>?B$%(,X@D[2:*S4*(= MQ-M^(:=(5BGAF(5%#,;PLO9>G.RP$Q.CF)TF]\>92 MWT.DZ4-(,8@3$%+_?A/EH9X[2-30SVJVK[S7D!0&<4Y"SXUTG?&D*`^5WD&B MA'YD_D2#@N#I`@Q/[N$HRR?%QHHH:2[479=P@7>/)]\OF$!"M9Q^ M0TY(Q\EYQRTD)X9B$$^A$/X#-0S5/:M2#ES>:R@P@SCADZ1_%DI_#Y%K3P@I!G$"0N??+]DL5','\:Z_E$.5 M]_))<0)OW]W3M[\SH>:ZBN<-@2:2**(5?U%$.>^XA;3M&<1S>)+XXTL'K9UT M,'60^03"1K;?,M@7^=NR>2Z7Y6;3CE;UJ_Y.`=F\NQE@^Q'%0WYYK4]-Y#>P M7,%B&D1:9E-\>6$*$%CT-QGF,4=@26%)8_O,,EC,$QRY)L<:7+UCW+`&E]68 M)8?%I"2(-H/%?*@16.:PS*/1%K"8&Q6Y)L,:S/P1!AG68/*.69!KC,0Q"W*- MZ3-BR9%KS(`Q"W*-22QBR;`&CPAB%JS!W7C,@ESC-CEF0:YQLQJS(->X48Q9 MD&O+65`%/+6*65`%/#N*6!*P MQ@NAF`7[X$U-S()][$DICR?!/G@S$5N#:MN[6+DF1>7L!5U:L"3:'PE6X,UM M;!=D&F])8Q9D&J\O8Q9D.HEF.D&MDUBM\1G6?3P6%L3VT&6.X;K-(OA]?GUO M/_.2*=%G>F3!`ZH8+2)J&"TA*AAM%-3/E&\R;(S/N_;%<_E[T3Q7NW:T*9\@ MJU,S)S3V`S'[HZOWD&I\Y%5W^+#+_/<%'_*5^'AIJL>PI[KN^A^HPF3X-/#N M/P```/__`P!02P,$%``&``@````A`-\_RLQO!0``)!8``!@```!X;"]W;W)K MV56JFJ M^O&<#0:B)1@EV67OO^\X8Y)X@!3VA=W@X_'Q\IE$ME4WV6&=[>5!+.T?HK:_K7[^:7&2U5N]$Z*Q(,*A M7MJ[ICG.':?.=Z+,ZJD\B@.,;&159@T\5ENG/E8B6[>3RKW#73=TRJPXV!AA M7MT30VXV12Z>9?Y>BD.#02JQSQK@7^^*8WV.5N;WA"NSZNW].,EE>800K\6^ M:'ZT06VKS.??MP=99:][V/XZ=V(%( MJ\6Z@!THV:U*;);V$YNGGFL[JT4KT#^%.-6#_ZUZ)T^_5,7ZM^(@0&TX)W4" MKU*^*>CWM?H*)CL7LU_:$_BCLM9BD[WOFS_EZ5=1;'<-''<`.U(;FZ]_/(LZ M!T4AS)0'*E(N]T``/JVR4*D!BF2?[=]3L6YV2]L+I\',]1C`K5=1-R^%"FE; M^7O=R/)?!#$="H-P'<0#]GJ<3WD4L"#\_R@.,FHW^)PUV6I1R9,%60-KUL=, MY2";0^3SSI!'M]=;6X4]JB!/*LK2GMD6[**&\_E8,>XNG`_0-->8Y`K&1*1G MA#H*H-=QA)T/.5Y7_4Q%@145=0J*6X)?0.R.&R?K7B)FK(,83$"A^YDH,)ST M8&'&^[A(#C'^`!-T*[>(=`QA<(,@0V[J)*$F;N3H62TU:6F#`)TXC!-Y$L1$ M[;%.?![X+N5H()@;1'S60PR2D.Z/DU23J)">*5."&"#2;:1G@$*.(0R.H.&B*"5V(O]H(]@,(,">UP]-8DR)-HDB,'U)XQ'?F1N(46` MCSD0>#?X*;\;-)-QY128\@K-91/$C"F'"&3.W,CMNXZA7/P(,P4VF454,(1H MP;S8FY%\3!&`@MW@Q*`Z[Y>K19NL&)\1O32(+HL%H`>1-/?YH!D96C'5A^\^ MQA9->9'T230(EXYF@Y4U-6S]W?@MQ52G'C"[K\I9I'C M]JBK,02A5A/N>FZOE:8Y1/`PZ".8'(E?C'<4]4IVP8VZF08AMY!SD@BI,0YV M%_4!3&H/V02[XA,>Z1F)!FG96.3W;5:K-O2)"?.\OOY-;E\R"G;%*0:=7J?@ MT"H\'OL4D>HPNE!<4+#?ALGR(;M@5_S"HVU9@V[TOZ%73'SWEE>PA\RB1=." M(.F>:-#Y9/W`#0@D)1`76LR-S.,/^4:+)F]/@[S!4]4@*,JN^Q!ITU&(<:Z< M^,=]7;J=176D/J)!J"/SHOBBL9@(Z#RW3IE_R4O:690E:2&)!HVQ)&YSFZ5J MYP\W:8XF8#B>3\U$@W1.ABP@@-0$L-OYJ'KY@.-XD^;8^4UN??O7^3BTAY"% M%]2&XR/,'K(/]2N:VH??UZ!FAB#L,.R"UW"T'S3+@QC'G>6!K1\.MJM0YE,# MX0@"<3K011F/04R>7S(1?L5$J(\E&J0+)(X9V4AJ`.+("P8OX"9)XB%WBGG% M2WRB5,*'=A%R-^[/LTV%U`!P%H(7=B^5)DEB*'>2Q)\09J$0UT@X@K22OO%* MH%D:"'AK[;N505+=%0RK^#Z2[2S2#_W^K01K1H/P!H&J:`SZWJS?(=+#2SF\ MLRI%M16IV.]K*Y?OZL*-PR_2[MON,O")J^L?\GT"EX3MC9K3#<`=W3';BM^S M:EL<:FLO-A#2GV/:\,HTF/69$TT^J%C?3":DS=D52O[Z=)VE5 MG,'B)3_E[<_.5->*=/7C4%9U\G*">7\R)TDOWMV'D7V1IW755/MV"G8&#G0\ MYZ6Q-,!IN][E,`..7:NS_4;_SE8Q6^C&=MT!^C?//IK![UISK#[B.M_]GI<9 MT(9UXBOP4E6O7/ICQ_\+.ANCWE&W`G_6VB[;)V^G]J_JX["DVLW@2>O0EC7S:Q>Q-X]B:6,V6..?O"0)S>`YXW MCSDSE_;\^=F`LD,"S][$!K\G4'$+(J4BEBD$/#"/(1Z><#;LY_(@XITH)@+! M0XW30;`6!**/K8C(`D*$07#I_9!!.'286$"8I'RDM(AE"@$2[$`4DGI7XITH M)#)&#S4PCH>QA(H!J#$KI4FH5$1*12Q3"+#@$*&PU!'%.U%89(/V4(,HF.DR MNB/X@H`M;9LX!"B0X`Z'%A/852P2UI'2(I8I!%!POE%0ZJCBG2@H:I#!8FZ1'=K' M9@G$0*D(Y:^(E`:Q3"'067Z%#A<3.HQLP!YJ^@A9PA%-SKAAN\7<4?1@NP1? M.'28,'=!DC52.L0RA4"'P8DV#)[G3KFN%^5$PL3K19*)^KT$67:LQGNXVB94 M2R*U))9*1&B\!'TZXQ@6K%"478^RT0;M]2(D,;/,)8DZ7Q#,9Y"68M@%O4"" M.Q0\8`^?+XA)I#:)I1(1$Z]#!YB>C"VL7D5<),<\AB+)9/U>@D0[8(Y-CJQ` M;1.J)9%:$DLE(C1>GPZ@R7=SAM6L"(M4E%XO0A+\Z!Y\(>@*=[]72'`&:DFH MED1J2=Q+[HY6)`7#_0(IKJ9;%HD'CZ$(2_-1!EX:;WE,^@>R_N&U\6'_2"V) MI1*1#Z]+!Y'T9/IA-2M&%"W.^8T4P`0@URV-H/#5DN`JX5_U1GO#P=\%)D'A:S(B=R4'L,17TL.Y;KF"-.LJ*XR\Z@=Y'0#M622#V6 M6.HBLN+%Z?.LL)056='2G*'H?!XEW:98DGE+";\D?#Q9)X2TXWG*>DT/V1U(?\K+13MD>]A5SRB]Y M:[P#QP]M=>YN,U^J%NZNNU^/\+>*#*XZS2F(]U757C[P6_;K7S^V_P,``/__ M`P!02P,$%``&``@````A`+6?G`L9!@``TAX``!D```!X;"]W;W)K&ULG)E;;ZLX$,??5]KO@'AOB+GEHJ9'Y>+=(^U*J]5>GBDA M"6H($=#3<[[]CAF'8M-ZZ/:A;>#G/YZ_Q_80WW_Y7IVM;T73EO5E9[/%TK:* M2U[OR\MQ9__]%[];VU;;99=]=JXOQ<[^4;3VEX>??[I_K9OG]E04G04*EW9G MG[KNNG6<-C\55=8NZFMQ@3N'NJFR#CXV1Z>]-D6V[QM59\==+D.GRLJ+C0K; M9HY&?3B4>9'4^4M57#H4:8ISUD'_VU-Y;6]J53Y'KLJ:YY?K75Y75Y!X*L]E M]Z,7M:TJWWX]7NHF>SI#W-^9G^4W[?[#1+XJ\Z9NZT.W`#D'.SJ->>-L'%!Z MN-^7$(&PW6J*P\Y^9%ONAK;S<-\;]$]9O+:C_ZWV5+_^TI3[W\I+`6[#.(D1 M>*KK9X%^W8M+T-B9M.;]"/S16/OBD+VJ^3K,L>[IOZU8($AO#;:R:F`]N"LC#9@Z%"2P;;/W(=[!8BCT)E M9Z]L"YJWD"K?'CQO?>]\@^'-)1--F=521>(;(@93Z":W"V^Z3&V2WHA;$XX7 M^E%T(,8A4!C)<:#O9]$M'@&+>&ZJ$5X`[2%`5^U(/"566E^3*:*)I%-"%^%3 MQ%T-75$BAIR='[&`8>A'`7K>9M#M1R-"!I)Y,"%0B9@D$I)(28*;",4!Z.K8 M@5MRF\=>--K98/,0I>=KB1HALUKUJ;YL5!#8D1,#M`B*2G"51'F>R'S MA[%0/!`%XCM;GCD;1"/5"\_7YP,RADACDDB0D!GE,W?#6!AJ"9^.(3<,0G_M M+O7UV$4,( M[?"@^M=F3"P!HQ6H84!26H4;$=4&46V-;)A71#<50[M/(@DI`AE)A&$HG( M/8CY;JC-QY06X49$]0.Z._:#F"6"UM>+R9L10D8?2"1A))+2"#U_4/_MB&2D&G9 MI)&$1E(:X49$->)3Y::+E:1Y6DC(:`3J&)"$5DEIA!L1U0A(\?&TF+=@NJ*5 MGAE:WD82&O)6VV=B>=_H!C[G(XF4EN!&1+5"E(VC%6*F%:*5;H566DH+GRJU(33N:D+VLM1)"'\%I=Y\(JNO9Y+ MP&!30FFDM(8X2A2=??\Q:`(>%>+Q554TQR(NSN?6RNL7<0SHP;>PP]7AB/+1 M%8&L:7H]85LX4(+KSM``3A2OV;'X/6N.Y:6USL4!'K5Z@[/$_M\3G!T7<(H%YP.V=:CK[O9!/&`XC7[X#P``__\#`%!+ M`P04``8`"````"$`L1L>?OEV/DV^EDU;U9?'J3%;3"?EI:CW MU>7UZ.><=?&U>Y^VU*?-][W0^S7;R=RTM'@S3E*>]@_.VQNK8\VKGX2+ASWGQYNWXJZO,50KQ4 MIZK[W@>=3LZ%&[]>ZB9_.<&\OQE67O#8_1<4_EP53=W6AVX&X>9TH'C.SMR9 M0Z2GAWT%,R"R3YKR\#A]-MS,7$SG3P^]0']6Y7LK_3]IC_5[V%3[K+J4H#:L M$UF!E[K^0DSC/4'@/$?>0;\"OS63?7G(WT[=[_5[5%:OQPZ6>P4S(A-S]]^] MLBU`40@S,UX?BXW;FH,VL,_ MS'?T;G.Z9GT*>'F7/STT]?L$]A7XM=><[%+#-4!\OOCTID,Z_%,V0!J0*,\D MS.,4)(.%;B&%OSZ9&^MA_A72KF`V6VQCJ!8[;D%RC(3U=.#K(-!!J(-(![$. M$AVD.L@D,`?A!O5`L/]#/1*&J,?GO>5`DE.3BEMP%T\'O@X"'80ZB'00ZR#1 M0:J#3`**5,L1J2S(U?%3AN<5\8+S1,FKE2K%EMH8:\E(,]D-)H-1@,BB)B(](@$B( M2(1(C$B"2(I()A-%21!-V:RW,X]8]X+QB6XI,2'!I4/.5B7<#4;(C$B`2(A(A$B.2()(B MDLE$$0,VRAUB$&M5#$8<)5DV6K(,1D.R(.(C$B`2(A(A$B.2()(BDLE$T8<4 M_W+=<'LS$6M5'T:D9$'$0\1')$`D1"1")$8D021%)).)(@:L\AUB$&M5#$HL M40#L&-D,>\FC9`T?XO2QEVI"^8,13ZB`$GL]!`H'&SF05JM%@Q$/%*-`R6`C M!7(6ZHC2P8@'RBBQ^JDI*I)"^`X9>W-51X9D(3F2E&0(I.1C\C$*&)*5$U;2 MC&VMUHB$%0\?XUB)L))C:0=$*JQXK(RA,?U(E2KO25K+STC_T1VKXLNVIFW8 MR%Y=0LW.*GE:ZT*EP&^Y)5T&9*PB*T.RK!2M1:KYS%%"`4.*K(.C),7&41,I MPK%B'"L15E(L6XN5"BL^QXRA,5E)12O+.B(?](:#?K0`5O2CR*(=+VEL=J35 M(I*:@\H>1\L!^1Q9`PHX$HXA1\(QXD@XQAP)QX0CX9AR)!PSCGI'=<.2HO4. M95B-*V<612;4;.)4VVAGR,Y@5O3A`VT,!T>^@CZW6O?MIVTNC:56G`7<1`0* M.9)'8#BFGGST=M"OD-9V.5MHD6,>1D1..!)2I@P-85;:^9UQGSZ,JC4I:V6M M_]WF9L6QO`04F?!++Y;`09TYLY+W.T4K,3_?8(C*],FP#$,3*F`FI@@4N$L3&U_!#A0R)$\@I&TIK%%/FJK%?,P8H@)1V+9 M4X98&'.F[[N,^XRD-2G`;RW!Y_H*O_$_>DQ`FG^MIF)(2K0=1AY#MC@5?8Y$ M[@78,<0H8L@2BQ=CJP2C%#MFBI6:M*0DOZ78QW[E66$OMLZ6/!L@Z2BGC.EH M)]2.6XF,\!BR14;X'-&#P!Y-6G8[$2CDL>41C"0M=;R1M"AR(B+SK98R="-I MY3#J$I!&X-82?#!I63\AKP%%)B2\.#A6VJ[<&8,5GXV'D8]1@%&(4811C%&" M48I1IB!51-('R"+^H*RB;0.L&I_SUJ!(%1KCMPB.'$;YQH?L>X09< M@!S#5V+')?T!OI`X+C2E(]Q8N*3?&KMBP)6Q6!G18^P"O+)[[G]2=)W@5=Z8 M_=:$5WPCM]XN77@RC(?T;$'\L;%N'9>T:]ACY[B[T0N>XY(^#7L$CDNZ-7PA M=%QX/C#"04'2_8Y=,>!*'VL^*`*O$*_Y:_EKWKQ6EW9R*@^0=HN^6VWH2TCZ MI6,5P$O=P&ULE%5=;YLP%'V?M/]@^;T8"$D7%%*EJ[I56J5IVL>S8PQ8Q1C93M/^ M^UW;E(:UV^@+X,OQ.??<:RZ;BP?9HGNNC5!=@9,HQHAW3)6BJPO\X_OUV0>, MC*5=25O5\0(_E``>N[$CSJL"[)+],8DRV&U^@GX(?S7C%3<,*@HT4;IT3$RUD`!RT< M(T;L8*R2OP(F&9@"1SIPP'W@6*RBY7F\2/Y/0D(^WMX5M72[T>J(X,R`I.FI M.X%)#L2O^P$C#KMSX`*?8P2Y&FC"_781)QMR#X5C`^8R8.`Z8IX1!$1'95"; MK^S`3ME5UJ5R&0*G,NF8R$1F\189!RXP7,?D%_$S;U`.F.P$LWQ=&2#S#3HP M]&!:V\5('*0#:(8T'*KYT@[LI7+I?1.23U[T/J-DXUA@@CMQ-L..VSC5&")3.ZO7NP,S\0U^/'HJ-H2R9T-A1H8A(KFN^4?>M@8Q=7#S M+X6Q,$;'V;SS!?DSGN6[,+/)^`9F9D]K?DMU+3J#6EX!9^S+I,/4#0NK>L@3 M1J>R,"[]8P-_1PZC(8[@B%1*V:>%F^OC_W;[&P``__\#`%!+`P04``8`"``` M`"$`AX`2?.D&```W&P``&0```'AL+W=O'^R[?+>?1:U$U979=CRS#'H^*ZKP[E]6DY_O-K>.>- M1TV;7P_YN;H6R_%[T8R_K'[]Y?ZMJI^;4U&T(U"X-LOQJ6UO_F32[$_%)6^, MZE9V:(9V?[/3U7UGT%]E\=8(?X^:4_46U>4A*Z\%N`W]1'K@L:J>26AR(`@* M3[328=<#O]>C0W',7\[M']5;7)1/IQ:Z>PHM(@WS#^]!T>S!49`Q["E1VE=G MJ`#\/[J49&B`(_FW[O.M/+2GY=B9&=.YZ5@0/GHLFC8LB>1XM']IVNKR-PVR MF!05L9D(?*+(U'#MZ=S[C`J\KZL*?#(5SYA;YL*9?W]-YDP#/IF&97C3J3OS MB,@'38#YT+TE[^M\Z&GJ8J#P0F>48W(`^;&!TOJXZ!83_#/2)#W,-V MKQ%P.VW%*HS`(H$*MBH(51"I(%9!HH)4!3L59`*0K')^CE5$!M8.8:#9[ESV M9DUCK)D0-)5#-GU([Y]&MAH)-1)I)-9(HI%4(SN-9"*1C'1_CI%$!B:]/&45 MF]8LZ",G^Y#>28UL-1)J)-)(K)%$(ZE&=AK)1"(Y"2NU-'N']S)13"22/]#MG_"'1,O^ M4`+^8-,W&@DTLM5(J)%(([%&$HVD&MEI)!.)9`9,%,D,NE$:9+MO3^7^>5W1 M]&5@$#FP(=)MDHC('E'B"AXQ8O>N!8PLNGW5-BU'7LRV_7/T.=1(I)%8(XE& M4HWL-)(QTM57`,Y'YH#8F6K:'$Y=OBAA&/6T/)#*:X,`55?_J@ MWA]&N'34QXA"2@83]T$HE&A":1_S@="N#T*AC!*W:YKDXN)3+I)HV45*1!<9 M$5RD9$;S=I)X;342,L)+18S`A^"]LH/$?1"V--&$TC[F`Z%='X1"&24#EEEP MNOG$R.O"9=,8$EU#Q`T(&!)]TU&(B!>,$$$+!.MF\K2.>10V.4'$M5)$LI8G M:^UX%&IE#`WY1])=<>;^T%I'#BS*6&1(LI5&T5JPI)^BV:R?YEM64$`A(FY% MA`C6<,%6)3N,>11:D2#B6BDB66NAVJI5-6,%AVPEJ;%HZ\<+(CF-J?Y1).X6 M+,H5M@M$CN`?*^CV*,0H7C!"Q`O&B'C!!!$OF"+B!7>(>,$,D;Y36"39_80S M+#?FR_>Z4UB.;6DC\$RYNS88Q1>Z`!&OYQ;1K-MO73A?F%.EXT.,X4H1(K$* MUD))!V,6Y9*-[W5E&HXR/!.4XY*KV\PB@^E@"&GN^SKM+:(K,ZH.\N:SY1-/-2%(D1\3,8, ML:$]-6;*&$BP#*]/BHC+[+@,KL\91@T,7Y*O_W^':=8O.4R1,JJ5$;0A=PRD M'_@("AAR^/*X142'HF//G:F]4'++4)>*$(DS:V!%H75@`]TT3*7W$I3AE4P1 MB<-)*1.H*@;''1BT?MI M>H-Y*>JG8E.;.-QC>C&^=GVX`8"AI/*I#R??`3[SX1"H\]3S M(6T?X`L?>OQE\$'@^2>-TJ=#S M23*G/X@\'TY<`WSAP[%B@(/C)&D>>F+!DZ%W))Y/LC\H,NE;#C];W/*GXK>\ M?BJOS>A<'&%HF=U)OZ8_?-`O+1O6CU4+/UAT(_P$/U`5<'XR#5B@CU75XA?R M@OXGK]4_````__\#`%!+`P04``8`"````"$`C0?6V/\$``"E$0``&0```'AL M+W=OXT_!MO9-*ONRS`Y.3[XGGOM:V?U];VIC3?4 M]15NUZ8]FYL&:DM\J-K3VOSK6_(E-(U^*-I#4>,6K/VCR355VN,?'809R%IVH'O/2 M6EJ@M%D=*HB`V&YTZ+@VG^PHMQW3VJQ&@_ZNT+6?_&_T9WQ-N^KP6]4B8'`L%@2QN=C!GXHS,.Z%B\UL.?^)JAZG0>(-T^1$0"BPX?.]27 MX"C(S!R?*)6XA@G`7Z.I2&F`(\7[^+Q6A^&\-MW%S`_FK@UTXQGU0U(12=,H M7_L!-_]0DLVDJ(C#1.#)1!QOYCE^$/Z(BL=4X,E59J'O>XLP@*G<>3U\.\8` M3S9P>9[YT_^,]L&;&]\"3C0MG=\99U.HQ<[MB*#:K#E\-6`Y@ M9G\IR.*R(Y@I3QF-4"3Q>SF$Y!&1)Z*R-B$&2$\/A?>V<5UG9;U!L92,$^L< M6V9L.8-4!I'=J!1(52%4@4X%\`EA@@G`""N8G.$%4B!,\AI@#G]8HQFPY M@P_9J!1(52%4@4X%\`DAANWK8+JS\VVN6YYL,@M4YR;?C^'(V8\JQ%Q.2 M0MD*B@A=0_8:DFA(JB&9AN131#(`EOA/R#M1@34D+P%7L821[EDB*,(2#=EK M2*(AJ89D&I)/$(^K(76T'BPW8:LM>0 M1$-2#!,A)9S62@3 M)"Z44\0+23(D.\CQ4FMQ,])?AW-5OL08Y@NU>J/*76AEM,$1#=DEBOCCZT;. MEB+NQ!**>,NQ(SIS6]D/]N)['D2B::2"0[HJ:"C=(Q/?': MH9Z#Z8^0U?OK=3318NW/#4E7TC?0.1V\"#>I.:(OJNC=* M_$KN9W!HVZP$3"^/>1#!S@()4G"X5#Z-=TH%C\EE\P8_=B(XB^HZL1O!&4W' MG[SHB5Y:U1=X$9Q@]`&Q'T'#OX$O(FB9-_`@BF\%M@TBV-)U_BZ(H(W=P,,( M-G0=3X((MG4=3X,(NM@-/(Q@4P?<$@'#)?E2G-#O17>JVMZHT1&2-!_WHHY> ML^F'@17(,Q[@>CS6RAE^#D%PEYK/H-\=,1[X!_("\0/+YE\```#__P,`4$L# M!!0`!@`(````(0#`)+DQL`(``&D'```9````>&PO=V]R:W-H965T;GL+:-EHTRAMI%:JJEZ>O<:`%8R1[F-)=MCN,@PHBU5!:\K7+\Y_?MQ25& MVI"V((UL68Z?F,97N\^?MB>I[G7-F$'`T.H,/-DR/%2-#LKFJE(H<&?#_&2T*?N=W#&WK!J9): MEB8`NM`G^M9S&J8A,.VV!0<'MNQ(L3+'^SB[CB,<[K:N0'\Y.^G1/=*U/'U5 MO/C.6P;5AC[9#ARDO+?0N\*&X'#XYO2MZ\!/A0I6DF-C?LG3-\:KVD"[5^#( M&LN*IQNF*504:()D99FH;"`!N"+![6A`1.`/B\[E`$A:[M^`< M;S`"&0T%?-@EZ6H;/H!IVF.N/0:N`R8>$"&(#LJ@-E_9@JVRK8I-Y=H'QC+) M>9G%5,86?0&M>]^H/02XD8DD70_\/@./68XP+Z68&`7(?*,6#+V8UGCS2MJ# M9DC#7,R7MF`G/12YCT"YAF8FZ>60S,3E^B-2%CR5ZB-^6,=C`I68;\&"I[Q] M!)R,+*3G+=A%._M;L."I5!])W/=T(IF#X_1FTIZ8"?01&?_"RB*+S M7F"1?<",0T_%^M#RQ8U?;'Y["*8J]H4UC494'NW22F`?#-%AH>Y=-5['E]G> M+]IP>`.+KB,5^T%4Q5N-&E8"9Q1LH''*KTK_8&0'><*ZDP96G+NMX9?&8"=$ M`8!+*&ULK)E=20\^ M?/^XG`<_DKQ(L^M"48=C99!L_RU."5).0"':[%03F5YLT:C(CXEEZ@89K?D"M\: MO!>M]X/BE+UO\O3@I]<$L@WSQ&;@.F=0],`3!(Q+M5#/P6SXX),?H[5S^ MGKUOD_3E5,)T3^".V(U9AY]V4L204;`9:A/F%&=G&`#\'5Q25AJ0D>BC>GU/ M#^5IH>C3X60VUE60#YZ3HG129JD,XK>BS"Y_*V#6P/HN2@,KQHYO-9QDZ%F3M3)E(V\)W!:!\)K':B.FUON"9S5@?"*M_FY M*\)BJX8*KW6@^:D+JE`.?'987?#,:T-S,C&FYJS_)E4QL?"F#IWWID75\6+P MYHL7PSF$2L?0NQ<;\>JKBMF.RNCQ(<_>![!#P""+6\3V&]5BY8MES&=#%/:_ MU344-'-Y8C8+!>8'2K:`Q?CC4=?F#Z,?L(#B6K.D&K6K6*&"K19F:\M@+0-' M!AL9;&7@RL"3P4X&O@P"&>QE$+;`"'(M$@[K\_](.+-A"<=4+1$T,Z!)V44% MAM@R6,O`D<%&!EL9N#+P9+"3@2^#0`9[&80MT,DNK""271W6\/U=&:N71<'^ MVZI>3=6[V5MRC0I[ERCQ25>R$A*184+6A#B$;`C9$N(2XA&R(\0G)"!D3TC8 M)IULPZ9#LLTVD2]N'LP&]I_.[J&/N\E=UJ*^_`N)R#\A:T(<0C:$;`EQ"?$( MV1'B$Q(0LBT+"-NED%4KL"UEEZFY6.8&L8L)6A-B$K`EQ"-D0 MLB7$)<0C9$>(3TA`R)Z0L$TZ*82E_(44,G4WA9P8K1361!-)M3G180RB>#5U MUMTUUD*$<^$0LB%D2XC+B::+RWM"T[Z\V;W\3HCP\CXA`2%[0D).C.KN.XEF MI\EV^]:_`S!U-]&<&$T?L:J)*>[4YJ23:-64FKNU$.&=.C7A9Q_6S6V$IDD9 M,=H*$1JYQ,@3FAZCG1"AD4^,`J'I,=H+$1J%G!A5CCK3`;UW9SIX-SUD1X;R ME,:ORPQJ%;;;.].D0]?,>VEFTITE3MJS5)/6+-5D7C7?VECN7];B>[P+AQ.] M-4%"PQIX\)`ZR*WX'CUTA]5$[\3UZ^,0C$)K[X]B+[]$CK`F=$7:2 MZTS)G=3#L15S7\F[R:]1>S-"U-J-$#4[Q!I1]1"BFEH'41.X0=0$;A$U@2ZB M)M!#U`3N$#6!/J(F,$#4!.X1-8$AHBJP4^3LA/N5E/*3$+1W.%O+RF&A:-#8 MM/9N:4M9H:HI4!M1.U"=2V6ZKE4&6W5X'-4TJ:%TT*NQWR#JM=^B:EHMM;D^ MD\X!+@H:9P]1K_,.5=Q9-683:=`^*AKK`%&O]1Y5W)H]9)*L0U14UMT)9Z>M MS_^74?GAK#/A'&G-?K6J52UD4[2ND3$5Q>-0U8:B+0UTJ0QQUUY`F-^_LV1+\,X$=#A>?C:BW7M:UZK_6$+'? M?,I^BRI>CE-C(C5N+@J:@7N(>@>^0U6]AE15E9:GCXK&.D#4:[U'56T],V;2 MJ$-4W%E#8/V5"6=RZ?\01]46S6N)/YOFC_,N2?Z2K)+SN1C$V1M[[@R5\?@@ ML'@H_E1MZ!)?LH?EK$1DKEGPJ.4.URUX*D#YDV$]\8?NLI%AP3&6!BPG%AS$ M[O"I!:<+RCW3@L;N#I];T%E0[IL6]!>4!Z8%?=T=/K>@NZ`\-"WH,2BW9Q:< M%BCW9A:T\90O36MYSV=E6JM[W#8M:*VICSVWH*.CW#$MZ.LHWY@6=-9W^-R" MKHYRU[2@MP,^$A,)/U[\?6U8Z1I"%9Z-T!=H#%8B[/:EM)C+8MPU(ZW7^_AQ>1 MK"+C1$:_3$^JBL7#P^(A1?/N\X_#?O*].7>[]G@_C6[FTTESW+3;W?'I?OKG M'U\^+:>3KJ^/VWK?'IO[Z<^FFWY^^.<_[E[;\[?NN6GZ"3(FWLI&A_TLGL_SV:'>':HS]]>3I\V[>&$%%]W^UW_ M4R:=3@Z;U6]/Q_94?7OK#;G-NN_:QOT&ZF0+JC_EV=CM# MIH>[[0XC$+1/SLWC_;2(5E4>3VYYLF\?Z9=__KWW]=[-[>NXQW1E&)`:V MVOZLFFX#1I'F)LY$IDV[!P#\=W+8B=(`(_6/^VF,CG?;_OE^FN0WV6*>1`B? M?&VZ_LM.I)Q.-B]=WQ[^5D&13J62)#H)_M5)D.Y"?*KC\>_0:703I?-<].FW MFRG,DH*J[NN'NW/[.D%=`55WJD651BOD$F-/P*#*8-AXBPRP()(4(LO]=#&= MH'F'&?S^D$39W>P[6-_HF-*/B6C$>H@0%(NTE6.8`:\!#6HX:#%A(T&++`+T MT%TY&.PH8H9PB!B:5(Z!(,0TFU" M#$K70F!BQCG,*X@465`_=/IS!EP'70)N0@QPUT*`@TL7>'BI#KR*8(EOR%LJ M2XQ"-P4;97RR3=#0K'(M!`Y&Y<*1"G(;";D86Y0B$\6J+#'6@H,UH>RN39#! MZEH(5DR3B_4R=2*8PE&65"JJNR;%;LB$Y(I2$EF\4EK0P98Z"",TC/`U8$(, M'ZZ%\'%+@5_F0P13/I2%E5)*$:]-D('C6@B<"$7I$3F'SHQ4-YF'0M4F5DJ< M.AMEP!(312LDVIGVR^Q%2M"A%$/J4IO\>HJ$M#J9AUUY+`U*H9DX+>G\E+(S MD'6II&S,`+XB)LJ+D%P'_3N\:(%V>5$F5E=,5->1B;*87!/%)-34P2093>6A M9G1Q:6%V`2L3*RZV=->1B;*`71,%+/36`?P.B4J=27$I4Z"XA#HZF:\M+B6R MK+CXEBVJ2HC&Q>(R,987UT1Y&27A`AW3+&UBQ<46Q=I&64PJ%QK"1#$)?66, MYLG-8OP.&&FE=FM+F5AM,9[7NB&B+%[3T,,K!-C!^TYM*;D&(T/J,M(*;GM; M^Z:*F`AA@GP7@"S!*+V&,9F*2KTV4<;R.96]M8T:AE41$P4\2NI%SZSJM,E? MC?&OD7J91M)@SP5)S,9<#E&75J.-L;SH?23W*C\6@OOA2I+1;*Z,8EO<437*:,:A4GI@&GI;ZRC'5!$3)4R(K4/8.P"T-#MR$&M3X@#0)HS:G%.CG)W< M*]O0C;('2`ISE/+'OO(/)A>FCGH'IHY"R3F#L6='"I-M!N^PZ0M^[.JVO`M8 M^Z:*F"@`INZB_N/L9OQF%/O"KTVL_/G)S$8-!5D1$X$K;EP^7GTRFI;_8+JU MU>>;*F*B`)BV"[Z2>2XWH\N3E_@Z/YB@F$ZIV),@[9EI_SN]:15V%EZB3>[0 M/5-%HB@`)M]7ETJBU-A5RL&$(G*8X.!MC>5$RCZ,T3)07(;8?YT5+ MLUM'RB3./P91E/,S9F*B+";71#$QM9:,7G,IL*M3?YJ3`.*?,5JE&F\UFP*E M]6N$7OR>H;[P;-$D,1MS.41=+"U7U=4O/[89J*+3*.3VPT*?*G%V-T!M8J5E M#]QJ\[%1=JY4+E5M%%-(Z*^XLTU]E=XG0E73/HFBC:42J?^BJO38'* M"LCW-:)EM-NM+#9#9:JC+E:6B;&SZ)H(+]DH,9?15+2T2=P>&!F-%OS+P$89 M3,1$,86V@2LJ*_./Z=K$*LL>T]4ZL%$6K%]1 M63*-MQVRU50.49F6;Q#PG=T-T.B8E65F`7 M6.#=PN@?FC*S#PQ,E-K$2HN?I6W4T+`B)@I7B.^'93]34NW*OC:IJM6UK:(< M4T6B*("0QN?9-?>UF2_SVD096_+#O(VRC+TI\]DHF9?1K.B4\@<6HY!09RZN M_%+,M!)C!$8NDYC)93E$75R,KJ:K[<\V`U5D(O-1,B^C*2_:1!?CDG]'V"@S M5\1$,05D_KKOGMP7>FUBM<7/TC;*XGU3Z/$/<]2;Y,. MS?FI63?[?3?9M"_BZ16H>[@S9OTN++M=%>IA&/.@:%85*@`CX9Y\CL=D\@[= M\XAG9O+^F'F*%/U@LPID@Z?".23@R=`/MO60!_U@5_4]19:@GV7`@QT);>2= M+<-69BD\^5[-\^3PR%W*\RS@D9](.;EI!G"4]P/`EJ!Y<-?ILBCE<%;NY\#WZ\6E4X7H8\8!0_ M$84\J!#\&!/R8*3X223D`6KS(+:\CT/QH.?A_U^\#,N/,'QQ!B/.DJQ;,5R5>#9 M2B`9>@EV@CZ"743H`F]K_$Q%A!+`^=;WX*D*V@3)C$`F'H2$VJ`$\/+"]^!I M;1'.A0:!^%+47\@NYC%@+])5$5P6`!3"4PK-"N0I,>?J6&WF`B]P3_53\WM] M?MH=N\F^><0V,9?'L;-ZPZO^Z-L3MAZ\PVU[O+V5__N,M]8-WI?.Q6GWL6W[ MX0\0-#.OMQ_^#P``__\#`%!+`P04``8`"````"$`;A`SJA4#``!6"0``&0`` M`'AL+W=O$UG>O=05>F92 M<=$D./!\C%B3BHPW18)__WJ\N<5(:=IDM!(-2_`K4_AN]?'#M7)6_5GJU.+Z&KJ7S:MC>IJ%N@V/"*ZU=+BE&= MQE^+1DBZJ<#W2S"AZ9[;/AS1USR50HE<>T!'W$*//2_(@@#3:IEQ<CB3+ M$[P.XOM@@LEJ:1/TA[.=&OQ&JA2[SY)GWWC#(-NP3V8'-D(\&>C7S(3@97+T M]J/=@1\292RGVTK_%+LOC!>EANV>@B-C+,Y>'YA*(:-`XX53PY2*"A8`5U1S M4QJ0$?IB[SN>Z3+!X<(+;Z?!=`9XM&%*/W+#B5&Z55K4?QTJZ+@<2]BQP+UC MB6;>=.Y'P7D2XE9D#3Y035=+*78(J@8D54M-#08Q$)]V!%8,=FW`"9YC!&M5 ML`W/J\B?+\DSI"[M,/<.`]<>$_0(`J*],JA=KFS`1MGDUBSEW@6&,N%IF>@: M&0-.,%S[Q4?^;<_KE!UF,L!,>\3(($`N-VC`L`?CW"YZ8B?M0!=(0U%=+FW` M5KI/;A>!V_\\!'Z_F)'+V352!CR6ZB+VU(QX(1-#"^;(18MS!6I>&O-W$2B7 M@94W*M*TZXO/@@&/I;I(:%O)L-)AV4->8V4!/>C]LV9>&O.[2`0R`RMO5'T` M_$/-][4L>BRV#QV["L/@&%LRV-FQJ>ATJ057M0R+ M/C#5=8T3I@[:A#$UFWCG+;EN`.>V/SR!"QU8FKQAZ:HF`3/NL"BZD!U^[ORX M*>::?,UDP3ZQJE(H%5LSH4)HVWVTGYYKFY'#^"1>NZE*^G]@JK6T8-^I+'BC M4,5RX/3MWDLW%]V#%BVD'D:;T##.[,\2OE\8M&[?9#470N\?('.D_R):_0,` M`/__`P!02P,$%``&``@````A`.VC19HQ!0``M1(``!D```!X;"]W;W)K&ULK)C;CJ,X$(;O5]IW0-Q/."8$E&34))RD66FUFIVY MIHF3H`8<`=WI?OLM8YM@.Y.)M'W3=#ZJ?KO*Y1.KK^]UI;VAMBMQL]:MF:EK MJ"GPOFR.:_W?[_&7I:YU?=[L\PHW:*U_H$[_NOGSC]4%MR_=":%>`X6F6^NG MOC\'AM$5)U3GW0R?40-O#KBM\QY^MD>C.[RZKL/P91 M7:N+(#LVN,V?*XC[W7+S@FL//Q3YNBQ:W.%#/P,Y@W94C=DW?`.4-JM]"1&0 MM&LM.JSU)RO(+$3SU,-QSB(@$%NP_=J@K(*,@,[/G1*G` M%70`_FIU24H#,I*_#\]+N>]/:]UQ=.T9=7U<$BE=*UZ['M<_Z4N+25!GFSG# MDSO#OP\ZN\P9GLS9GMG+N35?0$?OM0IOAR[#DSGZL[EG.M9O_#SF!\^Q02R.^=D3EF!KVM\I&A^Q['[ MU=#!F!&1)Z*RUB$&&)T.ZNUMX]C>RGB#&BF83:C:6*+%EEN0@B"R.QE$,HAE MD,@@E4$V`08D82D:3,24*B102*R112*J0;$J$E,"J-DW)[76< M+P;$>(B<]SBDQ(82'-<':RFM#]O1B+OM%!(I)%9(HI!4(=F4"('"2#P>*#$6 M`Z4$`N4Q;!6R4TBDD%@AB4)2A613(D0%1?AX5,18C(H2!ZIC,GQ2*6^9$=W. MA]6;$>C5Q,T79T`T&O&,Q8Q?>K MF1B+Z:`$TL%;VC(RB9V1Q;`7VJ;EB+V-QO=<(V9D$O9H0_93T)#VC71\SS4R M1M2(86=_/&)B+$9,B2T4@"_OWLQHDH2;;E(4$3.BF8+CDNN:4K)B13EY1#F5 ME!W7M:3])ILJ"R5BP9GW\8P-UF+*&+*A"*_5[TN1;;G5NY"R&'.3JU#"T54HY8@*SFZ(%-R!1%0DWYT@!N+69T MK80=0PZ\F=2B5$(1MR*#];9Q3=?V%])\B57QA+O=%4^Y%15WEK[C>U(',D%< M3"@YJ]U)Z'=\_E7IP?5KK#UVXIO6'D7#4DY;I'=:>D6J47M$6U15G5;@5W)? MAIG.O``67BAGB<,E^VDX"$@\))?O&_:A'<`A7=4)G0#.JBI_HF7&W`#.,FI#N$\@(//#;X(X.AP@WM!>"NPK1?`CJ?:[[P`MO,;?!G`?J?R MV`M@UU-YX@6PF]_@RP#V/.#&&#!\-#CG1_17WA[+IM,J=(!!,HB/ MGA7(,^[AL\%0*R?X/(3@DFG.8`$[8-SS'Z2!\8/3YC\```#__P,`4$L#!!0` M!@`(````(0!G`!)D,P$``$`"```1``@!9&]C4')O<',O8V]R92YX;6P@H@0! M**```0`````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````"-P9*M`>/YNS\K!"6BL;!HVLL MN*#`)Y%D/!6V1%4(EF+L106:^RPV3`PWC=,\Q*/;8LO%.]\"GN3Y%=80N.2! MXP,PM2,1]4@I1J3]<'4'D`)##1I,\)AD!']W`SCM_[S0)2=-K<+>QIEZW5.V M%,=P;.^\&HMMVV;MM-.(_@2_+!^>NE%390Z[$H#883\U]V$95[E1(&_W;/?F MZL3[JL"_LT**SHX*!SR`3.)[]&@W),_3N_O5`K%)3J8I(2FY64UR>C&CE]>O M!1Y:_7TV`G4O\&_B`&"=]\\_9U\```#__P,`4$L#!!0`!@`(````(0`5;GR? MX`(``#D)```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!```````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````)Q676^;,!1]G[3_$/'>DK;1-%6$BH"[ MH!%@L9.I3Y8+3F.-&(3=*-VOWR4T+6D=IO;-V.?<>^ZY^,.YV6V*P9;72I1R M;%V<#ZT!EUF9"_DPMA;D]NR[-5":R9P5I>1CZXDKZ\;]^L5)Z[+BM19<#2"$ M5&-KK75U;=LJ6_,-4^>P+&%E5=8;IN&S?K#+U4ID/"BSQPV7VKX<#K_9?*>Y MS'E^5KT$M-J(UUO]V:!YF37ZU)(\52#8=;RJ*D3&-%3ISD16EZILLS M7=8#)?Z";9?6X)XIWL@96UM6"R8UR&I@[<=^7%1*U^[OLOZCUIQKY=@`:"?W MPRZV.Q8C]VJT1\#H&-E$:)7`PK%&(G3!5;)*6:T-DJ]&7=A[(>I%]')`HDC!>@*%0W]PC(7ALC!:@>;B$]26B4>A-P@@R&X%- MU3^G200$3-&OQ2DWNZ\CO?N1&I,8-N2ACE.Z\-N] MV2'L=#?+T1WUYE:*A/RC%A4I`Z;YX=H]GG3PFM4\APOIL/XZX4SAQJV+)HB_ M9O*!YP?,^X7FD;!L7T+NQ>A\>#6$^[\SY]BO;Q[W'P```/__`P!02P$"+0`4 M``8`"````"$`&C,95=H!```Q%@``$P``````````````````````6T-O;G1E M;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P"```+```` M`````````````!,$``!?]^4 MT@$``!P5```:`````````````````#D'``!X;"]?&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``UYWMM4#@``UW(``!D````````````````` M@!0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`,8I&TS*`@``IP@``!D`````````````````KRH``'AL+W=O"@``&0`````````````` M``"10@``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.5E^P.?`P``-`T``!D````` M````````````9T@``'AL+W=O&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`.#E.'B\`P``,0X` M`!@`````````````````.U(``'AL+W=O``!X;"]S='EL97,N>&UL4$L!`BT`%``&``@` M```A`/MBI6V4!@``IQL``!,`````````````````%JL``'AL+W1H96UE+W1H M96UE,2YX;6Q02P$"+0`4``8`"````"$`^[Y!U2`$````$0``&0`````````` M``````#;L0``>&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-(%L*DO#0`` MOT8``!D`````````````````!<0``'AL+W=OG(UO((``"E*```&0````````````````!K MT0``>&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`/BY_<:."```7R@``!@`````````````````X^T``'AL+W=O"`$` M>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(>`$GSI!@``-QL``!D````````````` M````X1(!`'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`.D&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.VC M19HQ!0``M1(``!D`````````````````&38!`'AL+W=O XML 27 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Income:        
Revenue $ 18,674 $ 6,783 $ 141,992 $ 55,331
Cost of goods sold 3,657 749 27,687 3,880
Gross profit 15,017 6,034 114,305 51,451
Operating expenses:        
Research and development 14,031 21,377 41,623 90,084
General and administrative 81,884 93,549 265,150 268,437
Operating Expenses, Total 95,915 114,926 306,773 358,521
(Loss) from operations (80,898) (108,892) (192,468) (307,070)
Other income (expense):        
Interest expense, net (93,208) (87,149) (274,758) (295,650)
Net gain on derivative liability 89,536 534 12,848 534
Net (loss) on forgiveness/modification of debt 0 (163,566) (10,336) (473,566)
Gain on dissolution of Combotexs 39,373 0 39,373 0
Nonoperating Income (Expense), Total 35,701 (250,181) (232,873) (768,682)
Net loss from continuing operations (45,197) (359,073) (425,341) (1,075,752)
Net income from discontinued operations 0 6,457 11,115 17,477
Loss on write-off of discontinued operation 0 0 (11,179) 0
Consolidated net loss attributable controlling interest (45,197) (352,616) (425,405) (1,058,275)
Less: Preferred Stock conversion inducement 0 0 0 (12,235)
Consolidated net loss attributable to common shareholders $ (45,197) $ (352,616) $ (425,405) $ (1,070,510)
Continuing operations loss per common share - basic and diluted (in dollars per share) $ 0.00 $ (0.01) $ 0.00 $ (0.03)
Discontinued operations income (loss) per common share - basic and diluted (in dollars per share) $ 0.00 $ 0.00 $ 0.00 $ 0.00
Weighted average shares outstanding (in shares) 311,664,926 55,644,823 240,252,062 42,169,055
XML 28 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE LIABILITY
9 Months Ended
Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Disclosure [Text Block]
4.  DERIVATIVE LIABILITY
 
For stock based derivative financial instruments, the Company estimated the total enterprise value based upon trending of the firm value from December 2006 to September 2013 considering company specific factors including the changes in forward estimated revenues and market factors.  Once the enterprise value was determined an option pricing model was used to allocate the enterprise value to the individual derivative and other securities in the Company’s capital structure.  Significant unobservable inputs used in determining the value of the Company’s derivative liability include the trended firm value and volatility. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
 
The Company’s derivative liabilities as of September 30, 2013 are as follows:
 
 
·
The debt conversion feature embedded in the 8% Senior Secured Convertible Notes entered into in March 2007, August 2008, September 2008 and October 2008 which contains anti-dilution provisions that would be triggered if the Company issued instruments with rights to the Company’s common stock at prices below this exercise price.
 
·
The debt conversion feature and the 2,647,059 warrants exercisable at $0.425 per share granted in connection with the 10% Subordinated Secured Convertible Note (for which the rate has been increased to 18%) entered into in November 2009.  These agreements contain anti-dilution provisions that would be triggered if the Company issued instruments with rights to the Company’s common stock at prices below the exercise price.
 
·
The 882,353 warrant shares granted to the CEO of the Company at an exercise price of $0.17 per share on January 2011 which vest over three years, for which the value is not material.
 
·
The 28,500,000 warrants granted to the CEO of the Company and to three independent contractors at an exercise price of $0.0014 per share on February 26, 2013 which vested upon grant, for which the value is not material.
 
The fair value of the derivatives is as follows:
 
Derivative Liability
 
September 30,
2013
 
December 31,
2012
 
8% Notes conversion feature
 
$
10,516
 
$
24,285
 
10% Notes conversion feature
 
 
2,368
 
 
1,447
 
Total
 
$
12,884
 
$
25,732
 
 
The decrease in the fair value of the derivative liability of $12,848 was recognized as a gain on change in derivative liability in the statement of operations for the nine months ended September 30, 2013.
 
Significant fluctuations in the variables used in calculating the value of the Company’s derivative liabilities could have significant impact on the fair market valuation.
 
Fair Value Valuation Hierarchy Measurement
ASC 820 establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows.
 
 
·
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
 
·
Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.
 
 
·
Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value.
 
A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The derivative liability was determined utilizing Level 3 inputs.
XML 29 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 30 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details Textual) (USD $)
1 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended
Dec. 17, 2007
Sep. 30, 2013
Sep. 30, 2012
Feb. 26, 2013
Dec. 31, 2012
Jan. 31, 2011
Nov. 30, 2009
Sep. 30, 2013
Merit Consulting [Member]
Sep. 30, 2013
Five Year Common Stock Purchase Warrant [Member]
Sep. 30, 2013
Platinum Long Term Growth and Platinum Advisors [Member]
Sep. 30, 2013
Longview Special Financing Inc [Member]
Sep. 30, 2013
Cape One [Member]
Sep. 30, 2012
Cape One [Member]
Sep. 30, 2013
Senior Secured Nonconvertible Promissory Notes [Member]
Dec. 31, 2012
Senior Secured Nonconvertible Promissory Notes [Member]
Sep. 30, 2013
8% Senior Secured Convertible Notes [Member]
Jul. 30, 2013
2013 Senior Secured Promissory Notes [Member]
Jun. 30, 2013
2013 Senior Secured Promissory Notes [Member]
Sep. 30, 2013
2013 Senior Secured Promissory Notes [Member]
Nov. 30, 2013
2013 Senior Secured Promissory Notes [Member]
Subsequent Event [Member]
Oct. 30, 2013
2013 Senior Secured Promissory Notes [Member]
Subsequent Event [Member]
Nov. 04, 2009
10% Subordinated Secured Convertible Promissory Note [Member]
Nov. 30, 2009
10% Subordinated Secured Convertible Promissory Note [Member]
Sep. 30, 2013
Convertible Notes Payable [Member]
Notes Payable [Line Items]                                                
Notes Payable, Total   $ 4,042,965     $ 3,893,972                 $ 3,771,865 $ 3,642,972       $ 138,906         $ 271,100
Notes Payable Written Off                   3,148,349 623,516                          
Debt Instrument Convertible Conversion Price Initial                           $ 3.74                    
Debt Instrument, Convertible, Conversion Price                           $ 0.085                    
Debt Instrument, Convertible, Terms of Conversion Feature   In consideration for forbearance in 2012, the conversion rate of the note was adjusted from $0.085 to 75% of the lowest VWAP for the 1, 5 or 10-day period immediately prior to the conversion.                                 As compensation for forbearance from the lenders in 2012, the conversion rate was further adjusted to 75% of the lowest daily volume weighted average price (VWAP) of the Companys common stock for the 1, 5 or 10 days immediately prior to the conversion.       The 10% Convertible Note is convertible into Common Stock at any time prior to maturity (provided that such conversion does not result in the holder and its affiliates beneficially owning in excess of 4.99% (9.99% upon 61 days prior written notice) of the issued and outstanding Common Stock at $0.085 per share (the “Conversion Price”), subject to adjustment upon the occurrence of certain anti-dilution events.  
Debt Instrument Convertible Number Of Equity Instruments For Outstanding Principal                       9,000,000       9,500,000                
Convertible Debt                               10,013                
Debt Instrument Convertible Number Of Equity Instruments For Accrued Interest                       8,775       42,000,000                
Convertible Debt Accrued Interest                               31,838                
Notes Payable Interest Payment                                 30,006 21,000 49,400 36,000 2,500      
Forbearance Charges Added To Principal Balance     50,000                 55,000                        
Loss On Modification Notes Payable     50,000                 30,000 25,000                      
Proceeds from Issuance of Secured Debt                                           197,500    
Notes Issued                                             225,000  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                 2,647,059                              
Class Of Warrant Or Right Par Value Of Securities Called By Warrants Or Rights                 $ 0.001                              
Class of Warrant or Right, Exercise Price of Warrants or Rights       0.0014   0.17 0.425   0.425                              
Stock Issuance For Interest Payment Percentage Discount                                             20.00%  
Interest Payment Percentage Payable On Default                                             18.00%  
Liquidated Damages 146,028                                              
Liquidated Damages Paid Value 63,539                                              
Accrued Registration Rights Obligation   82,489     82,489                                      
Liquidated Damage Allowed As Percentage Of Note 0.0333%                                              
Stock Issued During Period, Shares, Conversion Of Convertible Securities     13,594,382         25,872,435       12,000,000                        
Debt Instrument, Face Amount   9,900                                            
Debt Instrument, Interest Rate, Stated Percentage   8.00%         10.00%                                  
Stock Issued During Period, Value, Conversion Of Convertible Securities   $ 19,913           $ 21,478                                
ZIP 31 0001144204-13-063027-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-13-063027-xbrl.zip M4$L#!!0````(`-5] M%[H/HHH)`T4%,Q0PP&S/Q,8&(:PTY+0LT3HHV(W][YLIR28E2YDI69(EHYZ. MGBKKR/=]\LGWRD-?__RV=":OP`^@YWX[$+\(!Q/@SCT;ND_?#OY^?SXU#B9_ M/O[W?_OZI^ET\@.XP+="8$\>WR=G5FC=^];\]V#U_`0]_L68X#^8TROO=2H) MHCSY+T$\4K4CU?SOR?_>_/R_R?>[^\ET\NO7KR\V>D,8O^'+W%M.IM-5.R=6 M@-I`[_G'R>WE1/HBIM?>'GT''N'_3I#8;G#DNA:2^CD,7XX.#_$K72N,?,M! M/WOXG8=8`L&4D5;)`PYT?\\\@%_VQ?.?T)V"?(@O/Z+&5[?CJS9K!TF M%]>W;KSZEQS?*YJF>1A?7=\:P*(;T4O%PW_\O+R;/X.E-85N$%KN/",+I,B> MOQ\&GB*).NV)Y([5`S9X\<$<=V_I,^:AY<]]SP&'"VL>3L';BV,AR#W__1S] M??6BN1>YH?^>A2T`\R]/WNMA>C'NF:D@3F5Q_5CD^XA[9<^E5_O9!&\#B M9]"%@G;`V_RY^'Y\I>`!Z+Z"("Q^)+E6\)!KP7E0_$Q\"3\B9A\)X+SX`72A MZ/;PQ2^Y'UTI>"`*ID^6];)^9F$%CW'/IA<*M'AS*/SYQR5!ZBCT*;1!5P_0 M")Y,ON*!(1/5Z/XRUM@ M'TP.T8L20W'JN2%X"R=W8!XB^Q,;"=1$8B;FZ46(Z'PCB`_H7TR=>T\P'V0A M_G,BTOH)X(8P?$]_6_\*;?S[`@)_$HL-,FJN(#^]^.O!L8#^,339,-6OA_F' M5TT=YMK*2/`"?.C9>0G0N/9#9&[!\8K[@KAZS\>UU:L(=6SB(7,J"Q^-V^DC MI$A$XZN?4@S3=[.`%:4'6?QLP*)_9;%-8&6"L?(0@97K`"NWQMA9<.TB9!.F MB@,!-''NX?&'45^_/KW2%#+2@Z0-B6H$,H@STE32VD)&?I"4!^S-!H<,&DJ" M/)64%I`1]#URK'J?'*N^1_:_.K`MV_^A`9JUG;-+!LH M/=RAMX/@Y,8'"^#[P+X+O?GO/\'R$?A1@,N'=R$R?>CUX:EC!<'U(KYA]@:# MCN'.&WGPA(5:MY=>L)$@;R\.G,,P46)BK[#Y=I`61(\H*JUO*8?EZV%A0Q^: M'Q9)V._P<&UW1SX,@P_M>IL-^W`Z\J&(#X6P?`;[,/*AYWSH*!I=\>%LY$,1 M'PIAV4,^;/B+D0\]YT-G_N+46RX]MYP%W_^(D/SHKA?/17\-]H0)Q6JM;ML` M90]M`L$!#F/P*6G0&VO0&1-FM@UQ?<)R;BQH7[BGU@L,+6>DQ.HV*D#[S8U; M$%K0!?9WRW>A^Q2,I%C=5HS,?K/ARG/Q9=]S'*3R!;K1!T$XB&8/[N>XSV]DT2Z<&VP@"X,P25\!2C.0[;R"3XZ8!8$ M(`Q.WG]:__+\>"T&[H.'.\L!P2UX!6X$[A(HR=>=HJ&.?O(M'#K>PN#WD_<3 MX,Z?EY8_\'4I%8$Z.,;',AP5`5_.U#IRL1%?#ZZRKAN'3OGY%^/0&8=._X9. MSTXXR5=:GR%8?'\#\RA$_7V]6,`Y\$FJW\/00;\C7L!7:$>6,VQ^EZBSIEDY M''N6'^5K;//X)"LT<.8`OEIHP%>Q=R.-&J!1NV:QK(/WC-9E$]XCO4=Z?]YX M.6?L3\#"\\$,*6Q_A$Q'<:'GWZ$QZ@,[ MJ>J]`C_$H?R-[RUA$'C^^Q6*VC-3)I>>^Q0"?WD&'L/[]Q[8C988L'L$V`_?^Q4^SUQ[=6%FOT*$2(8K MM\#!1_'>(#_X?N];;F#%YS4$)^_DE6$SJ(J.,:\J(KF'-HB@%0;A%8)?=R]@ M#BWG'"*$YO$4*-(E)D2A_J-1 M81F57"*!;QCM22DH^V9*-,*4:"-!AD20O,'1ZA@#D+R^2+,9L^W MH8L+XYMUJ&R_BL*GKM751VHW#$R^]%'U*Q;)0TK[#$P_H#(R<&1@`0.[*"&> MPU?P3V#YQ-D0-Y$_?[8"\)OE^U9NVT)R3&MZY=J_A4_/`R]#4U2*"<<+T)X5 M%#?.4\G.R]Q8[_DUL)_!!!'+2LOAV#,FE!TB9[V`:S?#@'%E1<'*B@Q.8Y&& MLOEN9-1P&-7O/6G4)06?S6>Q%UGLI=OBGRH?"5&$QY[3@9I&?F([P8O+'M*C M;#O#2(P>.Y`./])=R?"S*,/D1,X"E5+K&MPR7@:V/:JM$HA>62$8Z M#81.4ATZM5W$2(]^TZ-EZZ$]B..'U0?V875M*G:Z.7;D15]YT>L]L6:ZAMOXR'X% M8WVJ%5ZNXR)[FSV3Z>(56=W&3RA*.7SRJ3A<^Y2L;7JFG/JM#L/"GMW-,!0, M',]57$ZMTP//U4PY";PX6P-#N>>F82/M,P3%-UR=SY\/M<7K`M%S(. M/TJ2DHPCR6ROY-6#<32ZL=&-#7<C*=+9YYV8V:[:&6B,P?F MN'UE2\YVG&\EQ]_RLF-G,5_U8T72A_068KZ2,3:&88/)Y'M%I_*]QB.52O<= M]ZENW](T']W,H-BF$8^^EX1)E^A7`VJT1NO)Y9%M>\2V3-Z1H4U7QFI,J9M( MJ3^]%1IIU$<:=6)>BKW2R(<>IEJ=\*%D1\UBR`ZB= M\NZG]-]#KPSW*L@8X%":.2_/UJGU`D/+&6=%&-S?!&ODUD9M6'H@3N'<<^O) M50W.@;&3^J_4S9E-TFA/AF)/NB>'_%!P6/%Z!'W_(T*RH]'RXKGHKP/=;[QA M&(K56MVV[X<3$_N_QK[O7=^W>-`.&6S**0?DA[]82Q#\AK`)P]$W,'S#!E8# M"S5E@EEMI3$?S+JQ(N<2+'P/CM^C9V;P>:Q&9E&8=6:]0OLR>H3N2"P&L?)0 MC;RB\&KF@#?+M8%_&\U_MRV`^WW,F-@94REJ(]NHW^P<)XCZ.A79Y\H>E4Z? M:Z9DG(1HC4YC;:`?M8$^4R=73KIP\3?CX"M(/O;EH-B!I,_LE^7;PS_#.:=& M'`*5:KYG-:1<[7CL\'YT>.??,!L[?H<=/R"/<`(6G@]F2&$;*YU`@G%<_S1, MAB1Y;U:'^+="A??0"1!]?(->X=][MP"?E9<,BSND9G8VP7*?!FX,"!62BBU5 M[?WN\MDB!/YGZW":TOO8W<*#J&:7=C:UI#-Z#,`?$4ZX7D$NP\Q>&GX(4:I0 MR0V]6`A-[^\=1;BB,!75%KB^VGZ&(USTY_7DY."]$UN;5)6.>^?A'`R=VU'H'R$MN@3N)=JP"-F1AF_@HO77 M/TVGWYUX9<3D#L0.:3I-;K4!/#KSYM$R=0J3U!S>@D7II.%!+-XY]FSV@WAP MC++4OWT]S+]II17^?3V-6?TPNW/D74ICLZPN00IV&'KYP;?#V M5_!>N7TS&R>7OIAL^33R_0Q'ZPX[43@XGJZF06AOWM3['#K`/T67GCR_NM8B M,F!WB`?H'9-;\.+Y(2867CIFN>\D"IEF5E*LHN?LHD04XU_[\6(T^S\M)P)H M$,7TV>1KF5`20=ALB$CP%IDJX8N`X^1J8C0E_,<\8E9X>7?")Z-T%H7/G@__ M!]C\B"M4$S'5L)M+_BF3.-_VMI*6P:NV)FDZ'4[>>@G_B*`=?],W[@8:H-NL M@\]HJ&4)1*HG8.V^'G)(NI52Q!1Y4TKI5*7DBEK1.O8B""(Z]1M3RF`[5I5) MQ$3>;31KH;M,MF:B(JG-Z4:-:YKO.DEHHNL*XJ':.C;?B9+83"<6:-F,J:RU MQR.CH42U*IJ&"V*=&\OMU9*I:AF":79O+;?7BAYCQ'2494'6E&Z,2@O]1H]- MDD1+4$P%)QA=V946.E)KJ",KJLGM_K;7D"=CYNG(8JH2>?76N9)DU$LW.&1H M1.R2,%XR=R%V[?Q(Y@@7#&$C[Z`TO964):#*'`Z_82G9[B,KH<1C.B13,!5! MHTC('%>5[']61)DMHBE+B)5Z,2^9MHT;Q#().1PIAX1-8%C6S1R.D*>;VW(0 MM3[YG5&0PP7N*#7:7C<.YR?N-#/:7D6.Q+V;V*6%[N-)W>OE[:=6\#QS;?Q_ M>(OQJ^4`O+LX/+5\_QT!P6?SN1>A MVV[!'*!''AUP!<)T'H`?5'I&+*DZ:7!I36XG7AF*],Q654AB5I'NPL7+=CS_ M'=W"#Y9"9Z`LJ80#)9NHUGP9&"J]>5,Q!+[FT1!^L:#]_>T%N`%`S+L.GX$_ M"P(0!I49Q"@_2T(NK6.UW(BP91#2R\JB()K:5L+6Q-"@TQS97YW@^18"E.%B M4@501$G6*@G`K;I*M^J%JO,V6:*L2C?-AVBJ!( MID94",A&J@E0ICG=G,J&*9NZQ"?`RMJFEZM27J7;4H2$J8B;MCW;6EV9RN"A M&UA5D`Q1J2&3CV*C2V@]0@>&N-Q4%2K6!!^2R\R(5=S@%I*5`48WIZ8F*W(- MP2Y0ZRBH#.M2BVY--573-9-TE$6MU96I#"F&@54441:KRI0">F8'YC[*0O"1*5O8?HT571N&0G9S>9/;B5>&(-T!H/11ENJ)MPUF M#/LOZZI!&I%FA"E#B&[X-4'4!5.L*0PW)#K=U-,@J=1\"0@ZHQA"`8%>+.ML MD95.]P$&&347B%A+B^97>.@,KZ&(8ND*P_IZ-#^CK-/]BR8JAM%!?VRO!Z.B MH\J:4DT1/"4"PV5X;XCDY?C%FM@UQ'&(Y-Q:T M+]QTER0W*@;=1TC(-JBJ0I0G2AJL+5<)2@;=>2"Y5%.4EX/T3GCL+0Q\^1B%.]>^]*\_%XON>X\0?8:W*3GK&,-5DG$03>7TS M\G6E=5E'TA.1*0H)9(TLWK6C-1&X(D>XV09_+U::$6`UN[V89;!7FC>H*F:] MZ'+K&7&3[@A+I\(;C"RWUX'N-*OI<&@7UF4JW](:8F?EA--^,M#1D6:4LE722K4K+6=!T6X!)Y M]1ID8A2P#,$PC0*A/MJL+Q8-*T:%"1EL@TS6&I&+AU9T/S$5\2D]3>/%PRVZ M1YC*@H[^QR57^@&:I.26<@^EG->+Y-;J%),8*Y]D23#2A1_ES6XG'04YB;D& M2C%;DHZ#;XP]])*NZ&I;X''0CK$77C)5316XQ=M9A`:G/V.DME*FUA9!= M:T_I6];.<44M'?H#`(!C2#+VI(MX(>(>($"C`*-ZB7+L-CD0)\=)1O&;#T/@ M+18H$BMZ;XVQ38\55JDY5^N-R4OK"GK7C)]"X[DIF&,V,3D"3)I:=&\LF=(?SLU8).XOZ)'27I.MP3*X#S&O2N MEJ]6E*<==6@]PLQD*9:V:WUX1@4[QRVWUKO2A]8_[.Q74,GMK%LJM-KKL3HQ M-+X)KPJ"3A3F3VGC&2_YDQ>*3S.5D"KX.-,//1B"-",W!?C\Z0Q4N<6.Y.88 M`/D3''J!-P?1\Z<\4.66:\M=&$AS9)6KI!(UDVNAX'!?KG&AU.NGEA38+4XT M7J@C3ESC7AMQXK(S>J]Q^@W@HU:`/4.QKO4$KB*\&^IZ$=]+G*NZO5OF..95 M%A&KLHL'ZXG7JI*TON8X[U55-44QR%7;/=*18]SK',>O2XH@J9*@2;U6DM*1 M.L?I[8J$^EM0U:9U_%AR@K>!72].H@"ZH$Z!C7&PBFS*Y)QA6;M;RD=#F;L* MTK!L/#1GK"AN%3L>AC)KYU5E:W]7^0.1$Q9NNTV:Q5\\]-SXP)/-3Y?1JR&Y M8SV&NOW^@6.+,@=6S-+_X'$J.8ZD+F",#:`;IZ$,%K?\21MU`6,4BS:/^!@L M8L6/U,2-<1Q0[HB9EC"K]+&'[2VWP1%2;7XIA?F!AVIJ-&)7,V<4L;]80?]P M7RQ(\HF'L\C'71I_YCKYBM):VO@5R80$BAC7Q=7XY^JQ#>.$(PEO?FQ(N!WH MV@17Z<&?),4'P`X8HF;])O.D)S2DM4[Q2N[L%ZZ3@ M'!TNH\+Z_(,JXD"@JB!M*M!$K])#1E$T97GSNZ>[U;KAP<^:,%0D2>T$@8ZZ MW.0H@,7]KAGKD5QML*XBAYG]KRA(COZ\]TIZ[3?+]RTW+/JF%<^H99QE9>CD M'N7*\G2B4,-\9ARHU3`B-'?XL0#E>I$R!J(`_P[,T9V;9T1S=3=C\:N)\MM< MXE%7N,XU;6)H,^(^4=VH+@T'GH:'"2/F$U7RL*PNH")-:P^HQ!/N83X)_]_> MVS8W;N1JP]]/U?D/O.?>G)U4R8Y(O<_L3I7&]F2]Z[%];">Y\WR9HL26Q0U% M*GRQQ_OK'P#=))L4)=$V)5%RIS8;2^)+`XU&`VC@0@F1*DE:MO`;GF*Z8X;7 M9L&-AX'4`F6V`+A?2H^L-O:Z1G.0%(*7'\SJ@9T16O^;6F M7J^_$0Z(5LB[F7>C6<+@H\EOMSJKJ%]"Q6(F+&*UO2AWW%@#D[>0C9B^ZW6C MJ"B@;*Q!V'O&^#>/#%V%9*WI&9<#R]^OX+G$J2K"KL8:>,&]/<[:E+HVUJ(< MYIL.["W?JM(^:U+M%P'V]Y9C51YG&6N@'S>_,I_5FKT"M5TFEXUT=UON\%S% M65;E2O6Y' M98:]B`$V]^%1))SPM\-H>W"MX0QWBO^\K![:6`?+.6AW,D!@Z\>0'_>E!:?GB^2!%#_;X16-<ZU2T8GPOW!^@&NFO+5D19^"+'^Q:\>X@H>KL'YA"$NLG#%$!./G@=% M`@Y/=@/[E!^-0XJ%8I>#%_!R#>1G'N9MW0`J&O`JSJX+@N1`WIX[8C"Y8=D% M[)3Q_YZ[<;?U&S9FL/@6VMZ78O.:I*)F2[:%RXRAPG&OXO8Z@+5N1Z]ZW.?N M`TR8Y[_D#,]8`Q5ZU#6,P:H!2R^O8J2K6+NF>8'1-RH;Z%4X97Z"1@C5`J,WRHKZB'_;K*5@U8>MV^6N38:P>,(W%_I,/_2"U\T#VMP;EK]0;.;Y**5'$:E@U_%_C7^ M+5B.4B+=,P>_9LZ^V/#4\6M7P1JK07#_^4.IG(A5L[#.)VYE%-++B<#;L),Y M_`F.>-5I25])9$\_J^N+YK]?VZR!, M>19GZ0%4->)5TKQZAQWTL1U2E4,6-FOQ66@I'J_>4>4,MQ+OKVB\JSB\>A-% MK(+V*J%8/>`T\3"7R0[7OZX8S5@#4*JW];2"XAD#J9B`59Q?LW%VNMW!*\>? MX@]BP0`MA5=(]NH=,FW@L_2=KQS;"EZNP3X%79T&ODN.C\XUW5,["#PG"HGU M7VW7\RGWX*4\7(.+*M`ARKZ_HO&NXFNY\];GCO7.-]U@@A@G.6F^\^[8;.[Y MIO]4U/6^%(O+'9Z6'T*U(U_%[-6;7;O5Z[YX\+$I$H-X#,?PX]6A,\T/GYZ:OY M;[`R'#.@4^YO<@/V6W:/6D9^W,)(/S]]9NYX.C/]/Q9/R3,(KH6\E./@J[A0 M`<!['>/!`DLE8&J_KH%WJ\5F4X!--6[G:,Q':-9TD03"XALO'3W#/3 M_4B_W9[_?V/"2,"%(F*"9@>9-X"7SD'9HK=5L:"B8&FA`>+BOA?"8<`K6%7WC M@F.CS>"=TT!C8!-;RV[%!:DA0G#DFI$%=K-UK/W#>P2+V&]HMDN/]>9@47LN M#@`H!CU&!B=\PA\QT=9TGQKX(6#%@P,YE^#N<>1C6ECV%A?,GB``5U,+/6T.&P(.:F+:/MR,`TM',O>X M(U_!4TF& M:L/0;-BQQI0H&G,P?CJ0,8(O1[PHB!YO:I,(>/8$LLU'8H+-1_P6V_$:J9F: M\)H18RX.:FZB+PUSB@_Q+-)+ M-^+GN6E9XG.\R81^\I>5;#SRGW[Z)[X&/\D-Y,M8'0L9[0'X6F>@`E%!OL3N MZRN;I%*;))F+MV"`\.V!:SU0A.O5`UL#<=A1!8(WZ''I&,M&][K)X8,4#;QO9G8;9(A'VM7 MN!."#KSW\(DC$PR!"1#Y$NDP(U,PC3S?1K7) MOJ.9P7#OQH'#CP]@5WC`-`_U=`&3?+0`'!LL.DN8&)A/X;FHN!H9`P0F_G%J MPYAP6ND7&C1I;I@/I.+?D74OV#8"Q4H7C44>@89T,7J,R;.!<81.FN*WGVJ] M6$'GU?<7,#PID>)JDNC^.A M5^ MTY)=T%/"(,VX"/+;`ANU+%SQ1$H4+&P_/`*=/\/MQ#7#R&?QY@'#3IX>;T7R MJR<28?RM_)E^6@$$7\=L!:5N,9AJB_M\Z8_37*/L#&B@P>/=Q*(- MQM*BN<=WQ#\C#[_%0P$6XK8]3AFC!>:,QA78,]L!:]W&K!LB0-R-?CEZW3[? MJ'!;Y&R7!BEF:Y0$#.BI/M!G(^@%;J,"!XQ3FYTEF8L!W\/SW(#YH\?+4[^IZ=\CKUCL9[USEMH;"X['TBK_5T=L>TVUCU:ZCWXFRQ`$-C-/ MA[YUEHO5QEMI[%70=@"LND159SJ8O=``@V-\K+V/5;C1_"C]FGRK?Q3;A29= MF-/^<-&/L#<#F0^F9<+P?,S`P=EHD+JSX>6/4P_]%.\1`XM!-`ILR\;(J?1. M[08TJ>F/IT5#NTQ^E=\*+SUECOG(&\PEKP6W"?;MP+YW[0GX+&[(PX5'PKU* M64*;)^82F2(\F(8KP6&9`6N%MSB696Q1%QZ$:$EAP(.D[YSO=@&>W5E@=YC@ MIONX*E!9-[(6@^V@!Z^=H#V#(A32UB@E^-%6"I<#(]AW&-7%Q4D:XZ252.L- M1O^[Y_^A12YLC/AJNA>VPU9LC"2=K$Y2^=4NS$9+[2C&*/VWM0L9`= M?OY!DY!_^"K&/$[@34*7%+XF[6A)D_1H!FG09P3:YO?;.!(#1/D+4@"*`VX0 MX8C4NA/:@1,/8G:T;%"28A.O"23@+LVBY`[F@A\>BX*8M)'IT&E(,&5@T>&P ML_IGZ8CC'[G-C]_^I]'QV=2-LG!V+>K3-5,2D*L;4Y9,/;M>366K:XL MVTHM6VER\KO$H9NWLCGXOHS5"2(;Z\@;;PS:.L2T@7A_:U#HP;TW[U,U:K$' MYGASRB"@*),WFS$?+>@8&XNR#$2.0##FH>XDV9=B/'38`#;B;#[E7HBKF01! MBLA/F`S@.4\SU/@4(:>PN.U:P`&>=^#RXT]P/GUM[GM6-`9;%+:GD(>X3>O! MY*EB./M)EC'_'L,C@@2BZ6@*M@#CD8O"J(P(%IAIB2M:RY;MPPY$&A*L9TI* M$+:WQ)]&/+KX3)U'''",,#(TZ^'WN6^SD)(@9!:!QJ62[E@#PV2;8<+S('/6 MXV(R=33"N`\>8TQ-Q_&>`AL#9J!,D^,1>>+@+GH#D^D9+HWF<<=V#\IX3TB!-43_QKIPP7Y+-TOQRM_.3^_^@5?@#OGYZN;T M[.;HY.KB8GA]"S>.P8@RYP';&'/*[+]\T'X\XE_/;N[.3X87\22'WERZS,H1 MUOHAL_.0:EX^%V)+7_:HC]KU\/3T_/+GHYOSG_]!HM27.1N_H,#D$KR[?0*S MV'G5]B.&WV]]S.TVL4GV/*H&[0K(JGR]C+U@!IIL#,^8,M,)^8G#B)D1^$"Q M3BY/M;#/GB=)KY:;`Q*6V@E(O(7#'NB8`4I*;"U0,A][H7"DUONBDZ$VISVU M6GG+&1X=>$[::S::0@)X.K;D,(]-KT*-H1"?F8HJMV6(:F!B1?Y M8%-D@U1Z=KTS"ARB#X=I`EI`Y8F:F=13"B^3NX_C.,F=A[G`YZPV[-K,J0E^ M4#/*'-!D_,J3LZL&3Y-SHXDY3G(1`IAD[LDSAI)[DD+3DR=RI/7"HA2D,5;I`)12`LR%4S70N_X]+%#:Y$Y(O6"%5!1H M7T7H->!I`(U,'L#)U_-L_#<]]8EK7"B-ZM)[X`K`&*`":';V\WRGY)E-/G/I MPOXSLBW0.J<\_QSVYM><[QCJ?*?2\YUD>F@C_IF2\PF:P#_X]*4,L;%&[(B3 M^]>7%J)MH_%JA[%X1USU0'J"9!_41)++R=MH)"<14M4`3Q0-[6!B)E:>G.-3J/=["QF!F!.B,ONN57YR+$MD@SLJD?1;;2,=J/?;"V.P\RD7D@F MD)R%L8'Q]'L-O9L?3U@P)T7GS?`\-B'B[F]!//N(]/%^DK#-E@ M$0Z>4)I^?&XGOIDAA!'J+\HUXBS6[M+@SKGK>@^FR)FYN#@AIP*SW&$I>1A2 M!4,9SQ#1LX5/,S,I2F:\9$@6?7(%1Y3X)+*;8UN3FQ79YH.#=`,Z35!-,8*\$GD2/ZLJ.A.J4FOHFJY*=9LP?L]F#L;Q#=` M?D3(&7RFJ`TH4]R,.9=IY3R?XQD"K,1&8>(M)4\/GS:79JEBX9NC;[D'+B_J MU%T$J1.%EV#%VXA:D]9KC,&*=S%?\<'V'$G"P7QE;D`?>:Y&1-K(XD6,-X@( MB,\E1]6@QSFXA.'1\2MX,H.X3WH<+X=A5BJ0XL[]]!_*.`2+#:QMS^<(V#=L MC#AU/`,6&[@E:UA.47J^0]%2#D6E#D5^G@X^3>R$[Q%HT\#B)B"'./:6>@5^ MPA6N9D2U>!Q*CA.CZ&Z!F+(DO7^?EOISE^]2A*W7YX6VU3*O&*.*(OPP-V\# M$N(D7Z[#@7_X,0'P)Y@.H`R\>]>.7:2T'#7SO*3^%?%^ MT,V*8^'I5?`#F`T2^%)&C\A86.D[)A$=C^'=_#`C25%/"C9CU&*![<#($^-% MT+[_=`3/Q#1-L&Z^@FL##XO/8RP!?QR/,#'3DXI2L*!XHB>\W3$?X]`_G50B M.6@T-=+ZDMGJY^,M(DK"BU/AMVC,CQRD$E2X:@0NS(1._L$3P.,ED6XJ\!^H M>VF^=B.><3%;_\$I@?$[/&U5JO5.BB[B8T-X;N0FMUG9$=B9"11'77B$F/^. M`LF51@2J?%;VK"<;8E@,!B5H8(P7.ZS(0]GO'6_9CI7?V^ M?H/KJ`VNVL`XAC5A>C2:GT/?XK"`>X0'KEH?44(%CL#@2=6N$?TRH M0''P=\0A!A\%3.V1R7%J-9>`:E%S<[!;'@_D3Z8>YW+]DY4FK'!E<:P)@-LE MP[JG`@>QAX'*M?!J#/3*(<=Y#,G/W]A8B$.O./HK?QNI&)-B-\`R$@ M"`E%@GW'$H!`0F20P1C()\!MB/R"/(H<9W02/;7R'."DFX&`V1#48TFD&]I' M"0N2#9?4<#Q/<>!^>S7#*L*UHPA7BF9*>(4<":;;:.M&8Z#KC6ZW4WWRI='H M=N`5?:/1;&C,IZ8F$-?IN<6'%U35+:5L_ M3H-X2`Q5DV!RQRD0"0LRF#\1)<2)0Y`B=83*D5SG("%TLWB M8(:49/;M`FA6>BL67>$S8N:#F@6#F+P6?,/$<\7/4^&ET.N$A'TN, M%6:7&^5C+@1)MI(T7,MCL<^`'2NK72_MXT$N73F>C#P-8H>A`CYI,123ECE6 M2BD@F98.ALPHG'H^^2=!LIOQ0^:GW`R9//^Q>,E(,R?!^PRTVV@4P`K!5YT] ML-AC7F(("`*#]!X83,$QY5[[!FML_L4^H8_#!$/RVO=<#\^C)(R@U_L,7>4S M5!W[1ME-ITW+SMNA>Q%?4SST1.\(M$T!O\GC*7`!8G_3HF]HHRBD*Y_`3DWR M:QLR@"II/$I9!GD1,2X\%+8\!--H:(^T]Y.&,]-R:6$<>P49+\70TQ6'6E9D MF.Z1UGJN&EK7!R_%@,GJJUX)?;6ZR^2:AGW)BW-],>)>[,-D0Y1::[Y>QQX> M$'49/;/]TPC>HADSR%/#1C:+#EWW7KG:/R-0BKIP`,-L")MG$I@K()ML]'98 M1`8?90J1HHQ3#V9DB24U#[QD@F"H$+LASN`R%YZ:/``)`XI/Y50X[3T9BYT? M*3EHQ@0^FPGNW]CA9B+&RE,L*HZ[[R<%,T49:I)A*\>+1"Y9M1[OH-W0]5ZC MV^YE(^"I15WI^_K-)M9Z+-9[%)O5RTM0Y*A`I2/,A!BR8]RYT[\;GV@O-_\7 M;(UY]^7*OP=-P].9,Y!00]>ZEC(<)!34M#M$FAH$5]^FV(F2)8)O!X7RFJWY MX-'$M[3[ZL=2G%6[OCF_/#F_'EYHGW^Y/;\\N[W5AB=WY[^>W_VN#2]/M5O8 M),^_G)\,+^_@AY.K7R[OSB]_UJZO+LY/SL]NM[!/'VY`>K=66*4[26;S4!W1 M5$E,=3I3G4[&:Y,>U^J-NF:FRF&INIQF9[8[WO MGC[5V$PU-E.-S9XW'V^XL=F^F[/[O%DPQ9VAXNYA]=^^WG@]VB%M:@J$6H%0*Q!J!4)=>Q#J^N^*ZO3V@+9&U4Q3 M-=-4S315'4*]UZUJIJF:::IFFJJ9YEMMIEEGIT"=MKSJA%2UI=SKMI1[UT!J M5UV@\EVHI'Y5W,T8RH$YJ6'4,+ARTT91WSXS4+!LB-%`',I74IW8%2OY:OC= M#K+]I/I-J3TEU\URA\KSRR_O/AF#MJ[WNNU>RJ(50\Q3,BMRV-7D%.RF M.V3W*_I?]?6#ZW^UWF^"?:^#*GWKI:7P@^?>X\?+#$IO##-KQ?9*8I%Q^)7T MOMTXFC5@6&[7WRA'-B6.%VP2YEUX=."EDMPE9I?G3\_-GO)'E5XRHM`T5^GEX\J^?;ZY^N3R% M36`\GDS&XY=.?GN-7KUE+J;`WF(#0,JT2*.=I'*W.-C\5575S6C5YF]-8%=)[2?T\/?7#;NLT8@:D'-HN"6.ZUNVLE+R M\H'O)OVCZ6G$N<9SOWT&[*MO8?3TABYJ"93,*YE_$S+?T9/ZF3?>3FSGA7E0]FP@//I,O-?)O7LRL`H78;C3; M1F/0W5F`42T6M5AJR:S":'Q_T&H,>F\ZNE46YGIO4V=7)7OF$T,I-G^=9A0N MS6OEX7T1=[CT7*E`*`WUT]-XRFL4X/,O//<>T11I($]S5I#[:DBYK[_[R=,TS^_A(C=)Z[XTHH[*RDL&NT.GJW/($H M,^=)C8X4MCM):GRN?7O,SA&?B2".=[`4NUF2O\V9_XTRRV7B#9C>XUY;D/Y, MNO(KMNSM^FX8TBO#D-:[3\WC9E_24:6I*B= M=*RXRZ8LE:)&JU.OV>T6]).\#J:JC'6S-Y*,MN#]J9G4V^F9,+?59'Y+2WBIQI^^?K<3TLXTU\MYYV-,T::?_B[ M/HQ9;:>UNB]2`&"2C)CI(Q[O"2CZ>Q8,+8M9=UYBKGX6W=V*%XDA+1(C,^!6 ML[ERP!W)E"H]BLS8$6_KROWJ60DJ^O)-I]2`5ULZ\H!7OSJ_%X*X(!9(\`7$ M!C=8I.1J(F1IT>:/);`Y(`ELMNGO;W)2S:*%EQ5)O?D26Z_57!W@T@<]6GZE MZ2HT"KB)H:^DF>9G2S2OCH,9J'&:.8M!D+#@R2$8_=7D-XXR=.7?8&0^]@92 M4^G$=!QF?7X2UP7BPF"EF?3%?F"_PQJ1"NFO(W\\-0,FGB.373B2`MK;)0S% M;KO7[`PD%_!U5&9=GJ)G79O^KZ83L9KRK%,^T-+48\_HM726$K4S`2-'`9OD MQUWR*A^E$S434SL&U47 MQ@S6!23T.'I2FK9*#;BLEW-BSN$]K()#B9:^QOSK[,3\VQRY:\)DSS8>*S)Q M*Z5QM7EH=%YJ(&\AG%8E&TJ$U_0D5KR9\%HV!`@C8\/9XH:P(E3:TE='R@8# M>?#+7K?#0Z$J)[13XC#H];'_58=!VSU`J9)WW?6\Z_=ZG4T=FO"6R3C`4W,& MF^40<:68-0S2_?-J@KHG9Q$8PB+H@45@?--[]'>.M-Z*O;O+#?QFJ]6*55[9 MD:PKO;-/I+!A>L'L2U:5ODF[R`:ZOC5-U6IS58-JCDM:7/ MWC%[)(AU)NK/+\PD\-ZMQW1;!E`WY,#GS`TX(#<"F$Y2ZV:A>22">.,NWS9AE\]:QO"-?W&(O&?)Q MB9R"9;-5\73OSMPWP-=!+%V]^<-"O1M'Q4^_LUW@809A6(!T8COBE,M),]+W M`IW9XG">>23C!/13-,X5\/`"EMB,&[Y,)K9C4Y?S/)0Q8G/"38A;'!#>+J(- M_Z"]']!_"(:YJW-QX(.+&]#`2T&^$LE:`CV04Z6Y/=7H'.*AQ-A:.YOIC;XP"Y(%][[BEW31]A#J-'F)&6IQ M0I'6THEHXT483>I&J&Z&RQ"".3:B>!8B]&*-2P,TK!F0>-( MQC18`O#34@2_AG9Q<:*]#SWM<>K-TIMCK&,:@!D$]KU+-3[,]K$LA_G!U)YC MM1"O[[1=(1X^L-!^(`E)RLH$+3_"LQZ8=H\0&?"L1]/&,@H>%.".!&8`W%&Q0.CM?J/5'F0%(ISZ7G0_79"*%C'RTGO(+Q#@Q)R-0R#+ M>3K6ALY\:FHGYMP&GU`;ND`0D)AP.D9?U@3\LL;QEUF6X5@=59+=HJ1%8G:0 M\-H4W'X&LZMFZU20*-'`0@M@N;@LS2"CN[8ODZIV:9E7O27IP!%1@I-P!-Y1;+%:$1-&K=;_ M(>_++SK\4^:0'EW&*+3@`P^>*L0%-BTA))L6!?!.FU7(PC9F"'RB?JN_,$.) M)%4]*N757Y6NS;WS&@EX( M+*F5?#`K.1MIIPB9BJ17HN"H^)9B!J!G'DRX,PK6\19<;?"U[TU21:&7"E^U MEEFKWQ@T<^$\"A`D*QW=6FZ8O)<`E+B_7D)$)&"E8PHB%=R5$K?(!9\E$?O1 M4T,S9Q@.]\CY!&/.O4?GW4Y\?1PR,BP)6,BV<(+4%`0L#'(N)WKE&(X(8PL9 MP;B"PG"!1K!RV=`/CD(,X]IA%KBW26BLH?'@O^VF8:-<^(%"!W;R`'@\C&,Q MR-80;S9I7/S]7?Y^SMNY`,U//?HR-[]/P_*(0G M;%)@TMP+1+!C;+K@7F!$(PIX"`">#B-%OWQF_L$(<&S.$8=Q%\,8%,*(PMCQ MER`%6<5M3K#]@H<@"D];EHC/(D$8V4BFOD&A(=^'[Y#5(8:)!%85V+)S`C"+ M!1TYD1Z-`87!%+G-P5V"#Y5O_@O.@=CP_QF!IDF52;6V/OHDW26O=9XV]=KV MH-%>0FV1_JR6T^B5+[[Z:AQZ\EM)!*KE=;=XBA=/2F#5"WO/)/3;@!^SC1A# MV+R0;S3Q08L2VV(3S9N+R=J(!_\6'6;\%%&.6NE:P2C1 MM+N&"U3QE,V(!\UP,!QIV>S3)RX4%+W)$'F#/]/S" M7?-Z5;SA5AY*FF13$#7'X(=)F.!K]4[.35Z(YQ0!B\OQFW@CD;R+6>S05^NN M&9W%C1!VM91Y%&PQM0D(T=$3.ON9:'Z<8!'G52"+D^^J/69H(&)%LY/+.>2G M#!D@\6*8<"GI1C`WE;N2*1$-;0[T/U!#A:H3B9IZ;O$D@.H$)U^0+E/Q"-I& M9\D(>,`K8\W9`0<>-Y?D/J-15*V<2C70\0@;F30G6"@^,RE@5F0D9_P&UY). MFHB$9*&I4Y:#V1NIQD<&"BZ+[+NA0:V#]TT'+17^%M8H)?S,4)2KV&H>]W-H MS;$9E%^4FTQD+6RA@?FEL)-VCKB7A?MQ@R+)01I!`[6']V:#QJ!6TB.*9YPR MF`5YE7&(?\'06!H05^U`]J<=2-$<)LVU*&.:GAA/(09I_HQ,<.)]YRDYCP!V MV!-@_3WBSX/0-6+^KTV>I+./:NV?[.;W@V;%S4,+\L6FE3P.2]?=HPQNQ+L*T MJSX1*(@CR(4Y5EK+L?2$P(UWG1T>#+0*#@8J/ZLN"KHL/7TH):!R)25EP90] MDM#VO`L9+XYRN5<1/.\07W@4KO?(LP'@8[SW`GVJQ/+M;08[3*/6GUW#D&CU M;:1/#QJ#_,C*U)7D(N5DCI_DBE2/ZYK9/GCQC"#<0)R-5_%$]!N]7F=A(A([ M@7W'XD/@_\BQ[[F.7S(7Q:>E;TG)U28;B?X[F(?;I/>&HAIBS[_!@M$@/?YZ M$RE*5VX^L7BIF6]J*]F5I@,.[^4*?9X\'9]-PECEF"2WCC,)2_@\,I/G8+[1 MV0\\:&([/*H#2J4K:G"%*;6D))X?C$CC38T_-+A`3YB.')ZX3=.#AV/26/J@ MU8H-/DG%41DY:HIDQTF.I<2(?A/EU8V<"DSTDP<3!V.@!V2VJT82*0GX@5/, ME:0`.N%.!.^S*;R`"F^"D9F``E$F_H*/R;PT=/H/%9LD_+(;9XX+XSC=-PFY5;3(YRD:3MI;%..+.F4"):,0I3XA<5 M<_DM[8(';NK?$5)*H3+$8RB7RBK`:8SF?#4DJMQGL$(".Z0UBEH82V#0XG6H MO,0<@7_(,S<#6K#9[0.=81"Q!#M(G)HG60BQ5*[<5[**$+0)V&\$3A0B;&[U M63SM;J-IY&HD8W54H#!,$2<7^4=Z9A^E&%>XG/F/5*J3U\3'`DXMEQ"/#ZT6 M7*G5Z+0&"V8TS5%J.M,@*5:65*A4'0KJ&XUV/S>01XK?Q),=Q*E.Z-\XMCD" M20R?N&CP%%^*?)"]P;.80#L&L,TXG/\%$X?4R*J34EJL.&B>10V)]QM,`)+/ M"84*9J[%4[KBS9YO1S"/X;*(U0)HW$(,-(X+\G?_AD?2_SM MIR@XNC?-^8=3-@I/[6#L>`&X>'?L>_C9@5G^]-__]=__I6E_BR^C,]MS()\^&7J[UT\I?A4I>;Z0G7"=-A]/R1P&5ZY$'@]G"$=:>C0]0"86 M#S8QQP&)OGN:LP)R.RO);>E&N]ULI03+8ZQF_&G&(M[_S-%W5XZ^V^ZUNT;5 M@Y>"&=5,06^UQ/5T6-=5$*$;WUJT6(Q*):B_1H):[;;>V>3X7R5!@Y6C[S3[ MG4ZOZL%7+4&MYFH)ZH``E90@4-]S#[STGWTOF@?GY+.`6D.MSBNOF765G.$4 MZ/HRZCDW>/W=IYW7VFGO#LOWR$;<6H7Y%:O_.CV_/8$!GE_^^&MOH+F%\8DG^!M<6VPY/^->180)@W@HGW@AI@) M*G=L9UW7K\RRQ^`@?O9,W])&46!3`E;`[A>]2DR>#"B[:&HGEY"=;C'4=[8; MYR:"JK3`)T:_SG;!?^!YG.0\(YRK#TK&O.2#W2;+7BV M\`SA^B":XXDU']RM?%J=:KHT^#4%#YEC22?G12O.R7TV<<"_#%8QAU`S+4G! MIJ?D_&28O)[D6#T^FT]+QWUT9H/`GM@Q0@.]-/;[60#DT...J_1>LIXC#W:@ MO7AOW:%V:SOK-ZU7:7Y+Y?_7IV M\^7BZK13;[\@J(,^GP;DL6;)28EEU^< M?2E^DT3P6A\:]*-][_[]'?;QD%/JRS;06N!V9G7FYZ9T%ZSBEB+YQB-)VX]V MJX(F.:\D95EODF>24D6[GTU,2J\,)6,Z!DQH,7HH@![*'XA89X&P+YZ?T@:; MC?P!=JST(]^QTL^T=>UP6DLQ0TWKPK2B^5'?6=WF8GU9NT*E;6LS@95/ROI. MI:]>N'I+7KC&8C/IV!=(>0!.`5XP\G\2934"+EGIW8.=X+)MX-0$[^D$JQ5\ MX!.\RQ6LC"AE1%5!29D&I]N>LT,FE'K;KFP3JZ2S=I/V9@A5TKF'D_9F"%72 MN8>3]F8(5=)9+\?A\_#D7S_?7/UR>0IB,1Y/)N/Q1KR)&\3VB9CHN5!\CK_= M^=X$Y74*#VR'O+_L)56DA190USJPTE9IIB,EH/6;2B6@*:V#1DO4ERLAK=5T M*B%-:=7;C5ZGJ:2T?O.II#2EM:4WC+Q#;^BZ.J&KX7PJ*96DM-=H]]ZT+BW;/2CS M83.P(&+PKP2>>!L(/+P?BLLX4(V`U+$)JY0#MX:>QK[;X0HLF2P2+.)W(V;K M"2*+4?\:0LL^1:PTT;/.RZ'^)$`^!)=*W9"!XM\]_P^!VAV(X>G-9BM&DOT< M(]F<>/[<$\@U%^8C1_O,4X3XWZ9KS[!Y4=SR#_O`2.UPJ<^!]^@RG\!D@!Z8 M3_8]((Q6N?5JAC^-I!]*^?/@F:L/"D4]%4R"\E1WAC2OP;BK'#,4]N)=#;17=9`3L3XHP M70[+:`V$T?8`J5^QV!3$5UE`ZDO3A:4TGKJ>X]T_I2!4/D,,>`*C6M9FTG.= M)P%#Q3L5<8FBGHOWQ=CE>P5>^TKDPQA)T07M]N%V/&56Y#!O8HG'WM-C[?BQ MLL)(]05'-TN@JJWD+0$-&($51_BN._ST&LQ%0V$N;@CO74&@*0BT1-DI"+2= M'(QLX`SDS=7U'!)6EH)`.\AI51!HM3B&5MJVALMR7_!U%(#2@4^P@D`[\`E6 M*_C`)UA!H"DC:B\FL/[X(6^&T/KF#ZM)4X0JZ=S#27LSA"KIW,-)>S.$*NFL ME^.@(-#JD72Y%Q/[QE.#51E0#:=2"6A*JX)`J^ET*B%-:540:'6=3R6E*:T* M`DU!H+T9&`I%GD))4?.GR%/BJ"KR:DR>$L\:NQD*`JU.GN9>3.L; MCX>HLX\:3J42T)16!8%6T^E40BJ=?2@(M)K.IY)224H5!-I+(-#V`:UF^^@R M,:Y-C).3)()E46=Z1:@SWX2O1*Y2#!/VE2J.D)!B;)WA=YO^S4'6M-YID6OS MU_UR>_J.<+]`?@)DZJ=F"N03#_"9`S>D@1M5#KR]68%/A_CLP6^,]_V5@^^" MJ?^J\6]<\`>K!1_^Z51"P*8FH-U<34`/#(0R!)PRWWZ`%SVPWYN&1M7>&258Y+AH3`#YY[CQ_;QY()E?QU>G9S M_NOP[OS7,^WB?/CY_.+\[G]W/@;;$8YL%4-R4(7SP\ MST!--C(#9H$*C96A-K%!(8]MT]'L5"]FX7?!K`:%BWBL!+;JA7`QE>?/?3M@ MVH/I1$P\.)HCO*_/7&1EC(([L?V9N(K.'4[9F$.S&LUF%\&`4[!6PNY%$%T; MAPB/&(LQ!'/0^A-[K$U`PWI^H"4N`KUB/#7=>X;?(BCL(YYGI*/V8[,-\65G MIO\'"^/'%.J0*W?,Z*D+1"(*K@7^A3^#'G""!X2(4)FWF6!GX]V%8$C)6F!H<+JY*#%4<^[4XQ)&X1KNG8G-LX M-SB-XQ`VL$+J;NU[ET"40?0BUQL%S'^@M6F[\R@4`X>WQ'3&+.8#%E-:]'II MY(YMCFS'#I_$-''J22[@X9(\((D/G@-WX=4CRB9,44IHO'(=$R4LF#*0!AA1#"_ M/@$<^[B8C^*/?%4A2+,@D'X/-9>%1V,SF()DA*&38"/CHPN9!>LH80,0BWC2 MB&*-HWEDSD,"GBR>D1V>!?S@D+@Q4G,E(8NJMET)MO*@]M<=$W=7?IF3G)/P M+,)N+\#$UL7Z:A]WB(U[+R=OP@Z+1YR/VH;>O"@K0Q!619YU\JC7VW6W3[.1 MY[Q"@OJMC^7U<#F+=="NH\%Z1QO9"/R@%MT-!8PY6QL0N&#H0"&;:^A M#:-[(!8_]!L9&[?9)\/G"DS0Y(O'J0TW8J"!P]>[H7UDV:*[Q=SW'J@U!(+: M@V'R&._FH6_?W_,!9`PS,&6"B(:5FD+4MH+.88+8[BRT(KT9&`/"78!WH6D+ MA(X8J&_>IX)]9_X8;5CZZ8660>DE_>H%?%"K=J]6*@IYU2M4,QK==J_1[.1Z MAX#/YYLHYD(Z:9L#\:VT:4GSN&UTLN^=H]>!;5ZT>WP_5TM%S6(J98+>S"NJ M"$_XP)Z2]1A'X8G@3:[%;<;V MCIK'1M'Y&?\O#^[L;P2G'D>KE:W%C#CA2I^8MI\]/TB#B`%*XS;B@^H@=A/R M>L$FX6+[J&RSI>+8X_KN3NL:.F6Z/\7AK-;J2&;E':PVWDIJ/;IZ/NVT.#EU M=3;L0O)LV38Y28YKM[\8;)6.QR[B(\$7V#$;(VH9%G^EZ>7/FT`.?+^;*=3U M+;914!-_^ M#^*88S&XNT4I>!D_-B@:=2#OM=/]BLJB@KJ>(JH7:WUJRHEF0>%1L]'1N[47 M`B7C2L9?+.-&NV'TRY:`'J2,UV2+SR"?/-N^6[>'P]37;A,O3?%6%-QV/.P- M3?GV&;`Y=5@A5XKT7:/5[2N)5Q+_9B1>;[3;9:OG#U+B:[+!/]O,>]8&?X<% M.6_9C%N[K%NPK"TOHFC_[B=W!][,,_ERH`Z/;C3Z_;9:*6JEJ)6RQE3N-'JM M;0;Z:[=27H2[4U4&!3TXR?P1@U=)$#7/H>&9\#R'.JY-697Y(E7)5IU`ACM= M.UO+0D7)6`-[[P)15`5K:O>8FNVYHGR:5_T6%O'2T!/`)1QOBL9$*6;XNVN[ M22$IK_1=+`<\WMC<*]'>''URS?C$P>)R,?5",AY,WT8=F5:/CTUG'&%=]RNJ MQVV*66)EP-2$KP-I$#8\8!RBZ":K3!3V\_IM&-PF)&VKV5S;AU3Y@GS\E6;J MUYB-VC]L6.C^>/JD?07-%OFD`8CP'4"J;)4YP]L3K6\T-0XK9P=3+'-.!4R; M)IQ!#9BBT,5B+@`50D^Z)X:%F'%>2AL$@A_8@?30N6]["/KP'Q;(CZ-B')ZD M//(]TP*;ZX$Y<@ZETK'[*&UD5*OB[)=5:<3^&O<35KR@P,BJ8\%&K8NS+U#A M:'JLD+`FX<_(P\(#45OW/G+YLYCU(QH#"(J&&".T0W-[T<;*"NH^8`8!?@G? M2?O^WI0'R8)79VE;HRO7JS^4NNTH0BY>QG+Q0OD)[)GMF'XL/5B[(YN-BT*' M,B?V8ZPXI4*:%/LH=F'H<;(L/C4T9A/RCF6#]Q0Z3_Q)R2?8B;WH?AJ;GV// M][V1QUTC7GT31",P($#:38>NA[=%CJ,ANE**D+4(PE5V%Z_3U+WJ6$8MV7VN MZ..KMB6OVB)TL030:ID?Z#VZN`JCV9Q[F'F#>[+3FY579XJ MO'RC$ZP*+_<_:5,57JJB-%64I@HOE8PK&5>%E_NPQ:O"RUHFH:LRM,,J0U.% METKBWY;$J\++>FSPJO!2E9.I$,@RM7UWGZ37.02[]I22VV>4L* MN67=Y^,;KO7[`Q2,M:]OM1PSP2._C4F]B8_!N+7X!DDM+-=PK]]84RF MH?7N$_7N63/^->-9["D^"M,\JW/JEA.$-V;(;K%4TKJ&I\$/YCU[!B4=B9)Y MY&?(T)$,74[W*CN`UTM/$P9,B5QZ;L#=]=+3[QNM3FO7PK.4@MYJX3&(Z[UJ M9><%$V!\,[I%V7/]$LNWWZ&-:>=3L(R&P>HI:.,48%.,JA=PK($3I5NDEI^& M,R]RPTLOO)I,`A8.L6XZ"$\PN0F6G.D4$+HDU;'3S!(J$]E\]TDWP%`N2N=\ MW?BV1[=NB#5FY.C65])M=,#LV6>ZT_G^1C'_DR3D_X5'_+]2?D<4X#C2-WY^ MNJ1?A]_M(,PWK.JO7:;O=VSSK;K&YX=1SP.,)SJB9/=)9D./__-S\3E?E MYF\8=J$CM=+4;N^N3O[UCZN+T[.;6^WL?W\YO_N=/,D=@"T<>/;^[L5@&&!9 MQB)(3J8M'=8MF5$X]7S"[<%.K-@+58OF^#?RHKI>E;R#WF(7/=&G$@:;[:;J M6M4.0%_[_KG/)LS'!K$TA,U!7;RQQ;!#]8>?;/SC.IE;VL^T563_QQ9OX;07.> MXL^>%%&1=`?7)W'5/V*V4Z;]QF8L#/G0`\]!7D[L,3`'=T%3P$-X?NX5#=$./K`M@9?' M,2&8_T!8%M0)W9+ZTL:S2B"-Z*#O/M]\:/J3PF M-PS'M$;T00OXC3;$C&/RX7!OV#V!L\'=ISB$6>3<4^?XT5/^,7CYV7]HA35#N("]!BJ:UN#%"7-?O:-:$<1C-: M*1=@F#S8\$KSWF=\5;-X\5@,U25-8-*5&GZ?1SY\&U3;#[M29=K3&]V!WM#[ M69U:RD7(]=A&W5-T5:?C&):0ON*7-(5P:HI,]=;+N-S<%]YIA2 MC_&O"'FA48?N9D\D@8=8^HS=MU'WFT\)^%!=>=(I=,B63;W80S_36C@I=M9J MV6>\9J`K.0U;M:"G-AH9IO:":XOPI\A2_>4 M(6Y,8MGS(\"&L._(A&W(U\"G_XU,)P&PX;;/A0U&M/B<-?I/%BS%]_AK;%0: MS8_)A=);DI_UCS\21$YL<`'=ID]^"YW=)R^+/URR!],R&S0H6%ASTR>:\1QG#^:T.[N#AI:`RM41>W]&H- M\G;#Z*P,["2\.I'T9)[!N=WD?0&O9?Y*<=7TKW7"9#J!MR.)^EQ6HC[71:(2 M>^=VS@@BZDM$OG8#=L7Q\>;$J5=*F#Z_4I@^KQ6F.WGRD(^)&!-DM0D>^3U8 M@NA<:8[]9V1;7'A2-[IZ[/<"SM`,F\"'L3W'H2`\(I`,VP5.CT6>O66#[K5' M$1=,8<+$MEPF7N`277%96\AQO.P-P@Z_,9=P]]&X,Q.##V3JYC541LA7+2\[ MR)B\!%M=;8RG^^P8S\+IQ0,9XK%$'^4D6GM/ZI2EW(!5C;H,7LUOE;4"A0>E M4D\?5QKONF!%8^X65,J`P7%;SZUS!"@''D1.$A_%4V_X"@?%M&#NV*'V'@^' MM?Z/#0U6.XT0(4K9GQ%S$=&4NZO(`A[\0F+-@/1'_-!L0$MR>^AML$F,0/(Q M=,_]8$*A$Z\U?CS6/GO))E4D59:T@X+6A-TRD$.]THS&@4EXLY@Z#2]>(99\ MMR.HUT0QPTQ2>-A[A*2Q@`?$[,AVR"H(I8R$J(_*IQT+'\--!@Y^S+KP7S2^AC5&C M(S@PLWT9XC1!$S;I(-0;)XXZOIN!%,R$G8+[*:'!S7T[B)L3"86Z^&+D$&T' MTG&FS.;7P!EF6,,6F0$Y3V@)G!YN)9GN/=/XE^24&"9T^#`.+B/DIX M5]Q#Z1EMD]YS4./S\W,!:]R`P?.XL]8&"VSH/DE-OQ9A8O-,`(&9VF`%XR18 M:-"1M3=B"Q/?0&+@9H>-0TX!'@@AV<"1N6F+YE#$H>UINUUIM@/7<:>P&H1L MENG]UM"&SGQJ:DP(AV2U5^L8MGJ-3HG@T,)*]QY=?@:>A+6J]UH-HSC%+6/2 M"_6VX$W"Z#?K0F='@0=>Y/PF+*,?CE/^D-44H+N&BST,"IG+HVW`6S^8VI2U MR.7@1"C*(?@4IE.ZX84R?@Y/,20G$YO6#;UVI]'O=%8$CFP_=1@6-,0&HECZ MH-%J=1O]?50()T(A;$"*W\9"69()>\*Y7KLTV'HKD8*DPHQ'7_5BZ<&J[1F- M=JM8G8"AR]TW>5LQPFU:Z[5G;YZFAH^FVZFS/#G-Q_$WS&13T0("KRWP&U]'%XS3G.8Q6 M)L[;U$[&]E=2MV'`8M([W=& MS28*J*WB@VU%ID,9"51`(8)MH$E=D>].9[)SWYLPRD3G!;\89^4U'H7Y]#SC M0:+9I`K;321?Y`UYI?,/1NEXQ//D21QYI1%Y7JQY;1 MZ+4Z#6.PZ2VOW3#:O4:S,RA2Q`T\G9HSZI*+20)YO0R,0+\S:;@H&*;=T_]+ M>1U!-)N9_.!JQ!SO42F\@UG;5Z[VA8W\",]WC&Y!9>:JQ5YB>3>6GFN=G%TE MY_=%OU,%WL@S?4N;T8JG0[9`*JUYGY?+'X7HXB,I;R@S6N!$FO&6S1,+41

G[2L$`$K:XD.8V/Q`+5TH`GSVVX,L=H M@RLTQ.M`IIG:V`RF#I@\\D@\[*7GN<=+FCVF0\GV/AT]Q:>AL2&YY$@T=W#- M#UBC.9[F^DRH3&I?[<_$'6+,E!TF,I7H5M0T>!RLH7V-M3*DE\T)O!!LL[$3 M)0_CQY)D]$T\_Q%G.#VZQ40V-Q*'LJ+EMGBB4CL'HW9^D[>:`.;98FEPBL0- M/-(_8;&$O!*;;__4''KS[4QW;H'N:0UH/.(U;=YSA+4J@%Q.'O7ZFM+7]H#O M#YKZBYK`QUU6VW4LC*TV>E!</6*SQ>NSJUBOG9H/MJ5=1",P>)7@ M*<';FN`-'?;=)"29FVC\AV6R8#QECO:9G&H.@_DR*=Q]P;[RR6HMD1FQ&HH` M8B%D5Q+!P)2$)/F;PCG;\_"4;&U!MJHEY(+:H2S"5DCN\A*'.M^'9L!&W3%# M'L0-7<05%V=?[@I_EQ"=DA?V.ZO=\RO8K[]<7/WV0<.('G6[R;2563H*L6,M M7+#6,]=,Q[YW__X.&\<4N>G;Z-66G\#GMV5K%[1EVTF?Y;6DU+"]Y)CBO=N; MN)Y$;:OSPSN4?Y!0$,+^8B.DIDBY.OSIVUVO1+7^#GW]O;@WF2XO3V.!,[=T MA/R"^=T@S?$,5]B\3@G`,@'XC>$)*K/PJY'_$W91 MHJ-$9[7HW+"9:;M@K M(`2A@UVQ/!\+LR?,%F?X;]7Z?VGJ1LTF>_L,>/&YQA9=V_ZRLR:'%[@FU\VNU\3SR&O7J?7&P]<=FH_ MB4I&]\5CVJRP]H\[._.8ZB"L92$[-H+ZL#@R^0.OR!]YOL5\*E:/WT]$?^!H M=W31D6,^@;7Y86)_9];'4GATW`1/_K*2X?';CFTW__UW__EZ;]S75-]\,)MD2\F@@C M64JLO,,W)/<0Y"=\N&&3O[^[;NK?X']H,M]YS<&W5I/^?J?9%DP&0M5;WUJ= MWKM/\?R_%D/AQ;@/VJ:@'';5OU/!DBA8$@5+HF!)J@J.O+GZB!J7-F>H5;`D M-8M8JO5WZ.M/P9+4(HYZ>`*@8$F4Z&Q6=!0LB3(.#F`"56F]*JU7TJFD4TEG M[2E1TJFDP;%UD%2U('\I2X*EB2?3(#%2S)KG24@B51L"0'+>`' M+KZ'$(M1L"2[)Z].PEH;P=RC^3M\&U'!DNS>75"P)`J6Y%D:5,&2U(6\_3^] M5K`D2D;WQF-2L"3;,DE7P9+L'7K('4L\[=!Q:$,P:W M/[K,#Z;V_)KY6'EEWK,L>L@PN'*;W6\Z1PWYAD@(+#B]]MF$^3ZS",?D*YG` M48#ON0U-L(CA26*8=,'PNQWD`$?Z[[3(M?E+YI'/WFD6&]L@;0%65GUJ@@BG M:"FEQYXGFMY^'@01LT[IE!\NM3V+%WF""--/00XOI2OAI71CO)3J*!](E`VY_*_0@;<"T(_PE'R^_ES]1P' M!IP#S7Z*&-/L?[MVS-!VH]FUZ8?(^0L/9([YLY]][S&K#9X^T< M"#*=+S8(+"Z%B6>9["]5ML]])65Z":8M\CF=(C&:O9+L" M5K?6RW:'N\LRGU,_,'?,2$44ZM/8(WB=G.58T,^J-YG^)CD$,O%EA[\]&0"% M5LGJRW&EC*_4K4PJT-),S4J)D/1.@GC1%\5B6QSI-M:&+D59 M!F[T[/N8X5B*[J9;EL0,=B$J/7U%0*%-9D%[,!`AE/*$;9X?K]^O>\9:T@># M_HM)?[W.W`3-K97ZLMMM]EZO+BND^/6;9*^]9H=X/;U+;+C$Y<[;OH7`PM_J MZZ/U2ABV>@LMC;5V;N]/O=-9RNY@_.Y#NNG.[7T*)Z(,6 MF/35RSAMX2L?=B5,]UZWWS/:K8XP M35Y#5QD&D80_BS]+)'3HS*?FB3FW0].I(AK0;ZXV9HSFH+F:1V5(J_1T8DN, M*7%@8.B=W':RX4.;X!?WY* M+[DVGVA7?#1]ZVI.*YXP0H)SEPL>N"#!*A.Q)7C5^O9/<\:"W^`-85B%EAN4 MR%[1%\[D-D!\7?A[;4;.!9OXGAU4PM\RF2EY._.`V7MJ/MC6132RW4JX:Y30 M?F](>(<.^VZZ%O-OHO$?ELF"\9158@P-2AC2.V'T*\X=EWA6544L!R5L[`J/ M&#?&B=<'M@9EHN,5[5$[@;M575:;PH$2R MA]'?P[WV"X<.B=#+$N_9!CM+A:-[W4YUO"P@=`>+NSH.EG!,%GVSVJ]NZ05Q M7QK1BR9N7409'YO3FE3+4RI7!:%A-\+9580_F]_!LU1,>9YO0BVTFWH9WO/D MD*;^'+FNC@V5ST"!8MKU-)1*P(-;I75/L\*M\36Z M9[3^M:-GOS;I-0;V>.@#S`#`Q^U_6O^FE\_%$7\JN9E!<+ MQ5;8WP7V]W_O?FV_FOLOIW/A?-L.QHX7P-:`)Z/I($1DZ<0+PF!A#$%25ER& M;3DN]-Y]BHNX7]L(_<7-V[5-]6/?86-Y^,%S[_%C]UBJC$_^.K\\.;N\.__U M3+N]NSKYEW9],;R\I9+R],Z%RO>JN),TIS_N8+?X[3)G.4S`+F7PI?.,O\:# MSB`Q_#7WNK\V_AK@B_ZZ`+^0X`[\A`_##T,MB&8S['CD30CZ'O1*&`7Q)QGG MRG8Q(]Q^P&M0`\P=TPTT.]#F8%XR@M`?,<=[+`;$^J!$[#7ZY8)`.;+T(K6_ MG9_>_0,OE_$_.&S%$HBI`1MUP>9NIEA-XHJ+LR]WA;\G',V],+GSY.KB8GA] M"\,>>XYCS@/@V=6O9S=?+JY^^Z`]V($]6F@^O'08`DIEX8*UF!J:Z=CW[M_? M(7Z)Q(L]ZRG;Z=4$G*<>,$.U:QJ]G-K6_G:45U-8:@J?VQ,^X52-.\*KJ7_> MU"G.%-!U!D_XD$I)_B,'SP4]+:\Z^"#OMZUFO-A^[ MZ.M9(0<*5-Q[O=W0]=[.^GK62\`/7'SW33CW:/Z4>"KQK/'\';Z1N.$@(4^D MKF\CSSJX"[MMY/EL`5"-/+?*M:*897/0:!I-M69JKA'??,RRHV*6>RBC;S)F M:1R_[4.@FIBCU5GFM2JPJ`*+ MSS8H?R+(E/2C?,]&<'?B\6X$@JI.L#C;`L@I!N`:$+5;H'CH.-I8@E&##T$8 MP`T^X2B9(^^!:9ZP[J83"D[,4UH?'SA.#UUTY)A/7A1^F-C?F?5Q+9Q.++)\E7!] MD(BQ_*>?_ADO(JGWV.M@YA80,L=39D4./*P80H^PZ(43-1R']H,=/MWAJ%X# M7-<_.."ZK2H#!3&F(,84Q)@".:E7*?0A@A0IB+&]GT(%,::F7D&,U?2SKTPS13$6`T.U>I`GCH!5A!CARZO M;RNK1D&,[9H\I5,5Q-@^V7\*8JPF*DM!C"F(L8,6\`,7WWT3SCV:/R6>2CQK M/'^';R0JB+&=NPM[5LNG(,84Q%B-ULSN%X2*6:I*P+J25R<#M-;"JBH!:V&. M*HBQO=9+"F),08PI\5883DH\%7E*//=Q_FIB!RJ(L9U[!'L6EJP3!_;5"5:! MQ5J0IP*+*K!8=_)48%$%%BN%&-LG1*?70S`M@#H5/F?H^Z9[SQ`/ZO/3`D34 M\-'T+?$6J1KG,B(3-H/Q-`RN7-WXUB*<)^/;>8PQ1`.]1H2AKV3X1@&.AAY\ M]S1GP^]VD`."&KS3(M?FCPT(:^.=9K&Q#:(9_/W=^>67=Y]Z1DMO]21N54W; M#IB7`F.]@GEZLP3SF@.PP/:3>3%Z@\!LB#.#"99C0_*HZQ)+?[D]_39G_C<: MK\Q9X]TG+*#8"%=7$5T;7E.GOW:!'_D!-CL`W,BT[EC M_LPH@ZOW&OZWWGVZ;OW>_:KKISGV;I?.F-6N:[H;G-YE[P\VS>QQ)8FN5/$"DWP&OP6G3/QQ[EXSW_:L2Q9NBKW]]1*K@U'7JTCOKJ0Q+[GP MBID=$OAN"MG["M!SRY/SLUORW$>)#R_'%BI@P]L!Q"V&%-_>U%^P>]/1KGUOS!A:3\$6 M)C9/N9KM#=-WY6I?37\\U8PV'KLV!P2*C1K?=`D4GL%>8VDF[!0S7.FN%Z(% M,/&]&:Q\S0Q#SW<97BDPLJG,1+OWO6B.$-MCYH=@^2$2_0R,,3:;.]X38PG\ MMGA3`[&WG8B*5$91B*_1''N&=;5OPT@*'M`9L\D?)@CCF<_XBY;&*'P;%V9L)D">8M M,'5,#(.GXZ^9&6MH9J`],L?!_X*?3L,&4SQO<]H MOP\T*_*1>R`F?7B#">QV'.\1ITB2&9@NHBVAE`\V8-D&!8+Q0-&==/,41F>. MQWX$#T5NP;)R4?R`CLB-P-!89`G]F'`3'NM[U`PA[G]@SKP(!\\Q-#P&<5<(7Y--#!B1'J"SM?)XKAA=0&Y-*.1&S`'YP$,%Q=?"^-]M,,I MO,T.XHG!?]&PL=T(7@-L8P^F$Z%0RE>)!8=_\I<$<\^UXF617'>L77J:.18E M7[XV][T1QTAG8>C0_&D66%91$-`E(Q8^8@<(G+FYZ8C@A&T!4Y`IY M)4Y.(I^D`41V!D:S$#F<`.J;@0O%A^W1IZ<04_@8]KM;QFHK/&^S7WA!<$+R M>\_<\=,9;%\SD-ZKR37\@'CX>$&!,]/Z9K2_X1+*FNQ&,^O^RH MF!FJ]B$H+8OT/&Q(:!3<,&SS`I?F+CQWQYX_]WQA;J&Y@;,N0W%G?1+_.$2-B;+;-"N/9G`#@]#JM)\U(_`#CG2>[#+D-(2#6D"5%OX M?B01]R;8E.B7C)W9T$3;)Z'Q-%)Y&ND\-%OL0%@*M(])/:!H;S/G8#L\),91 MX=;^V8.MC\PB&UP$<`'`YD@G0Y?9AZ#FS[<.G4TQZ]R+&D1ESH.(4. MM^J$TP6\RX^@V*(L?&?JNB&A\$I'D,OM5C#Y-#2M9,LWI/,=P?5%?J)+9I*L MI[)11.P;4LX''ANX6[+ZS"B<>CZUBA,+(_&G08G,?1O5C[=4,D,O-%'4J]27 M6J?1;#;C?S/:D`0>AD!"S$GGZZS2]QL#`J5J=-N]Q;<7J]'I%)"Q<2:V6XUFM]70.]D9+&*566IO6<[]C'X;@2L'#J5OQB`IN!^` MCQH>%3%^3F=@#FT?_R0)-,(<4; MP%L4N\GX`%A`5&M]41UFO$_U5`E`Z5OBJQVB42`E@%*M=-9-5?2 M4"LC:S@!%?$BHCKKB6JW0%>#JGX93;)%?/9G9(=/"^-<$I4Q[KR4Q-RPN^\^ M/==SDA()U@\I3\4I&X7G+AA/$2[D$]/WGX#6(6GR@IEI?M,[_!C_VC$Q[CN[ M\-Q[S(/YV?<>P^GY0V9N>(_::U#T3W>^Z08BO/OY2?X%)^_;;30*V)\1C.'L M(5$R_"FYGXIS`XS>RMB;WFX:4NAM%=6K.72.[<_`,[^!X9,O;5TS'Q,:S/NB M+-7Z\DO.I9A'"QDJS>-F?QF_5O%@<>6[*(%`Q=6$I/"4!6/?GHL6SQ*_@%=) MT!+^YLNC?GP;O/MTY6I7X]##LQ2]PTL]&UH\3@T'JN%(-3Y4[?S7AG9Q<<*/ M;[@Y,B:NA'!KK]'OMK+Q`MLGAP<^GZ#I)`YZ8C\%/?]6JV%T^HUFOYDH`OZK M,.G&"=,U7X1[P,>++T(3CN$97/(6[E;+:G#YI+UB@J6H-/RMUW."6TV:X$OO M@9^6Z?KK9KC5;W1T_=DSW&_H7;W1Z^YPAGD.%?YX3@&C4SH[Y0E0?'>\34[F MKB:Q4K@:.?:]R4-*B_H01*#'IWWHS*?F";?>AZ!:3"?A9W=EK98Z+]O(X1#\`/H4 M/PX*,_72OVY_^7Q[]K^_G%W>:6>_8N8>.<3I_6\H;IOA6RZ*NP.&;)7X=%'C M1KL(NT&AHDSP,9?]P>--#9&`A`E`%+JDM`QO3(D;UHP@\/PG,.]"%O`YCN(SVT6;7CZV'7F^3YEBE2;9Z>T&.*:Y'#O,3%QO;(+3 M%D0F7P24-Q0??IG`*A>E/V`@RS#B'-T\I.S"7]H(6UZCQ4D;:6Q)UXHOQD)/414<7PT"C_25*<5>J(`XVK9+5[Q0P[R#A%AF,E=6"MUM9S M%7BM!I^82VG>\5`DM,T6VE$A`PNJ+^WO,0J[>W@`Q*\RE MD`0\?XZ"N4F8VA],1&Y9U145W<71P"L3Z\N38CNPM"ATHXG8C2:"-P4'U8>. MEK,LA$.QGK_]GZ.C+YX7HEV+68\T;S=L*`-DXL)-N@:)8T-(X M)E8F79)RXBWZ[QW*%]_.W''_9_\GWO#!@(HB#T!C/OF"AR+4CP52[L M/33?^N#I#[O^)9_ZVZWVCO=GJ[WW[OW>N]V_O'^N/OWKG?2O/=^[N[O;"K$& ME=2P%?"QY_NZG8BRKP,BP4-@3!XT1DI-]II-7?Y^(*(M+FZ;VZW63G-1L#$O MN7+?C"",?$IDXJP8&FEJ\FS:^_N[C:3_V)12?=D8G_! M`Z*2KBK%Y166T-_\13%?_^2WM_V=]M:]#!O8!YZW+W@$/1AZ"8`]-9O`04/2 M\232P)/?1@*&!PW&"$NZN;6[T]+V/Q]Q)GE$0RW3(8DTU_X(0,F&IRN]Z9UG ML#.B8D$BK(9K$9JZ3--01Q/QO2#"/GH`C($IV1UV)]JYL'.?"K6HLE?$?$3D MZ#3B=R\!^5%=+X#XDBN05V1&!KJL-;BLV0O@.*8RX$Q1%D/X)(6+*GC`%I`H MB*/DYPM$DL$(]PI8".$"I:[Q.?Z?C$YL,^)!IIU(SPM<9#LC;289_$,B!\D, M$$O_EI!)4W=2$R(E%[\DW>:WVNE$\'/Z\Y>.E,G(F]<-#@OUGY._8SHE MD9Y/.NJ("#'#=?QW$L5@4,;2WAG%5GQM53A+.@X+V@D"'B/F'@2`^'$FO@1E M,<*,9G61S\PB7[5M%U0[9U.$R,4,\1I4RA:KBRI9U/DJ[+B@PI6`":'AR?T$ MF`2'9.9Z_Z=1YRAU?S[(ZJ4(_\C9<;2I1,-%GH#DNQB"U2K/8A MU:I!K>0I(N%P+(60!6[W*TUH!INZR57$P^&XZYPI$""5]=`J,JB55D4DK*.J MC0VM/D95HLJX6C.HE5!%)/*%>N>"4,1?\R,^'G/6 M5SSX.N(1=J`\))(&!O>J7-.&-JZ/8=K2<6)X/%&JM7UMEIC#&]LES%/LC*/Y M<2EEMX_/2PV1>+FQ:Z(6!^3E7!S6,87);JT&7FYI!Y2R]\95^7(9.:S7F4"$ M5X(/J2F-5H58@^VP&$=< MJN[PC/-0]G&9-5T]6"U9#S'68)>G4OW-KRGI0:#5BK(LZX`B%>:K'`(N:],# M"=@;^K[*,8[MB$_T5B?%;M"IQ,XES5:];E6Q$BH.3W/SV]`1`N^$8\K2#,D4 MRN4KM:R3@*5D'#YGNN2,9R>7LXZI'.G%N3L\AH%QPUMN6T=!+6@Y?$*_=$*]E^P.#V-)&1@3 M3,4F=94OGXW#Q_79]3S_69ADD;@F]QVE!!W$:I[L[L&$BR2`0P,ULTX`/ZL- M%_RB>I[X692_9W`T=]_/`GN`#X0!+XJ3+(U=E[`*E_+I>',1TY5(KSHD MYU$8J:=/TY540H$NVC?0+ZC$V#+6+7:'GRCCN"F:+=+(10)9 MF=9?*2N:Y<\`O.18>MBMZ!V0WL2H,JV,)O77R$CO>U[[7P[KST0(@L%RI9DN MU^@-R&,FZ/#E_RLR2[?9.C??0W\2<8";<^2L+_`8DRNEIK46UIYF^0,"FTN@ MK6YBS]GZNT/,66\+\S>ALQW5?*UW'=5Z\482<\ZFQ.Z-JIOA6+3C=U37Y"4E M2_9E+S^SK>"-*IU/MD#RY]X4*8B;EFA69Y?TL>CT*4+\AOT5I=\6U\HZ#/^A MT%TOM&WY$Y:OU5JM'>15>Z;`FYQ())6-"+MW]U2JI=:.\B3&!0[@Q*V6@JXX MI3@B@F>>[.16XH#\KWBRDTOY>]YP0$`!0)A`L``00E#@``!#D!``#M?5M3Y,B2YON:[7]@:YZKBTM1!6VG=RR! MHH9=BL2`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`1UG8CE;F:98U8 MD/$B*:./C,YRP8LZ6Y#A7MN);47*]ZS=F0FQ7)"[3^PJZ3\#%)883T M4*^D$:?3G4Y[&L*!^^ZONI51)&Q8D1.?[V[!@6?7$*I@? M312KVZ!+[9IW!W53%N2]`EUDO,LU7[L%W?28PF2-6.D/DTE23>`3):R0Y\W< M,X8=Y"9KL$&;%A#<,;Y];=5S_PP#N[?CD3C?<3W?5GTMBD(5>L.F3@/RZ?+-/]I M@XA.6S;6[CRJ><,P`7R#\5^]766CO)@T3)LLV])FYG*&1303=?ICM_7YX2O) MJD]Q,ODT+?,I3-,/2FS(,7!VBN/GO^,&[J9A/(%$1U8_LXUP%%H45MKZI MR%E>#:R.I5F#<\&@QR99PH?]-32W]"%8\5@6LWCV*2[1)H:/QBP#GTSS:.D[ M*;<=Y84048-F%):/#:2Z_#@.P^=/?$;\Q-*JG/VFF2,_[A],C47_,OUU,)^' M`1R[@A_+V5?2\)&ES;<#O'#PY?-"59XD?^"F`!VIFX+!\>F2Q`MZ!\6R[-#% M9JU.>YO1O#XJ\HF6^J;?S)52UR5(D#]S6?D^*R]@U?_MPP&TT/3A7_GY';KD MM[2I!^.`C?D/B[^G>AF4YW<`,7A.M;K=:)_BR[Y!+R6PH MX79!EX)7(1@QQ8>^V.K*>+&TS`IH6B\CG60,!R-F[(M?QBYZ,2:L%1P? M?-U)RB1HQ)Q]]<79H"SA"#1X+/F]?B6A:;E@\.78/S%&&WN!_&(J3KQM*L+R MB9O/X7_*?.`$7R!Y#&Y*8RU-O MPZIU-RCO6,1`;#B;W+#JO"Z*]F"(#C))M>`+@;E0FSDE$N14O>^+L:N,WZKD MQ1O(*6&H6RSX.AJU M@R\N;5"V^=(%A-#HS7BA2]@RDJ\N34K6)[S]N=_AVO6PQ@9;MXG@*P'#@]'6VP@9PJPW,T37\5'"7K=8 M\)6`H<%(Z6+>UC`AW'@S.,PVF5,9]??7RQ6"KY_?!5\2=`AS_LP.4534+.Z` MUB)/7"?X2L`888<_"4"$0F_FBJNL8@4K*^W!)ZX0?"5@D+!`G@0=PIQ/XP3O M9_=A&A8F(V^E0O"5@$'"WK`3H4/NA;T9*2ZF5F7NN)K5&F-.7"'X2L!P88$Y M"3J$N1[&C7571_Z;6:^Y8^.$R\D_=)>,GZIR^)@FXZF_XAHONE6#KP1,%1LP M9(03XLC#@%1H1+;X80(P9%F`@82"SPAB!#V*)@ M1M&C*3@A8`RQRT\#"2'&FQ5D^3Y;=1,I*!V MG4HU[,]V/Q2.-?0(F_Z, M.W&.4@BNI)G?(PM3:H6,:ONG)P M0L"2M#7&-?6!]`%O%B<[^G&^N0M."5BQMM:7+.H,Z6\4K&+"C?$&;BK!Z;NS MF.$X$5ZG)V5`_VDYC-E9<+.M+&A&H=#XS$C;Z]LJCF%\W#$>Q=6*&, M(Y74`K0$;I]Z#5'$$JG"2BR6&S"W&F?7(&\,9Z,P&R>P7K4N_6=O/\)_Y$43 M:*M8GPU;`FVXO+;:TLK="S2QX'`%A@6"FW#"E!-\C]9`*TZOI+37]EYL]NH8 MN!J(1:&3Z!RT=@#^>XEJ?]#CPA(YEM^$65ZQZ"G+TWS\AJ[T:%F0EL`]9._! M*#BAXRB)!;J?YTVZXIEW9_GGV=L9RZ*G25BH\HNIJ@)>ES>06UJ[]5!2BX9? MEWHFLSK=E:(J`'9Z!ZF]#NLQH\NJ""2U"'O'K-):0%W3JUH>_47@WXM35:=A0FK`U`)7"#KC3?D'D\.C5SH_EKF%"5Y6)7@X(#`A>TFW,F1V)FW3DXJW,>B$0;(>O"C`\]H+R58I&%R)1L>#XT.^1'M.73*M=T>T% MU%O7*XW%?#,%*Y?H'@8/1-%G;)07;"Z#_`PK+`P">SS$XGU4H&J)_-2BU!?^ M$'_52=EH\Q9F4)`Z',/<^/>\ZOCJM*6*A?.%8*WMUR#T6H^!2GTLNLJB?,*N M\U)F/EHJ!U`\AB=M,KX$,)S'KO^1%W^"G%,?=]S+&"\,@GJ,[^D]+"18J`6A M[XI+\,&!]UU+OX%G$S^UJ/<_&,^SP.+!"RM@#;BIN?J&HXLDK?DC8$\AB#ZL M*_ZR,L@&E%C_?KB0/X>L=@[X:)6G2&%W@%__6/'WT M)G>M4%4&T![#AS9A5Q>;O;A[S`.9SSKG>39]@?TZF2358K.&NA]+:X'H'DVT M_;V0-4#1"ZM?L64N!#Z0#"U9M>#@T*.1=I-!I49E+Y@>&4X7-;L$+*W?'#9Z ME@J!8!X#5'H/%@$&PG'D[7(YJ*NGO$C^*;6G2&H%QTZ=]YR.#`4H>U'CR,#X M#M"&V452ECEL8.`SPQ$(]9A7[!6]R)#5"8YWJ6#IAX>#` M8H]>7"UVOZ49/[=6!18SE[,\'CDG491HMZI"\!ZBY:[S;`Q#;G+!'JL'^)C" M@T]4')3ATC+8YP(<(4R\=..8B`7)K0JJ=.$25P!L3@UXVNYXN.+UB.K"(1;8 M9I$J&M?R]CES$(R&K5XL2_+BGD5UP>);@,0WA\4;GR3DM_;*BH"#0,HDV;@0 MK6MZJ*P%E.FPTAJ%*NX[W\S=!KR(JP(&`GF/-F%&ALM:I!?&3?T(;289SZ+3 MCR'=!@`/`6=34Y[,T!$+O>KSOLW!D6\3FO;>'9=?&M3D]]!H,QN+C;/C%[IG MQR-29\?UU]+U$/SGV7&Z=3S:@;/CD>'9\>@=GQV/*)\=CXS/(4?O^.QXM!-G MQSZ<>3H[=C9YR^>FGN<582.`C_"9\LCLY")!N-7S9>O*M3EY&NT`.L(G3QW^ MM$$Z/X;*SL,G4]^##4P%RTT`)L)'4<.!A^*S=A@U-[:5O'1OBUNG=G#PF4"4 MXR9,*:"Y3K\A-V`L"W>PKS?0^C<)F"EDD#6D5"SV05(+4^'!=9H'>E=TJ>,Y>YAH<&B M2GE*SJR>\)7B`5:*[T7^LWH:9/'L#X/X)8'57'%4-&P&0!)X,@L;.X(]3R]\ MSE-V<&E>$O;S_IE%29A>PIXLBQI?PDA.E[(B`""09!JH62&\OMX>E+3U//3@<_1$6,#-7PZ)YBEF5H@^K`Q!=FK6< M;_@4P.RE"W'(G3IG&UX+8#JU;NDGX9,38%QBU+"1.^*.U]W-!I'+/9R]> MYC)Y8?_.PJ(3N7-;%]%36+*I=/+E2[=^<'!,P%BI'$"")>=$@ M0,R4PGHE@!A>4`$H%'5R0#14R/``.U+!_\YN(J M*ZNBEJ0FQ0L#*&IOHABM6A@B>[D[7-"D]7(%5@4`TGB[!-.]#E.K<*CE]K#, M%ZWERAYQRF7*GO?(#U8D%0_]AL\EV5A^`A,6!H$)V&SEXT!PUI)@H9;UX[Y^ M+-E?-=\(O_D^G+&FG.S0.@"1QHL>4@JT6>N" MLI<=A"AOM%8IVP2JUJHC;W:,%;'5[W.(R@-$`CZJBB&D15L7#T*5-P-&KPC) M+T0C)-?\8QG"`[AEXB]HB,^=\8J>:*[&8I+Q@//98N7<5N@$M\)X.WQ+0>)\&XQ MB2DFURP)]2P]^:Q(>9D7G5S4T$FS*'GN,5V;?@`4XCO;NZ6)O!]RI"MX3+DZ M!\21RGQ)EDL"'-]YVHV'KQ`"PH@]QY!>/6@0147=/`&,O<)@K6U0@^^<[%L8 MDD+02+2WO60E*SU.DU5Y+1#==R)=,[YTX"!,V'NQIBOR[-/P3]X]AAF:.49> M*SCXZCM%;O^3(P8'8:*'\01SE,N+1Q8681:Q\Z>P&+-R$,%!VG[WGX'1'"=H``-H98TD?9`A5WBPF\VT)R`^'BFP,8B?Y]/GEQ?W\[*Z^ MN958G#]D_I,;-0S*VCFKC`W$2/<@XO)R&49L,$'V\:HJ`'#G+"]R+`A9WI*6 M+$L[V[W>P=S4Q,[&TF>OS1L!)>R,6:4O.H1B?\$_XCFFV:0YF*WUV@V.CW;F M=&$1,-(W3K?^H$UC,>#OO@*8X3-K=XIEK_=0[?32JPQD8_.`_>DE[/T38]4@ MBP=QG+1*XX*G>5G#&#Q[@W\\YV68?B_R^KF$)M*:.X2)P5U+'M;Q($5P<.HM M5X![F-AC05N6`&9DE_8CX=M#WOJ2>-;:JJ;]OI&$>0<*I>8Q:T@0K$8MT+C+ M]4LK$-8+PX+CK(ZFK+VM9,1Q&^*&!E]JU@0$3HURRM!9;2UKD[,.S]J+2IX( MHA$CZYZI[;VC](/%212F9WE8Q&=U"6M-J4BFC-<`R7W;474'@H`9%2YK[R+9 M2EG^P@"E_-6`M@C([]%F1FRGM*P4:R\E67,W'"45=Y24^Q5."P$&`HG*B1"[ MJA;I@TI4#N&]WI?=E>,AM;,X*.(_S^+.SP^G+MUOR)S%F[[D^2Q^BN='W])9 MO$M7R:)?QOD+3*M).R[@A]7A`+\*KMDX3+\!)O35(T$I`.O2Q$/S)'ZZEK,% MU8R35XUU&6V%0<]WJT5@[#B]%5">M%$MKBM[76XGCQ([U#2-(_,&*M_>6;@- M4.*98%@^&@U'PL&).K+H5`8\'D_(1-9)4W5)#][;W,BS(GD!N5[8=1(^)BGO MI?ZNTKK2J+?9@M+!H;]7\A;BJ+:M*R6A1[@\\4JWEZ@.,8\"@>1TMFLVR#M[ MNVFRLR@37XLJ@$)<>HD8;>F$7*EH70?C9!=F@RC-%,KKQ0&7T[`8@W37N-I5 M1*W"<;*%\TX3C8V>?;ZVM_]K?(764D_);T-D=4!ZCZ%(ZG$@V):IX5B[!C$B M`?:ELTBV/GRL50U/@/X('(-[[^=M M@!=WGA-"AUJ/5U,VSK;>$OIO<+8](':V7;//225_#V?;%=/8==XF*E(<<"6U M0#5T3[D'Z"E7B8C841>15WF8DM8#I#0.OTHVC$CL@B-V%'9&(ZW#L2L^'1R5 M[?#ZG65\Z]/<+DQ`YVW4\@O[]OH,.L./V$;U00,$CML:@T[,K@%&8JZ(VPXO M/#PD=8+4W#&9P2/FF"A,-=3)SBTA5E45\'K,AM&33CU0Q"P$%-)L'1Z2/?F; MD:T%5'K*]WDT_0YJ:J_@.Y8P)H_>5]0%Q`1>&>Y]D)6B$O.X_8#>)CCY*4_A M\V6;G-VC!T*3O^(LA#,[?]09]BCM)I:/@W'K6/*V*#)-E37X&1:QCE%G\\:# M0X]ORLT?KE3B*#$@*NN1M6]`%W=YS)7:G6S1+![=EE7T'@Q<\X/)RG/L6)2L M5CU0C\N3EY&1RS+G2,=2:X.8@6Q%4*5%15@>D#F]-=5_7E:M?S%Q$EC$3&'6 M"*-E^K+/'%FCU_1(H#1N+96#Y8R`<4,R3,3L"#`0,U+UWFD,&PAEYW#?9EAW ML7G%O@4:)7!L=KQ9I[(0\5=O`UT"J!8S[MKHBJ MC9A!<%.G2,?]O'77'Q"OS-/V0:%NQI;R%F!G,$8KGKW4BQ_0W-=9QZ]GK7!P MV.?10LNB*YUME@I"U_`6J84I4.&HT)'[7;FQ3'TS&\6U3J@%C(Q6B+" M%-2*X1#S/^D*J?1E6"\,F&B$8BFT+J8*PT/,Y<0"1T2=338GBZR7R3TK$E:> MW4*3K"A8W,BM]#F1U`*T!*Q=V)!!YD(5'&K.*(V\Y[U($]8"E`3RF?0A30*' MFNM&(^]%+]*$M8)C"@&+?4B3P"'FXK`L*)R5AD4;<-/J0ZJ*NGO$C^R60^*/**@)6"&64#%L6(K%V0(\:W M91EF#Q_#UZ0/I,MK@>04_,RTN-"&0^U25]1YVK329[UW8]HU`;8%!S,C)C4AF7O M)LDZFP;[$$DM@$G!FZHO>V(X\FL4`JPI5SVD!L`C<(;;D*TN%(0I;Z:2-6$U MLXY(J@%0`L:2#3E;PX,0]X5.D@*/&2474<&M1#\8S$_Q5?;"RJKQ9"6@$G#0/]R(-:N+N5JU]+U7"X"]@=S!7>E=WZE M"&OY-0.I$\4#,VL%@\.O!$*83)9.,0)[=X6(BO]'.&'E'W!@K?`<1>*"("`! M;P<#%2,([-WM(2J^"%^2^+I^3#*YAE?+@7@$'!$,%"P&X#S@3;7K'&1Q[WV* MC;9!#02<&"QNX_5!.X_X&J3L-5V'ZT"0A-P73#:]RNP MV+MRP]:/9**U>BP7`^%VZV0KE)_:+1D?E!6,4_[,P`-\3&'%%14'8'2B8#:V MU^((Y?=D_JE36OK$%0`:%Y*56^*&E4!3`$S""RT2%8K+1Q(>1X2YHU>Q%' M]T4H87F`1L"PHD^9!ACD'M&>%@J8").[&P=]XM0P9",.^@3-O(3A04C:W4#HDT-:VSN+;*GV=X<>?7KG M$[IAC*:B)L`F8,7#!@]"G@XDA$$*OKX:G*V4!4@$+'BF+`E!(+QXCGRVFF/@ MA(`1T(PK)1R$-7L7_,N?YD[[/`N4ZGY45@D$)^!JH<>#+AJ$!GMFA^LTFJ8N M,%]QS!H`0`1,$`;T&")#J++G13`=LX,LWHPQTW8`'@%#A`%Q_0`B_K+VC!-7 M&7\4.7EA;6!@&F:'^_O'U&`0#NSY,`A%^-J#@Z]SL0DX MCVS*P1(8A`-[?@Y"$4YZ<'`R%YN`?\FF'"R!03BPYV\@%.&T!P>G<[%WYE2I M"0;AP)[+@4B$@P-S#F9U0.R=.3-J@D$XL.==+Q3AL`<'AW.Q=^8LJ`D&X>`= M92X[/"40)='G_"Z!@[#F[W4VZTD"C_=WYE2B#0=AS=\S9FX>V#YU::?Q=66' M0T58]>:>8.DUYE.GYAQ;SV>?HHX*$EA(U*6W-`C6&"-ZDV>-.F7@K#>OAYX/ M:)\26.0D`T5,CP`#0H=KK0$*5=AO!T3X!*Y&= M1".&H!'>O7E#S*]:6'Q1%TDV;E]W:],0+2`,1QUDC0AJG]_25W52U>H.OW[B9K#8$R")C5MM`M$.1(-_"7ZEZ, MHNLVJ@#3)L`!1!P>-H2]4N8D9Q8WLQG]M-: M'U&X?+`UF2M@(FR2>C3`QGLI1P<$W*GL<*J#%*'57S"1\Y<$C@[>C15.&R[" M,GW[V^_`C!5[6],0*.,_GGVM@QSI!M[L:>C[0NT?6!8Q[+DETR9``>_&AF:& M&2'=GO?4M]>(\E/I?'+/ MJJK-`S\%);/'VJ5>ITD`O?,V M,CLZ0(CWYPC&^^Q96/(\+!.>UR-L22G";-Q@.7M;%+D-WQJ3P,^PB(<-AO([ M]PQ_#=3Z;NQPSM2#]#IOQKK.*6>:%+R=.^]8R8J7YJ[H MLJ[J@LUB)_4.B'IM@4K>C?FN)W@D[;IG-[A5%0Q_\N2>3\FS=+MIW`:HX-W8 M^`Q!([Q[S!@DV4C=L)_-GWH;"^8-!$>'[\8":((8H=M>Q%]G^IE?\J]FK,*V MDSIU`<;.6_8,P2*<'6W]@;SU`*)R^D*>V=-XL@-*NV_A;5]+7K:3E@>M6'%`Q7S@:^8'NAT(6U%_=HF$8[ M;U_?U*IX:-O?`HUZ-'(8[SX=Z\'U,X.;B@T#HV#P-SAA37^8&7%O6(6>.EQ^ M-#@Z\F@RZ7EZ<:\0:Z\CTIBBOKW"B2,I^:'!^12U]BW0J$?7'6]3%*(':P]` MTNA9G8GX#Y:,GRH6#UY8$8[9%#]K@DFWLR3*)`#M>_0BHK!0JK5C[1E-&GVS M,P(]]4U-"4#['AUF*,R0:NW8>X#48N=\5(-_-!Z8=XS3!;\_S[.J"*.J#E/^ MZN&AJJ-N5QJ@Q:.OSV:=UH>FG#_OZFZIP)#AESC;%P64[-',XN<@TUM-]I[" MI3&9XBL)I@A9?*`':8`6C[Y*WB;3WIJ2O^>[Q=MS?N&?M-X!@XR_<5>!S"R+ M>'+']A;]`1H&X:UM?7 MJO0:7@_?>[B1ORWR9U94;_?UXS]85#WDPV+P`N.$H[S,BR'\D3_Z/;[FACG% MK;UQ6Z!&EZ:H/C?[>LR+I]^>^(DY`ABA4-[$]F@-M.+4-*1]C=^33PN=HZL( M8C?Y)+H'K7MX"OUD>U?Q,P&OLKL-C>(>>FGO"]9:XXVJP4`QD)I,99Z[R"W;!0<-?'DPN6Y9,D4ZMU MK2#(1^"DJ*-81'37GK"W19(7#_G:WE)U_)/5`LD)G`%UE*Z#PYH+*<+`8`2' M?4/]R^J`U`1RM^AH7XW"FI,EIGM8=>+F,E.\/UPO!'(1?#-+:X.(@;'F+:A2 M,FK4%16#1@ZR21\3R#1D;,91(I)[V1`@KN,`9\)^#V*_^N$%8ET;A2P*L'1B;]`Y&69E+<)@N+055P:A*37"'*5 M(KT?Q?`>KA!6T:GST"`U0"4NS5%FIT>4,CV*ER`1NV40R*I._8'5`81.S5GZ M#RS+&-`FK0N*V.V$==IH''1=\>?@5L,)C\K[)F%Y0$C`CJD80%JL=?$0RYER MQU+^7LEM6%1O#T68E6'4!'2FJX_IFB).88UA52.:FN M%P9,?LVQ?6E0D]D%2"Q?B`72:"V!+ME3+8?VKHUN4^X]6D^X`#QS\W6>C7E0 MV_I:R>#H*P'[ MDX'B,0C.+Z!FC`_BEZ3,"T5B/7%I$)5`QN@>W5P$P_E-U.SC_28<;$1^]9C6 M:0,&9'#L755IS#!-AO!AAOO5*6J`R!2\O_K-."(H]NZ;=+7_\#,WU/Z\!HA, MP45L`^VO0+%W8X1H_P<">9Y/'O.*O9;*CKQ>$D0DD!381,$(!$3+ M%MT<.[/6("OAORH?1ZQ"<$SA.?>>$[8`":)Z?ZDD^1/&_`ZN>P>NNN_"ZD#O M)"+26_I!BV01,NB M9Y$ME0'OT-^[9[#Q8^7Y\JO/ZFLMO%9P=$+`R(0-&F0Z5,%!6//G!=`(?-&+ M-6$M@$G`6-6'-0D>1*KOUL0((L*P-_<`#>&52Z-V&Z`"&DFAC"CKS7H7-,*[-V>#K?-.:Z>T M[0Z@W$YY\T7H>+TKE^.UL@"-@+W6<"@BVV`Q-H0N;UX('-]55E9%W>SSPZ)X M2[+Q8)+7FJU; MOQ%0`@&3Z.;4JC$B1/LS`#4/%//%:'8Z8&54)(V`TAD6KP9`"=A:^Y"I1H4X M/]OSCY`^_7W/JJJ->1B.9EUM^)@FXR;UMOQ9Y9YM!L?[.S;I6H*,,&WQR0:Q MB'\/TYK9)5JG20"]8S.P'<0(S8<>DLEG99XF,5\TYO91V"A.\TYRUGU$U\TD MN=:)JULK'!R=^K^24L;2+14$D5TZ&,BCZ!`%*JZ:.G*_B\@YNW>)IR[7+S.# MG8`PXUO$4_RTL+/W4Z=.EQX;EXBG:%)8#`^Q,#D+'-&RC%DDBVQ,',\&D-6L M'#R6S3LX$LI6BP(N`J$`9@N:&`.QZ+?[,&7E5%+QP\U(R>#S/H'K6[&.D55( M!(!8B-IY#IOZT?<\C\O[/)7G\%DJ"6@(W,N:#1`A!&+A9]^+O"QOBWPDS>G2 M*04H",02F!&Q)CZQEYWGCQ5\>^4OLVFM(&@=0$@@U,",(`488H\=W[&2@3J> M!EE\`=-MFC]SH%/1I8N^I!X@)7#GI2`"VP@H<5%[$O@[RP!H"A(/X@FHF8.L MDA>F)E%1$^`2"'CH1:,6,GOQ;XZF3I,I$R`1L);W(@O!0BU_XUS,JRS*)ZJ7 M:02E`18%0W>_U6P5!K4DC3=YEB_+.NU-&OL/95V`3.%>T8@Y35#.P^]F]Q_3 MK\-ICM^)<'FPNR2\!HA,P+2@J5G!G9$*F;V8/%N^&$7RTBR;^]FA?:JQ!](X+!3-QNTA?!U459$\UA6_5.?O\CSG17..A0K5FS;C&WP#5$C`TK9) MQ]@8O+W@2^0`TRXB?Q1)Q?+1"#8`(HFQLXQ690!"P-"FQZ(I*FI1EM"SM.PW M2^4`"@'CFN'Y?QT`M=C)Y2C/A0MT>97%==2Z(4HHTJD.P'?.YJ:/BUJHY%*? MFS]A_I!W(H>F;TZL:#S<&U'Y MY5F2UI7T82-%38!+P-1GQJ@6)&K1C<*U6V./-MNB`=@5G`UVF670S1>#SX<$ M;!9F/<:I*J@%9O[!DO$3B#B`]2PHKJ`KX<)2R+WG8Q\.3SD;\727H&GGP^=&E%,`T\:10H M'@SVY?3';&"X"`6HV*83%"8=N^SS\?`>_.#0R$6M3*( MXZ25Y39,XJM,]0Z,5CW80Q.PA1B3IH&)6+C+'7^%.&/QS/2GI$U<`;`1L$D8 M\R4#0RS0Y2;/^$$0U)$V+B6M(Z:2+EDUP$G`S<:8-#4D:A$NZQ:BJRQ*:V[Q MNN4.`:#O)3\!,4+I,=K&!T!Y-)TQI`85>\BIQ=.T*9V-^AFD)UVY@2V[(L$WZKS3]]V054$;!<]CCV;`:86023=/SCH')H- M@[((&$FL]`XCQ/8BE+"X:I`OS"+&I9A?130=>%#.SN6WX=O4U4&XLALT`:!H M1B!AR[LQ-GMQ2":$M7UJ,\:0-@#6SIBC>H)S'OMSDV?GZ^:N"[9P98-/\TC3 M88'$D_1I)C@F&NZ',=<+G[W((.6`$[XJ)CV@ZM0%&#MC(C0$92]2J!\W/6D! MX7=URI/@H1;ETV8?5,3/+0K!5+TSPP237AYVX]N'NH05,RR?+M/\YTZFZO]\ MO'L>T\DS?1RP+X7BFZRG=+0_J<&FZV,A#FA.E MH'0="C'/Z)F`OV?E,XN240(':I6S+5H'$#JU))A[2*_K'R%,#HF8=[1UTHAZ M25MACZR']`VK^)X`-C(O">PRSMY^ARG[*IOG,77P. M]$K`O\9NQW&G)V*^YQ?LN8`EK3'/P<\I:VC+XL&$^_[]$\ML9%(=R4]K=CS;K>6+ABV>"6[8.W_._"G?J4:!W/]1D`)!%Q#MMTU M3/5#[1V-=?D'4937H#Y0'H/3@/SN4:W[T MR`9](<3J;`([#CZ5P#^+FL7P+^[`./W7_`&[#/Y0\2LD7G?XF"9C:<)W-U\# M51&PHF[6.9RKA^"C(-)1<)V$CTFJ"K\P:`740,#&NITI9`TVM7=$]*^DK%R\ M@Q((&&:M7^`:H;<7#N"T"UPF,!-&EGPP)(T%G[\2,`=:\<%0HG0>3``218S% M34KN>Y8EW#P5U06+.S%@-WDE"Z/6;```$3#_]25"L.8;(J?V2HF^)JR,7E`" M`>.?'?K[HJ<6\<"%A[TG_Q]/DO02IMSTU4:%KFY4))W`I!E0!`%#G]GD;8Z/ MVG,F8@0#Z+U%\08=%8L9,ZH/T`F8ZFQ0*P1&[8&366@,3UT&/W)[4]GL'K-8 M,`'QYS;2O(3E26-/MFG3H#`"-A_SGK`Y9GMODR#[M4X(<1O)?YD7NELUG;H` M@X!%Q@X9@CV;O@KDSXLX8G)J%U+Y2FA4!1`$;"9;Y5&H`81&>UYHW;P9*[F7 M0!*M3%0&30`H`N80A[0::@*),;+GI/90A%DYXH\2KA,5;FV`4 M8U>_A>"8POO6SL@U503"[<'6@Y,O\JCF^PC00/M"[U4VRHM)>U_2.RZY9-$O MX_P%0"3MI@]^6-WKP:^"V=<['[V6Q".KJ@2?3S>,F]Q`<"P:658LIDU\7E"`(A:QW!52 M&?6Z7A@P.;7:F,7.R',,?800K#D@\GH'ZDB)'XR0Z MUFR87"8I*\Y!HG%>R`?)4DF0W^-MS69#1`#$25"J+A%P_.5O5]R_31[S%*%@ MJ0S`\VC"ZZM\`00G3R89+A.KF3?ESZ?H501T'HUQ&RX@2EQN7DLR-1X\0+,* M@P$O`B+OX$2UCL#-6T.Z2A^`,#$7Z#(-L6&Q5`:$]GCEVU?M`@CVPBDWZ>RM M2X%\XR0L"R`\AE)LVOT%4-Q$19KRT>[G6O$NX7^M:>0#C\39U4UX0.&Y" M%?MQP_?:^LS,2P,0CPX*=GA9`2./#13>EOSM$__$8UBR1A'_'U!+`P04```` M"`#5?7-#T=6TH,M/``#27@0`%0`<`&YN86XM,C`Q,S`Y,S!?;&%B+GAM;%54 M"0`#,LZ+4C+.BU)U>`L``00E#@``!#D!``#E?>MSY#:2Y_>+N/\!Y[F=L"-* M[FY[=\<]^XJ2U.W5G=RE:&G&M^'8V&"1J!+&++),LM2MN;C__?#B$\2+9`%0 MSX<9MR0DF`G\,I$`$IG__&^?#REX@D6)\NQ?OGKS[>NO`,SB/$'9_E^^^M/# M^XL?O@+_]J___;_]\_^XN``_P@P64043L'T&UU$5/111_&M9TP-,_NT/@/SC M[<6'_.GBN]=OO@>_O'[SQW_XQS_^P]O_!/_W[J?_!][=/X`+\.G3IV\3W$-% M>_@VS@_@XH)\)T79K]NHA``SEI7_\M5C51W_^.H5:?]Y6Z3?YL7^U7>O7W__ MJF[X%6OYQ\\EZK7^]'W=]LVK__/3[7W\"`_1!1Q5=*BT?`%I"_+31=WL@OSJXLUW%]^_^?9SF7R%QP"`?R[R M%'Z$.T`9^&/U?(3_\E6)#L>4,$Y_]UC`W3@7:5&\(O2O,K@GDT6^\)9\X]OCC1*\RE*S[O8('RY%TVC>$AM7O.[ZNH MJ&;PWJ5WR?U#7D7I)+Z[E"XY_@"GC7-+YW1\L=&$T\:W0[DTQY7(K?6@"J.9 MDI]O,0\][N#G"F8)3&K^"+7"KM+.J3VF)I)TF\>]#E-BG/-B5%[:URXJM[3# M4WFQCZ+C*[)`O8)I5=:_H4O6Q>LWW!K_CO_ZOZZQ*CYAR_\$;_`"4IP.,*O* M=9;\.TSV>*E[T/_^9L3P8AW711T54Q+50^)^:@>`M7L4Y]A&.U45O3'9%?EAP`CF3 M^8*CW,5$T,KQ@)7_$K/TZ[+:T>GV):A'=Q26TP_2*Z#=2C1D]E!@?W^;-TO0 M%S`B@=L,05L6,!H257%G->XK_/''/$VP-_/NMQ.JGC_DEJ_RLBKO'Z,"DE.SY"YZ M9HNK,]*Q4"C-QD1I+@=*$\QJ>=:AF61/@EI9%]*BR2;% M1(75DR9W M".P9,^L%QG8;/!VA3Z":;7"ZR`QR]^9.(D^Z9;$KLX&;B?9D6911G7C]]OO7 M[/X._^:_/D(2H@'I'O#^F*)*8<%U!,XT0,OY$">\+:"-`6T=A/DUFX(:&C;C MOR0D5-912^$9%"KK,8H*[\;PQLW<[-XCO#S$*$KO\6^@Z;7%0OT[U[:EQF6(Z&Z_ M*]#KF9[`=/LF#D73.VB[#VI96!1`0W4Y`WIF;#9NL@H6Z##RJ3O,6/RLW7M8 M=.!V*V(CV1#1G%:"5$8/O*\^7XJ81AN9.7+V;T6B.,Y/]&P4')F(N[P`B(_% MKAF+LOF"[^V.M9+V=C\3-=3=>OVG$FYV[\H*'3!CI6+A'39TOH(*G`Z1AAN0 M.\FFR0IP+0K&:%B)DL\2Q>62/8ZAX=JK`I`[O+^/4/'G*#W!SA+?B0YEPZM0 M`T-ZY]IA*M<0:80.4$*B.^UBU*$-5X\6$#I?3&B7&F>%XJ$B3H"PRRO*CE>N M=X/-R#Q<3RJE$*_R.LW#53>W4KF]IM2C3KRD-(7]M:^&3MF??^SQS3>MM\&S5 MS-U*>HM^.Z$$5<]VH3YJ,NA7*ZC)I@;KJ/F@'.G M.W<%R@N6:.(CC-.H+-$.L1PGZ^0OIY+&)G547J%/]ETYU[$)T@XA2KL`K`\P M[`2TO:RZZYU?)5Q`ZB%=V$[N5%`/%78>HMTI\4T6YP?X$'TVWT;*29PKI8)[ M\2J!-`6X;;A[1T?BN-0G';Z&>F,&KEGWB7$!HQ+>9.M3]9@7Z*_D1<7AD&:+@#K@X<1!K8/FRWS1WADE]LEJ!YAO1,K MX#XJ2$H[/!1\3,B.K1V3F(T)BSU,3@5I2NFI[?>]89N&]L'MW'2HNUO'WD5% MAH>^Q$LN?1IEOIQI*9VO:GI9AMBM*8ASR1[.A;O(^9'.Y9IGB,7ATF<%1)R^(_'/,R2G\L\M/1-'6)54]>\B[8R3IVC5+W`-HN:$QO MW0E@O81ETZ?-\EB>@,E3/&,+72M.ODOXA_;T0WB'E)[(7BGI,)8WC"&ZM6^" M%MLW7/A76/FF_OXX]-CA31.^V3HB M9?^+[I;$JI/O..RAIN["P&8UPPUDEHX?`S9#WO%B2W>C;'1`XWN@Q]^.UKP` MQLP*?'I$\2,X1,^`,0;I:,HI[8B,A-@:?HO:3O@^XO*Q% MO?,QCPN1GYUO7NL,E*W.D-K"O0 MB;T->?>XU%CDTK&()HV%KYWG%,U0[4JGJX7+U+C<@G4"I>_R$M&;;I.,S";D M'A+B&DDE9HBM%_K>.X&:,JA-J,W$B1EA;6?-`R"I?IA`CS?T![*:4SF\"EH_.%CA'_A'0%I0A92?CE/FH4$ M%]D42)&C'G^';VTZ?%SG![Q)4Z!GK+'[=S5C'.OPPAH&@!CY>`MO2S2#[=#0 M8$\-EI=WN$M8%#"A+/T$#UM8J$R-BLJ]L5'*(*Q,M#6X!$W[&DB,)``@&4R* M8'Q,9\0UM*XF04M"Y0E:,ADDT+H*'EK*21F'EL&,>'"/;E$&;_`_C?RB3F-_ M#E&78X733)H!VBX$T$B'6^H#2<;:'43690F-,DX-&SJ'AL#I$!:L@78'[NH8 MS9!?_[`=A\`0LJKY=^BK1^4C22R._T/JU#Q%*4U)55U%1?&,LCT]-E.Y[V;T M[CUZ0[D$)Q\3L!3SY!\=TA4Y6*VIV>'J"M#:NYX?S\\0]$R<'X5*RF>:I@IL MX1YE)`24[,O8=\\J5%O:^FPB00P^C3!.-YO.";P M$GP"8VRY?.Y(,L#FQ3-F1:$6_68>GC7VN!1?9_$_<[`'@'%3COTC>0P!XB-$ MV?2[?%T/CQ%*WGTFY9\@7GT)O()#Z;IU2`DU&'EA(" M1ME8>]]/Y><(!QD9B_+*J70Q(P)1(#M!"T2*K^$MX>CZB,/`4_*L.SH@#73A MO*M"1?HV.^*0.W5X,"Z:$<0Y])3%8=_1KN4(Q@%@?@]MNB M54S`-06J[K215&0O[Z)G36HCY;"@+_:@R-J(`)@%Q>(&#/`9:5L=F7$7BX5)!P/EIT M"3<,S.P;\U_#'G$"_[!7@T:\?=`CQKG9OX_2J+"Q^0*!+X,O=BNC,>5\U;!H)W M>_YY:@3_@%>#1DS2ID?,C/0\7)\^PCTB9U+DL.`CVC]6Y6:;HOUHCHXZFX(1 MJ=M4.&;2R$QBEPPP.M`2>JR',DVLGC@%$R?EOO&SBQ,HHTPOTV1KPE%9[A,2 M-EC?#9)4([PT;]YTT1R\;9]IDA*2X"3*G@&IZ@UE[ITK2,3]E;7[^7F)^W"[)>H2)"[,IO+Q$82EX0P6M`5H]!N1VGN[JGI*-MO81 M<#O"\T@,:O>A]:I^$'93EMA]]!Y5:R\!N`#_\]O7K]_@+4(!GI@P;UZ#`TI3 ML@TH27;]LE/$P[\**,`U$DNK1I;+.L2'`Z*5K$A0S!5-JP(<)<)EL81HPUR7WO MV.G&NJH*M#W1[)\/^0<\.)AOUN@!MV,K6EV:SHT#:[PL6W`N.J[@A]>O5Z_9_[IEY\BJ_?WW MWZW>OGZ[^OO7_TA_?OO]"K.W>O.'-P!1R=ECLE-55O@?&'TK@`4]PIB<<*4! M:*P,A6/KN1R"#F,ADH2F.(W2NP@E-]E5=$1X-ZT*AI!1N(^&D/(NW)TU+0%I M2E+!\\9!/#6>),B1"Q*SQOZAKX&2$"-A@B-WBO`3RK`=(DL?6\X4&B`V=0[] M$6X-?$)3!]"O-AC(AOF^Z#)>Q\41?2A/VQ(E*`KA9;X,5$-=4"/*G1)\A%6$ M,IC4=1O7<7PZG-*H@@ESBU5J84+L7%&,)!)C$A@1:,IT?MVAXSN$ZIL@UHY) M`G:E25@K_\IB#KZA^M@B[Z6=D9S];.3%GHDL=!9229?"`)[LG6VDV+U9*3QR M330G("_K^"J'ROMI,D$6(OZ`2V9O7D)(G&$1M&*!O1L@[+P7QT'Y!M^,5OS/C?:]`W7LP%L[- M$.7U$&W/,$1.]P"+Z9:\J.8RBC7#56E9X>D]Z!XD);Y>*:M8:$KHITB]2A*5 M7K=4H";S7^?0;HY&"T$;3I"[->L!582K&[R,/J'D%*6:&HB2]LY7%AG?PI:* MM"-FL&T93`%$Y=@/S93!P'M$S<^H>OP(4U:^_!$='_)W&./5L[8JHG5/_I&F ME56\!6L;DQ-RUCR@NHH3IU,+49NY=!C?]HC@[MUG&)](K--FMT,Q++1E\Y14 M[J/>E#((VV'2&C3-`6\?4-4\@SD1`K],)\1E`BAR,I>A"MYBEI(;O/7/]@BO M[BP;[^7S3]%?\H+N8C7+K'5/'E)&V[A(21>@[0,T%=G"6*DG3JR8 MO6G&K`8#XY;)#]$!:E?X2;V%!F>)S/:07@':%6`GE*2S@/R`&1-O"77]K,_8 M1G^(LKR"\6.6I_G^6;JR*]JZW2Q+^!5B]7K-`EB\M8/=VP+K1]KE$P(B*7S4KLY[4PQ,(K33BPX(."2`TH"$)9M4UG27Q28#-%/E$ M7=ZI)7$GJJ\3+:=S? M(BGX%PZ12=LV>2%O'L!B:3P9POV$V4SX+">J19.<)(`RHE(LC900#0A(NFG0 ME]R<"B-9;DD,S83`4^)!C35RG"]RP*$PX?7?O;M`\@'M9_&3CZ8[>W!Y*E$& MRW(=_W9")7V*=@<+LA)&>[C9_3FO.G&2K%4!$X6UF-JA$["4_(8^#2',_3@J&Q7D(%9ICR[K?JKVRR^]/QF#ZO MZPRI,A-O2.S6])M*)&2/:O&WV;6)/3898+2@(?88*/EBA3.*D%Q`.FPZFI>M M),D7DZ[)]>L[)M)*W7H.P`1=JH[4!NW<5YX;\"D>PJA:"&7LY#HQ8UW_.2]^Q8/!,T3(7Z*K&KM=MV4<#]'`V]792.JG MY1X7Y3`Y-UIQ35DGMB3NI^9G[PZX2#RC"HCH;TGV_"U[4PC*1XAIB>[Z7GN5 M*M%;:PWTP=W:^C,DV?IALL90Q*O_AQ,YRMGLKE%ZPK^ED8? MHL\?(1D?E")JF_$O_IVZ-\_J.#$]L8=8&@.)AF!]M]NQY'.UJXV;@X_D=5N_ MEQ7]`^]H!=9TU?%=?7""O%TIY0(&D('=')]B#)`=..>\G"&/=/".`,]8B3]Q MBPZH:O?&,@]71^7XS8Q.AM$$+:"E`)2D^/5\SG>D_8[)0&(]Q-2U+;VQB:GID_N-I^E+H8VE66F7Q&D0S,BG: M`!KIC,Q8*JY/\#WFEKU$D:T,@T9N%X(AAT*%K1,$9,`!I"U\&D9+5GV;O-&Y M[UDXQ<0[/#C/*UCR$L\&:?W'F[L_1A_G6DPYBIO5]<.U&?*='LPJAETXG]6. M^2+OP+N?,7P!/D+BZ^WW&/>J5]\#:`3VWELZ%Y*7WIJ)<)@C+,_V%2P.UW!; M/>"/:2+DR M`N^HD<:BC^,FF!AT]0SHL+/P@ZI[F*&\N(?QJ8#)'>85E65>/!,#IWY=94#H M>&TRD$18H2@-X$2@I6)UL/Q'!-O-47^ULIN@I3#$CA`J\AZ0KI(6*)*1>L21 M5!H-DCITW/4)$4OJN9*CR62BYN#IM,V+!&4D_&,:JLP[<(PM"\D$A'5H7P#. M;.>PC[9I$SCG87''H[]%&;RIX$'ZTD'2V/'38@G'FDTY:0IH6]\040YY_WVQ M?KS/L'SUU\R)"YFDDS"6-)F$%HO;P&4*Q_Y,F52C%<]@1I<"(\M'/A^/1OUX MA*29G!I4]CMY&<"TF&`Y-JUG]URN_@_\3F>&RS_L(@P[.2Z=]1;@A_H63X/% MV4(:W>+/DO6'OP-?Q(YG'++F.Q\57L]S*E.2UI./9GK4P9S/]&6R.Z0I`2$. M3J-L!*0"Z*0,49NTR#0]D)+"\FRG"/WOOWEMMG3-Z3*DDP:=]-9G#\.3TS>O M@UKK%AV,-Z_QXF<[(*&H[WREL#BHL=`(IR%EO26=JSTX'$$CS`XO!CD7^J'M=94O]AG3PAO$QKSA2MNW&UGFY@SMS.@2;[WA."G^R.,492^QZYD M%M,$.+$:C`:$;N%G(LE8I!*A`9P(-%3DJ5PH^#*>HQZB+"=H3AG(Z`@WF29> M:=#(<4G'`8>";X[_#G"#4&9\=$3[]?KDP^EP*]Y33NMW`* M_L?K7N9MWX'_`J+C*#P=>2O`.3^9C5$+^7?6"9$[O=JVRD&N()D(*""U@Q+P, M94W>@"R050 M;((V`VV[8-9'HQD14H2;3X<[;`UXT:Z0DO;.L23C6X>A@!9#Y=`/P6,P[@[3 M6FD614D[]RFI-(M<.(N8PN-& MH&T5S(HC'^XA.G1C[0LB1F7HY"2>X:(L*#<`S2JTBG&ZB5!#Z`RUWWZ"!:I( M:MA32E*DJW=7DL9NMU(RCH=0H.U`VS"`M44_XKW=D,%P.]SZG+8E_.U$G.8G M_'\&[^*E%.ZW.U+>1V*R>$M`FX;U/%XS!\(VQV0"O")(NPHI:$)`D70=DN`H MF'5(.Q<&6/)1_^3(:>@UPSOC"]&>\6E8PV^QV M,O]%UMK?&],>S^I'IKPI*4;O,>HW6.:-TJ\9<__P"'F"=G*/DU%9CER6ZC&J M0%1`\(D+E>]VOA.UJ?5`^NY7I@1ST@7V=BR=,-(V#>9=@6)XDZ$*10+.FLQS MMMTX3CEH+:7N>*,;2=S)ZDI[`;P;CWK_10ELEJIQML0W%2C@$3-(;TQ(.8?N M6]I.>MLCZ<>W"9FHN/ULD'.TUM=QF)Q-539H'7(5X*B^DTD M[UM.?R>'!IA5'R4:`S8`K22AL^5FU_+Y'D;5J1C+[3FCKW"T5"&O'8II1R11 M:`?.O*]`%7=AT7-ST8/091W2C77:#.;GZ%.!Z++IB\^Z8B^DMS*KZ, MX3F?*Z$?GX6]B(B/6+<(_1?D3$C,TWP_0FF;YCP&[1MW0_.JHW+\7%0G@VXI M#LG,N1+&W>-8(X3U7\M:P&NA$(.Z<_PC4;E-)JTOI*/R%W(P*H/Z]KXF`9R& MO*H.)`9A`6E""4@P$H4$)NQ043:+YY&UQBMN1G]NEDS^!U#6!:-VV!7I+J(T MJL'W^FFF7=(`!IUJS7F*FA=;&!41EN$*^S1[6*Z3!"8/>;-#OXQ2\E>9";#H MP/%C5`O)A->H+2W@Q(!2@X>\/2P#O`./1N+%"VED/^9(24Q)S*4CMH%8CUU' M\FA?0,BN5IJ0IXB.0I4/SOJV[".^C8FURO8?'T_3UUEY>LIRD_V4)VB'8CK/ M7=LFLRLZ*M<9>C0RB.EYRA([$*!+TL^=Z-%JO!QIC,R#M3C$)J1$I`+&>4%T MO;8,AZZ`W/>HZDM6\D."?7#?!L!,H089EU.6)V)V M-CN>#%9S+&]`Z_R@WD0>(7$P:L:[!] MK@G*AJ+T?)7\`L?&>X(S>STR2H(V58GFW,B,\7$7%7^.TA.<:"B6ZMCQO:!G\@5XHN/` M]\;M?36(&ZM)_O")=^A[X[R8.>G?T"UK2SP[8>\^PR)&):2O))H_3O:\M-V% MX6[II;;P(^K.^"N_MDW8;E4@8^#=?3+4`".?R0K^?)8A^^*D M-G)=EA";N"H)_S,HH@J2,#OBE?1]%SHX/)Z/W`8,(PR\.R^35;Q?=6V>?L\P M4=(O\4N(378-=]$IE9HFBP[2".#,T?* M!Q;^6PNO7AE`AL>5)&'UM=WI)5WR;&&L5[9F6B?HY)[(`_79""2E]=1T= M\(>DQSTC#1W'#XQP*ERR-VT`;^3U4MV`XX_]O!]I*T#":,3(>-\0ET*F?UVN MQLN2D+V+4$)/"HRQVZ'P#.(N[WHT`]*ZG&O33-%6@/6W#\D==.@3A@EFP-?,*K/23YBSX'6 MZ$I:?\$86.I./$--(Z$6?,UY(>D`+QT5J\_>]!%26C<_LOK3/A/TJO71'+KN M-/0FB_,#;"KF\2=0]X\05NLL62<)(CNF*"6W(FE>GC#_E\_XAV->1NF/17XZ MEKB+]$1R&]&;DXQ4/H?)!N]YZ&:K?)`\=G+.@7/;X&YLQ7L'\F70?'I5/V8$ M].L@RA+0?A]T&""12S4+@/%`5)5S`;IL@)8/\`OE1%*\P(U3[V^T)PV*2T/F M6,F'5M"+AL_)237Z#5);1U(2R8C*<1XIG0RF(";-O5=(LIB6?I8=BSE9'#"L M@(ZT!I(Q90C`&M+4!REEWE4))>G$F6P+'4U M^^04K@OW*7@7J_?1QH"V!EO>/(`B2(;3,"CD9S8'7Y)7?XNEO,&]JP[+G7+Q M!7KWW3'V[^$3;@!EYPMW\U7#/GUTOBQ_7U!_]SZ_1/?=&=F/\`EBEE06L&WB MW#QUN!.CE]B?5N`AK\Z6^MQ(FPVX9'D4QAT&_ZHV!,%0#\81X#33R`Y5)`N* M`J;=1CYRA[0<"DD&(#DTIDO=UZ3)-]VEZBXO:+J:=545:'NJ6/F^''S`4X?M M!?YZ2IK5QZX!P%TI*_NC/=Q='?]K)XID%O*OD2+B1Q*8C,+=5BM+&'^[SY]> M)1`QA<3_&.HA_M5_W<)]E+[#"UCU+#E`&FWE3!/'>10BG$@+P)HH#X3.JTH+ M,^L"F0H,U-#4`N!R$RY#81UI$O42C^02QRT)J"\,+3$H"0I/NIC*O MJ;VG27Q1TKUETF78AE8P^=*DLT\*:2^>6,XVY0)'R5].947?KTDE[CYXP=T0 MSQS_%,C3%QOS,Y(]TLKVN`RN*M`3YN`)ZD(LA)8>PJ2&O(KQ076+<.[-)2,L M1ODHAM<''BZ?/]!RD)+=AH[`(SH&G,M!LB+'V*RM=__>;`+DJ)&/O@_P?(@. M4+H?4#?W")P>URK8D(8!^.(FXRY'C&S0Y]9!:>/1>4%9]>6SFL9##10Y_^/9 M2SMO,CB!Y@K:B?MM*5NR,I'%;!D0#+K$(B!&R%H?\.DOJ;$53 MT#]"'H(BC$EEK!/D,KG)8A6L@IB(^.;U2U46*2P-]$:#R3EY2F%NIBPC#1WG M$1WA5$CK!O.@<&[$\[N-*<_NTDW*4-%/'ZF&A`_?]]8@JFFTM4?/]U85KM+9 M5-^&%*&B&'*YURL9;Q]`>1^A.LUIE[]HBU)R?4,?W6%;O-GM2EBM]]A1+ZNK M/$VC"A:1,*^C`S/W$QXA.7MT%#ANNB%/-1%/2+SB+S;)V@Y8MX#W"]J.SQL` M8/R(SN,H?8!!/&I=5HOD!F-)%?(6O'N;L[I%FL,\)97OX-B!#+I@5E"W#^9H MSV!.-!&0\@GQCBSM:9^&+A1T2<__%/@*YB#0:&X,,3;U:'`9E/T(,V(^:9CO M`66HK`IJ>-]]/L*LE!\I6M([1YVI7$/T<3H>DM^E!)PT@'W;I,D;PG'"S'E. M^K\Y566%)P9E>P4B]:1A)//O2V.1M+Y#&&!^_O.)Y3WE_@C^C-+K2\'G8S/\ M(UYL6*1$YX8*JG,%:6D];E_E\J@N%@D5#U(G03.].T=XYN!SZ[VGN8@DL/OK MM)8J:;>8:;V/\AE0/U4BLM>SD\?/#EFC6O*MKY%>.4S(&#_"Y)22JD`D\=EE M5,+D*C\0MX#MBHAQVU,GMKQ\;MOPE-KK3U&1Z**<%OR&^S2-"XZ/D(6/]TWK M^Q'*BRTA!=W^0?<#)+2FV[!.7D^_$DYTUN*8$E+WG0=0#K5.Q[:,:Y-[D"4Z M=Z]G2XS(:)I+C5)I="JHRYGE8"-HU,*8>0&JM#G2U\H=AYV5$SV'9LF_]7(4 M33%>B^L=WB&RK_6VBG4]W!6XA'N49220G;]?/Y.KR\+D[ZNHJ'0.K[-Q+;M# M`B(\D,U@8#_B&4;%60?C729]Q.%A*/+^4,`L40_"B[#6.LNTF/$V,TLOQY;_ M2&-6;C*6R?G'0OVX_BQ?>W'V?'S,QBWZI=JB7]86_5)IT=D7P4W69&*G7_6< M8MW=,)9L!$A!BO9IUI=ALA0*N+31TFK?RS%;[_-B!Q&)!VWD.:/9&OW:BS-; MXV-V3K/5^6)KN_R\EO4PB*28/#8AM(9Z7I!ZI(022@;@)=DLA?8M;;.TJO=R M;%;'9_P9DHLOF*SQ4AOM8:_`M)O-M)J#%V?;S,?VG/:NM_&N^0"ZXSN#LZU0BW)17BKU*)C M/.6(6'W?*9XHH/9$P<]ZM=19PUE'7F=U7^[AQ/)&P=KLGLLBO"#3.[+)\65_ MK5EY>4;8?K3/:HF[AR1_,^9X_ASH;/*+/7LYD[%8W"[/LA2.C?-6[_9OK=W^ MCY"\3,&_OR()FJ.X.D7I`RP.W^GLLVMN_)AHYV/N[V2GX0ITV`*$KP#,M/=Y M4`S7+=K!"^(J3XW0<&ZY_5B24>/MTXS,2+,R^1SFW6\G5#VW)4C+#=YH%0^/ M4=;=*<#A*B232%K\+B`&W::5"4CP<6,.#(TY&#'F@#'9*=N+;0YA$Q`^:TO? M;.4M;+RG,(S@I\S,[EN=G

4Z.LPR$/*L,WVU'&73V(^G&B9:?=D>M!1/4` M,CU`'3W(J1Y41`]RK@=[/BV?ZDF,^"06S23&'3VH"+N^=9H+[\.URMMU^'_TE?;1:=`LZX"MJXV>?1LKX0#7V// M@&;-JXL&S2/GN&="<_A+YGP3OLSBN)3]GK$,=NM!WF$>,[P\5Z3BV4VVRXL# MDV1;TH_+UB^[/MPN/);R#76L7\NUUP'H]`!^J?LX5Y92([MT/F%]>\=38-K3 MT>D8=5DB$NY@4<#DOLKC7S&7FX)FE$IHZKP[6%`KHCB@-^W`0VE)0\G$4HR< M$%#*%4$EN1-CU"R;(KEU9(N<[[*,2PEYQ$(^4=&^1AE(2")$[!0=L9AT9_R- M_^-D.ZB*=1_M<>I+#5DT_/I4/>8%^BM4O=30$7I6NQ%)M$CD;P%:HI!4;(I` M)1,HT@CD3Y=D>%/KD!IL,_S#_F=NT6\GE-#%DJJJS"/44;GU`;4R:%`#.B1L MR?&XC9\KS`I$^WU!WQN!M"/7D3:#YWM;;^3!6DOW\"@3@Z^@^8Y7F*@0J4J- MNX9X4T7^>6P&IB0?\^WBFFE:SZFU43._Z^=-69ZLU\Z:*(AULY'`=,UD!.&M ME^:"\+42*03QO4[V<66R1HZ!RJ]NF*4^U5(&H27J#*$R50DFZ^D"(G&ER74B M^=8<@X2G5I!SF#\X/QSR;.H9B1&U^RS"1C()&706 MMD6E%W6S.`M14OE4+X-#@S[N`CL"F2-*@(C.A',AF:6-"%N M94Q`IM63`#8Q;4IK%B'Y$\1K6'*3/<&RHG&2YDG6U1UXS*"ND4R5'IW'NS-: MT"$.,>NYR0S*4YJ;3]^<:YPTJE!V.N#-197!HKS-LST))/JQR#]5CS=/ZIK! MIM2.KW5,91+.;#@AJ"D!(:4A;8`1@YL_!U`*:L+,]:\')DS;#(RMT^-C=!4= M416E:CR-M72+G5%>ASBAC0!O%0H>Y*/GNG MJ3@N;>^X\+B<;\$/PDT!;@N:QN`6W(4"`=T$](M[&XW^G*4E.J6W$+.(-)7G M1QHZ7C!&.!76!MP&\$:AS+=TA/O67CV\,V;X?T4'6/X,#["JU#,\TM#M#(]Q M.IQAV@:P1J',L'2$>S.L&=X9,WP=/:'D]K1%F7J"Q79NYW>$3Z$2'&D":)M0 M9E*;'^3Q?,V!F9]A[5M,!R/*9N* M)UIZMNX=\.Y!TS_>Z,:A@'9)V%CM2NPQ,VO/`C_C.8'%QU/\:Q+!$F_+M9L7 M!8GK78R*>W$[PUN#;O-0\&8P$X,-CN$TS'%\T,'([1DV<^ST"%P*+@\ZA.;P MC(]LW]U1#:N[D]J;K()XSBK3JNF2]L[/865\#\%1MPNP!KIRZ(6Y1R)MXD6$^3E]MT`8T);G_?L"ARUU]%!`4U@@ M6%[9+TJV';B%D(UD0SAA6L"(P14(>[V:-HL]I$VCG+M=9,@]\]OTX M3FQE+Z<0]\)@>$D/!U\2)J?.<3]YSJP)GH'0&RQ@5J$GR*+N\93@`?@'-1K5 M-&Z1I^%?W.;SYAQ#A``0BE#09#(?/>283\;2*/G#!)3\(2"4_,$:)7\(&B5_ ML$7)Z&0LC9(?)J#DAX!0\H,U2GX(&B4_V*)D=#*61LG;"2AY&Q!*WEJCY&W0 M*'EKBY+1R5@8)6_>V*.DI?&/D@[_ABAY\R9DE`SG0XN2\""9OM-%42EI/\51J><8CJ@@-V.P& MF8D:0M^I)F:)E5N*Y3Y2S`"!X[%BQO#SKE-,YRL)14>8^(.0-O# MJC7JG5*F06E?0"*[U,]IF![JZQQ`!Z2_ZT-^RJI9FMMT$9[.MM)-A"[KX`5@ M=C"/UF@=G43OIQ9=%Y(MC7_*4#7Y['&DHU#.+>223CF%Z_M]M*<@3R[.)G6N ME#J`LPL-LJW.'C6P]I7QOU.CXZZI5"(KI6/?A><:`$KIM)GSNU5V6O*5SXH[ M@8CI4C=M\:HN&F`*UAF1,.\^Q[`L-SNRG+=K=ZO_V"J02(MH+ZU69=.#VR@9 M*]F&R&/$9+&CCEU+WUT4VAX\UK3Z`L0TJFXU2\Z/\(@9HW$`U2,$D(F]A1G< M(9(E)7T&^2=:IWG[3%LD9#A0\QG?]:WL];07+S552>>\85(Y&/>PJE):W7FS MJU,/;+8IVE,$C+GC"_3I^&W3//FGN*MMKT2AF]04G8X]FJF_I?$PLF<+#\A- M!8J^D2M;\?'N!=7BYVTWOJW:$C:B_QYN,0.QO.6CCMNRAL^LRR#LGJ'T$P(, M7J+5^P)'8X[-FS@<(R:/#A"K2,+K79'`D[XE#-\`VI@*$_MG;R>\I%[A&;>9 MM?Z(I[5XHC$T[T_5J8!UB@?E_;IU7SY3MQC+JZXT4N=8Y[=B=43[ M\'TY[TKTG:GHGC+?V"%=D1EG"LS=Z?9X8/KF$\E<^HB.RL.E"7TXUV4;^823 M%\E#A15HZ+4'+R[1:SV70]1.G,A`K@P_P$_T3Y.O"CL=A'5%V)5LRBX;T[,6 M(=\(3A.R7E=T(@9S_2>@U.K:3P+168D_FY6JB8@>YIJ4[7G-:%TG!3621YF* MK_,(0$@=ZG&G.D^TWL:+>%]Q1[3LC*(9;3LGRL:J0.,=8VPJ)$B8^2![4;PU MS?'?\$]'JF.^]YHVNCA(#FNKB',.SYI7C?2#FR.]_<33(JWI9T;F^!!,*X7T M#6L=5@T8$7VL'T#A/IO)Z1])V,R,.V=O_2DJD@?\E?5GI/+I!NV''C]Q>RZC$B;8QI'$YW0561<%'F%Z4E9> M/K=M[J)G&MA(.&_9SQ("Y@_1`5[GAP@):U#7=3O+Y]SO)LXS:I(-,@/X+ZQ9 M`.@^)V8$;_WL@%DTB8XF@[*"P'?Z''GFY+'<.<%D3=9.@29ISM+9D@4SZ+;CG^7K-/\P:+X, MFD_CW]7':OCK2Q\'O&7#F<%]5,%$?2?O8U1+\"/N'[/VZMUG6,0(4[VZ(G\;@\/$(0)0FB",L+4.!]8DQ_0!D]0,BDG>LI-THO#ST=4L-ORD`]ZG-C=_E+B MSN@&M#G4",7UG&#MPTF7!7#Y;X6W+9PP7J.F],)P@;H86:!6]0JU`IWOK0#[ MHN<++%<#6-96CMI!;$DA-F[8!C[#2#($06VPI^J=]>YZGM*]2$OU,T3[1^R' MK#%FHSVL?96[`BD#KYQQ\)*MFF9LG=FZF@_`&:G_2DJEH+/%B%6P<&H"+4=; M,RA_*Q;31/_/:$?-E=^Q==WJQ=M:B_<1D@-9O'&XRK.JB.+J%*6DF+887 M;OQ87>=C[L\"-UR!#EN`\.7=&GN?!<5@W:(=!/^!;7`)?HX*NH,/WU#[,26C M1MNG'5DD1H2$IB"6[7J=)>2#^+LPBQ$T#1?1]^`K!+3B92$EMC-HLO\)?D1%M7S_6G[%QA7#_FF6#]%*"4\O<^+#?YC1%B])8=> MFDB4"7UYR&AB+Z^8\X/U`7@GY*`V+T#3#XV\:WH"M*M@8E\F3[B8"636;`<* M<6V(S*3>PH:Y-,!E&M"#"829,?&SP+YP&$O][9OL8X[7DQ)[QKI"X%("UT7` MY9Q+L7:3@:9U*&$LVBD8%/XV&O]%('&'JJK$:IB80D(@\`4)D7,5))K6X4%" M,@422"C'?^9#%HF#J8UR,J-U_Y#%0)ZQUQZ*344XD5`V\R4\=K";+'>NUFU> MEBU'S^_*"AVB"F]_[O`?R%,,TD#A7!G2.W>G3.4:HI'\N@/!YQ6H2!'3I#UJA<^@!3H"FC_)[-&;R\ODJC4KI`9,1E<<">V,RJ"KJL8C7 M[3.@%/Y/CBQF15XR3S,E[K#UD9RW:DY^.FVP8^X\&<08R,Z.BL+[P;^'`ZD!.)7'-2(#1SZ^.+7`ZG MLVD1RK9/,K`]#UTYJC,F]1IF^0%E^FD=:>AV8LF5S.Z MLXYU4%X\Y!\A27K+'D'='U-4Z)I@I M]LA98%"UK32A]I-A2BO3Z&-*3O7[WWW_]I]X^?;5&`;]>YL6$S>:=\EFUAS" M\;0MX6\GF%7OGO#_:8\U1IN[!]PXUP+"FF:`M@OH^$(Q[`)ZM&,^QRU*R=WJ MZ;!.GE"9%YI'_++6CMT@&<^"^\,;@KIE*"N9>M3[OH[!D"\P_[=YMB=Q>C\6 M^:?J\>;)#`F%&HF,S*'+3G6EH*QRZQBG?!(2:-FRS#M#G`[4-!B'X>^LZPX20LB8R'3[DE,CH4 MGI'1Y=T$&;A]L,@0YD&-#,DDS$#&3[!`I.)0>4II*%<:JW$A;^\6%0J^AYB@ M34';=@5PZU`0H1O_'A[,!G]>/,TVK^#G4HN#L9;.8V5$7D:JX26ZB,)27B*O)8^F,M8RWD<;G@G36)0*-5&NEOT$2)2I5'M%E@-YAK9 M>CXGX'5JV/I9#OEN%3&K>A+?AWVWJOQ\PH'?;0A!J:;SH#GYDTR".QP-"HA& M1?&,_2RQIF=2%='EEX#Q;'N]@E`J,@^5R912B#N>ID!T'26Z`AT2W[7& M'`CC4E=,,"86"C,%F#M=N1])&XU; M@J8IWICQQ@$X(9HI&*+(:/P=1M%"[`F=\`90CQRQJ?MX6I%;L38]:Z+%B"O; M:<`SP\0?_6-9A@8A#%@)!8<;L2@EA1HI,^-IK*4MW6^[!%XET"5%X+!7^9!7 M4>HYAZ8IR_Z1*T&"L`-4P<"EBUM6F]V/>9Z4]WF:*+W:04L/CNR05]'=*VDI M:-H&D$9!H-><\3UEO,2-_`-9`@W1&57@PAV0Z=;WKLAWRBC+7BOG`.[S.,0` M_2M@?SXO;"O2MPZT)LP>Z9_]0W5D\H?2:9V8Q<706-<_BJ M^!_BH\UO4S<.Q@V>)@;DC0/PC;4X&F+?$$0N]WHEQ$(_KK/D&KM`:7XD.U#. MG7+CIZ3SL`M4RR$ZJ:P]O3GK4-1*$H2W,DNHI*7PKRA&,!-WE,88<^C=P`RK M<(IY6B<'E"&BOJ3DEUYEM)3NO2"M+(*SP2@HP/HT02G./,&B'HU_Y3&$G.!G MV>#-H^]EXW.%X&L9^5@!;!O.P+A7W\K8I_*.;'9VJ\D5-=K:'[I[/,MAPJ]= MOB8-OPD)Y$K^&;N`@`SDC"+/`KB>5R!&BG(97-SA_$.>Y7UNN.89[*(-:)WK M@(D\0F*/#DVC%)SLFV`VV%,DVU2/L`"(B\0WV]\$L-DVAMU0=2PQ-ZMBN]2[9\ MW52;`J%6W)/JGC&_K=CF19%_@@G8G;*D!%$@*C$ZLPZIA(2`J[? MM,SG)]P@?HR*/6X?[2.4D1&)"E)AHE>&,XSBFWH=&]3D-E,PAR<(9(3)^@W+ M3?;N,[%*)U0^$G"PV&;5&8*>UOTI@H$\PG:;T#`O$F+'+,]`G[`.;#^SAVE2 MHV>*>,0:?IU2GQ.+AG5PC_?=&2S+5X<\03L4LRI'6,@$=^!_:36&I'#&8(=' MMTI&^-IDY'I_L[L\E8A,@$:WQDF\J)2$^S%-XMLQ@K5K5![S$M7PJ@D]'\=9 MBH-Y3U!9YNFIEJ-Y/Q>&KJB0-:8B>EBY#@\E'+W'LK&4P">LMYMF7ZS0$1-B M3T&C&HDD\:/=DX&6$K2D8#TH:7X7%=BZ!7#T,4ELLC*1A8E)'+<2AW0L8@[1 M\4A:%;B>>-C MH.O=#W2TG<99D@4'?V7E1_5-?-)S#A89`+X[I".5=$G@FY!YJ@QE))>9IY60\Y6&'<`4ZI'X. MKV8*=XL=RC^"H8AQ^^8*->3^%=<&EF(A,UM,.KP7@55K,IKR:@\YJ7B39]T$ ME9=1B6*%YEGWY/[.Q%K6L76FOS"W=?GP6LLZ`MV>5H#V%8#K/5]ZDOHG3U%" M;`(]DZ5.>31P.&(V""6I$\P[]*^^$V$NW,K,P;@[I7['#\+O8$'+-5-F2$0: M2D]X[A1*K*5TKK1Z688PK2D`)F%5V+D2LKA)1A=$R)>];%=CFU^FA_C'GNZ! M"[!MI$Y8C^!KE($D3U-2')T0T);?^-=/0\0.]=$*K@[S88RYW0:>>>V88W$& MDE#I%'I[MB^ZS\)QMK$3BF&,;J=7P'CGW=]X$VLCF!EF?WQNNSV-9\&'$\DIN-E1GC:GJJPP!+`U M-_=6IG;HW*A-EGRH8W5'@/<$6%=L) MM2'LUP$8CGG0']J%)7#OLK()SQ'"T\WT"EX8A%\:TGNH;F(FEUC?I$[_LMGU MS@KJ;(@A986QFCRQOHGUS#E,UXDR=#@=M)47!^W28\F'U==F@A<)X<\^7"8HB;_V3]7``HAIV]>&Y7[BLDX1&*47I7822FXSG MQM?B1D/G'$`Z.82R!DU[0`@NL&=5US@(!U1&DS-$E\7,N'S?7D4H@TE]NJ4O M#BPA\/"B7<*Y^.J;-03-86TX0%(/O_C@6S_V3I\YD>,`+&Y*'XZP.'(M@-1D M/AXWJ:08>=?4:0Z:%Q+A0,ID6D9>`!G.B<.M'-U/=[:8JFV;V-;]%FV$7V$[ M1MNL!@K!OJ,IWG4Y:65EY)K^J3ICH[ZGZ/T!%N_F'Z>1954,&DNH^FO M1_1SL9[=/O5;9"Q&2\VR.ET)8-T"UB^@'7>CD]@)8],WJ9Y=QWO0/_FXY#GC MR.`^L+B7X-B,0-R(/@AUH0?,\2,FAP!K\!/YL,\7B6<9$(:'?-<9$'[HW!N7 M[M56@`\1E[,HO0>+2YN3Y6TF^\I9C*9=UT%83?+])1K6*6;'Q+).MSES:D(;?8X:?9D)M>K"<;5H M*^D4A^TZ@\=<2V]F;YZQ,&&=)$T`[0[+P[6IO;SB56K3!X'QX&85M#>K*\"[XOLLOY%[2XA>R]-Q M^4M8/*%89I_7I]DRB'UG]N7OO[5?Q%E$,,? M%].$.?D=,0/D=HU\IWFE2'E8E_6M\EWT3"R6S'&VZL)Q!D@KZ80D&YR:J6'' MHV2G_>NR#2;@G7CSI.<)VM=`LO36V17!\:R"F:60G"5;RI%X2'`U%A!Y#4&O%T`S5VX*0#KR<\"PD,C7_=2;N,.+;DAH MK7<^+<]\(4GR[#U-G4AU=?T;JB[[1]OX@->!;P!+_,P8/ M;A`2<,8&7(H8^6@[A`KGX4]9>80QVB&87.<'O,E2P45.XQXR"OYEL%F!3FOP M"VL?`HITNX0D_T4M2D6..$ MSGQD(K:7>"P9,5T2ZV[`Y3/XFO0$;K)O0-,9:'L+I\CC$@-`A=]1?Z!;)15+ M'#7D(=2`G`SOD?3#L[#M*33P(SF1C%$*>^F3'_+EE/X\G_,;8+C?BME,*N$NKD.V M`@TAC=+OD@:1@GT!&:E@4:>]?SVVP:.0=-@:C.[T[$]9`:.4W'BV%0JO88&> M,%=/RJAD+:5S[=++,@1=2P&Z%30W&>C0^2T%9"_4^P@5_`HJ:E8$5F6V)@,I MBK8H581%N]0M0PP.UC&:&-S>=5!4@H@$GI38?6.9Z=E#?QX0 MUY64!,O;ILI(XR'D6T$621*UD=TA*G9JAZ#2F)>L$/FUV/Z$L M+U#U7$?!R#3>B-2MZIM),UIY>4,K2#?A7]@Z@EL(M7"NUJVT+^>:;!6OCG.0%-@D+P8IJ^,=+9!2>+8'5!R+Q;, MK5NS%`RT_;DC/XW\@?#%,',(%I3#M_(:*$9_/3?5BD4\=_X^N+1RWD>)?/GO MXQ*H7/B:(CPOWE(6O'Q]JF4)SYJVL.2UBPH2\W MNVNXK3YB@U23$"-"B$"/"E`RS_6Q[84B MYT.`*=<>/<$,EN6K0YZ@'8J;5QWD$;W_XS!3_`EU/:S`YTZ?;K*X@%$)KR'[ M[TVVCN/\A#G]"&.(GDC!7X5.F9$[URM#J40GCC4'7]>$W^`]-:AI04OL5\,F MBEL,?TV=9D9#%X"&]>4P M42V,O0[1F>Y'YVJ66BR)2B%.]!RB(HT`3J]!4K3Y5)U-]0B+-CZB+*'2`33M M(`!EDDAFJ%64NANN1.D#53!#4;^^Z2I83B6,3T5!]F$1)0I1UU0(U2N='IXS MSE_:SPQ72>RKDB42_UC@33#^B;PVYC^]^WR$60G+=8;_4.'!OR6TFVV*]K*P MG[-^S>V)S]G&3$![UP'E.M[U1/GG5H!_`O`OMK^H/TK#==AG`?TN:#_L\;S) MV4@VP]?U=(_U\$5\M([L,RRVB?\.\H_Y/,ER-DPD%I;GE.U.9L+ MTQB.EW;;!C?-<-5ZO03GK_5EG.BT=3H)(G1TGM!]69G[5L>Y!;E+TJ+6UGV3 M0C;$EV<*U;3I)."79I(UL/_\8UL__T"2YQ_GU^!. M?TL6F'*^1]A'B!=Z%JKL+!1E54ML^2RTZ2S$-UN+#,#P6>BND3BHMU;3X6VH MRL;8GE60)8\A3,KW6+Q[F"%R'QZ?"IAT5T;#LTW0A'^C>'ML3 ME!&+PF0E&W[4C=OORTZ3VZ.,7&C3H)A/CRA^Q+UD8`OQ5I\=*K`LN1%H,TIT M3@XRMATH63+XYQ7`(X3B*$V?Z;=)#:KJ^?>_^_[M/Y6]I-.[@)0U)EB]X_FXGH0Z#]@VY]_19T"XJ&J3D>P6V4E M*?(^X&'!_R2A%R4]H\B2$9-RC<%O`W7/W(Q(W9XXF$DCJ&ZWL@RO.D>>T-1A#^=Z`FMQRC!+L-Z#7M];$60:CK;HWJ*V+OV541-JJ"]<&Q$8Z M$97=HI1"<6G2@Y.BTF8692%)L88):=M1-BSA[M?$S!&U>/)O M9JQ5>&!N)NJON^W.IMA'&<^TU2MC0T*;6&+^B"4.X.Y6E#;9H;ON5I;X.?J,AVO.^&/%>?;*0^C/=32+@NK08DN&JW:88,8 MYX81T'+2W8T1F@XSH.4&U.R`7PA#@'+D><_VTB8@=S4!+O>*OFS.<&_IU^"X MS!BZK5IV34RQE,)#7E`9[^)KL&W5.R8*QNB<4P:WF3Z5.!*3>QJ`R*$6H/*8 MEU'Z8Y&?CMC_BM-3@K64<)@3?<5[0!Z0ADV!I;K,[MJ]7LT?C9&ZF+1+P/I< M@:97T.T6M/VN`L;Z0F@1E&)1J,QY@<8WA'CU>D=C/&ZR75XT1/B9#7R/&?-S/!1*&T8]PCP@TL^I# M=)`!9+RI4W!(N!T"@QN6MAT@#?U"0C7073CH1_F\4+C"4"RB]"9+X.?_#9^5 M6!#:>@"#R*\$#;PAH"T!;AH"'B2C+0)".=3G0L05RSGP'OM%4?H?,"K>95(&U!:0Q]DH20)K[A8=NZ+L(,1OW\YJ-]RB%Q17^ MZ#XOU$9CT-*#R1CR*C$8M!FHVX5@+48'6;05BA$^%P@>BHCLJ^Z?#]M<&'PN MPZ"-TXD?\B<\!F!_!ZR!W[D>'JK**,<*-V%)2$ M/KP&M20R%Z(3D+.J;\\[E"'8"),Y&G$OC"?HW+O5!]RM9H?*FGC9E7+NI#M1 M\O*Z97>//)>23[]-(9B8&;9S.[9`_H0Q@_7=`&OB=W=&Q M[$ZO8B#/K;DLL%R]19"T]:++0WZE2LT?1(2Q,5".]IBB*X;ZW(A@.Q+&P'O\ MN['(.TU[+\@8XUN*#KYWY""AS<-`B'3TQU"B&7HW2"%[5W.<=%I[1$F79QU& MZ/E"<`@11EV.#\F0S[@76Z?'Q^@J.J(J2M<9=CG3ZB=XV,)B!`(Z`K"M`6\,>"MP2^LO>^K+NT4].ZW#,??X7OL/&L2^;#ZPCQ=G"*"0$'C_K6U M@G_AI7&G;5/.FS4@^QE-MDPC6SOE>`-XY6@/78-$A4:XG>'1 M/)`Z2#M8"&\0'O('>#CF150\D^?8U=@UB74/;GT>*]E&SM@I\>B;E2H'5=T# M?8DORY1Y;C7[8N0T>H+D5-`7\`3)7GE[SO%4S5VV5G!32E9F8-0TWJL#=_DW M+`L<:O5GWJ/"4IL!-_REA5T)(^+'EF M_V\2GF[?E8<,7];2BDFO/O7>/O4Z6;&W4,_@%_[?8!Z'A">YV_1?TU`N)@&; M`W&'`<^W*(,WV`_1G2B/D_@.?.YR;Q;\3"@`)0DO`EJ8"TT4M&0BYAPV"X\% M5?C0DS@^<%9R+QPYC[U+#0(>IE/1/W8VG8<#"+ZR-]\D>']C^!*M&=<:D7D)L4N_IR2=+8[03+.!Y.,VL'.K,=QGV2 MW(5I+E$PMC+3`:?"%) MG7SD,>],%OS[7_'/^"?\CVU40BK<_P=02P,$%`````@`U7US0]/^%A/7.0`` MKKX#`!4`'`!N;F%N+3(P,3,P.3,P7W!R92YX;6Q55`D``S+.BU(RSHM2=7@+ M``$$)0X```0Y`0``[7UK<]NXMN7WJ9K_D.G[.9W8LA.[Z_3VK^^VR0>E`2-AXD*&RR^\LYZ82`L/;:>"UL;/SC MWW_,PS!)$LU]_^NWQ^NW93V_^_;__U__RC__V M]NV;SRQBB9^QR9NGUS=7?N8_)O[X]W15_@T4__GL#?_#^=NO\4O/])@ MZ^OO@]6W1^_^UY?;A_$SF_MO@RC-_&B\*<6K$94[.C\_?U?\*WR:!K^D1?G; M>.QGA:F4[7J#?L'_Z^WJL[?\K]X>';\='/W\(YW\!#9X\^8?21RR>S9]4S3@ ME^QUP7[]*0WFBY`WO/B[YX1-?_TIBORH,//[\\%[7O[?KN)Q/F=1-HPFGZ(L MR%YOHFF37OH)5-V\F2X`6J M>V&W@?\4A/`3)LT3E;;0JH9!Q%TG!1RYC^(UH!D-'P$Q:)ZW%0BOO&1^;2NP/"W`3 M@[8)RMKPL/PI97_D@/C3"X=MXE][12VTYRX)P-P+/[S(TR!B:3H<@[>`[P(? M#\$L"J;!V(=Q8#R.\X*=NS@,.#^K_S<`8.&W+"#^&F=0H__J/X7LD?^/"011 M81NC89"."^?/V62TX),LC+.I<>ODU;0S:ILW$J_#RK@4I>`M$[Y,N?!#/M<_ M/#-FU-$D=;0RQQB;$*^BG?G&N(&2.ER.65"993`^FAA6M\(VK6ON#NJJVIF?S=U!5DF[N\/:QC6H MLXV=8^UV*VMJ85=9WX,5%5D>*QXR^-^"TM%T,S'5'">PRMIJ\V@JZN]3ONZ+ MQB;"4:W:6V3BTD^?K\/XNPTB*G6Y7/D?8JUO?1U=<^7+O;Z$I6XV$\89%$S99-9-7V5"U+I1U^-TP'F_]5,@U_3A1&83_C2?[@>%3 MRD\SLE5%H?_$PJ)Z3[NL=W+^?F,BW<8NS5*<,J1L_/,L?GDW8<$[WG[^AP+( MV_='RS.&?X._6K>FTHC'TGGV6B_['!I\M-7@*JO#9+OQ?C)>50]_W*-T^Y1D M^<6[1;'@>SM^#L*U-TR3>%[+LLO6Q+K`\A2:&"_XW_+9+TY@+/[U)_@'@#EE M2<(FMZ6=4!@%AL*8S7B=^NE346N>OIWY_J(DEX59NOJ;79:7?^VM1^/+T$_3 MY;0R_!&D`JJ59;S3XV.7?*LIVZ98$Y"8Y^-.\5Q%=A7/_2"2$+S_,1ABX))9 M3:;$]&)PQ+P.'/#:8%R&R9'=@$U$'595!/I$I_JK'AXQK2>$:2WGI7LV"_AT M%&5?_3DVU8H^]4[?OR=(XPXM^U3B6,04GI*G\!(L`.O.&UB<_OB?[%7*X:VO@&;G'61,P$(,5OGA-E:S@3Q?!Y'I9[]#,9*1WG&HRHY/OE\*"D( M)CGO(J^ZR!`EX3UAME?F>(1J%5L/_@G@[.1HNH\!X_!`A^[3"<""*&4LE"SC8COD/0)77\-Z#]TG\X=.`B9320;L,R[ MW6/`-H\'!;=&C$X%[0CUFV;<1&F6Y*N0EO]@DQFL%Y?'S3RL!6@(XS1/F.1L MT4*MWM&YJT.+&JWFL2@7T*3?[1IC7:UW[%1JM<6G^*"DL6$LG8B^L.0I3MFM ML[%`<%G+P5"PWPH>R*'1V^4%O9U#6N>(S'JO=AT>E2-+)1G8J;0)T+YT/=&5 M1!?3\-K,H^EE/%^P*"U0WK.0![%=QFF6%F(.OZ8[N?-?R[%28R9N5+%W?.IL M,M9M^$6UX5KS<;.:O6.GRVF+Q"*SL@7S]&5TD%T)=C!*R*+.39;G1O5XQV>N MQH!*.\TF;7E![]BINE^?!7&'U0#;E_ZX?PW>1B#M7JVJZ%FT@#?WLNDX&+KM],&G4T?4L0;G#C;[NTT26M[AY7Q M!D[/-+3,C&SDI)#ZTFV:Y^]PT,]&RRIMJF<72=2$*'G83C>,Y>_1_Z"]6L"+>"0D5JVV/D<*W=!&I ME44*-#QA?LINHF&>/<=)\"<_85W?W]`624QJ\4Z/>[UZK6T2.G>@ZH\=G_PD M"J)9"L-G<4BO/X0H2GHG),(>VAY)=*Q@Z_H4A;GF*_M>DQZ?S)D$D>LM&4 M-ZVPI-;QIJ28=TI"\Y28&CG?5&'JRQ&G-(.^HR#5_?;`,`G_L(A3/_R"A?WA36=I.,EX,)/#P01]Z>+O6V?GLUV*H*W#;'UH5VO6-ZG2.R6QQVO*HWK98&R4OBPI\-=DG%PX6Z>77F^M M[N(T*-Q-Y]J9NKAWZBQX?=T\+)6M^$/OE$3,BK9QD MBY?R/I`(_D`H0_JN`@Z=)+9-B;ZL1;2PE/>!Q,:Y!M$X'#JI;IL2?56+:&$I M[_2(Q%%$#:8E>.CDP[6PX+J5Y!W'/_8^D`B8,5]B;2.@DPJW/I/#-&5:=UBV M/_0^D`A@08@1LRA`0"(&Q=(BV4^?^7UE^#^>)N3%#PMY)KOTD^0UB&:%A"); M-^N4]SZ04*($3"+K9VU0EH),*'C"\E@[O6=C!I!A:/O*LF52;UD'EQ3S/I"8 MB+5Y5V+I4ZS(3<3OD\;)*V"4QB)N/O,^D+B5I\WG7MO;"\1P$;G,%GXP^?2# MYW1A,%R-LF>6E+91=UN-TMX'$MJE-MNZD&PE]:7@!+IT;UOA(PFI4G]8WFN\ MK82^69SY(0$"E/N%5)3[ZF?>1Q)BI!%E8M;W4"',&BM5NQ$V[G9$2W3Z>Z'M M`MY'$K*5!:XE^!#6.WEC"V`F.;1W8S`MZL5EO(\D)"\[[$L@(@[025&LR,S" MTDR[XXL+>!])R%X6J)?@0WCOJ@3&/?S!#_W$I-?O%/`^DI"]['5Y$3XD0J23 M4MC5LL$\1V&4:_1W<0'O(PEYS`+O$GP([P>6T)#K`$M_7;T*RQMY'\R>LW3T M%`8S'[G`KUO4^TA"$&O`KQ%2A.E.ZF3"(&&=?HX7\\Y(J&A6>KL")>()GR=D1#=[');@$)(-5;;W).Z'2"EBDX0?.V= M]45YP\`A9'RCOKBQBG`HFX@;$BYUZ'W3?/S>IZZ%V<%,QE M61(\Y<7ES\?X:QSQ.Z/0>FC*;*5=U'KZJLD/>6=]4?Y:L`OBG9V4"RN9B)3A MFY_.\>);MBDV#<2#S#G5A[XR$6GDP?]&T".)!G50U[=BV]06Q M=TY"*3V8)UJT&N*MYH&.SI=&JFU(@Z`Y[[R'FBR.%/$);R-NDW/TG\*!OE69KY$1]2]'*4:1;WSDG(8QIF%1QLFF#L2PH@ MP8O7;E,*4GSW^OR#LQ7:.DW5YI'E*H""M=&B3)ZW?/*N1F*PNI5[YR1D!@OT M(BLQ.Q;JRV!1^Y7%*[ZW"HNW)W.PP-]O+2)YH\]K9!169#8=3??IP'*0Z17T MCMZ3V(_9,[E@+:!IA3ZD,7L,,H[S!I8Z+\$$^JS"'TTV4"6GBL5X" MJP_9S/;@?0NRYV*"Y)/7<[!XC#^!P;)79:HSPYK`A"3"8B3\:CJ$#LX^Y$B[ M?`[8]-,/-L[YQF`TA5F=)4!M9P)MX+;I&_(SN0K["DS-GZ.XC">O:+S"OHM0",1 M]%*;%<%V`\?9AVQOL#OC*N/JKDCZ^\7K!8O&SW,_4>5+5A4%(SF5H)K/%'H( M+:6,(^8&*YSJ],J*HF`D$M$M>F3J.H((8Q^>)7SP0Y8N[P8^L!D79-0)6[$R M8!82@2IZ]"$ZLQR:?'3K=*F(UE3%1;;BN-FUTN+M@T M3MBZP?(-CO!C0.=TAX-;7,",!(&MU&V6^\K>('`K22>N*@)(.RI5Z2&SE6C- MZ=IC&=-EO\L(ON^`?`T@" M*]\:75*"ID^9U+IR,^7HB,!"O5ZGMVF!/B5S^\9X,BLV&4)C8.;[FO/]S&AZ M%80Y_&T1!YI68L,E/F98$YC2_5%&36>J!95&*CA;Q]Y\_GST?]PSZ"7C(`P* MVN`O_J.(2WR51T>H"H/!G)YO-/$-770T\L5AX;1\M+R,(Z@\+0*JYT&V61ZC ML;324@#;ZL:U+.`6X!%'0ZE0#9NS]>_B;H[KJ3VG>R-LK`DTC<>$>-YMH^Z#"TX=; M=;=Q-(.>/K]B3]DC_)@BSE7T.1C#O4BM)$N\-L'Q].$RW2XZ9?RJN``8A$0D M.TZ6'KE5-&XOP&&#+HN".'E@XQQ^_P[P\S574B0%D8?G*`L":!(I$&24B(9@ M/5QN+['ID%FJ4!F_=E&,3P9TBHL"\<,HS1_@H8$$<_648]8 MW0K`""2BQ4WI-<-'\]Y79?UPJXJX$W[L'0W<;P$-%T0J-'VXWU7G`=.C@7ME M54*+>.&SC\#2O:PJ^L]Y,/&C,:.R:W>8M'F??#WYGU[K38@O'D?&&_>!YW8O%=6O=O;UIH[/V$E8`S2F_J! MV1Y0@I'^!K\,.VS.N48]8!+26W\=VK5ATM0!9"K&V3+,I('$LUT%&(*T%F#8 MS5&$EM2`=N+J<"$RY5_7EFO M7R78BT:V?T-G:(K8DE!!)!QS:\Q;;FO4&0IEYM7`H9S?VFSYO[=%&4O\LM4H2FW]/L?@R5( MB'&FW*D]H(J/9EZ9.YZ!-`O;]8<%X9O9EBG8>'SF6LZPL"*A)"',&O&IB MHIGOYM)?L%&D"*39^@C0D-#7#!@2M-]Q=AM+:^GM-X^2>WZ/4Y63$RL#=G%_ M2['FFDD!JA=I<(08U;DW\5)@&Q(*FH(\`\:KN&REK;$[W%X'+^P_F9]4;O_< MYMC"1I;>5O<+H;SIY3]D?-UQ`O\CT8()U(";.(^)U?=!;`,DN,,+:W1 MK!QWT3)@%Q+17U+:M)FN8NI%YI<=C.KW0D3?@SU(Z%4*PK18KB*BF>C%QH6O M#\0O?.T/ORHTCG.Z.+SQ]<&]EB3A1=SI]A&TD)G%&,6TRL2]RO"^^B2]CI-*0F[H'M$X M6-28:$Q_`(SI/F6^I2FH'G;$D;J:&7EE#&XEO>![_B68PKVP9CQT"$$@?!I+ M:70&AN%XG.3%B];8,QK6Z@83N@\9.\!P((2->(ZQ,->*Y^SXNJ9/R$L!;/>I M>LW8U@&$\$CCAF45[JK9\)_<,4<1FK9$7LH[^NA>EZNO%&"`$!YI7*.$0>2) M^0G/#'3Y[".SDDV=W23QF;)+R=QMNTC3GWCJ:+N_Z M*A;7RK)@K@X)?X:PD"0FG53["AMQK&PB$_2JGX$1.JC9[2-`:.RD+"<,6E_M M#PH'#K*`I9=^&++)Q>ORNW3YH?'E&_V:P=0=E.RL@$;\BX:`)T1XYR?_],.< MU709.Q6#\;HFV%G"C#A,-X4ZD4D^_6#).$A9<3BR_L?:HY"B.C!J%R6_VD@1 M]Z&A"Q9WHE9K*M@][6R)-R^Z705I\>0--KX85P3&Z9KB5Q,CX@`TY#T4P](J MH^B*3?T\1(G7K@",T371SQ`;0C0-_>\V^(,GE,Y@Q^3/`0*Z4MC[T#LZZYK* MAV!`"'+\CMI>8^_\8%*L4;0I6I<`G%W3[%1@$-(AL\BK<%D M,VAJLRZK!"S7(6&N+C[$,SIV'U4\#!:+W1:F%+UZO5,"KVG9FE%,(",NU>3N MZX%?:2IT)OX,-5AAM&#EJCMU^,JRN$'#:`+_L(A3/_RN4-MV%`%6'.8X3%L+&7 MI0[<`C`RB6NSM7Q#/(P+#8HC\"+&V81BGOZ)Q$XKB#4BS8 M/.M8R>U[6D9.45Y01_,K:)8$V.YU2AUFM`G=1T?R%:TO;!*,_?`B]I/)19[" M4BM5I-/&2P!,]RJE+AL"(E7(W+Z*U97%R7JY[G2!4MDTG)-(=N=PVG%F=4N/ MB359X-AZ1.*%`5+Y$R+E)X"?CU M\B-`3R)['Q&GV#6,I6?*=MV"DOKB\+5LAR+,^OSK;<+!$'_Q@<>9 MU2VI5BV<,I17>7E^/A9/IZ.I$`X:7Z=3&"Q`XOV*@Y,N"MK3-Y@EW68_;OW0 M.S*6!"]0X0N[#?RG(.3SB%)1N@_$[4&O;68U7SC9_QR,0>+E3QE5*G)WT9`\[BWBZO8R6,C$E%61KPA*"R=%E+(LU#=B:B5&<'78!$2"DJM=<\."DO' M?406/==^L,H@(MAOEK=98&`:3:4-2"DQ#4^,X0N=Z)9H^"!T(2*7B(2T'YB$A?2@9-"*^BLVM$&*'^L\LXFN) MXK!F'D3+E!8O[-./!8M27$`Q*@_F(B&F:'`J=@8#E'V(I;>QJ2,FLB@'>A2% M)3GE+W53__B8F%:SPRGF`F8`>R3C"+,^5I[TD;B%JBC8BIC`H^4,>K`L*3YD M7>#`&5./CPD+.F:NH@6U-?'&Y9KA,RRFRIBO&Z^669U'7[WDXE*NK/V&V`H$MM_'3K%O=>R M*?J@"*ZWSJ4EN37BJ%!1Y9J@M!R8AX0Z8)EOQ*G4ENB#HKB#3JDD"K\'<=NL[!I<",F4X"B#UJ?R[*YRLUF251=E MYN7,3S*GPDA3*WTN=*.;J,S[^3F1I^9HX=>`%1+B"VUG1@W7(XFXJ8VNXV3* M`AZZO#94BZXL^#5@A$0.(]JNC!JNJ5Q]7KIRQ&;\.*W3KNQZ>4$BH(ZV&R-F MLZ2VE\N+3U%OW/@;XP=3;#*$F<:?L:WSJ\,XMZP%P!V)T,'.N+S:F(@@;?QZ M36<6VNC&7+B$:ZL_V&L%T$CCB,5MG[!M4*1?=/)=[L;&$ZP%774,PZ8`F32. ME6CWCEI61;K(@9\6_WL)93KKTSA.Z\D2"G_HPO@8C]!FXDEMNB=CT]TS?KH& M?W\91T7<1>Z'CRR9'ZMZQ6%;XQV?D#B;/$`/<6%8I+?0R#Y1V^;E07+E1N$H M>V;)X[,?5=>?;'=6Q6R%/D)#IH%`)HTCV59Z"45;(QV'1DJ/]B;KBG" MN'6CC'?+@%EH'!X(R%+0*H;2AQ#A*C)E?/#^QV`(&N*WG"DQO1B:Q][Q*0T=U7R]M8.A#QD= MMUT5-ANCI,QG4:0>O&-)L7N7$*Q7`1B,ABR(4"DFW@1;CV[K;\,N,*;#/'N. MD^!/)@O*E1<$.]%0PQKX@!A3:W?T+6@^V^V_#?[(N=0$+2U\&%-YY*4`-8V@ M?RTFM0'9BGFCVH=OTC0W[K]E(3`0C=CXQGVWBJ=/P5PBK'HYFA0EP50TXLD; M4[\'JD^12I?Q?!Y'=5=Q&J7!9+1T4BT_T`9F*UJ'F"\8K-XDII-B`": M.\WAZP>MI5#[<.1,V%RG\2C;]87!=#&YB5Y8FA7Q6OKYT605`$0B.HB:"$00 M-<#9AWB#>Q86*7[])'M]3/PH!?OPX*6+U^J_*`(0]"L!P]&05PQH%CN**>8^ MA"Y4D2E#%_8_!D.04%I,J5,[0!4?R66LC&!1OXVC&(PX_)_'W M[/GF1?XHG5YI@$]"3<&($4FG!L#'!1L'?G@=P%^.805_$XWE5"D+`F@2FH4!Z=XPQ/Y'B"2D!\,:)-#<1LE(&=+BZ(U&!(B@3DOU?9; M.J6WO.[P\_"6`=1`\>[MWH?>\4<2L30FJPDQ!DM'Z':)^1_^G*7?V)QE>!Y; M\8<`BD2\BP$Q"`9;A^)VF;GR7X+);?X41')B=K\#3"2T%P->Q!!L'5T?=@AUK..8]5+,?<](*#J&'5,&!B'K4-H.R90#9R34H>:K)@5$ MY#S_4.(1D5P$9R0D)P558GXQ.`BQW0KKJ0Q:AA>7%27!1B1D)HP]A&L=4`CQ MW0K1J82.:E"]\RW8@83$9$JN$`9"YU\^J<@9"97*C&(E((1LQ]$YV^WE8?L\ M]Y7J)%16"-"2$"GTZ-/%@[#G.GXG'"\3G)C/IF85@!5(2!8&K!IB0QAV+D05 MP\HPFC0CVK0>L`D)X<*`[WH0$=H=1PC=P/@39<$+*^].AGX$OW0JIUA6QCL^ M)R%L&-"IAH-0YUB'$K;[8PWJ/JZQDI`KFE*W!0>ASG'$D;#=9S6H.UMC)2$^ M-*5N"PYR>DO($;,I M0(&P>"C-Z$"I4FYUA;'*5)T$T*Q\@+I-];>"/ MIA6K%*'!00:+9NFZL4G%8&@2DJH=_[)A"\3IC$6]#'Z+L,N5?W_-X\^3%^AR MM5ULKR(P(PFI]P`NA6!'7*B3F7@1_$7.60L^)*X'S$A" MS;A;27"Y'(+91+9.4I8%;)EB1YS(0I)A@DXTG,=Y ME#5RGV458#P:.NUA'&<+->(RW=)Q[;\Q,*!Q0F=K_E$`19S@[P?#JH8ZZH;J MJ^41.E@1ISCP2V+6!XB6'J09'/5(Z-4&C*1Q[;?$^UL49%8DW:(B,.1?4<*M M8$>]BO_@45CAKUU:%H%&*]'0JT9:L1E#BS1(F&@GWZ,&8^K$AV7 M%6=D+.%!DOX,??%2OP8P1P^DUEJ@$1\XL,B*7523C8,/+,O"(B!G-%TEEAD] MA<&L8$TTM32N$TS6`Z'5DAD0SSFP`&OF.<7@9]=Q=*H$@_5`B+5C!<1M.BG1 M%KWEPD]YYK(Y3VFU)#3QHUEAAXO7S2=W_FNA&WWWD\FHP)]^YI%DZ4U4VO!S M$J?2%;']7P-*>B3VMF8@Q&<[J0A7=J7+%T7*,?\>B$]>BF/8ZSS+$[9*6:"W MI=>K"\S9(XVX)GS$FXS%8@K>)#;?Z#O/:_T<+*2+=.,ZP'P]TI,-82->T[$@ M8]FJ\RO[7OQ3;55H78$W..Z1S&R"&?$2QW?@*P/E.M9G-[\DMNS6*0O8>Z`; M&\)%WHQJOX/;I^=O!\<#>MG;M8,6/ENO6PG#80[8ZQ:") M-.0O#4.*MJ0ZZ/KP:&VQ5]%(Z[_U'_01@^O"FK'*OFF*;U8U! MH@DWX5=_KL[]W\;/`1DD5"V!A]34!VH;@>3CMX+IU32+QBI=X>"8ADS4&H&" M:45A#9+OXNZ,KK>2*YO2[P&B4YVF[J2A`NF+$9CS2K=-'N2:PE&>Q;[[C06S M9Y@!AH#+G[&E[5B1UN(PXZBL!<"UV9Z,QX1[QM5? M^/O+."K.%W,_?&3)_%CEY(=M#1#J])"EF<.[L!7B_$1N-+0VQV%6P;7_PS<% M"')ZCN1&>*MM*,23.YGBINEP@,]_F!%E.2TH6*`[B+H3=:X(!V'<9HG.C%P M1O5X@Y/W+83$2=J@&1VGJ@$:3B+.M(:UI7%S>KC[$$)WE\2P8\]>'_*G?[%Q M]AB/DN$+]$&.\CI.1O"//@=_RP_(%&%VQG6!&0F(YX:LBR>%FMC[$+EG!%T9 MF%>C-C`EB90%-7W`@D-5[4`R]&Z%YB:ZCZ&_I;`$4;U^C!0`D"1BLVOS(YAX M%&!)1M9MVGP79%DZA5;I,KI3`$"22"+0#J-"L&YC[B27DI#I[U85-ZE3%J`3 M4.X:S?:&6"U%LCF=W6_C--U@?/V49L'"M_SW@6G3(@_&$1!EF3#3PR+.W]AF3W+2\`MC]W)O=M MQVY?O!:OY&';<(U2WN#4?X\QD`(B$&[-E8 ML)(4-IWD;N^*1?$\B-1L['T(H$CLUW7X0!I/@P();NF[3$"GJF(/K,.R5PDU=@8AD1U99;NF!AEXH+-HT3MFZO M?#`3?@S@W%^"%1I<0(P$@:U;`DYW/\4@L1PR9-*O]'NP1Q>'0`U,MD+EW7)L M_W&;4Q*I+"7$(4RK,-F*'J<0=K@'MA*,:<)[I1@8B406RN;$[X&B$3K=5CJW MO86X3(E6E_8&'T@DF33V`VULMN*/W648?,B?4O9'#K5^>N$'7>X#+G=;I)-? M$"D")!T[ZUW;;5(>[`@^A^:34"[EYD6Z$(JG#X1$F`2$F(H3I<> MO5MP^G#>(P"H3B&(E0&SD)!1I:QI$UW%Y/:[YY41Q[:I4&^"2$#(P8T2FH`3":1VOAXME?/A:C.`/=^](;?"0A.!CPA8$@ M><"VW(JA\%D),"",-:MBY@/0$"17JAZOJTZAL+*@">3X-CX($H.""'Z M4!J'_>@[I4BY_S%8@H2*I:!*S"\&!R&V8X^]P@J,I9=WJQ87*-7G3W@I;W!& M0@##6$/ZL`H00O:A5!:;9%_5(EM8"FQ#0DFK0[8$$!(]T*V`Z2_^O^*$'[Z" M8:[84S:,)F4@V0,;Y[#M`A,H9FK-&L!F)&0YTWG;"![B$MV*&=)`K)SL` MNY$0_8QHKNTI5[@05CN5O01=_V;*,V2O-C[^$GR&D2SX3S.(UE,LZP86(>$ MIBEG3\RX&A?"NK&<1N&.Q3;:FRACP%1V#QOA8C<\N6,)?T/7G\EBP_4K`0.2 M$%6;.X8:)>(FQAH>!3>YC"-^OP2@K/91+!TG00%..O7CQ2CIS"8%<3(WZ&N6:=W M^KYSTX4ET(B?.(ZC0G#]TP]S9M<_=*H$2W5NTK"#&?&.)KKBP9].B-(X#"9\ M@ESKZ[#?6N:FY0[CX`K?300-9.OV:-S@0TIX@_,3Y\=KRJM[6Q]"DTGLQ*06 M59RE58#TXK:>W8/2I`_Q MQFA"V6GK2[`$B3@$L\XI!-%:&O[#T_DYB=/T+HFGTBP^E:_``C0B"8QHW`-@ MZ>)<%F=^Z)3`]?,RGW[P-R6UYDVT#-B&1#R`&;D*.);NWE'HK??`!ECR>1A- MKF"*">,%-](2MG2A)"D'5B(1"*"@$5L\*9'9NKM'P0$^LPB,%`+:X60>1`$W M4!:\,+4+*$J"J4CH4;6<0`N;K=N`%-Q@STHF@SV8@X0T58MJ!(VM6X.$YO-2 MF56\DB7X&@Q"2Z4RF\-W@=BZ8.B>V:]Q%&^C7/JPQHI-61:,14O#TF)=$Y:M M:XVM'..OC@V7+8<]/S]*Y%BP0UB\!,`E(6!I\B(X;%5A:WP)\KRD,F(S?ICI M.&HK"5Z*A<9G/XCXD#6*-G\G5[J49;V3(Q+:5RU7,$1IZYYEQI/ONEV?`\R4 MXV2`]-,/;K0\2)_+``,>NB9;H:O*@K%(*&B-7$(3I:T;F31S`FR,'9NK!)89>&FJG.0@^Z!0G=M1'W"G2V+G"Z7^MO=C'7 M8,'R==\<0%<"KG`?4!<&MJ)S4WN`K2<0F:33:8BR7RH_]CF&5) M\)1G_.R?OT^WB)-"YX`"V:NVMS3X#3`^"1VXB5,UAF_K#FF3=0>RT2PGS6]) MD+%X.H7%D@@KMN?4*@PF("$"ZWF`*:[&5SX);3W!H[7TP:WOP`PDA%]#C6@? M@JUKG>XGB.W\!IL++>E--,G'99BVA%Z=XF"R#NK!^L@:W_ZDVJV'+WX0EE-5 MY7KS\KVA"S\-QKH=7UT3F+*+\G$=D+;NC;H?/#[Y203+E_2.)<5=IP(D/P@/ MPCR3/L>G*`F&(B%#FWF#%J@^70<5KG4TUL.KY3`8:L=&A=UDJG4[O^B=')/0 MM]"L&L),1S M,Q]K@M76I=;]H8["[<7E59:MYQ>OV#08!RP:OSIYD5#6-)WG"77*`[4#5SVY M[E7'DV-:NI+:ON+.*(+5JXN/I2E@];R(([[!TKW\*"H'YJ&E)55(4]"+P^G# M)<@==,I[D,+OP1RTI"2<,V2S@*/JPXW(+T$4S/.Y,BO').09HQIQ<&X?3?0#K/#R20H M`=SYP>0F4KU,IU7..QF0D$6,N=9`Y?9105NWL3(P!)NLA$'0R.WSNTQ>:NRG,3C<.<"Z9W//('.-D*"!+[N-0#;/P`6)R6/K;C"YCG MV,-NZVKFHLS[F/E)YC;A29%YLJ+/RWQH]ULP"2WA3,\=Q#!LW\9C`A+9%-Z@E605N[]6D_#%.:;;85ES&I&LQ' M0L-K[C/FJ&U=$VW!:?1@%-T$T M3G$)K#\W0H>3?^5I5L2K/L:(,/;-3Q(_RLHQ4*H6&M;EG9R04!#-UI(U8=JZ M,DHAM$^VCJH^>[#L1`%LL3;/):EVK'7K!3.3$"IK;%2;0;9U*=7]:"1=:[7@ M6)H5@YE)R*)6/,L(LZTKK^VD-@%L?C1F','Z4+;H.,-TI>#<^:_<8-AJQJ`* M,`@M]52]I#%&9^UJJ_U5JQ!+ZL4VT M+32:)VL8)<@EPSK5>*=D;ZYCK-=":.M]T9;'=>$SRU(90J_3&Z"=.:T^Z="A M5!O8;5TA+<\T/T5NKYPW/*L^Z=!IDP*&K2N7(EXIW)A+8=OBI\_78?S=R7-_ ME?M7ZW:878O;*P;$G;L;KVO>ACNE)Y;JT9N+5PS:/`X*IN'/(2LHCR;#.9>B_L3R MN)H4!YN1$&;:\P>Q_^G;QM(%10K^]%N4,#\,_F03T2L;LHE041(L12*.^-!> MI&66IO<=K:0=51\#6/(2C/&H8[P$H"41:7PH)]`R!XTW)1'VBUB$ MZ"I(TSC,LR("[4L0Q4EQZH$>$^D6]4YIO$)S4'_0MDOCJXRM#@OKW,D\YKZ( M250YA*2(=_*!A))]V(%!90];-QY;#@]9QL^G1E.#H!"`_NN-!AH6L76!D<+Z MCD3@:,*59UUDPQ(WO8Y(>B6Y@'1?!K\FO.$G+@9E(G"*TY1A[4!O? MMB3M$:/LF26;(3A-F729HUHB% M$7YK=T&=/SR&(+\.8/P>6XK/DE3FG7PD(3Q;B<]2XB1]DQ30C!F;%(]=/;`H MX#+H.(?(TS6;8CS0K`&"2$YKHT"E8ZAMAI7#P]]`AB9>0``Y*0F>TX M3UW\MJZ[NI^`.&Q8Z?/_X[?Y7OR0"ZQE^I7=A9W$@4RJ`1.2$)3-)AUSA/UY M'E6,?0A])DE>H7M@:0Z,RH/12`C"-MQ"",WN;5?WN9D/Y14DU.!VO`*_>&_E MKJP;G^`7(/FM;_@CU[K38@<73023*7_4-8Q36*AI[&Z:5@WF)J$9FWM2<]3M M/6!J8>=3R0!5IH"[CA/=38].63`!"477#I6"W8^^$1`_H)$C3P1CJ4FK8NLT MBH(!2&BN!_4"H0V02ZHT(FZKR1YWTAP#"JVTSP95@$%(R*DM.H6A+1#G,)96 M6W&.Q\2/TBE_MGL'RV/\R.:+./&3US(G#>8;^C5XITG2?*]@TH=@%@738.Q'V?*LM,AK%/+'T)VD>ADE M,S]:7K?:2I/(CVR=G1ZYV'(T`5+J+@OM'\+6+ M4)SXSU53P.PDABB+/B3>!+DQK*5`L``00E#@``!#D!``#M M76USVS82_MZ9_@>>;^:F]T&6%3=I[(O;D24YU9TLZ2PE::;3Z5`D)&%"$2I` M^N5N[K_?+DCJC01(2HJ#3/DEL4@L\"P>O.T"6+[YZ7'A6?>$"\K\JY/&Z=F) M17R'N=2?79V\&]_47I]8/_WX[3=O_E*K66^)3[@=$->:/%EM.[#'W'8^B43> M`O'3UQ;^<5'KL_O:B[/&N?7K6>/RY:O+EQ>_6?\=WO[/ZHS&5LUZ>'@X=2&' M0.9PZK"%5:MA.<*9DX5M!3:?D:!O+XA8V@ZY.ID'P?*R7DKA)/;3&1 M2>,7LN)J9XW:>2,1<5CH!_QI6T=!G-,9NZ_'+[/$0LZA&:KDXK9)1#'IUY=GI\DR%`_7LB@FR1Z%V&D&]31V3+R%NB;G.',X\``B>HD<>E9T/W M8OSI!GZO*H3Y?KC(SL0->!T1UR%1#5(13IV57+Y0+``CB66]L7V?P1`#0Y/\ MC4^62^I/6?P3'F#[OD3`8Q"W\(]W=UWMZ""U:S,GQ)&FZ;L=/Z#!4Q=RY0M9 MUHE%H8*T*5;E)PA<,J4^E4@;9PT8'Q/QS3\A*RO*R]K([$U]-X=OO]G-/A3$ M'?@_RK^!0P&Y25D<.&+Y.(E>=EU(64G']IS04Q8:B]6WZ-C(6LP7S*,N M-MIKV\.!;S0G)!`12>K7>H9>`"TCJ$(24]0:]$>#7K?=''?:UG6SU^RW.M;H MYTYG/*KHV8>>H0TC?#`G`05D.5QMI]43=UZ<..O7K8Q_JX@L2.2J?L5@.ECB M@A'`9'0X13H]@=_K"!R-X;_;3A_(&]Q8@V'GKCGN0H**NK+4#::C@#F?YLQS M86W?^2.$20=6U-2AN/#2<)DCJ"?W92%RD=O1>-#ZU\^#7KMS-_K;7\\O_F%U M_OVN._YH?=?NW'1;W4Z_]?'O%>U[]-B6+>8W'GO(Z;#K9'I*7Q7OKZWFZ&?K MIC?X4/57'7%#3GV'+FWO.A34)T(TG8#>0S>#Y>&(SGRP=1T;UIV.-*_`CA\" M?]#]8D+W%]<3_0.N5*EP/"9"3N#'\*[;;W6'S9YU_6[4[7=&(ZO9&G??8R]M M]H'\[MM^%_IJ$WITL]4:O.N/N_VWUA!:!_3?J@WHVD"?!036/4_VQ",1K5M/ M]$R]WF6J/QAW1M:P^;%YW>M4]:XS^Z#:&/:*$`K:6=HHWNFYN-CEHMT=P1`) M/>$=C(_5"J88*V#RWT.I]Z1'[0GU8#"+*6C<9;BHW/7?0\OD7<9'Q7$]%8Y>*S35?O-RKF-`PT04+V[&@@5P]PTJK)6>*&=A$JX69+H&> MG?-==EJ#V]ON.%I8V[YK13/*6S"*JH65GJ4[@GM94<<8+6'"B+A)/]8S\OTN M(W>=]S!J);UE-(1II.)!-XN$$T'^"$'?SCWVB'@.V7VJ9^%E:@9Y=SV"B0-] M",!'OW+.?AY#\T@&9S'#L_'JR(:G]5U2<.5`*FJ#CO$?D;9$X^=Z`E.>@RU[ MU/HNRJ0BH[QANDF+-H6>H)3#0&&D5E3M::UN\:1\K2O:T:S?Y4;_6$Y3R-V3:N!5%GW7IV":!33TQ)H]!F&S\ M'RLS/?TI%\?!R\BX>"LNOVHQ15>3<<6EEY/)"SV3*7?(SGHRSJ7BHR0?6YU2 M\U[/3LHUDLU.U6OV7_9O]1]]$CU7*0>*L0AK;Z5FXJ+5_GQ;PE5<\ZS&VRU;4T[_5<%76<5+WKL&,"6=VL M>'(]ARGOA_8(0=7S#CM4D,5D7B(]?RF?1\:!@XJU@XX@9,YR^C1ZSE*>D-3Q MA#\U8_@/WI:^(U-+7D.^Q!N>5R>"+I9XZCEZ-N=D>G6"5[IKR;7MWT'IT\>% MER3!$C07HB79N_44%YQD$5]JU5^3ADP8V.H!C+WU!/R)53^B8L!(6<6V2313 M+<^>E%4+1(AGKD;0``T]YLBL-"+XJY;(U?!1K?&B=MXX?13NNO;+@%CK6`Y$(K<'B.P8#06+3P2P MW)=%2]0&65`4+`O-%*P3+Q#)D]HZJU+Z:P(>Z`!EB,5_'PHD*Y!$$22;F1B$`B9#\:P\(Z?@<'U4=3*50ANU*' M\I0="*8<$N;W]P:C#Z&S_\PK\U)3%(>PDH`RO`+-B<"06=!(H[6H#/=T"<^H M/^L&9(&FU(EEQZFN3@(>XDI5IH*U(67N6,JY(8^#U?C4\W`7/TDKP*8-:!#B MV[>_$JTB0(#70;)\RR-IK8GGDNE#8`* MG;I^`!`6-Q3D'6I[ZSOR\A32DVDJEL"KT#@YA=4FPN%TB06:J6H1H$I6'4[` M0NCZS3"8,T[_0UQTM3(_T=F M%'7&(N[H;!Z(P<2CLUC%S6$?J"6!S9]*U59D@@?IRHJ23J+02E!R M#I+<"2>DF]TU-&`5:O9MGP7$F?O,8[.G6[*8$+[#H,L6-O6?=]V2#4O5)>%O M5X;Q>Z3B2]#B4B@=@ZONT+(#3`%_")2B6WL&],F9'T:F@3\*ETOOJ3GC1*9= M<0*$+".!XPPH11DIB%*AXP?&/P$1+7M)`]N+8DT%!H^3"KRJL0*G[A;SXQ"[ M/;J@P;J^#J7N"#-G#CZ%6NV0W'"VB*)9&DS6#L[<`3UU^=',H3P#IDHUXE/& M1\2!58T[A*J@0C#^A!D8,Z(7P%A$NZ@5!Q00R/HQ4S\52I6&X81Q6)O(^&VF MZUDV#\(?[GG[;32XYL6"4;Y7;+-HBVA5)@F><0"%>@SL9<(7 M4/Y#,&_Z;O*BZ=Y3R-2<;EX:L4)SE+^GY&&T).AYC5VP,!?YCC&Z%L"H*@/CZ%N.0!&E`9<5O%^B.UA,(UND:R3B!O&-WROJR@!.\M]K!'Q MS$Z1(^IRS-J*/?2)B^UKK:B4&JH9:9T=EJ/5?J\10ZW_@5ZG/.0%AL8D,?R4 M8?E]\IP*'S!&9@%73=Z,3V!"Q");<_Q>F&BZ+G'';!TQ)`)DL.HE=%`N*X48 M^+?,E7%0L+SMZ.#&JIX'O-A>(9>;C$.;O[>]D`RFTDZA>`:Z97L><:^?XI0B M3BJ^_)QY!!5TVP5=(4)D!-K63F]:>^9EA('P\,V?(^T@E(.L.XN3)1DWJ8$? M?Q3PRRM=`JJJVU.8&N5G.=KV`@2%P;LH&5B+:C6TJ2N[A MB-L4FYNA.!Y^^;9:`JIJM9H9S@1WKDW;5L]#6DK!MC2FHW\-L+.+@%2Z#ES\ M!MHUL[F;'*LSR'^@!J==,Z$Y3MAT.IAF5HWQ2Z=<_#H[86V>WQ"\_FJ.YTX/ MKY1.3=]-EDZ&JY>!5+7^)@$$P)WP\M_V!/-HKWF+QQ/U`<(4,TQ/4+\Q,=P1K`\_;0/_` M:@AM#YWX.[-.4@7/O?8UIS:.S5>,8\.K]>=@YA"]52?N-[YVNO5-THVO`)MS M+Z0<6M4N(2=3PCE^:^S>&S/2 M%P6J.D_K+>=V?/31&)VR0.EW.5?79WI#8[100U.U.3OT>F3*&35G(9&!28'^ MGWAA[P,\"\(`G';(;J?AA*A]):)$2S7HM0;5SU7]\-WMP++'TD[ M^&C&8>C+58ET"96J$;.VO0]22[E87YUNCG*^87QWG6QRG13#GWN/5&80N9+7 M7S`S\RZI`FKA`=X<`T:#3=>QU[H;=.50C>PS;?0DT6=$F\1_=/UH/.B3PX\: M'SZN?U[U.N M@=JDL&FF6`6I!@U@Q5"J3H-@U#^,Q6@,32E$RHL=/EM0WRCL&9B4'84R/F:I M.'K&J)('4.7.G\(@8:Y6>G@YVSC&WK*TV^WJN@5OF!VR52U/"I-NU.G!% M]1D_,'/UV0!7[#IMSS-G:U,-3;TDF(!E^BA,TB(+5,[-C\XC+NT)+,G1ZX#! M&0T^Q*L#O8.4W*?FOLAUV:-HD;N[ MK!,W_BI.*34.J@H#VL.!E"=;])&='WLM9=4TQ7@*J],^/((,O,\>:8IDFICX`;!O/C8ZEN8]@<<[YN8W`1*JY+;#**S#NWM M`P[&CW[%\.^GO%'-7H$P7S-,=X,!O?@]=9YW.51V>:@!K=!3MG"_C4&Y/)G_ M8'I+?<;E51'SPUX4@J^T`-S0D0]P\I/SX)=0N;0)H$&=VYB3*U=?6WO.Q*WT MAR8?-5A]W"`*0Y[$B8B#H\`O'/WC7[%)A9[CH1U`;CV4/6H8_<]539]+8?76 MAD.(*S#*L3:PH\%55D*'$J<.OJIX007@:T]'"SG:[M@3(/O5^`Y*J:$::Y@C MCSM!)^K(@-]&WJ\KAK*`$[:)>^J>0;L8:FP*;<8PC8@IQ@G;H7S,Q@2_ZP7- M,[HI:W+3+:-%\87?RGMJLNIZW.K/Y.Q\A\2@;6LMN+R/C!@3*B2%2'4SF<#0 M0U:IC1E*%+A0BS?UZ--]4J'_`U!+`0(>`Q0````(`-5]`Q0````(`-5]`L``00E#@``!#D!``!02P$"'@,4````"`#5?7-#N`C_?3@S``#U&@,` M%0`8```````!````I(&'B```;FYA;BTR,#$S,#DS,%]D968N>&UL550%``,R MSHM2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`U7US0]'5M*#+3P``TEX$ M`!4`&````````0```*2!#KP``&YN86XM,C`Q,S`Y,S!?;&%B+GAM;%54!0`# M,LZ+4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`-5]`L``00E#@``!#D!``!02P$"'@,4````"`#5?7-#"L!HS/00``#_ MN@``$0`8```````!````I(%.1@$`;FYA;BTR,#$S,#DS,"YX`L``00E#@``!#D!``!02P4&``````8`!@`:`@``C5 XML 32 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
DISCONTINUED OPERATIONS (Tables)
9 Months Ended
Sep. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]  
Schedule Of Disposal Groups Including Discontinued Operations Income Statement Disclosures [Table Text Block]
The results of discontinued operations are as follows: 
 
 
 
For the three months ended
 
For the nine months ended
 
 
 
September 30,
2013
 
September 30,
2012
 
September 30,
2013
 
September 30,
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues from Medical Board business
 
$
-
 
$
9,375
 
$
14,750
 
$
31,250
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profit from Medical Board business
 
$
-
 
$
6,457
 
$
11,115
 
$
17,477
 

XML 33 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE LIABILITY (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Derivative [Line Items]    
Derivative Liability, Fair Value, Net $ 12,884 $ 25,732
8% Notes conversion feature [Member]
   
Derivative [Line Items]    
Derivative Liability, Fair Value, Net 10,516 24,285
10% Notes conversion feature [Member]
   
Derivative [Line Items]    
Derivative Liability, Fair Value, Net $ 2,368 $ 1,447
XML 34 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
DISCONTINUED OPERATIONS (Details Textual) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Discontinued Operations [Line Items]        
Loss on write-off of discontinued operation $ 0 $ 0 $ 11,179 $ 0
XML 35 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details Textual) (USD $)
9 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended
Sep. 30, 2013
Nov. 30, 2009
Sep. 30, 2013
Alpha Capital [Member]
Sep. 30, 2012
Alpha Capital [Member]
Nov. 11, 2013
Subsequent Event [Member]
Platinum Long Term Growth Iv [Member]
Oct. 31, 2013
Subsequent Event [Member]
Platinum Long Term Growth Iv [Member]
Oct. 15, 2013
Subsequent Event [Member]
Platinum Long Term Growth Iv [Member]
Nov. 07, 2013
Subsequent Event [Member]
Alpha Capital Anstalt [Member]
Subsequent Event [Line Items]                
Long-term Debt, Gross             $ 14,025  
Debt Instrument, Interest Rate, Stated Percentage 8.00% 10.00%         8.00%  
Conversion of Stock, Description         On November 11, 2013, Platinum Long Term Growth IV, LLC elected to convert 238,511 shares of their Series C preferred shares into 38,161,760 common shares at the conversion rate of 160 shares per each Series C share. On October 15, 2013, Platinum Long Term Growth IV, LLC elected to convert 207,863 shares of their Series C preferred shares into 33,258,080 common shares at the conversion rate of 160 shares per each Series C share.    
Stock Issued During Period, Shares, Settlement Of Interest Obligations       241,164       16,000,000
Stock Issued During Period, Value, Settlement Of Interest Obligations     $ 62,090         $ 6,000
XML 36 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCENTIVE STOCK PLANS (Details) (Incentive Stock Plans [Member], USD $)
9 Months Ended
Sep. 30, 2013
Incentive Stock Plans [Member]
 
Stock Option Plan [Line Items]  
Shares Outstanding at beginning of year 723,137
Shares Granted/Exercises/Cancelled/Forfeited (14,117)
Shares outstanding at end of year 709,020
Shares exercisable at end of year 709,020
Weighted Average Exercise Price Outstanding at beginning of year $ 3.07
Weighted Average Exercise Price outstanding at end of year $ 3.57
Weighted Average Exercise Price exercisable at end of year $ 3.57
Weighted Average Remaining Life-years Outstanding at beginning of year 3 years 6 months 11 days
Weighted Average Remaining Life years Warrants outstanding at end of year 2 years 4 months 13 days
Weighted Average Remaining Life Years Warrants exercisable at end of year 2 years 4 months 13 days
XML 37 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
DISCONTINUED OPERATIONS (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Discontinued Operations [Line Items]        
Profit from Medical Board business     $ (425,405)  
Medical Board business [Member]
       
Discontinued Operations [Line Items]        
Revenues from Medical Board business 0 9,375 14,750 31,250
Profit from Medical Board business $ 0 $ 6,457 $ 11,115 $ 17,477
XML 38 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities:    
Net loss attributable to controlling interest $ (425,405) $ (1,058,275)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization   39,454
Fair value adjustment of derivative liabilities (12,848) (534)
Issuance of stock for services   10,800
Gain on dissolution of Combotexs (39,373) 0
Inducement to convert interest 0 24,221
Issuance of warrants for services 8,721 8,720
Loss on forgiveness/modification of debt 10,336 473,566
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable (20,306) 2,651
Decrease (increase) in inventory 6,229 (4,282)
(Increase) in other current assets (1,844) (1,337)
Increase in accounts payable, accrued payroll and accrued expenses 329,434 404,284
(Decrease) in other liability 0 (4,000)
Net cash used in operating activities (145,056) (104,732)
Cash flows from financing activities:    
Proceeds from senior secured Promissory Notes 138,906 103,000
Net cash provided by financing activities 138,906 103,000
(Decrease) in cash and cash equivalents (6,150) (1,732)
Cash at beginning of period 6,160 1,732
Cash at end of period 10 0
Schedule of non-cash investing and financing activities:    
Common stock issued for convertible notes 19,913 983,585
Common stock issued for accrued interest 62,090 216,943
Conversion of preferred shares into common shares 141,337 15,669
Transfer of preferred shares to temporary equity $ 0 $ 4,376
XML 39 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE
9 Months Ended
Sep. 30, 2013
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
2.  NOTES PAYABLE
 
Notes payable consisted of the following:
 
Notes Payable
 
September 30,
2013
 
December 31,
2012
 
Senior Secured Convertible Notes
 
$
3,124,403
 
$
3,134,415
 
Senior Secured Promissory Notes
 
 
647,462
 
 
508,557
 
Subordinated Secured Convertible Note
 
 
271,100
 
 
251,000
 
Total
 
$
4,042,965
 
$
3,893,972
 
 
Senior Secured Convertible Notes and Senior Secured Promissory Notes
As of September 30, 2013, notes payable include $3,771,865 ($3,642,972 at December 31, 2012) for senior secured convertible and non-convertible promissory notes.  As further described below, the Company has defaulted on certain provisions of the notes. Platinum Long Term Growth and Merit Consulting, LLC (to whom Platinum Advisors has assigned their ownership interest in notes receivable from the Company) have granted waivers of default on their outstanding principal balance of $3,148,349 through December 31, 2013 and November 30, 2013, respectively. Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) has granted a waiver of default on their outstanding principal of $623,516 through November 30, 2013.
 
The Loan and Security Agreement and the related underlying convertible notes issued in accordance with the Initial Note agreement had the original conversion price of $3.74 (as cited in the March 7, 2007 agreement) which was adjusted to a conversion price of $0.085 in accordance with the anti-dilution provisions of this loan and security agreement. This conversion price adjustment was triggered as a result of the issuance of the 2008 Promissory Notes on September 29, 2008 thereby resulting in a reset of (a) the conversion price of the Initial Notes, (b) the exercise price of the warrants related to the Initial Notes and (c) the number of shares that may be purchased by such warrants. As compensation for forbearance from the lenders in 2012, the conversion rate was further adjusted to 75% of the lowest daily volume weighted average price (VWAP) of the Company’s common stock for the 1, 5 or 10 days immediately prior to the conversion. 
 
During the nine month period ended September 30, 2013, the Company issued 9,500,000 shares of common stock to Alpha Capital Anstalt (to whom Longview Special Finance has assigned its ownership interest in notes receivable to the Company) upon the conversion of $10,013 of outstanding principal due on the 8% Senior Secured Convertible Notes held by Longview Special Finance. Also during this period the Company issued 42,000,000 shares of common stock to Alpha Capital Anstalt upon the conversion of $31,838 of interest due on the 8% Senior Secured Convertible Notes held by Longview Special Finance.
 
During the nine month period ended September 30, 2013, the Company issued 25,872,435 shares of common stock to Merit Consulting upon the conversion of $21,478 of interest due on the 8% Senior Secured Convertible Notes held by Platinum Advisors.
 
2013 Senior Secured Promissory Notes
During the nine month period ended September 30, 2013, the Company entered into various Senior Secured Promissory Notes aggregating to $138,906 with Platinum and Alpha (“the 2013 Senior Secured Promissory Notes”). The 2013 Senior Secured Promissory Notes are secured by, among other things, (i) the continuing security interest in certain assets of the Company pursuant to the terms of the Initial Notes dated March 7, 2007, (ii) the Pledge Agreement, as defined in the Initial Notes, and (iii) the Patent Security Agreement, dated as of March 6, 2007. The proceeds from the 2013 Senior Secured Promissory Notes are available for general working capital purposes and cannot be used to redeem or make any payment on account of any securities due to the Lenders.  The 2013 Senior Secured Promissory Notes bear interest, in arrears, at a rate of 8% per annum and are payable in cash as follows: $21,000 due on June 30, 2013, $30,006 due on July 30, 2013, $49,400 due on September 30, 2013, $2,500 due October 30, 2013 and $36,000 due November 30, 2013. Past due amounts have been extended through forbearance agreements with the principal and interest due on dates ranging from November 30, 2013 to December 31, 2013.
 
2012 Forbearance
During the nine month period ended September 30, 2012, the Company entered into various forbearance agreements between the Company and Platinum, Platinum Advisors, Merit Consulting, Longview Special Finance and Alpha Capital Anstalt (the lenders) which extended the due dates of all outstanding notes and accrued interest.  As consideration for these forbearances, the lenders added $50,000 to the principal balance of the Initial Notes and resulted in a loss on modification of debt of $50,000 for the nine month period ended September 30, 2012 and is reported in the statement of operations.
 
Subordinated Secured Convertible Note
 
Convertible Notes
On December 4, 2009, the Company received net proceeds of $197,500 pursuant to the terms of a subscription agreement dated as of November 30, 2009 with Cape One an accredited investor.  Pursuant to the terms of the Subscription Agreement the Company issued (i) a 10% Subordinated Secured Convertible Promissory Note (“the 10% Convertible Note”) in the principal amount of $225,000 and (ii) a five-year common stock purchase warrant to purchase 2,647,059 shares, subject to certain anti-dilution provisions in the agreement of the Company’s common stock, par value $0.001 per share at an exercise price of $0.425 per share. The balance of this note as of September 30, 2013 is $271,100, a result of increases as consideration for forbearance and conversions of principal.
 
The 10% Convertible Note had a 15-month term, bears interest at 10% per annum and is secured by certain assets of the Company pursuant to a security agreement, dated November 30, 2009.  The 10% Convertible Note is convertible into Common Stock at any time prior to maturity (provided that such conversion does not result in the holder and its affiliates beneficially owning in excess of 4.99% (9.99% upon 61 days prior written notice) of the issued and outstanding Common Stock at $0.085 per share (the “Conversion Price”), subject to adjustment upon the occurrence of certain anti-dilution events.  Interest under the Note is due quarterly in cash or if registered, in the Company’s common stock at a 20% discount in accordance with a formula set forth in the 10% Note.  The 10% Note and security interest is subordinate to certain outstanding senior indebtedness of the Company held by Platinum Long Term Growth IV, LLC, Merit Consulting and Alpha Capital Anstalt. (“Senior Lenders”). Upon the occurrence of Events of Default as set forth in the Note, the principal and interest due under the Note may be accelerated and the interest rate payable may be increased to 18%.  The company has entered into various forbearance agreements between Cape One and the Company which extended the due date of the outstanding principal and interest, which is accruing at the default rate of 18%.
 
During nine month periods ended September 30, 2013 and 2012, the Company entered into various forbearance agreements which extended the due date of all the outstanding principal and interest balances.  As consideration for these forbearances, Cape One will be paid $55,000 which was added to the principal balance of the note and resulted in a loss on modification of debt of $30,000 and $25,000 for the nine month periods ended September 30, 2013 and 2012, respectively, as reported in the statement of operations. In consideration for forbearance in 2012, the conversion rate of the note was adjusted from $0.085 to 75% of the lowest VWAP for the 1, 5 or 10-day period immediately prior to the conversion. This note has been extended through forbearance agreements and is now due and payable on November 30, 2013.
 
During nine month period ended September 30, 2013, the Company issued 12,000,000 shares of common stock to Cape One upon the conversion of $9,900 of outstanding principal due on the Subordinated Senior Convertible note. During the nine month period ended September 30, 2013, the Company issued 9,000,000 shares of common stock to Cape One in payment of $8,775 of interest expense obligations on the Subordinated Secured Convertible Note.
 
Registration Rights Agreement
On March 7, 2007, the Company entered into a Registration Rights Agreement with the Agent and the other investors, pursuant to which the Company agreed to prepare and file within 60 days of the March 7, 2007 agreement, a registration statement for resale under the Securities Act of 1933, the common stock issuable upon the exercise of the Warrants, in payment of interest on, or upon conversion of, the Notes. The Company further agreed to use its best efforts to cause the Registration Statement to be declared effective 120 days following the March 7, 2007 agreement date, or within 150 days if the Company receives a comment letter from the SEC, and to maintain such Registration Statement for the two year period following this date. This agreement allows for liquidated damages based on a daily amount of 0.0333% of the principal amount of the notes relating to the common stock issuable upon conversion of the Notes included in the Registration Statement.
 
The registration statement had not been updated with the requisite SEC filings outlined above and as such, the Company was in default of this provision of the Registration Rights Agreement. The Company recorded a total of $146,028 in such liquidated damages as of December 17, 2007, the date the registration statement was declared effective. As of December 31, 2007, $63,539 of this obligation was paid in cash and $82,489 was recorded as an accrued liability. The lender has the option to settle the liquidated damages in common stock valued at the average price for the five days prior to the end of a payment period. At September 30, 2013 and December 31, 2012 the outstanding balance for this obligation was $82,489.
XML 40 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS EQUITY
9 Months Ended
Sep. 30, 2013
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
5.  STOCKHOLDERS EQUITY
 
As of September 30, 2013 the Company was authorized to issue up to 800,000,000 shares of common stock and 10,000,000 shares of preferred stock.
 
Preferred Stock Issuances
 
On June 10, 2013 the Company obtained the consent of the holders of the majority of the outstanding preferred shares for the creation of a Series D Preferred Stock. The holder of the Series D Preferred Stock is entitled to a 51% vote on all matters submitted to a vote of the shareholders of the Company. There are no other rights or preferences attached to the Series D Preferred Stock. On July 1, 2013, the Company issued 100 shares of the Company’s Series D Preferred Stock to Jim Wemett, the sole officer and a director of the Company, in consideration for services provided to the Company. Such securities were issued under Section 4(2) of the Securities Act of 1933, as amended and Regulation D promulgated by the Securities and Exchange Commission.
 
On September 29, 2008 Platinum and Longview agreed to exchange detachable warrants to purchase 71,691,180 shares of common stock of the Company for $0.085 per share held by such Investors related to the March 6, 2007 convertible notes payable for 5,000,000 shares of Series B and C preferred stock.
 
On October 7, 2008, the Company filed a Certificate of Designation of Rights, Preferences, Designations, Qualifications and Limitations of the Series C Preferred Stock (the “Series C Designation”) with the Secretary of State of the State of Nevada, and prepared a preferred stock certificate for delivery to Platinum Long Term Growth IV, LLC, evidencing 4,250,000 shares of Series C Convertible Preferred Stock of the Company (“Series C”).  On October 7, 2008, the Company also filed a Certificate of Designation of Rights, Preferences, Designations, Qualifications and Limitations of the Series B Preferred Stock (the “Series B Designation”) with the Secretary of State of the State of Nevada, and prepared a preferred stock certificate for delivery to Longview Special Funding, Inc., evidencing 750,000 shares of Series B Convertible Preferred Stock of the Company (“Series B”).  The Series B and Series C have an aggregate liquidation preference of $10,000 and participate in any dividends or distributions to the common shareholders on an as converted basis.
 
Each share of the Series B and Series C Convertible Preferred Stock is convertible into 160 shares of the Company’s common stock and votes on an as-converted basis (with each share having 160 votes).  The conversion rate was reduced to 9.41 as a result of the 2012 reverse split (Note 8), but was subsequently changed back to 160 as part of the consideration related to 2012 forbearance agreements (Note 2). Both the Series B and Series C designations limits the holders’ rights to convert its Convertible Preferred Stock, and the aggregate voting powers, to no more than 4.99% of the votes attributable to the total outstanding common shares.  Accordingly, the votes attributable to the Series B and Series C Convertible Preferred constitutes 4.99% of the aggregate votes attributable to the Company’s outstanding shares on an as converted basis and the votes Series B and Series C Convertible Preferred and the Series C Convertible Preferred, voting together represent approximately 9.98% of the aggregate votes attributable to the Company’s outstanding shares (on an as converted basis).  As of September 30, 2013 the Series B Convertible Preferred Stock has an aggregate liquidation value of $10 and the Series C Convertible Preferred Stock has an aggregate liquidation value of $6,607.
 
As a result of the Company not having sufficient authorized shares to satisfy the conversion of all outstanding convertible debt, convertible preferred stock, warrants and options, the Series B and C preferred shares have been moved into temporary equity classification on the balance sheet as of December 31, 2012. The preferred shares are presented at their fair value based on an allocation of the estimated total enterprise value to the preferred shares and other securities in the Company’s capital structure. The valuation methodology used is similar to that used in valuing the Company’s derivative liabilities (Level III inputs, see note 4). Any change in fair value of the preferred shares, which are deemed to be temporary equity, is reflected in additional paid in capital.
  
During the nine months ended September 30, 2013, Alpha elected to convert 137,500 shares of Series B preferred shares owned by Longview into 22,000,000 common shares at the conversion rate of 160 common shares per each Series B share. Longview has assigned its Series B preferred stock ownership to Alpha Capital Anstalt.
 
During the nine months ended September 30, 2013, Platinum elected to convert 745,855 shares of their Series C preferred shares into 119,336,800 common shares at the conversion rate of 160 common shares per each Series C share.
 
Common Stock Issuances
During the nine months ended September 30, 2013, the Company issued an aggregate of 76,872,435 shares in satisfaction of $62,090 of interest obligations to lenders on convertible debt. Also during this period, the Company issued an aggregate of 21,500,000 shares of its common stock in satisfaction of $19,913 of principal obligations to lenders on convertible debt.
 
During the nine months ended September 30, 2012, the Company issued an aggregate of 6,221,156 shares of its common stock in satisfaction of interest obligations of $241,164 and 13,594,382 shares in satisfaction of principal obligations of $983,585 to its senior debt holders. During the nine months ended September 30, 2012, the Company issued an aggregate of 1,764,706 shares of common stock to various individuals or entities in connection with professional consulting provided to the Company in an aggregate amount of $10,800.
 
Warrants Grants
The Company has issued warrants to purchase shares of its common stock to certain consultants and debt holders. As of September 30, 2013 and December 31, 2012 there were common stock warrants outstanding to purchase an aggregate 32,735,294 and 4,247,059 shares, respectively, of common stock pursuant to the warrant grant agreements summarized below.
 
On February 26, 2013 the Company issued warrants to purchase common stock to certain consultants, the Company’s CEO and the Company’s sole board member. These warrants (summarized below) grant the right to purchase one share of common stock at an exercise price of $0.0014 per share. The warrants were fully vested as of the grant date, expire February 26, 2023 and contain a cashless exercise provision. The fair value of the warrants was determined by estimating the total enterprise value of the Company based upon trending the firm value and considering company specific factors thereafter including the changes in forward estimated revenues and market factors.
 
Warrant grants made during the first quarter of 2013 are as follows:
 
15,000,000 James Wemett CEO
 
7,500,000 Paul LeFrois Consultant
 
3,000,000 David Lubin Consultant
 
3,000,000 Alexander Ruckdaeschel Board Member
 
A summary of the outstanding warrants is presented below:
 
 
 
2013
 
 
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life-years
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2013
 
 
4,247,059
 
$
0.37
 
 
2.24
 
Granted during the year
 
 
28,500,000
 
 
0.0014
 
 
9.92
 
Cancelled or forfeited
 
 
(11,765)
 
 
5.61
 
 
 
 
Warrants outstanding at September 30, 2013
 
 
32,735,294
 
$
0.05
 
 
8.51
 
XML 41 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
DISCONTINUED OPERATIONS
9 Months Ended
Sep. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
3.     DISCONTINUED OPERATIONS
 
On May 10, 2013 the Company ceased all activities associated with the Medical Board business segment. The Company assessed this segment and determined that inadequate income had been generated relative to the efforts of production and administrative support. The Statement of Operations for the three and nine months ended September 30, 2013 reflects the Medical Board business as a discontinued operation and prior reported periods have been reclassified to reflect this presentation. The results of discontinued operations are as follows: 
 
 
 
For the three months ended
 
For the nine months ended
 
 
 
September 30,
2013
 
September 30,
2012
 
September 30,
2013
 
September 30,
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues from Medical Board business
 
$
-
 
$
9,375
 
$
14,750
 
$
31,250
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profit from Medical Board business
 
$
-
 
$
6,457
 
$
11,115
 
$
17,477
 
 
In connection with this decision to exit the Medical Board business, the Company filed a Certificate of Dissolution on May 10, 2013 with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs. As a result of this decision, certain unrecovered sample inventory amounts were written off during the second quarter of 2013. The loss on write-off of discontinued operations was $11,179 and is reflected in the Statement of Operations for the three months ended September 30, 2013.
 
The Nanotechnology business remains as the Company’s only reportable operating segment.
XML 42 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE LIABILITY (Details Textual) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Feb. 26, 2013
Jan. 31, 2011
Nov. 30, 2009
Derivative [Line Items]              
Debt Instrument, Interest Rate, Stated Percentage 8.00%   8.00%       10.00%
Class of Warrant or Right, Outstanding         28,500,000 882,353 2,647,059
Class of Warrant or Right, Exercise Price of Warrants or Rights         0.0014 0.17 0.425
Net (loss) on derivative liability $ 89,536 $ 534 $ 12,848 $ 534      
XML 43 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS and CONTINGENCIES (Details Textual) (USD $)
Mar. 24, 2009
Commitments And Contingencies [Line Items]  
Loss Contingency, Estimate of Possible Loss $ 331,265
EXCEL 44 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\X83$S-C=C.5]B-3,V7S0X9#1?83@S.%\W9F8P M,SEF93,P,C@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D1)4T-/3E1)3E5%1%]/4$52051)3TY3/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I%>&-E;%=O M#I%>&-E;%=O#I7;W)K#I% M>&-E;%=O#I7;W)K M#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.0T5.5$E615]35$]# M2U]03$%.4U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O'1U86P\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1%4DE6051)5D5?3$E!0DE,25197T1E=&%I;'-?5#PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+2$],1$524U]% M455)5%E?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+2$],1$524U]%455)5%E?1&5T86EL#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.0T5.5$E615]35$]# M2U]03$%.4U]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E M=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO2!296=I2!#96YT3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)S`P,#`X-C,X.34\2!&:6QE3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O M;7!A;GD\'0^)TY.04X\'0^)S$P+5$\'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)S(P,3,\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\X83$S-C=C.5]B-3,V7S0X9#1?83@S.%\W9F8P,SEF93,P,C@-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$Q,S8W8SE?8C4S-E\T.&0T M7V$X,SA?-V9F,#,Y9F4S,#(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS M<&%N/CPO3PO'0^)SQS<&%N/CPO6%B;&4@*%-E92!. M;W1E(#(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#`T,BPY M-C4\6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA2`H'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO3PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X M83$S-C=C.5]B-3,V7S0X9#1?83@S.%\W9F8P,SEF93,P,C@-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$Q,S8W8SE?8C4S-E\T.&0T7V$X,SA? M-V9F,#,Y9F4S,#(X+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'!E;G-E*2P@5&]T86P\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0O:F%V87-C3X-"B`@("`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`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS M<&%N/CPO',\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X83$S-C=C M.5]B-3,V7S0X9#1?83@S.%\W9F8P,SEF93,P,C@-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.&$Q,S8W8SE?8C4S-E\T.&0T7V$X,SA?-V9F,#,Y M9F4S,#(X+U=O'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG(#QD:78@#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2!A8V-E M<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@9F]R(&-O;7!L971E(&9I;F%N M8VEA;"!S=&%T96UE;G1S+B8C,38P.R8C,38P.U1H97-E('5N875D:71E9"!C M;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@#L@ M1D].5#H@,3!P="!4:6UE"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T M6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!F#L@1D].5#H@,3!P="!4:6UE"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6EN9R!V86QU97,@9F]R('1H97-E(&9I;F%N8VEA;"!I M;G-T6%B;&4@;VX@ M9&5M86YD+B!4:&4@9F%I28C.#(Q-SMS M(&-O;G9E6%B;&4@:7,@97-T:6UA=&5D(&)A6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@@,'!T M(#EP=#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE#L@1D]. M5#H@,3!P="!4:6UE',@*&$@9&]R;6%N="!.97<@66]R M:R!L:6UI=&5D(&QI86)I;&ET>2!C;VUP86YY+BD@4')I;W(@=&\@=&AI6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!.65,@:6X@=&AE('1H:7)D('%U87)T97(@;V8@,C`Q,RX@07,@82!R97-U M;'0@;V8@=&AE6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE2!T86MI;F<@861V M86YT86=E(&]F('1E8VAN;VQO9WD@861V86YC97,@9&5V96QO<&5D(&EN+6AO M=7-E+B!4:&4@0V]M<&%N>28C.#(Q-SMS(&-U2!T96-H M;F]L;V=I97,@F4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P=#L@1D].5"U325I%.B`Q,'!T)SX@/'1A8FQE M('-T>6QE/3-$)U=)1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA M<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE M/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@6QE/3-$)U=) M1%1(.B`S)3L@4$%$1$E.1RU224=(5#H@,"XX<'0G/B`\9&EV/CQF;VYT('-T M>6QE/3-$)T9/3E0Z(#$P<'0@4WEM8F]L.R!F;VYT+7-I>F4M861J=7-T.B!N M;VYE.R!F;VYT+7-T6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6UEF4M M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S M=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T2!D97)I=F5D(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6QE/3-$)U=)1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA M<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T3L@5TE$5$@Z(#$P,"4[(%!! M1$1)3DF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!M861E(&$@9&5C:7-I;VX@ M=&\@8V5A#L@1D].5#H@,3!P="!4 M:6UE#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@@ M,'!T(#EP=#L@1D].5#H@,3!P="!4:6UE2!A;F0@1V]I;F<@ M0V]N8V5R;CPO8CX\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A#L@1D].5#H@,3!P M="!4:6UEF%T:6]N(&]F(&%S6EN9R!C;VYS;VQI9&%T960@9FEN86YC M:6%L('-T871E;65N=',L('1H92!#;VUP86YY(&EN8W5R6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG2!O9B`D/&9O;G0@2!S:&%R96AO;&1E2!T;R!G96YE2!A8VAI979E('1H;W-E(&ET96US(&ES('5N8V5R=&%I;BX@5&AE(&9I M;F%N8VEA;"!S=&%T96UE;G1S(&1O(&YO="!I;F-L=61E(&%N>2!A9&IUF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E MF4M861J=7-T.B!N;VYE.R!F;VYT+7-T'1E;G-I;VYS(&]F(&UA='5R:71Y(&1A=&5S M+B!2969E#L@1D].5#H@,3!P="!4:6UE"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N M;VYE.R!F;VYT+7-T6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@ M,3!P="!4:6UE"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG&5S/"]B/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T"!R971U2UF M;W)W87)D"!R M871E"!A2!A=F%I;&%B;&4@=&%X(&)E M;F5F:71S(&YO="!E>'!E8W1E9"!T;R!B92!R96%L:7IE9"XF(S$V,#L@5&AE M($-O;7!A;GD@"!E>'!E;G-E('=A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG#L@1D].5#H@,3!P="!4:6UE"`P<'0@ M.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG2`Q+"`R,#$S('1H92!#;VUP86YY(')E M8V5I=F5D(&$@=6YA;FEM;W5S('=R:71T96X@8V]N6EN9R!P"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T"`P<'0@.7!T M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG&5R8VES92!O9B!T:&5S92!I;G-TF4M861J M=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF M>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!D:6QU=&4@9G5T=7)E(&5A2!D:6QU=&EV92!S:&%R97,@:&%V92!B965N M(&QI;6ET960@8GD@8V5R=&%I;B!D96)T(&%N9"!E<75I='D@86=R965M96YT M2!);FYO=F%T M:6]N6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF5D('-H87)E2!D:6QU=&EV92!I;G-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!R96-E;G1L>2!I M65T(&5F9F5C=&EV92P@86-C;W5N=&EN9R!S=&%N M9&%R9',@:68@8W5R6EN9R!F:6YA;F-I86P@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\X83$S-C=C.5]B-3,V7S0X9#1?83@S.%\W9F8P,SEF93,P,C@-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$Q,S8W8SE?8C4S-E\T.&0T7V$X M,SA?-V9F,#,Y9F4S,#(X+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)R`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#$S+C5P=#L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T M.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$58 M5"U)3D1%3E0Z(#$S+C5P=#L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J M=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$15(M3$5& M5#H@(SEE8C9C92`P<'@@6%B;&4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXS+#$S-"PT M,34\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO2!.;W1E6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@ M/&1I=CXV-#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXR-3$L,#`P/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV M/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E' M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T#L@1D].5#H@,3!P="!4:6UE6%B;&4@:6YC;'5D92`D/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2D@:&%S(&=R86YT960@82!W86EV97(@;V8@9&5F875L="!O;B!T:&5I M6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P M="!4:6UE2!A9W)E96UE M;G0N(%1H:7,@8V]N=F5R#L@ M1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG2!I6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPGF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U! M3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T M.B!N;VYE.R!F;VYT+7-T2!I#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE2!.;W1E M6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$58 M5"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J M=7-T.B!N;VYE.R!F;VYT+7-T2!E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!.;W1E2!!9W)E96UE;G0L(&1A=&5D(&%S(&]F($UA M6%B;&4@:6X@8V%S:"!A6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@ M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[ M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE65A#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!A9W)E96UE;G0L(&1A=&5D($YO=F5M8F5R(#,P+"`R,#`Y+B8C,38P M.R8C,38P.U1H92`Q,"4@0V]N=F5R=&EB;&4@3F]T92!I2`H<')O=FED960@=&AA="!S=6-H(&-O;G9E2!O=VYI;F<@:6X@97AC97-S(&]F(#0N.3DE("@Y+CDY)2!U<&]N M(#8Q(&1A>7,@<')I;W(@=W)I='1E;B!N;W1I8V4I(&]F('1H92!I2!I;G1E2!0;&%T:6YU;2!,;VYG(%1E2!B92!A8V-E;&5R871E9"!A;F0@=&AE(&EN M=&5R97-T(')A=&4@<&%Y86)L92!M87D@8F4@:6YC6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG#L@ M1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE M'1E;F1E9"!T:&4@9'5E(&1A=&4@;V8@86QL M('1H92!O=71S=&%N9&EN9R!P6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!P97)I;V0@:6UM M961I871E;'D@<')I;W(@=&\@=&AE(&-O;G9E'1E;F1E9"!T:')O=6=H(&9O6%B;&4@;VX@3F]V96UB97(@,S`L M(#(P,3,N/"]D:78^(#QD:78@#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P M="!4:6UE2!I6UE;G0@;V8@)#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T#L@1D].5#H@ M,3!P="!4:6UE2!E;G1E7,@ M;V8@=&AE($UA&5R8VES92!O9B!T:&4@5V%R6UE;G0@;V8@:6YT M97)E2!F=7)T:&5R(&%G7,@9F]L;&]W:6YG('1H92!- M87)C:"`W+"`R,#`W(&%G7,@:68@=&AE($-O;7!A;GD@65A2!A;6]U;G0@;V8@/&9O;G0@ M#L@ M1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG7,@<')I;W(@ M=&\@=&AE(&5N9"!O9B!A('!A>6UE;G0@<&5R:6]D+B!!="!397!T96UB97(@ M,S`L(#(P,3,@86YD($1E8V5M8F5R(#,Q+"`R,#$R('1H92!O=71S=&%N9&EN M9R!B86QA;F-E(&9O6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE M+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E#L@9F]N="US M:7IE+6%D:G5S=#H@;F]N93L@9F]N="US=')E=&-H.B!N;W)M86PG/B!/;B!- M87D@,3`L(#(P,3,@=&AE($-O;7!A;GD@8V5A2!A6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q,#`E.R!415A4 M+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)&3$]7.B!V:7-I M8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+5)) M1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL M87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`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`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U714E'2%0Z(#6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#

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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#0S)3X@/&1I=CY2979E;G5E M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H M=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ-"PW M-3`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#0S M)3X@/&1I=CY06QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`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`\9&EV/B0\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E. M1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXV+#0U-SPO9&EV/B`\ M+W1D/B`\=&0@"<@=VED=&@],T0Q M,B4^(#QD:78^,3$L,3$U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`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`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@ M/"]D:78^(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG',N($%S(&$@2!A;6]U;G1S('=E#L@5$585"U)3D1%3E0Z(#`N-6EN.R!F;VYT+7-I>F4M861J=7-T M.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@ M1D].5#H@,3!P="!4:6UEF4M861J=7-T.B!N;VYE.R!F;VYT+7-T M2!B=7-I;F5S2!R97!O6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE M9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\ M+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S M=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1% M3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2!E2!S<&5C:69I8R!F86-T;W)S M(&EN8VQU9&EN9R!T:&4@8VAA;F=E28C.#(Q-SMS(&1E2X@5&AE M(&-L87-S:69I8V%T:6]N(&]F(&1E2P@:7,@979A;'5A=&5D M(&%T('1H92!E;F0@;V8@96%C:"!R97!O6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6UB;VP[(&9O;G0M3L@5TE$5$@Z(#DT)3L@ M4$%$1$E.1RU224=(5#H@,"XX<'0G/B`\9&EV/CQF;VYT('-T>6QE/3-$)T9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!I6QE/3-$)U!!1$1)3D&5R8VES86)L92!A="`D/&9O;G0@6QE/3-$)U!!1$1)3D2!A="!A;B!E>&5R8VES92!P65A6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+5))1TA4.B`P+CAP="<^(#QD:78^/&9O;G0@3L@4$%$1$E.1RU2 M24=(5#H@,"XX<'0G/B`\9&EV/CQF;VYT('-T>6QE/3-$)T9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2`R-BP@,C`Q,R!W:&EC:"!V97-T M960@=7!O;B!G6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T M6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X M('-O;&ED.R!"3U)$15(M3$5&5#H@(SEE8C9C92`P<'@@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,C0L,C@U M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR+#,V.#PO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X M(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!O9B`D/&9O;G0@F4M861J=7-T.B!N;VYE M.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!P#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE3L@5TE$5$@Z(#DT)3L@4$%$1$E.1RU224=(5#H@,"XX M<'0G/B`\9&EV/CQF;VYT('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,3!P="<^(#QD:78^/&9O;G0@F4M861J M=7-T.B!N;VYE.R!F;VYT+7-T2!O6QE M/3-$)V-L96%R.F)O=&@[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P M<'0@,"XX<'0@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,3!P="<^(#QD:78^/&9O;G0@6UB;VP[ M(&9O;G0M3L@4$%$1$E.1RU224=(5#H@,"XX<'0G/B`\9&EV M/CQF;VYT('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z M(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T28C.#(Q-SMS(&-L87-S:69I8V%T:6]N('=I=&AI;B!T:&4@:&EE M6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E#L@1D].5#H@,3!P="!4:6UE M#L@1D].5#H@,3!P="!4:6UEF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-TF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG28C.#(Q-SMS(%-E2X@4W5C:"!S M96-U&-H86YG92!#;VUM:7-S:6]N+CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E' M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!F:6QE9"!A($-E2!T;R!0;&%T:6YU;2!,;VYG(%1E2`H M)B,X,C(P.U-E2!A;'-O(&9I;&5D(&$@0V5R=&EF:6-A M=&4@;V8@1&5S:6=N871I;VX@;V8@4FEG:'1S+"!02!O M9B!3=&%T92!O9B!T:&4@4W1A=&4@;V8@3F5V861A+"!A;F0@<')E<&%R960@ M82!P2`H)B,X,C(P.U-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF M>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG28C.#(Q-SMS M(&-O;6UO;B!S=&]C:R!A;F0@=F]T97,@;VX@86X@87,M8V]N=F5R=&5D(&)A M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPGF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@ M:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE M.R!F;VYT+7-TF5D('-H87)E M2!U2!E<75I='DL(&ES(')E9FQE8W1E9"!I;B!A9&1I=&EO;F%L('!A:60@ M:6X@8V%P:71A;"X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A#L@1D].5#H@,3!P M="!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG2!,;VYG=FEE=R!I;G1O(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U! M3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T M.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!I6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$58 M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!I;B!A;B!A9V=R96=A M=&4@86UO=6YT(&]F("0\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$58 M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE28C.#(Q-SMS('-O;&4@8F]A2!B87-E9"!U<&]N M('1R96YD:6YG('1H92!F:7)M('9A;'5E(&%N9"!C;VYS:61E3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)' M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M#L@ M1D].5#H@,3!P="!4:6UE6UB;VP[(&9O;G0M6QE/3-$)U=)1%1(.B`Y-"4[(%!!1$1) M3DF4M M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0Z(#$P<'0@4WEM8F]L.R!F;VYT M+7-I>F4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$ M)U!!1$1)3D3L@4$%$1$E.1RU2 M24=(5#H@,"XX<'0G/B`\9&EV/CQF;VYT('-T>6QE/3-$)T9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)' M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2!O9B!T M:&4@;W5T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!S;VQI M9#L@34%21TE..B`P:6X[(%=)1%1(.B`X-24[($)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI M9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&QE M9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,24@8V]L"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`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`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@ M/&1I=CXT+#(T-RPP-3D\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO65A6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$P)3X@/&1I=CXR."PU,#`L,#`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXY+CDR/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$P)3X@/&1I=CXP+C`U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)W=I9'1H M.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO#L@1D].5#H@,3!P="!4:6UE#L@ M1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$15(M M3$5&5#H@(SEE8C9C92`P<'@@"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO2`Q+"`R,#$S/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!& M3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV/B@Q-"PQ,36QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXS M+C4W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R M:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!M:61D;&4[($)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXR+C,W/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE. M.B`P<'0@.7!T(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE M9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\ M+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG(#QD:78@#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$58 M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE#L@1D]. M5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE2!R97!R97-E;G1I;F<@82!G65E2!H87,@ M28C.#(Q-SMS(&-U M&5D M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO M=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T#L@1D].5#H@,3!P="!4:6UE28C.#(Q-SMS M('!R92UR979E2!T:&4@4F5V97)S92!3=&]C M:R!3<&QI="X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5AF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG&5D.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^ M/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E' M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!.;W1E#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P M="!4:6UEF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6UE;G0@;V8@06-C&5D.R<@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF%T:6]N+"!#;VYS;VQI9&%T M:6]N(&%N9"!0'0^)SQS<&%N/CPO'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M(#QD:78@"`P<'0@.7!T M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L M97,@9F]R(&-O;7!L971E(&9I;F%N8VEA;"!S=&%T96UE;G1S+B8C,38P.R8C M,38P.U1H97-E('5N875D:71E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T M871E;65N=',@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE M+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@"`P<'0@.7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T#L@1D].5#H@,3!P="!4:6UE6EN9R!N;W1E'!E6EN9R!V86QU97,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE M#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M(#!P="`Y<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6EN9R!V86QU97,@9F]R('1H97-E(&9I;F%N8VEA;"!I M;G-T6%B;&4@;VX@ M9&5M86YD+B!4:&4@9F%I28C.#(Q-SMS M(&-O;G9E6%B;&4@:7,@97-T:6UA=&5D(&)A2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S M=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F M;VYT+7-T2!O=VYE9"!S=6)S:61I87)Y($YA='5R86Q.86YO M(%)E2!A8V-O=6YT2!H860@82`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@)U1I;65S($YE=R!2;VUA;B2!I;B!T:&4@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D M/CPO=&0^/"]T2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E28C.#(R,3LI+"!L;V-A=&5D(&EN(%)O8VAE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=) M1%1(.B`S)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=724142#H@,R4[(%!!1$1)3D6QE/3-$)T9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!P6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+5))1TA4.B`P+CAP="<^(#QD:78^/&9O;G0@6QE/3-$)U!!1$1)3DF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T#L@1D]. M5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE2P@;V8@:71S(&YA;F]T96-H;F]L;V=Y(')E M=F5N=64@9G)O;2!O;F4@8W5S=&]M97(N/"]D:78^(#QD:78@6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T6QE/3-$)U1%6%0M04Q)1TXZ(&IU2!A9W)E96UE;G0@=VET:"!A;F]T:&5R M(&-O;7!A;GDL('=H:6-H(&ES(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2!C:&5C:VQI6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T2!497AT($)L;V-K73PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6EN9R!C;VYS;VQI9&%T960@9FEN86YC M:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A2!I;F-U6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2=S(&-O;G1I;G5A=&EO M;B!A2!T;R!A='1A:6X@2!T;R!S=6-C97-S9G5L M;'D@86-H:65V92!T:&]S92!I=&5M#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE2!D871E2!497AT($)L;V-K73PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4 M:6UE65A&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T"P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\ M=&0@8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X(#!P="`Y<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE&5S/"]B/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T M"!R971U2UF;W)W87)D"!R871E"!A2!A=F%I;&%B;&4@=&%X(&)E;F5F:71S(&YO="!E>'!E8W1E9"!T;R!B92!R M96%L:7IE9"XF(S$V,#L@5&AE($-O;7!A;GD@"!E>'!E;G-E('=A&5D.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^ M/"]T2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E#L@1D].5#H@,3!P="!4:6UEF5D(&-O;6UO;B!S:&%R97,@9G)O;2`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG2!D:6QU=&4@9G5T=7)E M(&5A2!D;V5S(&YO="!H879E('-U9F9I8VEE M;G0@875T:&]R:7IE9"!S:&%R97,@=&\@2!C;VYV97)S:6]N(&]F M(&%L;"!T:&4@<&]T96YT:6%L;'D@9&EL=71I=F4@:6YS=')U;65N=',N/"]D M:78^(#PO9&EV/B`\=&%B;&4@8F]R9&5R/3-$,"`@&5D.R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T2!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2!C97)T86EN(&1E8G0@86YD(&5Q=6ET>2!A9W)E96UE;G1S('=I M=&@@4&QA=&EN=6TL(%!L871I;G5M($%D=FES;W)S+"!-97)I="!#;VYS=6QT M:6YG+"!!;'!H82!#87!I=&%L(&%N9"!496-H;F]L;V=Y($EN;F]V871I;VYS M($Q,0R`H)B,X,C(P.U1))B,X,C(Q.RDN(%1H97-E(&%G2!B92!A8W%U:7)E9"!B>2!T M:&4@:&]L9&5R('5P;VX@8V]N=F5R#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X(#!P="`Y<'0[($9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\X83$S-C=C.5]B-3,V7S0X9#1?83@S.%\W9F8P,SEF93,P,C@-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$Q,S8W8SE?8C4S-E\T.&0T7V$X M,SA?-V9F,#,Y9F4S,#(X+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E' M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#$S+C5P=#L@34%21TE..B`P<'0@ M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT+7-T#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0G/B`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!7 M24142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V8V4@,'!X('-O M;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`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`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$R)3X@/&1I=CXU,#@L-34W/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$R)3X@/&1I=CXR-S$L,3`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^-"PP-#(L M.38U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z M(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E M/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q M,#`E.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)& M3$]7.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@ M0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q! M4%-%.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`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`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#"!S;VQI9#L@1D]. M5"U714E'2%0Z(#6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#

"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+51/4#H@(S`P,#`P,"`Q<'@@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@ M6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED M=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#0S)3X@/&1I M=CY2979E;G5E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@ M/&1I=CXQ-"PW-3`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#0S)3X@/&1I=CY06QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`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`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H M=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXV+#0U M-SPO9&EV/B`\+W1D/B`\=&0@"<@ M=VED=&@],T0Q,B4^(#QD:78^,3$L,3$U/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE M/B`\+V1I=CX@/"]D:78^(#PO9&EV/B`\=&%B;&4@8F]R9&5R/3-$,"`@&5D.R<@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF M>3L@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-EF4M861J=7-T.B!N;VYE.R!F;VYT M+7-T6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[ M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN M.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V8V4@,'!X M('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#DS)3L@0D]21$52+4-/3$Q! M4%-%.B!C;VQL87!S93L@3U9%4D9,3U3PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@8V5N M=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,"4^(#QD:78^,3`L-3$V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#0T M-SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^,3(L.#@T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO&5D.R<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)R`\9&EV('-T M>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E#L@1D].5#H@,3!P="!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!4 M15A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS M1"="3U)$15(M0D]45$]-.B`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`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,24@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO2`Q+"`R M,#$S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR+C(T/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXU+C8Q/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X83$S-C=C.5]B-3,V7S0X9#1?83@S M.%\W9F8P,SEF93,P,C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M.&$Q,S8W8SE?8C4S-E\T.&0T7V$X,SA?-V9F,#,Y9F4S,#(X+U=O'0O:'1M;#L@8VAA M'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M(#QD:78@#L@1D].5#H@ M,3!P="!4:6UE#L@1D].5#H@,3!P="!4 M:6UE"!S;VQI9#L@34%21TE..B`P:6X[(%=)1%1(.B`Q,#`E M.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/5SH@=FES:6)L M93L@0D]21$52+51/4#H@(SEE8C9C92`P<'@@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,B4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$R)3X@/&1I=CXS+C4S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C M.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/ M3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$R)3X@/&1I=CXW,#DL,#(P/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`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`@("`@("`@/'1H(&-L87-S/3-$ M=&@@8V]L'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO7,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!;365M8F5R72!\(%-A;&5S(%)E=F5N=64L(%-E M9VUE;G0@6TUE;6)E'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5C=71I=F4@3V9F:6-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO6%B;&4L(%1O=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XD(#0L,#0R+#DV-3QS<&%N/CPO6%B;&4@6TQI;F4@271E M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X83$S-C=C.5]B-3,V M7S0X9#1?83@S.%\W9F8P,SEF93,P,C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO.&$Q,S8W8SE?8C4S-E\T.&0T7V$X,SA?-V9F,#,Y9F4S,#(X M+U=O'0O M:'1M;#L@8VAA2!.;W1E2!.;W1E2!.;W1E2!.;W1E2!.;W1E2!.;W1E(%M-96UB97)=/&)R/CPO=&@^ M#0H@("`@("`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`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO2!787)R86YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!787)R86YT'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\X83$S-C=C.5]B-3,V7S0X9#1?83@S.%\W9F8P M,SEF93,P,C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$Q,S8W M8SE?8C4S-E\T.&0T7V$X,SA?-V9F,#,Y9F4S,#(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H M(&-L87-S/3-$=&@@8V]L'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`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`@("`\=&%B;&4@ M8VQA'1U86PI M("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S M/3-$=&@@8V]L'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ M,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5R8VES86)L92!A="!E;F0@;V8@>65A&5R M8VES92!065A65A'0^)S,@>65A65A'0^)S(@>65A&5R8VES86)L92!A="!E;F0@;V8@>65A'0^)S(@>65A7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'1U86PI/&)R/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR M.30L,3$W+#8T-SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XU+#`P,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`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ilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 115 190 1 false 47 0 false 6 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.naturalnano.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.naturalnano.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.naturalnano.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.naturalnano.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 105 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) Sheet http://www.naturalnano.com/role/ConsolidatedStatementOfStockholdersEquityDeficiency CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) false false R6.htm 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.naturalnano.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 107 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.naturalnano.com/role/PrincipalBusinessActivityAndSignificantAccountingPolicies PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 108 - Disclosure - NOTES PAYABLE Notes http://www.naturalnano.com/role/NotesPayable NOTES PAYABLE false false R9.htm 109 - Disclosure - DISCONTINUED OPERATIONS Sheet http://www.naturalnano.com/role/DiscontinuedOperations DISCONTINUED OPERATIONS false false R10.htm 110 - Disclosure - DERIVATIVE LIABILITY Sheet http://www.naturalnano.com/role/DerivativeLiability DERIVATIVE LIABILITY false false R11.htm 111 - Disclosure - STOCKHOLDERS EQUITY Sheet http://www.naturalnano.com/role/StockholdersEquity STOCKHOLDERS EQUITY false false R12.htm 112 - Disclosure - INCENTIVE STOCK PLANS Sheet http://www.naturalnano.com/role/IncentiveStockPlans INCENTIVE STOCK PLANS false false R13.htm 113 - Disclosure - COMMITMENTS and CONTINGENCIES Sheet http://www.naturalnano.com/role/CommitmentsAndContingencies COMMITMENTS and CONTINGENCIES false false R14.htm 114 - Disclosure - REVERSE STOCK SPLIT Sheet http://www.naturalnano.com/role/ReverseStockSplit REVERSE STOCK SPLIT false false R15.htm 115 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.naturalnano.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R16.htm 116 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.naturalnano.com/role/PrincipalBusinessActivityAndSignificantAccountingPoliciesPolicies PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R17.htm 117 - Disclosure - NOTES PAYABLE (Tables) Notes http://www.naturalnano.com/role/NotesPayableTables NOTES PAYABLE (Tables) false false R18.htm 118 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://www.naturalnano.com/role/DiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) false false R19.htm 119 - Disclosure - DERIVATIVE LIABILITY (Tables) Sheet http://www.naturalnano.com/role/DerivativeLiabilityTables DERIVATIVE LIABILITY (Tables) false false R20.htm 120 - Disclosure - STOCKHOLDERS EQUITY (Tables) Sheet http://www.naturalnano.com/role/StockholdersEquityTables STOCKHOLDERS EQUITY (Tables) false false R21.htm 121 - Disclosure - INCENTIVE STOCK PLANS (Tables) Sheet http://www.naturalnano.com/role/IncentiveStockPlansTables INCENTIVE STOCK PLANS (Tables) false false R22.htm 122 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Sheet http://www.naturalnano.com/role/PrincipalBusinessActivityAndSignificantAccountingPoliciesDetailsTextual PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Details Textual) false false R23.htm 123 - Disclosure - NOTES PAYABLE (Details) Notes http://www.naturalnano.com/role/NotesPayableDetails NOTES PAYABLE (Details) false false R24.htm 124 - Disclosure - NOTES PAYABLE (Details Textual) Notes http://www.naturalnano.com/role/NotesPayableDetailsTextual NOTES PAYABLE (Details Textual) false false R25.htm 125 - Disclosure - DISCONTINUED OPERATIONS (Details) Sheet http://www.naturalnano.com/role/DiscontinuedOperationsDetails DISCONTINUED OPERATIONS (Details) false false R26.htm 126 - Disclosure - DISCONTINUED OPERATIONS (Details Textual) Sheet http://www.naturalnano.com/role/DiscontinuedOperationsDetailsTextual DISCONTINUED OPERATIONS (Details Textual) false false R27.htm 127 - Disclosure - DERIVATIVE LIABILITY (Details) Sheet http://www.naturalnano.com/role/DerivativeLiabilityDetails DERIVATIVE LIABILITY (Details) false false R28.htm 128 - Disclosure - DERIVATIVE LIABILITY (Details Textual) Sheet http://www.naturalnano.com/role/DerivativeLiabilityDetailsTextual DERIVATIVE LIABILITY (Details Textual) false false R29.htm 129 - Disclosure - STOCKHOLDERS EQUITY (Details) Sheet http://www.naturalnano.com/role/StockholdersEquityDetails STOCKHOLDERS EQUITY (Details) false false R30.htm 130 - Disclosure - STOCKHOLDERS EQUITY (Details Textual) Sheet http://www.naturalnano.com/role/StockholdersEquityDetailsTextual STOCKHOLDERS EQUITY (Details Textual) false false R31.htm 131 - Disclosure - INCENTIVE STOCK PLANS (Details) Sheet http://www.naturalnano.com/role/IncentiveStockPlansDetails INCENTIVE STOCK PLANS (Details) false false R32.htm 132 - Disclosure - COMMITMENTS and CONTINGENCIES (Details Textual) Sheet http://www.naturalnano.com/role/CommitmentsAndContingenciesDetailsTextual COMMITMENTS and CONTINGENCIES (Details Textual) false false R33.htm 133 - Disclosure - REVERSE STOCK SPLIT (Details Textual) Sheet http://www.naturalnano.com/role/ReverseStockSplitDetailsTextual REVERSE STOCK SPLIT (Details Textual) false false R34.htm 134 - Disclosure - SUBSEQUENT EVENTS (Details Textual) Sheet http://www.naturalnano.com/role/SubsequentEventsDetailsTextual SUBSEQUENT EVENTS (Details Textual) false false All Reports Book All Reports Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 3 4. Element us-gaap_DebtInstrumentConvertibleConversionPrice1 had a mix of decimals attribute values: 2 3. Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 1 2. 'Shares' elements on report '103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical]' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS nnan-20130930.xml nnan-20130930.xsd nnan-20130930_cal.xml nnan-20130930_def.xml nnan-20130930_lab.xml nnan-20130930_pre.xml true true XML 46 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)
Sep. 30, 2013
Dec. 31, 2012
Preferred Stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred Stock, shares authorized 10,000,000 10,000,000
Common Stock, par value (in dollars per share) $ 0.001 $ 0.001
Common Stock, shares authorized 800,000,000 800,000,000
Common Stock, shares issued 332,909,406 93,200,171
Common Stock, shares outstanding 332,909,406 93,200,171
Series B Preferred Stock [Member]
   
Preferred Stock, aggregate liquidation preference $ 10 $ 310
Preferred Stock, shares issued 5,000 142,500
Preferred Stock, shares outstanding 5,000 142,500
Series C Preferred Stock [Member]
   
Preferred Stock, aggregate liquidation preference $ 6,607 $ 8,099
Preferred Stock, shares issued 3,303,640 4,049,495
Preferred Stock, shares outstanding 3,303,640 4,049,495
Series D Preferred Stock [Member]
   
Preferred Stock, shares issued 100 0
Preferred Stock, shares outstanding 100 0

XML 47 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
REVERSE STOCK SPLIT
9 Months Ended
Sep. 30, 2013
Reverse Stock Split [Abstract]  
Reverse Stock Split [Text Block]
8. REVERSE STOCK SPLIT
 
On June 14, 2012, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Nevada, to effect a 1-for-17 reverse stock split of its common stock, or the Reverse Stock Split. This action had previously been approved by the Company’s Board of Directors on March 23, 2012. As a result of the Reverse Stock Split, every seventeen shares of the Company’s pre-reverse split common stock were combined and reclassified into one share of its common stock. No fractional shares were issued in connections with the Reverse Stock Split. Stockholders who would have been entitled to receive a fractional share in connection with the Reverse Stock Split received one whole share. The par value and other terms of the common stock were not affected by the Reverse Stock Split.
 
The Company’s authorized shares immediately prior to the Reverse Stock Split totaled 5,000,000,000. These were adjusted to 294,117,647. The Company’s shares outstanding immediately prior to the Reverse Stock Split totaled 732,073,557. These were adjusted to 43,063,150 shares outstanding as a result of the Reverse Stock Split. The Company’s common stock began trading at its post-Reverse Stock Split price at the beginning of trading on June 14, 2012. Share, per share, and stock option amounts for all periods presented within this quarterly report on Form 10-Q for common stock and additional paid-in-capital were retroactively adjusted to reflect the Reverse Stock Split.
XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (USD $)
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2012 $ (6,143,614) $ 93,200 $ 0 $ 21,159,134 $ (27,410,212) $ 14,264
Balance (in shares) at Dec. 31, 2012   93,200,171 0      
Series B preferred converted to Common Stock and change in value 284 22,000   (21,716)    
Series B preferred converted to Common Stock and change in value (in shares)   22,000,000        
Series C preferred converted to Common Stock and change in value 105,112 119,337   (14,225)    
Series C preferred converted to Common Stock and change in value (in shares)   119,336,800        
Warrant issued for services 8,721     8,721    
Shares issued on debt conversion 19,913 21,500   (1,587)    
Shares issued on debt conversion (in shares)   21,500,000        
Shares issued for interest payment 62,090 76,872   (14,782)    
Shares issued for interest payment (in shares)   76,872,435        
Dissolution of Non-controlling interest (14,264)         (14,264)
Issuance Of Series D preferred shares 0   0      
Issuance Of Series D preferred shares (in shares)     100      
Net loss (425,405)       (425,405)  
Balance at Sep. 30, 2013 $ (6,387,163) $ 332,909 $ 0 $ 21,115,545 $ (27,835,617) $ 0
Balance (in shares) at Sep. 30, 2013   332,909,406 100      
XML 49 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 30, 2013
Dec. 31, 2012
Assets    
Cash $ 10 $ 6,160
Accounts receivable 25,706 5,400
Inventory 13,251 19,480
Prepaid expenses and other current assets 12,040 10,196
Total current assets 51,007 41,236
Total assets 51,007 41,236
Liabilities and Stockholders' Deficiency    
Notes payable (See Note 2) 4,042,965 3,893,972
Accounts payable 429,941 502,814
Accrued expenses 100,289 96,343
Accrued interest 656,769 444,131
Accrued payroll 950,473 871,610
Deferred revenue 100,000 100,000
Registration rights liability (See Note 2) 82,489 82,489
Derivative liability (see Note 4) 12,884 25,732
Total current liabilities 6,375,810 6,017,091
Total liabilities 6,375,810 6,017,091
Commitments and contingencies (See Note 7)      
Stockholder’s Deficiency    
Common Stock - $.001 par value 800,000,000 authorized and 332,909,406 and 93,200,171 issued and outstanding, respectively 332,909 93,200
Additional paid in capital 21,115,545 21,159,134
Non-controlling interest in subsidiary 0 14,264
Accumulated deficit (27,835,617) (27,410,212)
Total stockholders' deficiency (6,387,163) (6,143,614)
Total liabilities and stockholders' deficiency 51,007 41,236
Series B Preferred Stock [Member]
   
Liabilities and Stockholders' Deficiency    
Preferred Stock - $.001 par value, 10 million shares authorized 872 14,111
Series C Preferred Stock [Member]
   
Liabilities and Stockholders' Deficiency    
Preferred Stock - $.001 par value, 10 million shares authorized 61,488 153,648
Series D Preferred Stock [Member]
   
Liabilities and Stockholders' Deficiency    
Preferred Stock - $.001 par value, 10 million shares authorized $ 0 $ 0
XML 50 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS EQUITY (Details) (Warrant [Member], USD $)
9 Months Ended
Sep. 30, 2013
Warrant [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares Outstanding at beginning of year 4,247,059
Shares Granted during the year 28,500,000
Shares Cancelled or forfeited (11,765)
Shares outstanding at end of year 32,735,294
Weighted Average Exercise Price Outstanding at beginning of year $ 0.37
Weighted Average Exercise Price Granted during the year $ 0.0014
Weighted Average Exercise Price Cancelled or forfeited $ 5.61
Weighted Average Exercise Price outstanding at end of year $ 0.05
Weighted Average Remaining Life-years Outstanding at beginning of year 2 years 2 months 26 days
Weighted Average Remaining Life-years Granted during the year 9 years 11 months 1 day
Weighted Average Remaining Life years Warrants outstanding at end of year 8 years 6 months 4 days
XML 51 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Notes Payable [Line Items]    
Notes payable, Total $ 4,042,965 $ 3,893,972
Senior Secured Promissory Note [Member]
   
Notes Payable [Line Items]    
Notes payable, Total 647,462 508,557
Senior Secured Convertible Notes [Member]
   
Notes Payable [Line Items]    
Notes payable, Total 3,124,403 3,134,415
Subordinated Secured Convertible Notes [Member]
   
Notes Payable [Line Items]    
Notes payable, Total $ 271,100 $ 251,000
XML 52 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS and CONTINGENCIES
9 Months Ended
Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Commitments Disclosure [Text Block]
7.  COMMITMENTS and CONTINGENCIES
 
Legal Proceedings
 
On March 24, 2009 the Company received a demand notice from an attorney representing a group of certain former employees of the Company, including but not limited to the Company’s former President and Chief Financial Officer, demanding immediate payment of $331,265 for certain deferred compensation, severance and vacation benefits. Each of the former employees cited in the demand notice, as well as other former employees, had executed written agreements during 2008 that allowed the Company to defer certain of these compensation payments. The Company has accrued for earned and unused vacation benefits and deferred payroll costs for amounts electively deferred by these and other former employees as of December 31, 2009. The Company has retained counsel in connection with this demand and continues to evaluate this demand notice and has responded to this demand. No actions or probable settlement discussions between the parties have developed since the filing of this demand. Due to the Company’s current cash and liquidity position discussed above and the current evaluation of the items in the demand notice the timing of future payment of these outstanding amounts is uncertain. No further communication has been had regarding this notice.
XML 53 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS EQUITY (Details Textual) (USD $)
9 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended 3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Sep. 30, 2013
Warrant [Member]
Dec. 31, 2012
Warrant [Member]
Sep. 30, 2013
Convertible Preferred Stock [Member]
Sep. 30, 2012
Common Stock [Member]
Oct. 07, 2008
Series B Preferred Stock [Member]
Sep. 30, 2013
Series B Preferred Stock [Member]
Oct. 07, 2008
Series B and Series C Convertible Preferred Stock [Member]
Jun. 30, 2013
Series D Preferred Stock [Member]
Jun. 10, 2013
Series D Preferred Stock [Member]
Oct. 07, 2008
Series C Preferred Stock [Member]
Sep. 30, 2013
Series C Preferred Stock [Member]
Oct. 07, 2008
Platinum Partners Long Term Growth IV [Member]
Llc Series C Convertible Preferred Stock [Member]
Sep. 30, 2013
Platinum Partners Long Term Growth IV [Member]
Series C Preferred Stock [Member]
Sep. 30, 2013
Alpha Capital [Member]
Sep. 30, 2012
Alpha Capital [Member]
Sep. 30, 2013
Longview Special Financing Inc [Member]
Series B Preferred Stock [Member]
Sep. 30, 2013
Cape One [Member]
Mar. 31, 2013
Paul Lefrois [Member]
Mar. 31, 2013
James Wemett [Member]
Mar. 31, 2013
David Lubin [Member]
Sep. 30, 2008
Platinum Partners Long Term Growth Iv and Longview Special Financing Inc [Member]
Series B Preferred Stock [Member]
Sep. 29, 2008
Platinum Partners Long Term Growth Iv and Longview Special Financing Inc [Member]
Series B Preferred Stock [Member]
Sep. 30, 2008
Platinum Partners Long Term Growth Iv and Longview Special Financing Inc [Member]
Series C Preferred Stock [Member]
Sep. 29, 2008
Platinum Partners Long Term Growth Iv and Longview Special Financing Inc [Member]
Series C Preferred Stock [Member]
Mar. 31, 2013
Alexander Ruckdaeschel [Member]
Schedule of Equity Method Investments [Line Items]                                                        
Debt Instrument, Convertible, Conversion Price                   $ 9.41                                    
Stock Issued During Period, Shares, Conversion Of Convertible Securities   13,594,382                           119,336,800     22,000,000 12,000,000                
Stock Issued During Period, Shares, Issued for Services   1,764,706                                                    
Stock Issued During Period, Value, Issued for Services   $ 10,800                           $ 745,855                        
Conversion of Stock, Shares Converted                                     137,500                  
Conversion of Stock, Shares Issued                                               5,000,000   5,000,000    
Debt Conversion, Converted Instrument, Shares Issued                                 21,500,000             71,691,180   71,691,180    
Debt Conversion, Converted Instrument, Amount                                 19,913                      
Common Stock, shares authorized 800,000,000   800,000,000                                                  
Preferred Stock, shares authorized 10,000,000   10,000,000                                                  
Common Stock, par value (in dollars per share) $ 0.001   $ 0.001                                           $ 0.085   $ 0.085  
Stock Issued During Period, Shares, Conversion of Units               750,000 160 160       160 4,250,000                          
Preferred Stock, Liquidation Preference, Value           10,000   10         6,607                              
Excess Of Debt Instrument Conversion Percentage                   4.99%     9.98%                              
Stock Issued During Period, Shares, Settlement Of Interest Obligations           76,872,435 6,221,156                     241,164                    
Stock Issued During Period, Value, Settlement Of Interest Obligations                                 62,090                      
Shares Granted during the year       28,500,000                                 7,500,000 15,000,000 3,000,000         3,000,000
Common Stock, Capital Shares Reserved for Future Issuance       32,735,294 4,247,059                                              
Equity Method Investment, Ownership Percentage                       51.00%                                
Stock Issued During Period, Shares, New Issues                     100                                  
Common Stock Issued For Convertible Notes $ 19,913 $ 983,585                                                    
XML 54 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Interim Financial Statements [Policy Text Block]
Interim Financial Statements
The consolidated financial statements as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 are unaudited. However, in the opinion of management of the Company, these financial statements reflect all material adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position and results of operations for such interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results to be obtained for a full year. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X for smaller reporting companies.  Accordingly, these financial statements do not include all of the information required by U.S. generally accepted accounting principles for complete financial statements.  These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
Use of Estimates, Policy [Policy Text Block]
Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate such estimates. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
Financial instruments include cash and cash equivalents, accounts payable and accrued expenses, notes payable, capital leases and derivative liabilities. Fair values for all instruments except for derivative liabilities were assumed to approximate carrying values for these financial instruments since they are short-term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of the Company’s convertible notes payable is estimated based upon the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The carrying value approximates the fair value of these debt instruments as of September 30, 2013 and December 31, 2012 based on rates charged being consistent with current market rates available to the Company. See Note 4 for discussion on the fair value of derivative liabilities.
Consolidation, Policy [Policy Text Block]
Basis of Consolidation
The consolidated financial statements include the accounts of NaturalNano, Inc. (“NaturalNano” or the “Company”), a Nevada corporation, and its wholly owned subsidiary NaturalNano Research, Inc. (“NN Research”) a Delaware corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.
 
In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a 51% controlling interest in Combotexs.  The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $14,264 and a gain of $39,373 was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.
Business Description [Policy Text Block]
Description of the Business
NaturalNano (the “Company”), located in Rochester, New York, is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house. The Company’s current activities are directed toward research, development, production and marketing of its proprietary technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for:
 
 
·
cosmetics, health and beauty products
 
·
polymers, plastics and composites
 
During the nine months ended September 30, 2013 and 2012, the Company derived 82% and 79%, respectively, of its nanotechnology revenue from one customer.
 
During the fourth quarter of 2011, the Company entered into a supply agreement with another company, which is 50% owned by NaturalNano’s CEO, to manufacture and sell Error Prevention/Safety Checklist Boards which the related party will then market to the end user. In the second quarter of 2013, the Company made a decision to cease the medical board segment’s operations and ceased production of Error Prevention/Safety checklist Boards (the Medical Board business segment.) This business segment was not generating sufficient income to offset the efforts of production and administrative expenses. The Consolidated Statement of Operations as of September 30, 2013 reflects the results of the Medical Board business as a discontinued operation effective as of the second quarter of 2013. As of September 30, 2013, $13,000 of amounts due from the entity which is 50% owned by NaturalNano’s CEO is included in Accounts Receivable on the balance sheet. (See Note 3 “Discontinued Operations”).
 
NaturalNano is domiciled in the state of Nevada as a result of the merger with Cementitious Materials, Inc., (“CMI”), which was completed on November 29, 2005.
Liquidity Disclosure [Policy Text Block]
Liquidity and Going Concern
Going Concern – The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company incurred a net loss for the nine months ended September 30, 2013 of $425,405 and had negative working capital of $6,324,803 and a stockholders’ deficiency of $6,387,163 at September 30, 2013. Since inception the Company’s growth has been funded through a combination of convertible debt from private investors and from cash advances from its former parent and former majority shareholder Technology Innovations, LLC. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations, to obtain additional financing, renegotiate the terms of existing financing obligations and ultimately to attain successful operations. The ability to successfully achieve those items is uncertain. The financial statements do not include any adjustments that might result from the uncertainty.
 
As of September 30, 2013, the Company continued to require waivers for debt covenant violations and extensions of maturity dates. Refer to Note 2 for lenders waivers and maturity extensions received from the lenders.
Reclassification, Policy [Policy Text Block]
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year presentation.
Income Tax, Policy [Policy Text Block]
Income Taxes
The Company accounts for income taxes in accordance with ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income items is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.  The Company recognizes penalties and accrued interest related to unrecognized tax benefits in income tax expense. Income tax expense was $0 for the nine month periods ending September 30, 2013 and 2012.
Increase in Authorized Common Stock [Policy Text Block]
Increase in Authorized Common Stock
On July 1, 2013 the Company received a unanimous written consent in lieu of a meeting from the members of the Board of Directors and a written consent from the Series D stockholder (Note 5) to amend its articles of incorporation to increase the Company’s authorized common shares from 294,117,647 shares to 800,000,000 shares of common stock. As of September 30, 2013 there were 6,412,911,665 underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments.
Earnings Per Share, Policy [Policy Text Block]
Loss Per Share
Basic loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per common share gives effect to dilutive convertible preferred stock, convertible debt, options and warrants outstanding during the period. Shares to be issued upon the exercise of these instruments have not been included in the computation of diluted loss per share as their effect is anti-dilutive based on the net loss incurred.
 
As of September 30, 2013 and 2012 there were 6,412,911,665 and 2,656,482,041, respectively, underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. These potentially dilutive shares have been limited by certain debt and equity agreements with Platinum, Platinum Advisors, Merit Consulting, Alpha Capital and Technology Innovations LLC (“TI”). These agreements provide limitations on the conversion of the dilutive instruments such that the number of shares of Common Stock that may be acquired by the holder upon conversion of such instruments shall be limited to ensure that following such conversion the total number of shares of Common Stock then beneficially owned by the holder does not exceed 4.99% of the total number of issued and outstanding shares of Common Stock. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments. See Note 9 Subsequent Events for shares of common stock issued subsequent to September 30, 2013.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted, would have a material effect on the accompanying financial statements.
XML 55 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCENTIVE STOCK PLANS
9 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6.  INCENTIVE STOCK PLANS
 
A summary of the status of the outstanding incentive stock plans is presented below at September 30, 2013:
 
 
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted Average
Remaining
Life-years
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2013
 
 
723,137
 
$
3.07
 
 
3.53
 
Granted/Exercises/Cancelled/Forfeited
 
 
(14,117)
 
 
 
 
 
 
 
Options outstanding at September 30, 2013
 
 
709,020
 
$
3.57
 
 
2.37
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at September 30, 2013
 
 
709,020
 
$
3.57
 
 
2.37
 
  
All compensation costs for the above options have been previously recognized in operations.
XML 56 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
1.   PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES
 
Interim Financial Statements
The consolidated financial statements as of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012 are unaudited. However, in the opinion of management of the Company, these financial statements reflect all material adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position and results of operations for such interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results to be obtained for a full year. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X for smaller reporting companies.  Accordingly, these financial statements do not include all of the information required by U.S. generally accepted accounting principles for complete financial statements.  These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
 
Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate such estimates. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
 
Fair Value of Financial Instruments
Financial instruments include cash and cash equivalents, accounts payable and accrued expenses, notes payable, capital leases and derivative liabilities. Fair values for all instruments except for derivative liabilities were assumed to approximate carrying values for these financial instruments since they are short-term in nature and their carrying amounts approximate fair values or they are receivable or payable on demand. The fair value of the Company’s convertible notes payable is estimated based upon the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The carrying value approximates the fair value of these debt instruments as of September 30, 2013 and December 31, 2012 based on rates charged being consistent with current market rates available to the Company. See Note 4 for discussion on the fair value of derivative liabilities.
 
Basis of Consolidation
The consolidated financial statements include the accounts of NaturalNano, Inc. (“NaturalNano” or the “Company”), a Nevada corporation, and its wholly owned subsidiary NaturalNano Research, Inc. (“NN Research”) a Delaware corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.
 
In the second quarter of 2013, the Company filed a Certificate of Dissolution for Combotexs, LLC with the state of New York under section 1003 of the Business Corporation Law in connection with the unanimous written consent of the shareowners of Combotexs (a dormant New York limited liability company.) Prior to this action, the Company had a 51% controlling interest in Combotexs.  The dissolution was accepted by NYS in the third quarter of 2013. As a result of these actions, the non-controlling interest in subsidiary in the stockholders deficiency section of the balance sheet was eliminated in the third quarter of 2013 in the amount of $14,264 and a gain of $39,373 was taken in the third quarter of 2013, which was attributed to the release of outstanding liabilities.
 
Description of the Business
NaturalNano (the “Company”), located in Rochester, New York, is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house. The Company’s current activities are directed toward research, development, production and marketing of its proprietary technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for:
 
 
·
cosmetics, health and beauty products
 
·
polymers, plastics and composites
 
During the nine months ended September 30, 2013 and 2012, the Company derived 82% and 79%, respectively, of its nanotechnology revenue from one customer.
 
During the fourth quarter of 2011, the Company entered into a supply agreement with another company, which is 50% owned by NaturalNano’s CEO, to manufacture and sell Error Prevention/Safety Checklist Boards which the related party will then market to the end user. In the second quarter of 2013, the Company made a decision to cease the medical board segment’s operations and ceased production of Error Prevention/Safety checklist Boards (the Medical Board business segment.) This business segment was not generating sufficient income to offset the efforts of production and administrative expenses. The Consolidated Statement of Operations as of September 30, 2013 reflects the results of the Medical Board business as a discontinued operation effective as of the second quarter of 2013. As of September 30, 2013, $13,000 of amounts due from the entity which is 50% owned by NaturalNano’s CEO is included in Accounts Receivable on the balance sheet. (See Note 3 “Discontinued Operations”).
 
NaturalNano is domiciled in the state of Nevada as a result of the merger with Cementitious Materials, Inc., (“CMI”), which was completed on November 29, 2005.
 
Liquidity and Going Concern
Going Concern – The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company incurred a net loss for the nine months ended September 30, 2013 of $425,405 and had negative working capital of $6,324,803 and a stockholders’ deficiency of $6,387,163 at September 30, 2013. Since inception the Company’s growth has been funded through a combination of convertible debt from private investors and from cash advances from its former parent and former majority shareholder Technology Innovations, LLC. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations, to obtain additional financing, renegotiate the terms of existing financing obligations and ultimately to attain successful operations. The ability to successfully achieve those items is uncertain. The financial statements do not include any adjustments that might result from the uncertainty.
 
As of September 30, 2013, the Company continued to require waivers for debt covenant violations and extensions of maturity dates. Refer to Note 2 for lenders waivers and maturity extensions received from the lenders.
 
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year presentation.
 
Income Taxes
The Company accounts for income taxes in accordance with ASC 740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income items is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.  The Company recognizes penalties and accrued interest related to unrecognized tax benefits in income tax expense. Income tax expense was $0 for the nine month periods ending September 30, 2013 and 2012.
 
Increase in Authorized Common Stock
On July 1, 2013 the Company received a unanimous written consent in lieu of a meeting from the members of the Board of Directors and a written consent from the Series D stockholder (Note 5) to amend its articles of incorporation to increase the Company’s authorized common shares from 294,117,647 shares to 800,000,000 shares of common stock. As of September 30, 2013 there were 6,412,911,665 underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments.
 
Loss Per Share
Basic loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per common share gives effect to dilutive convertible preferred stock, convertible debt, options and warrants outstanding during the period. Shares to be issued upon the exercise of these instruments have not been included in the computation of diluted loss per share as their effect is anti-dilutive based on the net loss incurred.
 
As of September 30, 2013 and 2012 there were 6,412,911,665 and 2,656,482,041, respectively, underlying preferred stock, convertible debt, outstanding options and warrants that could potentially dilute future earnings. These potentially dilutive shares have been limited by certain debt and equity agreements with Platinum, Platinum Advisors, Merit Consulting, Alpha Capital and Technology Innovations LLC (“TI”). These agreements provide limitations on the conversion of the dilutive instruments such that the number of shares of Common Stock that may be acquired by the holder upon conversion of such instruments shall be limited to ensure that following such conversion the total number of shares of Common Stock then beneficially owned by the holder does not exceed 4.99% of the total number of issued and outstanding shares of Common Stock. The Company does not have sufficient authorized shares to satisfy conversion of all the potentially dilutive instruments. See Note 9 Subsequent Events for shares of common stock issued subsequent to September 30, 2013.
 
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted, would have a material effect on the accompanying financial statements.
XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 58 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
REVERSE STOCK SPLIT (Details Textual)
12 Months Ended
Dec. 31, 2012
Sep. 30, 2013
Class of Stock [Line Items]    
Common Stock, shares authorized 800,000,000 800,000,000
Common Stock, shares outstanding 93,200,171 332,909,406
Stockholders' Equity, Reverse Stock Split 1-for-17 reverse stock split of its common stock  
Before Amendment [Member]
   
Class of Stock [Line Items]    
Common Stock, shares authorized 294,117,647 294,117,647
Prior To Reverse Stock Split [Member]
   
Class of Stock [Line Items]    
Common Stock, shares authorized 5,000,000,000  
Common Stock, shares outstanding 732,073,557  
After Reverse Stock Split [Member]
   
Class of Stock [Line Items]    
Common Stock, shares outstanding 43,063,150  
XML 59 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE LIABILITY (Tables)
9 Months Ended
Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
The fair value of the derivatives is as follows:
 
Derivative Liability
 
September 30,
2013
 
December 31,
2012
 
8% Notes conversion feature
 
$
10,516
 
$
24,285
 
10% Notes conversion feature
 
 
2,368
 
 
1,447
 
Total
 
$
12,884
 
$
25,732
 
XML 60 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2013
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
9.   SUBSEQUENT EVENTS
 
Subsequent to September 30, 2013 and prior to the filing of this report, the following items occurred:
 
Promissory Notes: On October 15, 2013, the Company borrowed $14,025 from Platinum Long Term Growth IV, LLC pursuant to the terms of a Senior secured Promissory Note. The note bears interest at the rate of 8% per annum and is due and payable January 30, 2014.
 
Series C Preferred Stock Conversion to Common Stock:On October 15, 2013, Platinum Long Term Growth IV, LLC elected to convert 207,863 shares of their Series C preferred shares into 33,258,080 common shares at the conversion rate of 160 shares per each Series C share. On November 11, 2013, Platinum Long Term Growth IV, LLC elected to convert 238,511 shares of their Series C preferred shares into 38,161,760 common shares at the conversion rate of 160 shares per each Series C share.
 
Payment of Accrued Interest with Common Stock: On November 7, 2013, the Company issued an aggregate of 16,000,000 shares of its common stock in satisfaction of $6,000 in interest obligations to Alpha Capital Anstalt.
XML 61 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
PRINCIPAL BUSINESS ACTIVITY AND SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Accounting Policies [Line Items]          
Business Acquisition, Percentage of Voting Interests Acquired 51.00%   51.00%    
Net loss attributable to controlling interest $ (45,197) $ (352,616) $ (425,405) $ (1,058,275)  
Working Capital Deficit 6,324,803   6,324,803    
Total stockholders' deficiency (6,387,163)   (6,387,163)   (6,143,614)
Weighted Average Number of Shares Outstanding, Diluted     6,412,911,665 2,656,482,041  
Income Tax Reconciliation, Tax Holidays     0 0  
Stock Conversion Limit Percentage     4.99%    
Common Stock, Shares Authorized 800,000,000   800,000,000   800,000,000
Gain On Dissolution Of Combotexs 39,373        
Non Controlling Interest De Consolidation Gain Or Loss     (14,264)    
Before Amendment [Member]
         
Accounting Policies [Line Items]          
Common Stock, Shares Authorized 294,117,647   294,117,647   294,117,647
Nanotechnology [Member] | Sales Revenue, Segment [Member]
         
Accounting Policies [Line Items]          
Concentration Risk, Percentage     82.00% 79.00%  
Chief Executive Officer [Member]
         
Accounting Policies [Line Items]          
Percentage Of Interest On Supply Agreement 50.00%   50.00%    
Chief Executive Officer [Member] | Accounts Receivable [Member]
         
Accounting Policies [Line Items]          
Concentration Risk, Percentage     50.00%    
Due from entity $ 13,000   $ 13,000    
XML 62 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS EQUITY (Tables)
9 Months Ended
Sep. 30, 2013
Stockholders' Equity Note [Abstract]  
Class Of Warrant Outstanding [Table Text Block]
A summary of the outstanding warrants is presented below:
 
 
 
2013
 
 
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life-years
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2013
 
 
4,247,059
 
$
0.37
 
 
2.24
 
Granted during the year
 
 
28,500,000
 
 
0.0014
 
 
9.92
 
Cancelled or forfeited
 
 
(11,765)
 
 
5.61
 
 
 
 
Warrants outstanding at September 30, 2013
 
 
32,735,294
 
$
0.05
 
 
8.51
 
XML 63 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information
9 Months Ended
Sep. 30, 2013
Nov. 15, 2013
Document Information [Line Items]    
Entity Registrant Name NaturalNano, Inc.  
Entity Central Index Key 0000863895  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol NNAN  
Entity Common Stock, Shares Outstanding   420,329,246
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2013  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
XML 64 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCENTIVE STOCK PLANS (Tables)
9 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the status of the outstanding incentive stock plans is presented below at September 30, 2013:
 
 
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted Average
Remaining
Life-years
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2013
 
 
723,137
 
$
3.07
 
 
3.53
 
Granted/Exercises/Cancelled/Forfeited
 
 
(14,117)
 
 
 
 
 
 
 
Options outstanding at September 30, 2013
 
 
709,020
 
$
3.57
 
 
2.37
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at September 30, 2013
 
 
709,020
 
$
3.57
 
 
2.37